Abstracts cont.  by unknown
Community-acquired infections: focus on unusual epidemics and update on S. pneumonia
P430 Community-acquired pneumonia caused by ‘atypical’
pathogens: clinical discrimination with a predictive model and
scoring system
M. Masia´, F. Gutie´rrez, J.C. Rodrı´guez, S. Padilla, G. Royo,
J.M. Ramos, A. Ayelo, A. Martı´n-Hidalgo
Elche, Alicante, E
Objective: To develop a bedside predictive model and a scoring
system to identify patients with atypical community-acquired
pneumonia (CAP), in order to select candidates for tailored antibi-
otic therapy with macrolides.
Methods: Data from a prospective study of CAP conducted at a
Spanish hospital during two consecutive periods, October 99–Sep-
tember 00, and October 00–September 01, were analysed. An
extensive non-invasive microbiological investigation was per-
formed in all patients, including detection of Legionella pneumo-
phila and Streptococcus pneumoniae urinary antigen, and acute and
convalescent serologic testing. During the ﬁrst 12-month study
period, serum biochemical markers of bacterial infection [C-react-
ive protein, procalcitonin and lipopolysaccharide-binding protein
(LBP)] were also performed. Clinical, radiological and laboratory
data of patients with atypical CAP were compared with data from
patients with non-atypical CAP by univariate and multivariable
analysis. With the best-discriminating variables from the multivar-
iable analysis, a scoring system model was devised. Each variable
was assigned 1 point. ROC curves were used to describe sensitiv-
ity and speciﬁcity of the model. Two separate models were run.
Results: A total of 493 patients were included. On multivariable
analysis, patients with atypical pneumonia were more likely to
have air-conditioning exposure (OR 2.64), normal WBC count (OR
2.58), birds at home (OR 2.18), age under 65 years (OR 2.07), non-
associated comorbid conditions (OR 2.04), absence of pleuritic
chest pain (OR 1.95), and elevated GOT levels (OR 1.87). When
the variables age was <65 years, normal WBC, birds at home, ele-
vated transaminase levels, and a negative pneumococcal urinary
antigen assay were included in the scoring system, a score of 4
captured patients with atypical pneumonia with a sensitivity of
33% and a speciﬁcity of 95%. A second scoring system was con-
structed with the 240 patients from the ﬁrst 12-month study per-
iod. When the variables age <65 years, normal WBC count, birds
at home, LBP levels <14 mcg/mL and negative urinary antigen
assay were included, a score of 4 captured patients with atypical
pneumonia with a sensitivity of 49% and a speciﬁcity of 95%.
Conclusion: Selected patient factors and additional diagnostic test-
ing can aid to discriminate atypical pneumonia with high speciﬁc-
ity. This information could be useful to ensure effective and safe
use of macrolides as empirical monotherapy in CAP.
P431 Effects of a pneumococcal vaccination programme in
adult invasive Streptococcus pneumoniae disease: a 3-year
experience
F.J. Vasallo, A. Gonza´lez-Escalada, V. del Campo, S. Pe´rez,
J. Torres
Vigo, E
Objectives: Streptococcus pneumoniae is a leading cause of serious
infections. The prevention of pneumococcal disease has become
an important public health issue as a result of the rapid increase
in the prevalence of pneumococcal resistance to antibiotics. Our
aim was to evaluate the effect of a pneumococcal vaccination
programme in elderly people (started in autumn, 1999) in
the incidence of invasive disease, and the changes observed in
serotypes prevalence and antibiotic resistance during the study
period.
Methods: Our institution covers a mainly rural area of approxi-
mately 160 000 adult population in the northwestern area of
Spain. We retrospectively reviewed all invasive S. pneumoniae
(blood, CSF) isolates recovered at our laboratory between 1998
and 2003, 3 years before and after the programme started, named
periods A and B respectively. Identiﬁcation and susceptibility test-
ing were performed following standard recommendations. Pneu-
mococci were classiﬁed as susceptible, intermediate and resistant
(S, I, R) according to 2001 deﬁnitions of NCCLS. Serotyping was
performed at a national reference laboratory.
Results: A total of 165 invasive pneumococci were recovered dur-
ing the whole period (period A, 1998–2000: 99 isolates; period B,
2001–2003: 66). The rate of invasive disease dropped from an
average of 20.6 cases per 100 000 persons in period A to an aver-
age of 13.8 in period B (33% lower). A similar reduction was
observed in those 65 years and older (49.2 per 100 000 vs. 37.8 per
100 000, 23.2% reduction). Penicillin susceptibility (S, I, R) in the
two periods was: A: 73.4, 18.4, 8.2%, and B: 67.2, 31.2, 1.6%
(P 0.05). Cefotaxime susceptibility was: A: 83.7, 13.3, 3%, and
B: 85.9, 12.5, 1.6%. Erythromycin susceptibility was: A: 84.7, 1,
14.3%, and B: 68.7, 1.6, 29.7% (P 0.05). The most frequent sero-
types were (per cent): period A: 4 (16.9), 3 (15.7), 8 (12), 14 (10.8);
and B: 3 (16.7), 14 (16.7), 19 (11.7), 6A (8.3).
Conclusions: A signiﬁcant reduction (33%) in the incidence of
pneumococcal invasive disease was observed after the vaccination
programme started. The slight increase in penicillin non-suscept-
ible strains (26.6% vs. 32.8%) was because of intermediate sus-
ceptible ones, with a decrease in those highly resistant (8.2% vs.
1.6%). Erythromycin resistance duplicated in the study period
(14.3% vs. 29.7%).
P432 Effect of initial treatment on bacteraemic
Streptococcus pneumoniae pneumonia (BSPP) mortality
V. Pintado, R. Blazquez, E. Loza, J. Cobo, J. Fortun, E. Navas,
C. Quereda, S. Moreno
Madrid, E
Objectives: Community-acquired BSPP is associated with a high
mortality. Recent studies have suggested that monotherapy may
be sub-optimal for this infection. The aim of this study was to
evaluate the effect of initial antimicrobial therapy on the outcome
of BSPP.
Methods: Retrospective study of adult cases (>18 years) of com-
munity-acquired BSPP hospitalised at our institution from 1990 to
2003. Severity of pneumonia was assessed using PORT-score. The
impact of penicillin susceptibility and initial empirical treatment
(combined therapy vs. monotherapy) on the 30-day mortality
were assessed by univariate and multivariate analyses.
Results: A total of 343 cases were evaluated. There were 220
males (64%); the mean age was 56.9 years (range, 18–94). Most
patients had chronic predisposing conditions and 32% of them
had HIV infection. Decreased susceptibility to penicillin
(MIC > 0.06 mg/L), cefotaxime (MIC > 0.5 mg/L), and erythro-
mycin (MIC > 1 mg/L) was observed in 34% (108/320), 10%
(14/135), and 21% (61/292) of strains. Patients were empirically
treated with a beta-lactam (50%), a beta-lactam plus macrolide
(26%), or other regimens of monotherapy (10%) or combination
therapy (14%). Overall mortality rate was 19%. Mortality was
signiﬁcantly associated (P < 0.001) with PORT groups: class
I ¼ 1/30 (3%), class II ¼ 5/59 (8%), class III ¼ 5/61 (8%), class
IV ¼ 25/123 (20%), class V ¼ 28/70 (40%). The mortality rate
was higher in patients with penicillin-resistant strains than in
patients with susceptible strains (25% vs. 14%; P ¼ 0.03), but
was similar in patients receiving monotherapy or combination
therapy (16% vs. 22%; P ¼ 0.13). Multivariate analysis showed
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that the presence of septic shock and advanced age (>65 years)
were the most important factors associated with mortality.
Conclusions: PORT score accurately identiﬁes the mortality risk of
community-acquired BSPP. Decreased susceptibility to penicillin
seems to be associated with a worse prognosis. Our study has not
conﬁrmed the beneﬁcial impact of empirical combination therapy
for BSPP.
P433 Comparative, randomised, open, multicentre trial
assessing the efﬁcacy and safety of intravenous/oral
azithromycin compared with intravenous/oral clarithromycin for
the treatment of community-acquired pneumonia due to
Legionella pneumophila
J. Roig, M. Sabria´, J. Alegre, M. Gurgui, J.C. Checa – Spanish
Study Group for Legionella
Objective: To evaluate the efﬁcacy and safety of intravenous (i.v.)
/oral (p.o.) Azithromycin (AZM) compared with i.v./p.o. clarith-
romycin (CLA) for the treatment of community-acquired pneu-
monia (CAP) caused by Legionella pneumophila.
Study design: Randomised, open-label, multicentre phase III clin-
ical trial.
Inclusion criteria: Subjects over 18 years with clinical and radiologi-
cal ﬁndings consistent with CAP with no requirement for hospi-
talisation in ICU and positive determination of Legionella
pneumophila urinary antigen.
Treatment: (A) Patients (pts) not requiring hospitalisation and
therefore, will receive only oral treatment: AZM 500 mg/day dur-
ing 3 days or CLA 500 mg every 12 h during 10–14 days. (B) The
hospitalised subjects will receive: (1) AZM: 500 mg once a day, by
i.v. route, during at least 2 days and for a maximum of 5 days.
After the second day the investigator will assess whether the ther-
apy can be switched to oral route. The treatment will continue to
complete a total of 7 days. (2) CLA: 500 mg twice a day, i.v. route
for at least 2 days and for a maximum of 5 days. After the second
day the investigator will assess when to switch to the oral route
at doses of 500 mg every 12 h. Total treatment will be 10–14 days.
Results: During the period of study 50 patients were recruited, 25
in each group (40 male, 10 female). The mean age of the study par-
ticipants was 57 years (27–83 years), mean bodyweight was 76 kg
(50–130 kg) and mean height was 168 cm (141–182 cm). No differ-
ence was found in demographics between groups. Twenty-four pts
(96%) received initially i.v. treatment in AZM group vs. 22 pts
(88%) in CLA group. Mean duration in i.v. treatment was 3.7 days
in both groups. In the intend-to-treat (ITT) population, clinical suc-
cess rates both at end of treatment (EOT) and end of study (EOS)
were 95.8% for AZM and 100% for CLA. Bacteriological eradica-
tion rates at EOS and EOT were 100% in both groups for patients
cured or improved. The incidence of treatment-related adverse
events (AEs) was similar in both groups and most events were of
mild to moderate severity. Incidence of phlebitis was seven epi-
sodes (28%) for AZM vs. 13 episodes (52%) for CLA.
Conclusions: AZM i.v./p.o. for the treatment of CAP caused by
Legionella pneumophila is as efﬁcacious as CLA i.v./p.o. Both treat-
ments were well tolerated but incidence of phlebitis was higher in
the group receiving CLA (P ¼ 0.08).
P434 Pseudomonas aeruginosa as a risk factor in acute
exacerbations of COPD
M. Allewelt, S. Balk, H. Lode
Berlin, D
Objectives: Pseudomonas aeruginosa is a frequent cause of severe
bacterial exacerbation in advanced stages of COPD. Its role in a
complicated course of the disease and for an unfavourable out-
come were evaluated.
Methods: Ambulatory and hospitalised subjects presenting with
an acute exacerbation of COPD were prospectively evaluated for
clinical and radiological parameters, for functional impairment,
and for life expectancy. From all patients valid sputum samples
were obtained at presentation.
Results: A total of 193 patients with a history of COPD and an acute
exacerbation were included. In 114 subjects, potentially pathogenic
microbes were isolated, Pseudomonas aeruginosa in 12 cases (10.5%).
In two patients, bronchiectasis was demonstrated by high-resolu-
tion CT scan. Seven individuals infected with Pseudomonas aerugi-
nosa died within 1–21 months after initial presentation. Between
subjects who did or did not die, there were no signiﬁcant differ-
ences with respect to age, frequency of underlying diseases, smo-
king status, or treatment with systemic steroids. All individuals
who succumbed had stage III disease (ATS classiﬁcation:
FEV1<35% predicted). On average, these had a worse lung function
(VC 49.1  9% vs. 78.8  18.9% predicted, FEV1 26  6.5%
vs.43.5  13.4% predicted, absolute FEV1 0.8  0.2L vs.
1.0  0.3L). Emphysema (5/0), a medical history with treatment in
an ITU (5/1), and with preceding mechanical ventilation (3/1) were
more frequent in subjects with a fatal outcome.
Conclusion: Presence of Pseudomonas aeruginosa in individuals pre-
senting with an acute exacerbation of COPD is associated with a
high fatality rate short-term outcome. Particularly severe underly-
ing airﬂow obstruction and a medical history of treatment in an
ITS or mechanical ventilation is associated with an unfavourable
outcome.
P435 Community outbreak of Legionella in Hospitalet
(Spain). Usefulness of the epidemiological and molecular data
to identify the source
I. Barrabeig, M. Garcia-Nun˜ez, A. Dominguez, A. Rovira,
S. Ragull, A. Pedrol, J.M. Elorza, M.L. Pedro-Botet, N. Sopena,
M. Sabria
Barcelona, Badalona, E
Legionella is considered responsible for 2–13% of cases of commu-
nity-acquired pneumonia requiring hospitalisation. Colonisation
of cooling towers and evaporative condensers by Legionella, with
the subsequent production of polluting aerosols, has been associ-
ated with community outbreaks of Legionnaires’ disease. To date,
epidemiological data and microbiological/and molecular studies
are both necessary in the investigation of an outbreak.
Objective: To describe a community outbreak of pneumonia caused
by Legionella in Hospitalet. Catalonia (Spain) and the usefulness of
the DNA chromosomic analysis to ﬁnd the source of the outbreak.
Methods: An observational prospective study was performed. Data
from affected patients was requested and water from suspected
environmental sources was cultured for Legionella. Isolates of Leg-
ionella from patients and water samples were subtyped by Pulsed
Field Gel Electrophoresis. From each positive environmental plate
ﬁve colonies were picked up and re-seeded on BCYE, in order to
know the clonal distribution of Legionella.
Results: From August 16–December 16 (2002), 13 deﬁnitive cases
of pneumonia caused by Legionella were reported . The median
age of the patients was 72 years: 92% were males. Of the cases, 11
were hospitalised. The case fatality rate was of 7.7%. The attack
rate of the outbreak was 0.029%. The majority of cases were
located within a radius of 200 m around the implicated cooling
tower (HC) with a risk ratio of 17.4 (CI 95% 3.8–80.6). Of the 17
samples taken from cooling towers and evaporative condensers,
nine were positive for L. pneumophila. A single DNA subtype was
observed among the three clinical strains (subtype A). Two differ-
ent subtypes were found in the HC cooling tower, one of them
(subtype A) matching exactly with the clinical subtypes. Several
subtypes were found in the other cooling towers none of them
matching the clinical subtypes. Moreover each cooling tower had
its own subtypes of Legionella. After closing the HC cooling tower
no new cases of pneumonia caused by Legionella appeared.
Conclusions: The results of epidemiological and microbiological
data suggested the HC cooling tower as a source of a community
outbreak of LD. The diversity of DNA subtypes even in such a
small area facilitate the identiﬁcation of the outbreak source.
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P436 Signiﬁcance of early Mycoplasma pneumoniae
serodiagnosis in hospitalised patients with community-acquired
pneumonia
A. Kuhnke, M. Bender, M. Allewelt, A. Roth, H. Mauch, H. Lode
Berlin, D
Objectives: The use of serological methods in early diagnosis of
pneumonia is controversial due to delayed production of antibod-
ies. Therefore the temporal course of speciﬁc serological response
was investigated in hospitalised patients with Mycoplasma pneumo-
niae CAP.
Methods: Hospitalised patients with suspected CAP were prospec-
tively recruited for the study. The aetiology of Mycoplasma pneu-
moniae was serologically tested by particle-immuno-assay (PIA). A
positive serological diagnosis was made if the acute phase serum
titer was more than 1:160 or paired samples taken 2–4 weeks
apart showed a fourfold rise in serum titer. The PIA does not dif-
ferentiate between IgM and IgG. Furthermore respiratory speci-
mens were investigated by PCR. In patients with predeﬁned
clinical parameters Mycoplasma pneumoniae was diagnosed in cases
of positive PIA and / or positive PCR.
Results: Mycoplasma pneumoniae was identiﬁed as a causative agent
in 50 patients (25 female, 25 male). 41 patients (82%) had a posit-
ive serology and 45 patients (90%) had a positive PCR result. In
28 patients (56%) signiﬁcant PIA titers were detected on hospital
admission. On day 3 of hospitalisation cumulative signiﬁcant tit-
ers were measurable in 34 cases (68%) and on day 4 in 42 cases
(96%). A correlation of these laboratory results was proofed with
clinical ﬁndings. 48 patients (96%) were complaining about
cough, 43 (86%) about fever, 28 (56%) about dyspnoea and expec-
toration and 26 (52%) had auscultatory ﬁndings.
Conclusion: The clinical course of mycoplasma pneumonia in
patients requiring hospitalisation justiﬁes the early use of serologi-
cal methods (PIA) in acute diagnosis.
P437 Prevalence and degree of Legionella colonisation in
cooling towers
M. Garcia-Nun˜ez, S. Ragull, E. Junyent, M.L. Pedro-Botet,
N. Sopena, M. Sabria
Badalona, E
Cooling towers have been frequently implicated in community
Legionella outbreaks. Since July 2003, Spanish regulation obligate
test water from cooling tower systems for Legionella and perform
a chlorine shock if colonisation are above 1000 CFU/L. This last
measure cause important logistic and economic consequences
troubles. Other guidelines increase the cut-off to above
10 000 CFU/L Legionella counts, considering little concern levels
between 1000 and 10 000 CFU/L Prevalence of Legionella colonisa-
tion in cooling towers, degree of colonisation, and its relationship
with the outbreak are underknown. Because Legionella levels ﬂuc-
tuate over time in the same cooling tower. and the real risk of this
colonisation is not known, the established cut off to initiate shock
measures could be overestimated.
Aim: To know the prevalence and degree of Legionella colonisation
in cooling towers in Catalonia (Spain).
Methods: Five hundred and ﬁfty-four cooling tower samples were
randomly screened during a 3-year period (2001–2003). Water
specimens were collected and transported following the national
guidelines. Specimens corresponding to outbreaks were ruled out.
Samples were processed according to the standard procedure
ISO17131:98 for quantitative Legionella analysis.
Results: One hundred and two samples (18.41%) had detectable
levels of Legionella equal to or above 10 CFU/L. The average level
of a positive sample was 76.391 CFU/L, (range: 9–3 000 000 CFU/
L). According to the Spanish regulation of hazard categories: a
total of 30 samples were between 100 CFU/L and 1000 CFU/L, 35
samples were between 1000 CFU/L and 10 000 CFU/L and 17
samples were above 10 000 CFU/L. Legionella pneumophila sg. 1
was identiﬁed in 69 (67.64%) of the positive samples, L. pneumo-
phila sg.2-14 in 21 (20.58%) and Legionella no-pneumophila in 17
(16.7%).
Conclusions: Legionella is a frequent inhabitant of cooling tower
systems, being L. pneumophil, the specie most prevalent. As a
result of inoculums greater than 1000 CFU/L found in most of
the colonised cooling towers, a less restrictive cut off should be
probably considered.
P438 Epidemiology of community-acquired pneumonia
revisited: a large population-based prospective study in the
Mediterranean coast of Spain
F. Gutie´rrez, M. Masia´, J.C. Rodrı´guez, S. Padilla, G. Royo,
J.M. Ramos, A. Ayelo, A. Martı´n-Hidalgo
Elche, Alicante, E
Objective: Over the last few years there have been signiﬁcant
advances in microbial diagnosis and therapy of community-
acquired pneumonia (CAP). The impact of these changes on the
epidemiology of CAP is unknown. The aim of this study is to pro-
vide a comprehensive overview on current epidemiological fea-
tures of CAP.
Methods: A 2-year population-based prospective study conducted
from October 1999 through September 2001 in consecutive adults
with CAP at a teaching hospital in the Mediterranean cost of
Spain. An extensive non-invasive microbiological investigation
was performed, including detection of Legionella pneumophila and
Streptococcus pneumoniae urinary antigens, and acute and convales-
cent serologic testing to detect antibodies against ‘atypical’ and
viral pathogens.
Results: A total of 493 patients (62.5% men, mean age 56 years)
were included. The annual incidence rate of CAP was of 1.03
cases per 1000 inhabitants. In 265 (53.7%) patients there was one
or more underlying diseases. 75.1% were included in Fine’s categ-
ories I-III. 361 (73.2%) were admitted to hospital, 6 (1.2%) of them
to the ICU. A total of 276 microorganisms (69 bacteria, 109 atyp-
ical pathogens, and 29 virus) in 250 (50.7%) patients were identi-
ﬁed. In 243 (49.3%) cases the microbial aetiology remained
unknown. In 20% of the cases, the microbial diagnosis was made
by detection of urinary antigens. The most frequent organisms
were S. pneumoniae 38%), M. pneumoniae (18%), L. pneumophila
(10.4%), C. pneumoniae (9.6%), inﬂuenza virus (8.8%) and Gram-
negative bacilli, including Pseudomonas species (14.8). In 30 (12%)
cases, infection was considered mixed. The most frequent combi-
nation was S. pneumoniae with M. pneumoniae or L. pneumophila
(three cases each). Microbial diagnosis of CAP varied according to
age, site-of-care and co-morbidity. A total of 27 patients died with
an overall mortality rate of 4.9%. During the second year of the
study there was a decrease in the proportion of patients admitted
to hospital (79.2% vs. 67.2%, P ¼ 0.03) and in the mortality rate
(7.1% vs. 2.8%, P ¼ 0.03).
Conclusions: Incidence of CAP in this study at the Mediterranean
coast of Spain was lower than previously reported. New technol-
ogies allowed a rapid etiological diagnosis of CAP in many cases
and disclosed a signiﬁcant proportion of mixed infections. Mortal-
ity rate of CAP may be decreasing. The results of this study may
aid in the management of antibiotic treatment in patients with
CAP.
P439 Factors inﬂuencing treatment outcome and length of
stay in patients hospitalised for community-acquired
pneumonia
A. Neiss, D. Elkharrat, S. Kohno, J. Schentag, S. Decker-Burgard,
K. Roscher
Munich, D; Paris, F; Nagasaki, JP; Buffalo, USA; Bad Soden am
Taunus, D
Objectives: To identify factors affecting treatment outcome and
length of hospital stay in patients hospitalised with CAP.
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Methods: Data were obtained retrospectively by chart review from
2183 patients with discharge or death diagnosis of CAP during a
12-month period in Germany (D), France (F), Japan (J) and the
USA. Exploratory analyses were performed to evaluate predeﬁned
prognostic factors affecting treatment success (logistic regression;
clinical success ¼ patients discharged [+/- antibiotics]; microbiolo-
gical success ¼ all CAP-relevant organisms were or were pre-
sumed to be eradicated) and length of hospital stay (linear
regression and analysis of covariance).
Results: Mean age ranged from 62.9 years (D) to 69.9 years (F).
Mean Fine scores were lowest in J (79.2) and highest in F (102.3).
In total, 80.7% of patients achieved successful clinical and micro-
biological outcomes. The highest success rate for combined clinical
and microbiological outcomes was seen in J (92.8%), while the
USA had the lowest combined success rate (68.1%). Median hos-
pitalisation time varied from 6 days (USA) to 14 days (J). Antibi-
otic treatment, Fine score, age and social status were identiﬁed as
prognostic factors at the P ¼ 0.05-level in ﬁnal models. Appropri-
ate antibiotic treatment during hospitalisation increased treatment
success in J (odds ratio [OR] 0.2), microbiological success in D
and J (OR 0.5, 0.3, respectively) and reduced hospitalisation time
in D and J (Cox relative risk [RR] 1.3, 1.5). In all countries, mono-
therapy with antibiotics other than penicillins and derivatives
reduced hospitalisation time (RR 1.3–1.7) and a high-risk Fine
score (class V) reduced treatment success rates compared with
low risk scores (classes I–III) (OR 2.4–8.7). Longer hospitalisation
was related to high-risk Fine score in F, J, and USA (RR 0.4–0.6)
and to greater age in D, F, and J (RR 0.8–0.9 per 10 years). In F,
‘living in nursing homes’ correlated with lower treatment success
rates than ‘living with families’ (OR 4.5).
Conclusions: The importance of risk factors varied between coun-
tries and resulted in different success rates and lengths of stay.
Appropriate antibiotic treatment for CAP covering the spectrum
of common causative pathogens — even monotherapy with antibi-
otics other than penicillins and derivatives — and a low risk
assessment at the time of hospitalisation were identiﬁed as the
most important prognostic factor for successful treatment and a
short hospitalisation time.
P440 Bacteriological outcomes in hospitalised patients with
community-acquired pneumonia treated with i.v. azithromycin
plus ceftriaxone vs. i.v. ceftriaxone plus clarithromycin or
erythromycin
M. Tamm, T. Todisco, P.A. Willcox, F. Carrillo, S. Fisher,
P.J. de Caprariis, F. Blasi, I.M. Hoepelman
Basle, CH; Perugia, I; Cape Town, ZA; Guadalajara, E; New York,
USA; Milan, I; Utrecht, NL
Objective: Several treatment recommendations, such as the upda-
ted IDSA Guidelines, include a beta-lactam/macrolide combina-
tion for hospitalised CAP pts. We compared clinical efﬁcacy and
safety of sequential therapy with i.v. ceftriaxone (CEF; 1–2 g q.d.)
and azithromycin (AZM; 500 mg q.d.) followed by oral AZM
(500 mg q.d.) vs. i.v. CEF (1–2 g q.d.) and either clarithromycin
(C; 500 mg q12h) or erythromycin (E; 1 g q8h) followed by oral C
(500 mg q12h) or E (1 g q8h) in pts with moderate to severe CAP.
Methods: This international multicentre study was a randomised
and open label clinical trial. Total length of therapy: CEF/AZM
was 7–10 days and CEF/C or E was 7–14 days. Clinical and bac-
teriological outcomes were assessed at end-of-treatment (EOT;
days 12–16) and at end-of-study (EOS; days 28–35).
Results: A total of 135 and 143 pts were treated in the CEF/AZM
and the CEF/C or E groups, respectively. 52.6 and 51.1% of pts
in the CEF/AZM and CEF/C or E groups, respectively, were
classed within the Fine risk categories IV and V. The most fre-
quently isolated baseline pathogens were Streptococcus pneumoniae,
Haemophilus inﬂuenzae, and Staphylococcus aureus; their results are
presented below. The number of pts with other pathogenic organ-
isms was too small, based on this study alone, to allow any deﬁn-
itive conclusions to be drawn about the efﬁcacy of CEF/AZM or
the comparator treatment. The MITT clinical success rates at EOT
were 84.3% for AZM and 82.7% for CEF/C or E; EOS success
rates were 81.7% for AZM vs. 75.0% for CEF/C or E.
Conclusion: In a relatively sick patient population, AZM/CEF fol-
lowed by oral AZM showed comparable bacteriological efﬁcacy to
CEF/C or E followed by oral C or E in the treatment of hospital-
ised patients with CAP.
P441 First post-marketing data on treatment of community-
acquired pneumonia with moxiﬂoxacin i.v.
J. Barth, H. Landen, K. Stauch
Halle/Saale, Leverkusen, D
Objectives: This post-marketing surveillance study investigated the
efﬁcacy and tolerability of moxiﬂoxacin i.v. therapy in community
acquired pneumonia under general hospital treatment conditions.
Methods: This open, prospective, non-controlled, non-randomised
multicentre study was conducted in German hospitals with
patients diagnosed with community acquired pneumonia (CAP)
and treated with moxiﬂoxacin (MXF) i.v. or with MXF sequential
therapy (i.v. and oral). The exclusion criteria were the contraindi-
cations mentioned in the summary of product characteristics.
Documentation included demography, anamnesis, antibiotic pre-
treatment, concomitant diseases and medications, daily recording
of MXF therapy and symptom status, overall assessment of ther-
apy with moxiﬂoxacin i.v. and reporting of all adverse events
observed within the treatment period.
Results: A total of 1749 patients treated with 400 mg MXF once
daily were documented until April 2003, 56.4% males and
43.5% females, mean age 66.2 (SD 15.5) years. Duration of MXF
therapy was up to 4 days in 12.8% of patients, 5–7 days in
38.3%, 8–10 days in 36.6% and >10 days in 12.4% of patients. In
case of sequential therapy (77.9% of patients), MXF i.v. was
given for up to 2 days in 14.3% of patients, 3 days in 25.4%,
4 days in 29.7% and more than 4 days in 30.6% of patients. 209
Patients (11.9%) were excluded from the analysis of symptom
improvement and overall efﬁcacy. These cases were considered
as having rather hospital aquired pneumonia than CAP.
Improvement of clinical symptoms in the 1538 CAP patients is
shown in Figure 1. Improvement was reported in 58.2% of CAP
patients at day 3, 84.9% at day 5 and 89.8% at day 7. Mean
duration until improvement was 3.4 days and 7.2 days until
cure. Overall efﬁcacy of MXF i.v. therapy was rated by the phy-
sicians as very good or good in 83.5% of CAP cases. Tolerability
was rated in 94.3% of all patients as very good or good. For 92
patients (5.3%) adverse events were recorded, but only in 32
patients (1.8%) events were considered to be related to the MXF
therapy.
Conclusions: The new moxiﬂoxacin i.v. formulation is a safe and
effective treatment of CAP in the general hospital setting. Because
of the rapid symptom relief, Moxiﬂoxacin allows an early change
from the i.v. to oral application for patients with CAP treated in
hospital.
Outcome
EOT (d 12–16) EOS (d 28–35)
CEF/AZM
% (N)
CEF/C or
E % (N)
CEF/AZM
% (N)
CEF/C or
E % (N)
Bacteriologic Eradication
MITT population 73.2 (30/41) 67.4 (31/46) 68.3 (28/41) 60.9 (28/46)
E valuable 80.0 (24/30) 81.3 (26/32) 72.7 (16/22) 75.0 (24/32)
Clinical success by baseline pathogen* in bacteriological MITT population
S. pneumoniae 81.0 (17/24) 70.0 (21/32) 75.0 (15/24) 66.7 (20/32)
H. inﬂenzae 92.3 (12/13) 50.0 (4/8) 92.3 (12/13) 37.5 (3/8)
S. aureus 83.3 (5/6) 100 (2/2) 83.3 (5/6) 100 (2/2)
Clinical success in pts with positive blood cultures
MITT 66.7 (8/12) 58.8 (10/17)y 66.7 (8/12) 52.9 (9/17)y
*19 pts had 2 pathogens at baseline (6 and 4 pts were cured in AZM and C/E groups
respectively).
yNot signiﬁcantly different compared with CEF/AZM.
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P442 Atypical pathogens in pathogenesis of bronchial
asthma in children and efﬁcacy of azithromycin as a part of
complex therapy
O. Lasitsa, I. Ochotnicova, S. Lomonosov
Kyiv, UKR
Aim: The aim of this study was to evaluate the prevalence of
atypical pathogens such as Mycoplasma pneumoniae (MP), Chlamy-
dia pneumoniae (CP) and Chlamydia trachomatis (CT) in children
with bronchial asthma and assess the efﬁcacy of azithromycin
(Sumamed, Pliva, Croatia) in acute asthma exacerbation as a part
of complex therapy.
Methods: Children with acute asthma exacerbation were enrolled
in the study. In all children PCR (sera and sputum), serological
tests (IgM and IgG) for MP, CP and CT, detection of MP antigen
(AG) in nasal aspirate by using immunoﬂuorescence method
(IFA) were performed.
Results: A total of 76 children, aged 6 months–14 years, with acute
asthma exacerbation were enrolled in the study. 29 of them have
mild asthma, 28 – intermediate and 19 – severe asthma. Previous
history of the disease was 1 month–10 years. Acute respiratory
infections were the trigger of asthma exacerbation in majority
(88.2%) of children. The prevalence of MP, CP and CT infections
among children found to be very high (54–89%). As a result of
high prevalence of MP, CP and CT infections in children, with
asthma exacerbation, 5-day azithromycin was added to the com-
plex antiasthmatic treatment. Clinical success of the treatment was
achieved in majority of children (91.3%), regardless the severity
of asthma exacerbation. We found rapid regression of fever and
symptoms of intoxication after 2–3 days of onset of treatment.
During the follow-up period (6 months) we found that 79.1% of
children did not suffer from acute infections and asthma exacerba-
tions.
Conclusions: The prevalence of MP, CP and CT infections among
children included in the study found to be very high. The results
suggest that such patients may have beneﬁt with short courses of
azithromycin. Nevertheless, further studies are needed in order to
assess the role of azithromycin in chronic persistence of atypical
pathogens in respiratory tract in children with asthma.
P443 Management of community-acquired pneumonia in a
hospital in Norway: penicillin still works!
B. Waldum, A. Bucher
Oslo, N
Objective: To assess the management and severity and outcome of
disease in patients hospitalised with community-acquired pneu-
monia (CAP) in one of the Oslo city hospitals in Norway.
Methods: Consecutive patients from 18 years of age with CAP
were enrolled. CAP was classiﬁed in ﬁve risk classes according to
The Fine severity score (FSS). Antibiotic treatment, outcome and
complications were evaluated. Comparison between admission
rates and FSS and between antibiotic therapy given and Nor-
wegian Guidelines was performed.
Results: A total of 119 patients were included from 1 Jan 2003 to
31 July 2003. The annual incidence of hospitalised CAP in our
region is estimated to 2.3/1000 inhabitants. 5.2% of patients hos-
pitalised in medical department had CAP. Median age was
82 years (range 24–102). Male–female ratio was 1:1. FSS distribu-
tion was: 1 ¼ 4.2%; 2 ¼ 6.7%; 3 ¼ 8.4%; 4 ¼ 47.9% and
5 ¼ 32.8%;. Based on IDSA recommendations regarding FSS,
10.9% (classes 1 + 2) could have been treated ambulatory, 8.4%
(3) would require a brief observation period and 80.7% (4 + 5)
hospitalisation. The median length of stay was for all patients
8 days (1–56), related to FSS risk classes: 1 ¼ 3 days, 2 ¼ 5.5 days,
3 ¼ 9 days, 4 ¼ 9 days, 5 ¼ 10 days. Mortality was: 1–3 ¼ 0%,
4 ¼ 12.3%, 5 ¼ 33.3%, totally 20/119 patients. We found no com-
plications in FSS class 1 and 2. Totally 22 patients were admitted
to the intensive care unit (3:20,0%, 4:21,0%, 5:20,5%). Norwegian
Guidelines suggest penicillin (pen) or macrolides (mac) in mono-
therapy as empiric therapy in risk-free CAP, and in combination
with aminoglycosides (aglyc) in severe CAP. In our hospital 159
antibiotics were prescribed in 119 CAP (1.34 antibiotics/CAP).
44.5% (53/119) received pen as a monotherapy in the whole treat-
ment period, in 19.7% (13/66) pen was changed to other antibi-
otic. Mac was given as the primary therapy in 2.5% and in 2.5%
as the secondary treatment. In 5/7 patients pen and aglyc combi-
nation was converted to pen alone
Conclusions: The relatively high median age in our patient popula-
tion may explain the large number in high FSS risk classes. The
FSS risk classiﬁcation seemed to correlate with risk of complica-
tion and death. Nearly 50% vs. 20% of patients were treated with
penicillin resp. aminopenicillin in monotherapy without change in
therapy during stay. The good ‘pen effect’ can be explained with
the favourable situation regarding bacterial resistance in Norway.
P444 A case-control study on acute respiratory infections of
patients in general practices in the Netherlands, October 2000 –
September 2003
A.B. van Gageldonk-Lafeber, A. Bartelds, M-L.H. Heijnen,
M. Peeters, S.M. van der Plas, S.C. de Greeff, B. Wilbrink
Bilthoven, Utrecht, Tilburg, NL
Objectives: Acute respiratory infections (ARI) are very common in
the general population: In the Netherlands, yearly 3.2 million
patients visit general practitioners with symptoms of upper respir-
atory disease. To reduce diagnostic deﬁcit, we studied the inci-
dence and aetiology of ARI. Additionally, we studied ARI risk
factors, healthcare demand and burden of disease.
Methods: From October 2000 to October 2003, the incidence of
inﬂuenza-like illness (ILI) and other ARI in general practices and
the role of a broad range of pathogens in the Netherlands were
studied. General practitioners from a Dutch sentinel network
registered all patients consulting them for ILI and other ARI.
Weekly, general practitioners randomly sampled one of these
patients (case) and one patient of the same age group, visiting the
general practitioner for non-respiratory symptoms (control). Sam-
ples were analysed for respiratory viruses and bacteria. Participa-
ting patients completed a questionnaire on risk factors and
burden of disease.
Results: Forty practices registered all patients consulting them for
ILI or other ARI. Twenty practices participated in the case-control
study. Per year on average, 1600 consultations for ILI and 5000
for ARI were registered, leading to an incidence of 130 and 410
per 10 000 persons respectively. In total 647 cases and 559 controls
were sampled. In more than 65% of the ILI cases and 50% of the
ARI cases, viruses were detected, compared with 20% in controls.
Bacteria were detected in more than 30% of both cases and con-
trols.
Conclusion: Despite three unusual calm inﬂuenza seasons, inﬂu-
enza was the most common pathogen in ILI-patients. Rhinovirus
was most often detected in ARI patients. Incidence for both ILI
Figure 1. Decrease of clinical symptoms over 10 days from start of
MXF therapy
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and ARI was highest for 0–4-year olds. More data on the inci-
dence of ILI and ARI and associated pathogens will be presen-
ted.
P445 Hospitalised community acquired pneumonia:
characteristics, aetiology and outcome
E´. Sze´kely, C. Ko´sa, Z. Va´rnai, E. Ludwig
Budapest, HUN
Objective: To analyse characteristics of patients with community
acquired pneumonia (CAP) at the Department of Internal Medi-
cine in the Central Infectious Disease Hospital during a 3-year
period (2001–2003).
Methods: All the patients with CAP were included. Recorded data
were sex, age, PORT score, presence of underlying diseases, main
clinical features and symptoms, radiological appearances and out-
come. Blood samples for culture from all patients, sputum when
it was possible and serological tests were performed for Chlamydia
pneumoniae, Mycoplasma pneumoniae and Legionella spp. In some
cases direct antigen detection (urine or sputum) and serology tests
for viruses and other pathogens (inﬂuenza, RSV, coxiella etc.)
were carried out.
Results: One hundred and ﬁfty-nine consecutive patients were
included with a mean age of 54.2 years (range 15–96), 98 male
and 61 female. The distribution of patients according to the
PORT score was: class I, 20%; II, 29%; III, 25%; IV, 20%,
V, 6%. In 45% one, in 36% two or more diseases considered
as risk factors were present. The most prevalent of them were
chronic pulmonary diseases, alcohol abuse and chronic uraemia.
Admission to ICU was necessary in 10 cases (mean age 42,6,
PORT score class III, 1; IV, 8; V, 1). Pathogens were identiﬁed
in 62% of patients. The most frequent were Legionella spp.
(34%), S. pneumoniae (15%) M. pneumoniae (15%), C. pneumoniae
and psittaci (15%). All of the invasive S. pneumoniae strains
were fully penicillin-sensitive. Overall mortality was 9.8%,
directly attributable to pneumonia in 7%. All of the fatal out-
comes with detected pathogens were caused by Legionella pneu-
mophila infection.
Conclusions: The leading causes of hospitalisation of patients
with mild pneumonia were fever and/or extrapulmonary clin-
ical symptoms. More thorough ambulatory examinations of
patient (X-ray, blood count etc.) would have decreased the
number of hospital admissions. The causative pathogens were
revealed in 62%, most of them were ‘atypical’. The unusual
distribution of pathogens probably results from the special situ-
ation of our hospital. Nevertheless, more frequent examination
of sputum and BAL would result in the increase of ‘typical’
pathogens. The PORT score was useful to identify patients with
poor outcome.
P446 Comparison of additional antibacterial usage in
patients with community-acquired pneumonia receiving
telithromycin or clarithromycin: results from two double-blind,
randomised clinical trials
P.G. Davey, M. Niederman, J. Paladino, C. Taneja, G. Oster,
J. Stewart, J. Chang
Dundee, UK; Mineola, Amherst, Brookline, USA; Quebec, CAN;
Bridgewater, USA
Objectives: This analysis was undertaken to compare use of addi-
tional respiratory-related antibacterials in patients with commu-
nity-acquired pneumonia (CAP) treated with the ketolide
telithromycin (TEL) or the macrolide clarithromycin (CLA).
Methods: Data from two similar, comparative, double-blind, rand-
omised trials were pooled for this analysis. Adult outpatients with
mild to moderate CAP were randomised to receive either TEL
800 mg once daily for 5, 7 or 10 days or CLA 500 mg twice daily
for 10 days. In both studies, clinical outcome was assessed in the
per-protocol (PP) population at the post-therapy/test of cure
(TOC; days 17–24) visit. Patients were followed to days 31–36 (late
post-therapy visit) to assess the use of additional respiratory-rela-
ted antibacterials in the intent to treat population (TEL, n ¼ 612;
CLA, n ¼ 411).
Results: Clinical cure rates in the PP population were equivalent
in the two treatment groups [88.8% (428/482) for TEL and 90.1%
(272/302) for CLA; 1.3, 95% CI (6.0, 3.4)]. A total of 155 patients
required additional respiratory-related antibacterial therapy:
14.2% (87/612) of patients treated with TEL and 16.5% (68/411)
of CLA-treated patients [2.3, 95% CI (7.0, 2.4)]. Shorter courses
of TEL were not associated with increased requirements for addi-
tional antibacterials [14.0% (27/193) for 5 days TEL vs. 14.3%
(60/419) for 7/10-day TEL; 0.3, 95% CI (6.6, 6.0)]. Cephalospo-
rins, macrolides and quinolones were the most common addi-
tional antibacterials used, accounting for more than half of
supplementary respiratory-related antibiotics in both treatment
groups. Duration of additional antibacterial therapy was
174 days/100 patients with 5-day TEL, 145 days/100 patients
with 7/10-day TEL and 181 days/100 patients in CLA-treated
patients. For those patients who received additional treatment
with intravenous (i.v.) antibacterials, the duration of additional
treatment was 41 days/100 patients with 5-day TEL, 28 days/100
patients with 7/10-day TEL and 54 days/100 patients with
10-day CLA.
Conclusions: TEL 800 mg once daily for 5, 7 or 10 days is as effect-
ive as CLA 500 mg twice daily for 10 days for the treatment of
CAP. The tendency towards a reduced frequency and shorter dur-
ation of use of additional antibiotics, particularly i.v. therapy, sug-
gests a potential for cost savings when TEL is used to treat
patients with CAP.
P447 Seroprevalence of Chlamydophilia pneumoniae
infection in patients with chronic stable asthma
M. Aslan, K. Gu¨ven, G. Saglam, S. Altun, S. Saribas, B. Mu¨sellim,
B. Gemicioglu, B. Kocazeybek
Istanbul, TR
Objectives: Asthma is an inﬂammatory disease in which the air-
ways become blocked or narrowed, constriction in the bronchi
and bronchioles and a feel of tightness in the chest. Chlamydophilia
pneumoniae like genetic and environmental factors contribute to
the development of asthma. This study was designed to investi-
gate the presence of C. pneumoniae-speciﬁc IgG, IgA and IgM anti-
bodies in sera samples of 50 adults with a clinical history of
chronic stable asthma and 50 healthy individuals as control
group.
Methods: The correlation between C. pneumoniae-speciﬁc antibod-
ies in chronic stable asthma cases and eosinophilia cationic pro-
tein (ECP) levels were also evaluated. 50 stable chronic asthma
cases (12 male, 38 female) between the ages 14 and 70 were evalu-
ated for FEV (forced expiratory volume), ECP, allergic state and
smoking habits. C. pneumoniae-speciﬁc IgG, IgA and IgM antibod-
ies were also investigated for this group.
Results: Healthy control group was matched with patient group
for age, gender, locality and smoking habits C. pneumoniae seropo-
sitivity (a past C. pneumoniae infection) was found in 68% (34)
and 58% (29) of stable asthma cases and control groups, respect-
ively (P > 0.05). C. pneumoniae-speciﬁc IgA was found higher in
34% (17) and 18% (9) of stable asthma and control groups
respectively (P > 0.05). The indication of chronic C. pneumoniae
infection ( IgG > 1/512 and IgA > 1/40) was found in 28% (14)
and 10% (5) of stable asthma cases and control group, respect-
ively (P < 0.05). A statistically signiﬁcant difference was not found
between chronic stable chronic asthma and control groups for
chronic C. pneumoniae seropositivity and smoking. Also a statisti-
cally signiﬁcant difference was not found between ECP positive
and negative patients for chronic C. pneumoniae infection seroposi-
tivity (P > 0.05).
Conclusions: As conclusion, this study supports that there can be a
relationship between chronic C. pneumoniae infections and stable
asthma cases.
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P448 Severe community-acquired pneumonia: impact of
empirical antimicrobial treatment on outcome
M. Daganou, P. Bakakos, A. Sakellaropoulos, M. Kompoti,
A. Paridou, M. Ktena, A. Rassidakis
Athens, GR
Objectives: To assess the impact of empirical antimicrobial therapy
on the outcome of severe community-acquired pneumonia
(SCAP).
Methods: Prospective observational study of patients with SCAP
admitted to the ICU of a Hospital of Chest Diseases since January
1998. Immunocompromised patients and patients with a known
causative microorganism at the time of admission were excluded.
After initial laboratory testing empirical antimicrobial treatment
was started by the attending physician.
Results: Sixty-seven patients were studied (45 male, mean age
56  18 years, mean APACHE II score 15  6), ﬁfty-one of whom
needed mechanical ventilation (76%). Empirical antimicrobial reg-
imens included combination of two to four antibiotics. A combi-
nation of a beta-lactam with a macrolide or a quinolone was
administered to 54 patients (80%). Twenty-seven (40%) received
an aminoglycoside, 16 (24%) received antistaphylococcal agents
and 14 (21%) antibiotics against anaerobic microorganisms. Strict
adherence to management guidelines of ATS and/or BTS was
noted in 39 cases (58%). In most cases (72%), non-compliance
consisted of using more antimicrobial agents than those recom-
mended. Overall mortality was 43%. Patients treated with a beta-
lactam+macrolide or quinolone combination had signiﬁcantly
lower mortality compared with those treated with other regimens
(37% vs. 77%, P ¼ 0.01). Concomitant use of other agents had no
impact on outcome. adherence to management guidelines was not
shown to inﬂuence mortality.
Conclusions: Non-adherence to management guidelines was fre-
quently encountered among ICU patients with SCAP. Overuse of
aminoglycosides and/or antistaphylococcal agents was the main
cause of divergence from guidelines. However, this was not
shown to affect mortality. Use of a combination of beta-lac-
tam+macrolide or quinolone was associated with lowest mortality
rate.
P449 Efﬁcacy of linezolid for the treatment of pneumonia
caused by penicillin (PRSP) or multi-drug resistant (MDRSP)
Streptococcus pneumoniae (SP)
K. Tack, M. Ijzerman, R. Croos-Dabrera
Ann Arbor, USA
Objective: SP is becoming resistant to many antimicrobials com-
monly used to treat pneumonia, a common and potentially fatal
infection. Linezolid is a new antimicrobial with bactericidal activ-
ity against SP. The objective of this analysis was to assess the
efﬁcacy of linezolid for the treatment of pneumonia caused by SP,
including PRSP and MDRSP.
Methods: A meta-analysis was performed pooling data from seven
studies evaluating linezolid for the treatment of community- or hos-
pital-acquired pneumonia. Patients were required to have symp-
toms compatible with pneumonia and a chest X-ray showing an
acute inﬁltrate. Adults received 600 mg linezolid i.v./p.o. q12 h,
and children received 10 mg/kg q12 h, for a mean of 11 days. For
this analysis, patients with SP isolated from sputum and/or blood
were considered; these patients were included in the modiﬁed
intent-to-treat (MITT) population. Patients who met stricter criteria
constituted the microbiologically evaluable (ME) population. PRSP
were deﬁned as isolates with an MIC > 2 mcg/mL; MDRSP were
deﬁned as isolates resistant to at least two of the following classes:
penicillin, second-generation cephalosporins, macrolides, tetracy-
clines, or TMP/SMX.
Results: Of 536 SP isolates, including those from patients receiving
control regimens, the MIC90 for linezolid was 1 mcg/mL, with a
range of <0.125 mcg/mL to 4 mcg/mL. There were 275 SP
patients in the linezolid-treated MITT population, and 212 in the
ME population; clinical cure rates in these two groups were 85
and 90%, respectively, among patients whose outcomes could be
assessed. There were 34 MITT and 25 ME patients with PRSP,
with clinical cure rates of 74 and 84%, respectively. In bacterae-
mic ME patients with SP the clinical cure rate was 61/66 (92%)
and in those with PRSP it was 7/8 (88%). Amongst the ME
patients with PRSP and whose isolates were resistant to at least
one other class of antimicrobial (MDRSP), clinical cure rates and
microbiological eradication rates ranged from 75 to 100%.
Conclusion: Linezolid is an effective agent for the treatment of
pneumonia caused by SP, including strains resistant to other anti-
microbials.
P450 Pathogenic role, epidemiology, and susceptibility to
antimicrobial agents of Neisseria meningitidis isolated from
lower respiratory tract secretions of adult patients
E. Cercenado, B. Padilla, P. Martı´n-Rabada´n, N. Garcı´a-Escribano,
O. Pe´rez-Olaso, E. Bouza
Madrid, E
Objectives: Meningococcal pneumonia has been a recognised clin-
ical syndrome for over 20 years. Because of the nasopharyngeal
carriage of N. meningitidis (NM), the ability to establish the diag-
nosis based on the culture of respiratory samples (RS) alone is
hazardous. To assess the incidence of respiratory infections
caused by NM, the serogroups, and the antimicrobial susceptibil-
ity of the isolates, we reviewed the 20 cases of NM isolated from
RS of adult patients which occurred at our institution from 1999
to 2003.
Methods: Ours is a large teaching institution (1800 beds) serving a
population of 640 000 inhabitants. All signiﬁcant RS of patients
suspected of having pneumonia were quantitatively cultured onto
blood agar, chocolate agar, and MacConkey agar. Isolates were
identiﬁed by standard procedures. Susceptibility testing was per-
formed by the broth microdilution method with 5% lysed horse
blood. Beta-lactamase production was detected using the nitroce-
phin test. Serogroups were determined at the National Reference
Laboratory for Meningococci in Spain.
Results: Over the study period, 15 003 RS were processed. Among
those, 40.7% were positive. NM represented 0.4% of all positive
samples. The evolution of cases was: 1999, two cases (0.03/1000
admissions); 2000, 0 cases (0/1000); 2001, seven cases (0.11/1000);
2002, two cases (0.03/1000), 2003, nine cases (0.14/1000). The ori-
gin of isolates was bronchial aspirate (13 cases), bronchoscopic
specimens (4), and sputum (3). Serogroups were B (17); C, Y and
29E, one case each. 80% of the isolates were non-susceptible to
penicillin (MICs 0.12–0.25 mg/L). None of the isolates produced
beta-lactamase and all were fully susceptible to cefotaxime, rifam-
pin and ciproﬂoxacin. Fifteen patients were hospitalised in ICUs.
Nine patients were diagnosed of pneumonia (four monomicrobial
and ﬁve polymicrobial) and 11 were colonised. None developed
meningococcal bacteraemia.
Conclusions: The pathogenic role of NM in lower respiratory tract
infections of adults is probably underestimated because its isola-
tion is difﬁcult. In our area the most frequent serogroup was B,
and we found a high incidence of penicillin-resistant (non-sus-
ceptible) isolates.
P451 Efﬁcacy of a 7-day course of oral telithromycin
800 mg once daily in community-acquired pneumonia caused
by resistant Streptococcus pneumoniae
C. Fogarty, D. Rensburg van, C. Salvo de, M. Rangaraju,
R. Nusrat
Spartanburg, USA; Witbank, ZA; Federal Capital, AR; Romainville, F;
Bridgewater, USA
Objectives: The ketolide telithromycin has a targeted spectrum
of antibacterial activity for the treatment of community-acquired
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respiratory tract infections, that provides coverage of all relevant
pathogens, including atypical/intracellular organisms and Strepto-
coccus pneumoniae resistant to penicillin (PRSP) and/or erythromy-
cin (ERSP). Previous studies have shown that oral telithromycin
800 mg once daily for 7–10 days is an effective treatment for
patients with community-acquired pneumonia (CAP). The efﬁcacy
and tolerability of 7-day telithromycin in patients with CAP,
including those with CAP caused by PRSP and/or ERSP, were
investigated further in this multicentre multinational study.
Methods: A total of 858 patients (aged 13 years) with CAP
received telithromycin 800 mg once daily for 7 days in an open
label, non-comparative study that aimed to recruit a high propor-
tion of patients with pneumococcal aetiology. Clinical and bac-
teriological outcomes were assessed in the clinical and
bacteriological per-protocol populations (PPc, n ¼ 723; PPb,
n ¼ 274) 10–17 days post-therapy [test of cure (TOC) visit].
Results: Clinical cure and bacteriological eradication were
achieved in 15/16 (93.8%) patients infected with resistant pneu-
mococci: 14/15 (93.3%) patients with ERSP and 7/7 with PRSP.
Overall, satisfactory bacteriological outcome was achieved in
87.6% (240/274) of patients at TOC, with 94.6% (122/129) of
S. pneumoniae, 87.8% (108/123) of Haemophilus inﬂuenzae, 80%
(16/20) of Moraxella catarrhalis and 80.8% (21/26) of Staphylococ-
cus aureus strains being eradicated/presumed eradicated. In total,
89.3% (646/723) of patients were assessed as clinically cured at
the TOC visit. Telithromycin treatment was well tolerated. Over-
all, 15.7% (135/858) of patients experienced treatment-emergent
adverse events (TEAEs) classiﬁed as possibly related to study
medication, the majority of which (occurring in 112 patients) were
mild in intensity. The most common possibly treatment-related
TEAEs were diarrhoea [4.7% (40/858)] and nausea [3.3%
(28/858)].
Conclusion: A 7-day regimen of oral telithromycin 800 mg once
daily is an effective and well-tolerated ﬁrst-line treatment option
for CAP, including infections caused by resistant pneumococci.
P452 Efﬁcacy of telithromycin in patients with community-
acquired respiratory tract infections caused by Streptococcus
pneumoniae, including resistant strains
C. Fogarty, P. Buchanan, M. Aubier, M. Baz, D. van Rensburg,
M. Rangaraju, R. Nusrat
Spartanburg, Eugene, USA; Paris, F; Fresno, USA; Witbank, ZA;
Romainville, F; Bridgewater, USA
Objectives: The ketolide telithromycin has a targeted spectrum of
antibacterial activity for the treatment of community-acquired res-
piratory tract infections (RTIs), providing coverage of all relevant
RTI pathogens, including Streptococcus pneumoniae resistant to
penicillin [PEN (PRSP)] and/or erythromycin [ERY (ERSP)]. This
analysis of data pooled from 14 Phase III/IV studies evaluated
the clinical and bacteriological efﬁcacy of telithromycin 800 mg
once daily in the treatment of pneumococcal community-acquired
RTIs.
Methods: Isolates of S. pneumoniae were collected from patients
with community-acquired pneumonia, acute exacerbations of
chronic bronchitis or acute bacterial sinusitis in 14 Phase III/IV
clinical studies. Patients received telithromycin 800 mg once daily
for 5, 7 or 7–10 days. Isolates were tested for susceptibility to
PEN, ERY and telithromycin by MIC testing at a central laborat-
ory. Clinical and bacteriological outcomes were assessed at
post-therapy (Day 17–24) in the bacteriological per-protocol (PPb)
population.
Results: S. pneumoniae was identiﬁed as a causative pathogen in
555 telithromycin-treated patients in the bacteriological modiﬁed
intent to treat (bmITT) population; 493/495 (99.6%) evaluable iso-
lates were susceptible to telithromycin at an MIC of 1 mg/L.
PPb clinical cure and satisfactory bacteriological outcome rates for
all S. pneumoniae infections were 92.7% (404/436) and 94.3%
(411/436), respectively. Clinical cure and satisfactory bacteriologi-
cal outcome rates were both 82.4% (28/34) for PRSP (PEN MIC
2 mg/L), both 84.6% (44/52) for ERSP (ERY MIC  1 mg/L)
and both 83.3% (30/36) for PEN-intermediate (PEN MIC
0.12–1 mg/L)/PRSP/ERSP infections. Of 82 patients with pneu-
mococcal bacteraemia, 74 (90.2%) were clinically cured, including
5/7 and 8/10 with PRSP or ERSP, respectively. Telithromycin was
well tolerated with the majority of treatment-emergent adverse
events (TEAEs) of mild to moderate intensity. TEAEs considered
by investigators to be possibly related to treatment were reported
by 1071/4045 (26.5%) patients, the most frequent being diarrhoea
(7.6%), nausea (5.3%) and headache (1.5%).
Conclusion: Telithromycin 800 mg once daily for 5–10 days is an
effective and well-tolerated treatment for community-acquired
RTIs caused by S. pneumoniae, including isolates resistant to PEN
and/or ERY.
P453 Epidemiology of hospitalised patients with AECB
(acute exacerbation of chronic bronchitis) and Gram-negative
bacilli in the sputum
I. Go´mez De Argila, C. Garcia Vidal, P. Almagro Mena,
H. Monzo´n Camps, L. Cuadra Llompart, L. Canales, E. Cuchı´,
J. Garau
Terrassa, E
Objectives: To describe the epidemiological, clinical and microbio-
logical characteristics of patients admitted to hospital with an
acute exacerbation of chronic obstructive pulmonar disease
(COPD) and Gram-negative bacilli in the sputum.
Methods: During a 6-month period, we studied prospectively all
patients admitted to hospital with an acute exacerbation of COPD
and Gram-negative bacilli in the sputum. Diagnosis of COPD and
acute exacerbation were deﬁned following GOLD and Anthonisen
criteria, respectively. Age, gender, smoking history, pulmonary
function (FEV1), presence of bronchiectasis, previous use of antibi-
otics, previous hospital admission, Emergency Room visits and
microbiological data at entry were recorded.
Results: From July to November 2003, 111 patients were admitted
to hospital for AECB. Thirty patients (27%) had Enterobacteria-
ceae or P. aeruginosa in the sputum. There were 28 men, mean age
75.2 years (10), 22 were ex-smokers and four were current smok-
ers and 46% of the patients had been exposed to antimicrobials in
the previous 3 months. Nineteen had been admitted to hospital
and another 10 had been in the Emergency Room in the past year,
respectively. Of the 22 patients who received antimicrobial ther-
apy on admission, treatment was modiﬁed in six (20.7%) accord-
ing to the sputum microbiological ﬁndings. The mean length of
stay of 12.3 days (6.95). Mean FEV1 during stable phase of the ill-
ness was 805 mL (47.6) (40.89% of predicted). P. aeruginosa was
isolated in 15 of the 30 patients (50%), multiple Enterobacteriaceae
in 12 patients, S. marcescens in one patient and K. pneumoniae in
two patients. Bronchiectasis were present (thoracic scanner) in
75% of patients.
Conclusions: The prevalence of bronchial colonisation/infection
with Gram-negative bacilli in COPD patients with AECB and
mean FEV1 values of approximately 40%, are higher than those
reported previously in retrospective studies. More than 2/3 of the
patients had been admitted to hospital during the past year and
half had been treated with antimicrobials in the recent past. A
striking ﬁnding was the prevalence of underlying bronchiectasis,
present in 75% of this population.
P454 Procalcitonin and neopterin correlates with aetiology
and severity in adults with pneumonia
C. Prat, J. Domı´nguez, J. Ruiz-Manzano, S. Blanco, R. Rivelo,
F. Andreo, V Ausina
Badalona, E
Clinical outcome of pneumonia depends of a multifaceted treat-
ment approach. Not only diagnostic methods but also early indi-
cators of the degree of inﬂammatory response can aid in
therapeutic decisions.The aim of this study was to evaluate the
94 Abstracts
usefulness of procalcitonin (PCT) and neopterin in distinguishing
among aetiologies and severity of pneumonia.
Methods: The study population were patients with clinical signs of
lower respiratory tract infection and pathological ﬁndings on the
chest radiograph. Samples were collected at admission for microbio-
logical procedures in order to establish the aetiological diagnosis.
Were eligible for the study entry only those diagnosed of pneumo-
coccal or Legionella pneumonia. Patients were grouped into ﬁve risk
classes according to the Pneumonia Severity Index (PSI). Patients
were also grouped by the presence of unilobar or multilobar radio-
graphic pulmonary inﬁltrates. PCT was measured by
immunoluminometric assay (Lumitest PCT, Brahms Diagnostica)
and neopterin was measured by enzyme immunoassay (Neopterin
ELISA, IBL).
Results: Eighty-seven patients were included in the study. Sev-
enty-six patients were diagnosed of pneumococcal pneumonia.
Streptococcus pneumoniae was isolated in blood culture in 15
patients. The rest were diagnosed by detection of pneumococcal
capsular polysaccharide in urine samples by counter immuno-
electrophoresis. Twenty-one patients were diagnosed by urinary
antigen detection of Legionella pneumophila serogroup 1 by enzyme
immunoassay (Bartels EIA Legionella Urinary Antigen). Patients
with pneumococcal pneumonia presented elevated both procalci-
tonin (mean 11.11 ng/mL) and neopterin (mean 87.43 ng/mL)
levels, being higher in bacteraemic than in non-bacteraemic pneu-
monia (P ¼ 0.059 for PCT and P ¼ 0.015 for neopterin). Patients
with Legionella pneumonia presented elevated neopterin levels
(mean 86.89 ng/mL) and slightly elevated PCT levels (mean
1.04 ng/mL). When comparing the levels of both markers accord-
ing to PSI class, patients in high risk class (IV and V, 33 patients)
had signiﬁcantly more elevated PCT levels (P ¼ 0.021) than
patients in low-risk class (I to III, 64 patients). Neopterin presen-
ted a lowest correlation (P ¼ 0.091). Both PCT and neopterin
yielded a signiﬁcant correlation to the radiographic extent of the
pneumonia (P ¼ 0.002 and P ¼ 0.020, respectively).
Conclusion: PCT and neopterin levels show a signiﬁcant correla-
tion to the aetiology and the severity of the pneumonia.
P455 Rapid centrifugal method for Legionella antigen
concentration in urine samples
J. Domı´nguez, S. Blanco, C. Prat, R. Rivelo, M.D. Sa´nchez,
M.A. Pallare´s, V. Ausina
Badalona, E
The aim of the present study was to evaluate the utility of the
antigen concentration method by centrifugal ultraﬁltration
(Amicon Ultra-4. Millipore Corporation, Bedford, MA, USA) for
detecting Legionella pneumohila antigen in urine samples by
immunochromatographic (ICT) method, comparing it to the
passive selective ultraﬁltration (Uriﬁl-10. Millipore Corporation).
Materials and methods: Group 1: we studied 35 urine samples from
patients with pneumonia caused by L. pneumophila. Legionnaires’
disease was diagnosed by detection of soluble antigen from Legio-
nella pneumophila serogroup 1 in urine samples by Binax EIA. The
second group consisted of 35 urine samples from patients with
pneumonia of other aetiologies (15 Streptococcus pneumoniae, 15
Mycoplasma pneumoniae, and ﬁve Chlamydia pneumoniae). The third
group consisted of 15 urine samples from patients with no clinical
or radiological signs of pneumonia, the pacients had urinary tract
infections (10 Escherichia coli, one Pseudomonas aeruginosa, two Pro-
teus mirabilis, one Klebsiella pneumoniae).
Results: The results of the ICT test using urine samples concentra-
ted by passive and centrifugal ultraﬁltration were identical in the
35 samples from group 1 patients (100% agreement). Urine sam-
ples, concentrated by both methods, from patients with pneu-
monia of other aetiologies or no clinical symptoms or signs of
pneumonia but with urinary tract infection (groups 2 and 3) were
all negative by ICT. The overall agreement between both the con-
centration methods, considering the three patient groups, was
100%.
Conclusions: (1) The antigen detection of Legionella in urine
samples concentrated by passive ultraﬁltration and centrifugal
ultraﬁltration shows a concordance of 100%. (2) The centrifugal
concentration is an easy and rapid system (15–30 min). Therefore,
in less than 1 h we could obtain the result of Legionella antigen
detection. (3) The concentration of urine samples by centrifugation
did not represent a decrease in the sensitivity and speciﬁcity of
the antigen detection.
P456 Usefulness of PORT-score to decide hospitalisation of
patients with community-acquired pneumonia: analysis of 509
consecutive patients classiﬁed in categories I and II
C. Font, E. Garcı´a-Va´zquez, M. Cavalcanti, M. Camps, I. Aldabo´,
C. Esquinas, M.A. Marcos, J. Mensa, A. Torres, J. Puig de la
Bellacasa
Barcelona, E
Objectives: Pneumonia Patient Outcomes Research Team (PORT)
has developed a prediction rule to identify patients with commu-
nity-acquired pneumonia (CAP) who are at risk for death and
other adverse outcomes. The authors recommend outpatient man-
agement for Fine categories I and II.
Methods: Observational study of patients with CAP and class I
and II according to PORT-score at a tertiary general hospital.
Prospective data collection has been done according to a protocol
of CAP (October 1996–November 2003). We analysed epidemio-
logical, clinical, radiographic and laboratory data and outcome of
hospitalised patients compared with outpatients. Decision about
admission or discharge was made on clinical and not algorithms
judgement.
Results: Five hundred and nine (23.8%) of 2139 patients with CAP
were classiﬁed in Fine categories I and II; 376 (73.6%) were hospi-
talised (364 in general wards and 12 (3.2%) in an intensive care
unit (ICU)), representing 19.4% of all CAP admissions. Mean age
(44 vs. 39; P ¼ 0.002), CRP level (17.3 vs. 13.2; P ¼ 0.004) and
PORT-score points (51 vs. 39; P ¼ 0.0001) were signiﬁcantly
higher in hospitalised patients compared with outpatients. Mean
oxygen pressure on blood was signiﬁcantly lower in the inpatient
group (68 vs. 78; P ¼ 0.0001). Chronic alcoholism (7% vs. 2.3%;
P ¼ 0.046), chronic lung disease (34.3% vs. 15.8%; P ¼ 0.0001),
HIV infection (10.1% vs. 1.5%; P ¼ 0.002), shortness of breath
(48.9% vs. 19.7%; P ¼ 0.0001), pleural effusion (11.2% vs. 2.3%;
P ¼ 0.002) and diabetes (5.6% vs. 1.5%; P ¼ 0.05) were signiﬁ-
cantly more frequent in the hospitalised group. None of the
patients died.
Conclusions: In our series, 73.6% of CAP patients in Fine categor-
ies I and II were admitted to the hospital (3.2% in ICU). Our ﬁnd-
ings suggest that some conditions (alcoholism, chronic lung
disease, HIV infection and diabetes) not considered in the PORT-
score are important medical contraindications on physicians’
judgement for outpatient care. Additional consideration is also
provided by physicians to patients who have low pO2, subjective
shortness of breath or pleural effusion. PORT-score is probably
good to predict dead and helps physicians make decisions about
hospitalisation even though the prognostic score should not
supersede clinical judgement in the decision to hospitalise as
some patients designated as being at low risk may have important
medical contraindications to outpatient care.
P457 Sputum colour as marker for clinical success in
patients with acute exacerbation of chronic bronchitis (AECB)
treated with levoﬂoxacin
H. Lode, J. Eller, K. Roscher
Berlin, D
Objectives: Bacterial exacerbations of chronic bronchitis are an
ongoing therapeutic challenge with increasing incidence in elderly
patients. Levoﬂoxacin, due to its enhanced activity against the
most common pathogens in AECB, is well accepted as a standard
treatment for this indication. The objective was to investigate
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efﬁcacy and safety in AECB-patients, documented by signs, symp-
toms and sputum colour.
Methods: In a post authorisational survey during the season 2002/
2003 a total of 1.297 outpatients (median age 59.8 years) were trea-
ted with Levoﬂoxacin 500 mg tablets o.d. for 7 days. 1.228
patients suffered from AECB. Concomitant diseases were docu-
mented in 49% and concomitant medication for 69% of the
patients. Two AECB episodes (median) occurred during the previ-
ous 12 months with a median time interval of 15 weeks between
the previous and the actual episode. The change of sputum colour
characterised by a pretrial deﬁned colour table based on the
Stockley criteria was documented by the patients on a daily basis
during the treatment.
Results: A purulent sputum was found in 95% of the 1.228
patients before treatment, but at the end of treatment in only 15%
(P < 0.001). For 1.034 patients sputum colour was rated. At day 5
a change from green/dark yellow to clear/white was observed in
45% of the patients and in 76% at day 7, end of treatment. Body
temperature decreased in 94%, improvement was observed for
cough in 93%, for breathing difﬁculties in 83%, for auscultation
ﬁndings in 88%, and for general physical condition in 86% of the
patients (each P < 0.001). At the end of observation the clinical
outcome was rated as successful in 98% of the patients (60%
cured, 38% improved). A complete release of symptoms was
reached after 6.6 days (mean) and normal everyday activities were
resumed after 6.9 days (mean). Adverse drug reactions were
reported in only two patients (0.15%).
Conclusions: The clinical outcome of a 7-day treatment with Levo-
ﬂoxacin, assessed by signs, symptoms and the change of sputum
colour as an additional marker, demonstrates a high efﬁcacy in
the present population of elderly AECB-patients with various con-
comitant diseases, accompanied by an excellent safety proﬁle,
resulting in a subsequent resumption of normal activities at the
end of treatment.
P458 Outcome and clinical differences between
pneumococcal pneumonia with and without bacteraemia
F. Jover, J.M. Cuadrado, L. Andreu, M. Rodrı´guez, R. Can˜izares,
S. Martinez, V. Ortiz, P. Roig
Alicante, E
Background: Few attempts have been made to compare bacterae-
mic and non-bacteraemic pneumococcal pneumonia, mainly
because the difﬁculties to gain agreement on which cases repre-
sent non-bacteraemic pneumococcal pneumonia. Recently, immu-
nochromatographic assay for detection of S. pneumoniae urinary
antigen has been successfully evaluated for the diagnosis of pneu-
mococcal pneumonia.
Objectives: (1) To examine and compare clinical and radiological
features, risk factors and outcome associated with bacteraemic
and non-bacteraemic groups. (2) To study vaccine indications in
patients with pneumoccocal pneumonia according the 1997 ACIP
recommendations.
Methods: A retrospective study (1995–2003) analysing the clinical
records of patients diagnosed of pneumococcal pneumonia in our
institution was performed. S. pneumoniae were identiﬁed by blood
cultures (bacteraemic group) and detection of urinary antigen
(non-bacteraemic group).
Results: There were 95 patients (70 bacteraemic and 25 non-bacter-
aemic). In seven non-bacteraemic cases another aetiology was
detected (Legionella, one case and C. pneumoniae, six cases). Table 1
shows the main differences between the two groups. Overall mor-
tality was 9.5% (without group differences). 81% cases fulﬁlled
the ACIP vaccine recommendations, although different strengths
of evidence were observed (grade A, 57%).
Conclusion: (1) In our study, smoking is the leading risk factor for
pneumococcal pneumonia. However, current smokers have an
increased risk of bacteraemic forms and former smokers and
COPD developed non-bacteraemic forms more frequently. (2) Bac-
teraemic patients need a more prolonged intravenous antibiotic
treatment than non-bacteraemic patients. (3) In accordance with
previous studies, the majority of our patients fulﬁlled the ACIP
recommendations. Then, pneumococcal vaccination should be
emphasised in persons at highest risk.
P459 Comparative assessment of moxiﬂoxacin and
macrolides in acute exacerbation of chronic bronchitis: clinical
efﬁcacy and inﬂuence on the long-term prognosis
S. Yakovlev, L. Dvoretsky, V. Nonikov, A. Strekachev,
N. Dubrovskaya
Moscow, RUS
Objectives: Comparative clinical studies usually show similar clin-
ical effectiveness of different antibiotics in acute exacerbation of
chronic bronchitis (AECB). In connection with this it seems useful
to estimate the inﬂuence of antibiotics on the long-term prognosis
for patients with AECB, i.e. the length of symptom-free period
after disease exacerbation.
Methods: It was the open randomised comparative study. Patients
with AECB who had at least two exacerbations per year were
included into the study. One group of patients with AECB were
treated by moxiﬂoxacin (MXF) 400 mg per day during 5 days and
the other group by macrolide antibiotic (azithromycin, clarithro-
mycin, or spiramycin) during 7 days. After treatment the patients
were followed up for 12 months.
Results: A total of 60 patients with AECB were included into the
study, 29 of which were treated by MXF, and 31 by macrolide
antibiotic. The average age of the patients was correspondingly
58.1 and 57.3 years, length of chronic bronchitis – 10.8 and
11.8 years. Number of AECB in previous year was similar in
both groups. Clinical cure rate estimated a week after the end of
treatment was 96.6% for MXF and 93.5% for macrolides. The
minimal period to the next exacerbation of chronic bronchitis
was 107 days in the group of MXF and 14 days in the group of
macrolides. During the follow-up period (6 and 12 months) the
incidence of AECB (requiring prescription of antibiotics) was 3.6
and 15.4% in the group of patients who were prescribed MXF,
and 17.2 and 44.0% in the group of patients who were treated
by macrolide antibiotics. Average length of symptom-free period
after MXF treatment was 49 days longer than in the macrolide
group.
Conclusion: MXF was superior to macrolides in long-term
prognosis in AECB and prolongs the period till the following
exacerbation.
Bacteremic Nonbacteremic P
Mean Age 39.8 70.8 <0.001
COPD 18% 40% 0.033
Liver Disease 16% 0% 0.028
CHF 7% 32% 0.004
Current Smoker 40% 16% 0.024
Former Smoker 17% 48% 0.004
Alcohol Abuse 30% 8% 0.021
Drug Abuse 19% 0% 0.014
HIV Infection 23% 0% <0.001
Days of Intravenous Antibiotic Treatment 6 4.5 0.006
Temperature  38.5C 41% 20% 0.044
Length of Hospitalisation 7.9 6.8 0.071
COPD: Chronic obstructive pulmonary disease. CHF: congestive heart failure.
HIV: human immunodeﬁciency virus
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Bacteraemia and endocarditis
P460 Human leptospirosis in a regional leptospira
laboratory, Piemonte (Italy)
L. Franzin, D. Cabodi, N. Bonfrate
Turin, I
Objectives: Human leptospirosis is underdiagnosed in Italy, and
often unrecognised because of the difﬁculty of clinical and labor-
atory diagnosis. The aim of the study is to report clinical and epi-
demiological features of human leptospirosis in a North-West
area of Italy with some professional risk factors (agriculture, rice
cultivation, animals farm, abattoirs).
Methods: Samples from 292 patients with suspected Leptospira
infections were examined. The serodiagnosis was performed by
microscopic agglutination test, using cultures of 20 reference
Leptospira interrogans strains (kindly provided by National Centre
for Leptospirosis, Rome, Italy). Cultures were performed on
EMJH medium (with and without 5-ﬂuorouracil) and incubated at
30C for 2 months.
Results: Diagnosis of leptospirosis was conﬁrmed in 42 (14.4%)
patients. The clinical symptoms were: fever (100%), jaundice
(76.2%), meningitis (9.5%), renal failure (73.8%), enlarged liver
(73.8%) and conjunctival suffusion (14.3%). Cultures were posi-
tives in two patients, who later died. Leptospira strains were isola-
ted from blood of a 88-year-old patient and from both blood and
urine of a 35-year-old patient. The strains were identiﬁed as L. in-
terrogans serogroup icterohaemorrhagiae, serovar icterohaemor-
rhagiae by National Centre for Leptospirosis. The largest number
of infections was ascribed to occupational activities (43%). Water
contaminated with animal urine emerged as probable source of
infection (77%). The typical leptospiral seasonal trend, with a
peak during the summer months, was observed.
Conclusion: The results conﬁrmed leptospirosis as an important
cause of infection in our region. However, strict laboratory diag-
nosis protocol must be followed in order to recognise this rare but
very severe re-emerging infection. Clinicians should be aware of
leptospirosis, especially in area with high risk factors.
P461 Streptococcus pneumoniae bloodstream infections
(SPBI): a clinical study of 460 episodes in the era of penicillin
resistance
V. Pintado, R. Blazquez, E. Loza, J. Fortun, J. Cobo, F. Dronda,
P. Martin-Davila, S. Moreno
Madrid, E
Objectives: SPBI with decreased susceptibility to penicillin are
increasing in prevalence in most European countries. The aim of
this study was to evaluate the clinical spectrum of disease in
adults and the inﬂuence of penicillin susceptibility on the out-
come of SPBI.
Methods: Retrospective study of adult cases (>18 years) of SPBI
diagnosed at our institution from 1990 to 2003. The impact of
penicillin susceptibility and initial empirical treatment on the
30-day mortality were assessed by univariate analyses.
Results: A total of 460 episodes of SPBI were evaluated. There
were 290 males (63%) and the mean age was 57.6 years (18–94).
Most patients had chronic predisposing conditions and 28% of
them had HIV infection. Decreased susceptibility to penicillin
(MIC > 0.06 mg/L), cefotaxime (MIC > 0.5 mg/L), and erythro-
mycin (MIC > 1 mg/L) was observed in 36% (154/433), 9% (17/
196), and 21% (83/400) of strains. The most common form of SPBI
was pneumonia (81%), followed by bacteraemia without focus
(7%), meningitis (6%), peritonitis (1%), and others (5%); 46 epi-
sodes (10%) were nosocomially-acquired. Patients were empiric-
ally treated with a beta-lactam (50%), a beta-lactam plus
macrolide (20%), or other regimens of monotherapy (9%) or com-
bination therapy (21%). Overall mortality rate was 22% and was
similar among patients with pneumonia (21%), bacteraemia
(27%), meningitis (23%), or peritonitis (20%). Mortality rate was
higher (P < 0.05) in patients with penicillin-resistant strains (27%)
than in cases with susceptible strains (18%), and in nosocomial
infections (54%) than in community-acquired infections (18%).
The mortality rate was similar in patients receiving monotherapy
or combination therapy (21% vs. 23%).
Conclusions: Community-acquired pneumonia remain as the most
common cause of SPBI, but an increasing proportion of the cases
(10%) are hospital-acquired infections. Decreased susceptibility to
penicillin and hospital-acquired infections are associated with a
worse prognosis in most clinical forms of SPBI.
P462 Streptococcus bovis bacteraemia: clinical
characteristics of 41 episodes
S. Higuet, B. Byl, O. Denis, M. Struelens, F. Jacobs
Brussels, B
Objectives: To assess the clinical and the therapeutic aspects and
the outcome of S. bovis bacteraemia occurring in our 858-bed aca-
demic hospital during the last 11 years.
Methods: We reviewed the clinical ﬁles of all pts with S. bovis bac-
teraemia (31 blood culture) from January 1990 to December 2001.
Results: S. bovis bacteraemia (mean positive blood cultures 2.7 per
pt) was detected in 41 pts (26 male, 15 female, mean age
64.5 years, range 27–90). All except four episodes were commu-
nity-acquired infections. Thirty-one of the 41 patients (75%) had
at least one underlying disease: neoplasia (12), cirrhosis (12), dia-
betes (seven), haemodialysis (two) and corticosteroids (eight). Ele-
ven had valvular disease (nine with prosthesis). A primary focus
of infection was found in only eight pts (19%) (six angiocholitis
and two gynaecological infections). Transthoracic and/or trans-
oesophageal echography, performed in 30 of the 36 patients who
survived more than 7 days, conﬁrmed endocarditis (BE) in 22
(73%). All nine pts with valvular prosthesis had BE (>12 months
after surgery). Metastatic foci of infection were found in 10 of the
22 pts with BE (spondylodiscitis (4), cerebral (4), splenic (3) and
renal (3) emboli). Valvular replacement was performed in two pts.
In 11 pts (27%), no primary focus of infection or BE was found
(primary bacteraemia). Colonoscopy (performed in 25 of the
36 pts who survived more than 7 days) showed one or more
lesions in 23 of them (92%): polyp (16), carcinoma (3), diverticuli-
tis (5) and ulcero-haemorrhagic colitis (1). Thirteen pts died dur-
ing hospital stay (31%), nine because of S. bovis infection. Pts with
BE more frequently suffered from neoplasia or cardiac diseases,
digestive symptoms, secondary focus of infection and lesions of
the colon and presented with longer duration of symptoms before
diagnosis (P < 0.05) as compared with patients without BE.
Conclusion: Bacteraemia caused by S. bovis was mainly associated
with endocarditis or primary bacteraemia. Colonoscopy should be
performed in all pts considering the high rate of colic lesions.
Morbidity and mortality associated with S. bovis was high in this
group of elderly pts with underlying diseases.
P463 Infective endocarditis caused by Leptospira
grippotyphosa
J. Benes, O. Dzupova, M. Kabelkova, R. Ondrejcak, R. Feuereisl,
B. Horova´
Prague, CZ
Case: A 42-year-old man with no signiﬁcant previous medical his-
tory was hospitalised for fever lasting 9 days, chills, headache,
arthralgia, vomiting, diarrhoea, and dehydration. On admission, a
marked cardiac murmur and hepatomegaly were the only patho-
logical ﬁndings. Few days later the patient developed conjunctival
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petechiae and splinter haemorrhages. Three blood cultures (Bactec
aerobic and anaerobic) collected before antibiotic treatment
remained sterile. Transoesophageal echocardiography showed
ﬁbromatous thickening of both cusps of the mitral valve, mitral
prolapse and regurgitation; two ﬂuttering 10-mm vegetations
grew from the cusps. The patient also developed severe renal fail-
ure, aseptic meningitis and hepatic abnormalities. Serum aggluti-
nins against L. grippotyphosa rose from 1:200 to 1:3200 in the sixth
week of the disease. The source of the infection could be an inad-
equately protected water well at the patient’s rural cottage. The
patient was successfully treated with intravenous amoxicillin/cla-
vulanate and ampicillin. No relapse has occured in following
2 years.
Discussion: The case nearly meets the Duke criteria of ‘deﬁnite
endocarditis’; we feel endocarditis was present. We believe the
simultaneous occurrence of two infrequent diseases (leptospirosis
and culture-negative endocarditis) is unprobable.
Conclusion: We suggest the patient underwent leptospiral endocar-
ditis. To our best knowledge this is the second report on leptospi-
ral endocarditis in the world literature.
P464 Optimal dosage of azithromycin for the treatment of
mild scrub typhus
Y. Kim
Daejeon, KOR
Objectives: Scrub typhus is one of the most important endemic
infections in Asia-Paciﬁc region and the isolation of doxycycline-
resistant Orientia tsutsugamushi prompted a search for effective
regimens alternative for doxycycline therapy. Although azithro-
mycin proved to be effective against doxycycline-resistant and
sensitive strains, its optimal dosage is not conﬁrmed yet. We con-
ducted a prospective, nonblinded, randomised trial to search opti-
mal dosage of azithromycin for the treatment of mild scrub
typhus.
Methods: Febrile patients with skin rash or eschar satisfying eligi-
bility criteria were randomly assigned to a single 500-mg dose of
azithromycin group, a single 1000-mg dose of azithromycin
group, or 1 week of daily oral 200-mg doxycycline group. Treat-
ment outcome was assessed by time to defervescence (the time
interval for body temperature to fall below 37.3C after the ﬁrst
dose of antimicrobial agents is administered).
Results: From September to November 2003, 84 patients were
assessed for eligibility. Seventy-three patients were randomly allo-
cated to each of three groups and 66 patients were completed per
protocol. Fifty-ﬁve cases (500-mg azithromycin group, 21; 1000-mg
azithromycin group, 17; doxycycline group, 17) were serologically
conﬁrmed and analysed to compare the efﬁcacy. The mean time
to defervescence was shortest for single 1000-mg dose of azithro-
mycin group (31.6  23.3 h), shorter for single 500-mg dose of
azithromycin group (39.5  26.2 h) and longest for doxycyline
group (42.9  34.4 h), but statistically not signiﬁcant (P > 0.05).
There were no treatment failure or relapses after completion of
therapy.
Conclusion: A single 500-mg dose of azithromycin is as effective as
a single 1000-mg dose of azithromycin or conventional doxycy-
cline therapy for the treatment of mild scrub typhus in South
Korea.
P465 Clinical characteristics of infective endocarditis:
descriptive review of 262 episodes and risk factors for death
S. Cicalini, C. Angeletti, E. Boumis, F. Palmieri, N. Petrosillo
Rome, I
Objectives: To determine the clinical characteristics, site of involve-
ment, microbiological ﬁndings, and outcome of infective endocar-
ditis (IE), and to identify factors associated with an increased risk
of mortality.
Methods: All cases of IE observed between January, 1980, and
December, 2001, were reviewed, and cases which satisﬁed the
Duke criteria for deﬁnite diagnosis were evaluated. Data were col-
lected with regard to demographic, clinical and laboratory charac-
teristics, blood culture results, HIV serostatus, and outcome. HIV
test was not available for patients admitted before 1985.
Results: There were 262 episodes in 246 patients (165 males). The
age of patients was 37.9  14.6 years (range 16–83). 145 (58.9%)
patients were intravenous drug users (IDUs), 51 had a history of
valvular heart disease, and 22 had a prosthetic heart valve. 80
patients were HIV-infected, and 76 of them were IDUs. The most
common organism was S. aureus, isolated in 43.1% of cases, fol-
lowed by streptococci in 23.3%. In 14.1% of cases blood cultures
were negative.The left side of the heart alone was involved in
52.7% of cases, the right side of the heart alone in 38.9%, and
both sides in 4.2%. Tricuspid valve involvement was present in
37.4% of cases, compared with mitral and aortic valve involve-
ment in 27.5% and 20.6%, respectively. More than one valve was
involved in 8.8% of cases. Staphylococci more frequently affected
IDUs (77.6%), patients younger than 30 years (44.6%), and the
right side of the heart (53%). In contrast, streptococci more fre-
quently affected patients with valvular heart diseases (39.3%),
older than 50 (29.5%), and the left side of the heart (80.3%)
(P < 0.001).Overall mortality rate was 16.2%. In multivariate ana-
lysis negative blood cultures, left sided and multivalvular IE were
associated with an increased risk of death. The mortality rate
among HIV-positive patients was 25.3% compared with 11.9% in
HIV-negative patients with an attributable mortality of 13.4%.
Conclusions: Clinical characteristics of IE in our institution prob-
ably reﬂect the predominance of IDUs. The causative organisms
were signiﬁcantly associated with the predisposing condition, age
of patients, and site of heart involvement. Negative blood cultures,
and left side or multivalvular heart involvement were strong risk
factors for mortality. Work funded by Ricerca Corrente IRCCS.
P466 Risk and prognosis of community-acquired
bacteraemia caused by E. coli and other members of
Enterobacteriaceae in patients with diabetes mellitus
R.W. Thomsen, H.H. Hundborg, H.-H. Lervang, S.P. Johnsen,
H.T. Sørensen, H.C. Schønheyder
Aalborg, Aarhus, DK
Objective: Diabetic patients are considered at high risk for severe
infections originating foremost from the urinary tract. We conduc-
ted a population-based study to examine whether patients with
diabetes have an increased risk or a poorer prognosis for commu-
nity-acquired Enterobacteriaceae bacteraemia when compared
with non-diabetic patients.
Methods: We included all patients above 15 years of age in the
North Jutland County Bacteraemia Registry, Denmark, with a ﬁrst
hospitalisation for community-acquired monomicrobial bacterae-
mia because of a member of the family Enterobacteriaceae from
1992 through 2001. Ten gender- and age-matched population con-
trols per case were selected, using a unique personal identiﬁer.
Diabetes was determined by record-linkage with the County Pre-
scription Database (for prescriptions for antidiabetic drugs) and
the Hospital Discharge Registry. We did conditional logistic
regression analyses to estimate the risk for bacteraemia among
diabetic and non-diabetic persons, with adjustment for a range of
comorbid diseases using Charlson’s comorbidity index. Addition-
ally, we compared case fatality rates for diabetic and non-diabetic
patients with bacteraemia, using Cox proportional-hazards regres-
sion analyses to adjust for possible confounding factors inﬂuen-
cing case fatality.
Results: A total of 1317 incident cases with a ﬁrst hospitalisation
for Enterobacteriaceae bacteraemia were identiﬁed. 225 cases
(17.1%) had diabetes recorded before the date of hospitalisation
with bacteraemia, compared with 779 (5.9%) of controls. The
adjusted OR for bacteraemia in persons with diabetes was 2.9
(95% CI: 2.4–3.4). The highest relative risk was noted in adults
under 65 years (adjusted OR ¼ 5.9, 95% CI: 3.9–9.0) and in
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persons without any other recorded comorbidity (adjusted
OR ¼ 4.9, 95% CI: 3.7–6.6).The case-fatality in diabetic patients
compared with non-diabetic patients was 17.3% vs. 13.4% after
30 days, and 23.6% vs. 19.5% after 90 days. After adjustment for
gender, age, comorbidity, and focus of infection, the 30-day mor-
tality rate ratio for diabetic patients was 1.4 (95% CI: 1.0–2.0) com-
pared with the non-diabetic patients.
Conclusions: Diabetes seems to be a strong risk factor for commu-
nity-acquired bacteraemia caused by E. coli and other Enterobacteri-
aceae. Furthermore, patients with diabetes appear to have a higher
case-fatality in this severe infection than non-diabetic patients.
P467 Predictors of bacteraemia in hospitalised patients
with infectious cellulitis
J. Carratala`, N. Ferna`ndez-Sabe´, B. Roso´n, E. Marcos,
L. Calatayud, V. Isern, J. Ribes, F. Gudiol
L’Hospitalet de Llobregat, Barcelona, E
Objectives: Among patients with cellulitis, the development of bac-
teraemia is associated with a high risk of adverse outcomes. We
sought to identify predictors of bacteraemia at the time of presenta-
tion to the hospital emergency department in patients with cellulitis.
Methods: Review of medical charts of all adult patients hospitalised
for community-acquired cellulitis (Jan 95–Dec 02) who had blood
cultures performed on admission. Cellulitis complicating diabetic
foot ulcers, orbital cellulitis, HIV-infected patients, and drug
addicts were excluded. For the purpose of the study, patients with
bacteraemia were compared with patients without bacteraemia.
Results: There were 329 cases of cellulitis (184 female); mean age
of 61.5 years. The infection was microbiologically documented in
115 cases (53 bacteraemia, 65 needle aspiration, and 20 surgical
sample). The organisms isolated most frequently were Staphylococ-
cus aureus 34, Streptococcus pyogenes 25, groups B, C, and G strep-
tococci 19, Pseudomonas aeruginosa 14, and ﬁve Escherichia coli.
Overall, 53 (16%) patients had bacteraemia and 276 patients had
negative blood cultures. The development of in-hospital clinical
complications (32% vs. 12%; P < 0.001) and overall mortality
(<30 days) (19% vs. 2%; P < 0.001) were more frequent in patients
with bacteraemia than in patients without bacteraemia. Factors
signiﬁcantly associated with bacteraemia by univariate analysis
were: male sex (55% vs. 42%), age >60 years (77% vs. 56%), pre-
sence of multiple comorbidities (25% vs. 14%), duration of symp-
toms <2 days (54% vs. 33%), hypoalbuminaemia (<30 g/L) (46%
vs. 28%), renal insufﬁciency (creatinine > 150 mmol/L) (25% vs.
6%), and shock (15% vs. 2%). Multivariate analysis identiﬁed age
>60 years (OR 1.88), duration of symptoms <2 days (OR 2.19),
and shock (7.58) as independent predictors of bacteraemia.
Conclusion: The predictors of bacteraemia delineated in this study
may help clinicians to identify a subset of patients with cellulitis
at a high risk of complications and mortality.
P468 Cytokine proﬁle and nitric oxide levels in sera of
patients with acute brucellosis
M. Reﬁk, N.M. Bayraktar, Y. Ersoy, R. Durmaz
Malatya, TR
Objectives: This case control study, aims to investigate serum
cytokines proﬁle (TNF-alpha, IL-1 beta, IL-2R, IL-6, and IL-8) and
nitric oxide (NO) in untreated human brucellosis and assay corre-
lation of such parameters with each other.
Methods: The study covered 67 subjects. It comprised a total of 37
patients with brucellosis. Control subjects were 30 healthy indi-
viduals with no history of Brucella infection. Brucellosis was iden-
tiﬁed according to the positive blood culture and raised Brucella
antibodies in serological tests in addition to compatible clinical
symptoms. Cytokine proﬁle analysis was performed according to
the Immulite chemiluminescent enzyme immunometric assay.
Nitrites/nitrates are representatives for NO. Their serum level
was measured by Griess method.
Results: Patients with brucellosis had signiﬁcantly elevated serum
levels of nitrites/nitrates, IL-2R, IL-6 and IL-8 compared with
healthy controls whereas levels of TNF-alpha and IL-1 beta were
not changed. We could not ﬁnd statistically signiﬁcant correlation
between any of the studied cytokine levels and nitrate/nitrite con-
centration except for that between IL-2R and direct nitrite
(r ¼ 0.471). There was also positive correlation between direct
nitrite and total nitrite (r ¼ 0.671).
Conclusion: Certain cytokines are only elevated in acute brucellosis
and such extent of elevation depends on severity of illness. Moder-
ate elevation in serum NO was observed that is comparable with
previous experimental studies. This explains absence or very rare
occurrence of septic shock in brucellosis but it may prolong intracel-
lular survival of Brucella and subsequent development of chronic
infection. Nonetheless some cytokines and NO altogether may take
part in disease process of Brucella infection and affect its outcome.
P469 The various clinical manifestations of brucellosis: a
review of 43 cases
A. Yuce, S. Alp Cavus, N. Yapar, N. Cakir
Izmir, TR
Objective: Brucellosis is a zoonotic disease that involves many sys-
tems such as musculoskeletal, gastrointestinal, genitourinary, car-
diovascular, central and peripheral nervous systems. In this study
we aimed to investigate the clinical courses, laboratory features
and prognosis of cases with brucellosis.
Results: We evaluated 43 patients (25 M, 18 F, of mean age
41.4 years). Acute, subacute and chronic forms of infection’s rates
were 53.5, 30.2 and 16.3% respectively. The main symptoms were
malaise (83.7%), fever (62.8%), sweating (53.5%), arthralgia
(48.8%), anorexia (46.5%), myalgia (27.9%), headache (25.6%),
weight loss (23.3%) and cough (14%). The most frequent signs
were hepatomegaly (27.9%), splenomegaly (16.3%), lymphadeno-
megaly (11.6%), spondylitis (27.9%) and peripheral arthritis (7%).
Laboratory ﬁndings were as follows: Anaemia (39.5%), leucopenia
(7%), lymphocytosis (16.3%), pancitopenia (4.7%), increase of
ESR (34.9%), CRP (30.2%), and liver enzymes (25.6%). Standart
tube agglutination test was positive in 90.7% of the patients. Total
culture positivity was 39.5% (32.55% of blood, 4.7% of CSF, 2.3%
of abscess specimens). Focal diseases were observed in 48.9% of
the patients (spondylitis 27.9%, neurobrucellosis 11.6%, paraverte-
bral abscess 7%, endocarditis 2.3%). Based on the clinical
response different treatment regimens were given and uncompli-
cated patients were treated for 6–12 weeks with rifampin–doxycy-
cline or streptomycin–doxycycline.Complicated cases such as
neurobrucellosis, endocarditis and paravertebral abscess were
treated with appropriate combinations for 6–16 months. During
follow up, one patient had pulmonary complication because of
brucellosis; four patients underwent surgery because of paraverte-
bral abscess (three cases) and endocarditis (one case). Treatment
failure was seen in two patients and the therapy was changed.
There was no relapsing case in our follow-up period.
Conclusion: Brucellosis is an infectious disease that can cause var-
ious clinical manifestations and complications. In all the cases
with fever, arthralgia, and malaise brucellosis should be consid-
ered especially in endemic areas.
P470 Brucellar spondylitis (clinical manifestations and
outcome of treatment in 32 cases)
M.R. Hasanjani Roushan, S.M. Smailnejad Ganji,
A. Ahmadi Ahangar
Babol, IR
Objectives: Brucellar spondylitis is common in endemic regions of
brucellosis.The purpose of this study was to assess the clinical
manifestations and outcome of treatment in brucellar spondylitis.
Methods: From September 1998 to June 2003, 32 cases of brucellar
spondylitis who attended the Department of Infectious Diseases,
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Babol Medical University were studied. All cases were treated
with cotrimoxasol plus rifampin or doxycycline plus rifampin for
4 months and all cases were followed for 1 year after completion
of therapy. Clinical manifestations and outcome of treatment were
recorded.
Results: Thirty-two cases (24 male, eight female, mean age,
46  17 years, ranged 18–77 years) were evaluated. Disease was
acute and subacute in 28 (87.5%) cases. Severe back pain, sweat-
ing and fever were the most clinical symptoms and were seen in
100, 62.5 and 47% cases respectively. Involvement of lumbar, dor-
sal and cervical regions were seen in 26, 2 and 4 cases, respect-
ively. Seventeen and 15 cases were treated with cotrimoxasol plus
rifampin or doxycycline plus rifampin for 4 months, respectively.
Only one case in doxycycline plus rifampin treated group had
relapse (P > 0.05).
Conclusion: Severe back pain, sweating and fever were the most
clinical symptoms. Four months of therapy is sufﬁcient in the
treatment of brucellar spondylitis.
P471 Successful treatment of Brucella melitensis
endocarditis with antibiotic combination
O. Ural, N. Dikici, D. Findik
Konya, TR
In July 2003 a 22-year-old woman presented at the hospital with
fever, shivering and weight loss. The agglutination test for Brucella
was positive at a titer of 1/320. A transoesophageal examination
showed vegetations and Brucella endocarditis was suspected. A
blood culture growth of Brucella melitensis biotype 1 conﬁrmed our
dignosis. The treatment was started with 600 mg/day rifampin,
2  100 mg/day doxycycline and TMP-SMX 160/800 mg twice
daily. Two months later TMP-SMX therapy ceased, rifampin and
doxycycline therapy continued a further 6 months. At the clinical
follow up, there were no signs of heart failure or peripheric embol-
ism. On the seventh day of therapy the fever decreased. After treat-
ment a repeat transoesophageal echocardiography showed that the
vegetations at the aorta valve disappeared. At 1-year follow up, the
patient was healthy. If there is no history of congestive cardiac fail-
ure and prosthetic valve involved and only moderate extravascular
cardiac involvement medical treatment may be a valid alternative
to surgical therapy as advised in some literature where the patient’s
ilness is not prolonged.
P472 Clinical features and prognosis of B melitensis
vertebral osteomyelitis. A descriptive study of 148 cases
J.D. Colmenero, E. Jime´nez-Mejı´as, M.A. Baro´n Ramos,
J. Palomino-Nica´s, J.D. Ruiz Mesa, J. Chaco´n, J.M. Reguera
Iglesias, J. Pacho´n SAEI Study Group
Objectives: To describe current clinical, radiological, diagnostic
and therapeutic characteristics and prognosis of Brucelar Vertebral
Osteomyelitis (BVO).
Methods: We carried out a prospective, descriptive study of 446
patients with Vertebral Osteomyelitis (VO) from January 1983 to
October 2003 in two tertiary hospitals. Diagnosis of VO was estab-
lished by the presence of spinal pain unrelieved by rest or fever and
spinal pain on physical examination, together with imaging com-
patible with VO. Diagnosis of BVO was established according to
one of the following criteria: (1) Brucella spp isolation in vertebral,
paravertebral, or epidural tissue or a psoas sample. (2) Brucella spp
isolation in blood cultures, high titers of Brucella antibodies or sero-
conversion in the presence of a compatible clinical and radiological
picture of VO. All patients were treated with doxycycline 100 mg
b.i.d. for 3 months plus streptomycin 1 g i.m. q.d. for 3 weeks or
doxycycline 100 mg plus rifampin 900 mg q.d. both for 3 months.
Results: One hundred and forty-eight patients of the total sample
(32.2%) had BVO. 109 (73.6%) were male and 39 (26.4%) female.
The mean age was 51.4 + 13.6 years. Cervical level was involved
in 14 cases (9.5%), dorsal or dorso-lumbar in 32 (21.6%), lumbar
or lumbo-sacral in 98 (66.2%) and multiple levels were affected in
four cases (2.76%). The mean duration of symptoms prior to diag-
nosis was 3.2 months. Eighty per cent of patients had fever,
91.9% inﬂammatory spinal pain and 41.3% had some neurological
deﬁcit. Blood cultures were positive in 42% of cases and B meli-
tensis was isolated in all of them. The mean number of affected
vertebral bodies was 2.1 (range 1–5). Paravertebral masses were
detected in 62 cases (42.9%), epidural masses in 44 (29.7%) and
psoas abscesses in 14 (9.5%). Fifty patients (33.8%) required surgi-
cal treatment. The rate of therapeutic failure, relapse and attribut-
able mortality were 14.9, 2 and 1.2% respectively. The mean
hospital stay was 36.6 days and 29 patients (19.6%) had severe
functional sequelae. A high diagnostic delay, cervico-dorsal level
and more than two vertebral bodies affected were associated with
a worst prognosis.
Conclusions: BVO represent a high percentage of VO in endemic
areas. In this type of VO, non-invasive diagnostic yield is very
high. Although BVO mortality is very low, BVO frequently
requires surgical treatment, long hospital stay and results in
severe functional sequelae.
P473 Psychotic disorder related with Brucella infection:
three case reports
A. Celikbas, G. Bayam, S. Eren, O. Pazvantoglu, N. Baykam,
B. Dokuzoguz
Ankara, TR
Objective: Three patients who were brought to hospital because of
psychotic symptoms and diagnosed as brucella infection and trea-
ted with antibiotics were presented.
Cases: Two of the cases were hospitalised in psychiatry clinic and
one of them was hospitalised in infectious disease clinic. The
average age of three cases is 33. All of the patients had a history
of cheese eating. One case had a history of treatment and as acute
psychotic attack 4 years ago. All of them had shared symptoms of
fever, headache, sweating, weight loss, back pain, vertigo, irritab-
ility and restlessness. In psychiatric examination patients were
evaluated as irritable, sleep disturbance, impaired orientation,
attention and memory, difﬁculty in cooperation, acceleration and
deceleration in thought ﬂow and auditory and visual hallucina-
tions. In one case there were symptoms of neuralgic disorders like
nystagmus, ataxia and strabismus. All cases have positive Brucella
agglutination test in 1/640 titer. Two cases had positive BOS cul-
ture for Brucella and all of them positive blood culture for Brucella.
After the antibiotic treatment patients’ clinic and laboratory states
came to normal. Psychiatric symptoms disappeared.
Conclusion: Acute psychotic presentation and increasing psychotic
symptoms can be seen in neurobrucellosis. In all of the cases who
have psychotic symptoms and also fever and infection; neurobru-
cellosis should be considered in differential diagnosis.
P474 Pulmonary involvement in brucellosis
C.A. Hatipoglu, G. Bilgin, N. Tu¨lek, U. Kosar
Ankara, TR
Objectives: Brucellosis is a multisystem infection that may present
with a broad spectrum of clinical presentations. Pulmonary
involvement is extremely rare in the course of brucellosis with an
estimated rate of <1–5% of cases. A variety of pulmonary mani-
festations have been documented in the literature, including bron-
chitis, bronchopneumonia, lung abcess, empyema, pleural
effusion, granulomas, solitary nodules, hilar and paratracheal
lymphadenopaty. The aim of this study was to determine the inci-
dence and forms of pulmonary involvement in the course of bru-
cellosis.
Methods: A prospective study was carried out in 110 patients with
brucellosis who were admitted to the Infectious Diseases and
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Clinical Microbiology Department, Ankara Training and Research
Hospital, between October 2001–December 2003. All the patients
were questionnaired about their pulmonary symptoms including
cough, expectoration, chest pain, dyspnoea and haemoptysis. All
the patients underwent a thorough physical examination, chest
radiography and when pulmonary pathological ﬁndings were pre-
sent, underwent additional diagnostic evaluations including com-
puterised tomography of the thorax and pulmonary function
tests.
Results: Of these 110 patients, 11 (10%) patients (six female, ﬁve
male) presented with pulmonary involvement. Eight (72%)
patients had pulmonary symptoms including dyspnoea, dry
cough and productive cough with expectoration. Six patients had
chest radiography ﬁndings but two had not. Three patients had
no pulmonary symptoms but had ﬁndings in chest radiography.
Chest radiography ﬁndings were compatible with computerised
tomography ﬁndings of the thorax. Radiological ﬁndings were as
follows: Parenchymal nodules in eight patients, lobar pneumonia
in one, paratracheal lymphadenopathy in one, parenchymal nod-
ules, lobar pneumonia and minimal pleural effusion in one
patient. Of 11 patients with pulmonary involvement, four (36%)
patients had coexisting chronic obstructive pulmonary disease. All
the patients were treated with a combination of rifampin and
doxycycline or streptomycin and doxycycline. Clinical and radio-
logical ﬁndings of pulmonary involvement were recovered in all
patients except four patients who had coexisting chronic obstruct-
ive pulmonary disease.
Conclusion: Pulmonary involvement is a rare event in the course
of brucellosis but the rate could be higher than estimated. In
endemic regions, brucellosis should be considered as a causative
agent in patients with pulmonary symptoms.
P475 Same involvement of brucellosis in two brothers:
epididymoorchitis
G. Tuncer Ertem, C. Ataman Hatipoglu, N. Tu¨lek
Ankara, TR
Objectives: Brucellosis is a very polymorphic disease and could
affect any organ. Epididymoorchitis occurs in up to 2–20% of
patients with brucellosis. In this report, two brothers with epi-
didymoorchitis were presented.
Case 1: A 43-year-old male sheep breeder was admitted with a-6-
week history of fever, sweating, headache, pain in his shoulders
and neck. Six weeks ago he had applied to an urologist with a
history of painful swelling and redness of the left testis and
fever. In ultrasonographic examination increasing of testicular
diameter, thickening of scrotal wall and testicular hypoechogene-
ity had been detected. After 10 days of antibiotic therapy, his
testicular symptoms had improved. On physical examination
restricted mobility of the neck and hepatomegaly were evident
but testis was normal. The complete blood cell count and bio-
chemical ﬁndings were normal. Standard tube agglutination test-
ing (SAT) was positive at titer of 1/640. Brucella melitensis was
isolated in both of blood and bone marrow culture. Magnetic
resonance imagining revealed cervical spondylitis. Cerebrospinal
ﬂuid examination revealed ﬁndings of meningitis and SAT was
positive at titer of 1/16. Osteoarticular and neurological
involvements of brucellosis were diagnosed and rifampicin plus
doxycycline (24 weeks) plus seftriaxon (4 weeks) treatment was
administered. The clinical and laboratory ﬁndings improved with
this treatment.
Case 2: A 45-year-old male sheep breeder was admitted with a
3-month history of pain in his right shoulder and wrist. Before these
symptoms, painful swelling and redness of the right testis and fever
had developed and he had applied to an urologist. His symptoms
had improved with antibiotic therapy. On physical examination
there was only hepatomegaly. WBC was 10.500/mm3, other blood
cell count and biochemical ﬁndings were normal. Serum SAT was
positive at titer of 1/640. Blood and bone marrow culture were neg-
ative. Rifampicin plus doxycycline (6 weeks) treatment was admin-
istered. His clinical ﬁndings improved with this treatment.
Conclusions: In both brothers, presenting symptoms of the brucel-
losis were epididymoorchitis. So that brucellosis must be consid-
ered in the differential diagnosis in endemic areas. Although
orchitis is a rare complication of brucellosis, it was observed as
same involvement in both brothers. These cases suggest the possi-
bility of genetic basis for the occurrence of brucellosis and/or epi-
didymoorchitis.
P476 Human brucellosis: a retrospective evaluation of 75
cases
N. Elaldi, I. Dokmetas, M. Bakir, M.Z. Bakici, M. Sencan
Sivas, TR
Objectives: Brucellosis is an important zoonosis worldwide, mainly
in the Mediterranean countries, including Turkey. The annual
national incidence of the disease in Turkey is 0.59 per 100 000 per-
sons. The aim of this study was to evaluate the epidemiological,
clinical and laboratory ﬁndings, therapeutic features and out-
comes of patients with brucellosis retrospectively.
Methods: This study was carried out at Cumhuriyet University
Hospital, Department of Clinical Bacteriology and Infectious Dis-
eases, Sivas, Turkey, between January 1998 and November 2003.
Seventy-ﬁve brucellosis patients were included in the study.
Results: Thirty-nine (52%) were female patients and 36 (48%)
were male. The mean age was 41  1.8 (range 16–70 years). Clin-
ical form of the disease was acute in 51 cases, 18 sub-acute, ﬁve
chronic, and one asymptomatic. The most possible source of bru-
cellosis was the consuming of unpasteurised dairy products, espe-
cially raw milk and fresh cheese (68%). Malaise (53%), fever
(53%), back pain (45%) and anorexia (43%) were the most com-
mon presenting symptoms, and fever and hepatomegaly were the
most common initial clinical ﬁndings among the patients. Eleva-
ted serum C-reactive protein levels was determined in 27 of 33
patients and elevated erythrocyte sedimentation rate in 56 of 75
patients. Cultures (blood 36, cerebrospinal ﬂuid 1, joint ﬂuid 1)
were positive in 38 (51%) patients and all strains identiﬁed as
Brucella melitensis. Various treatment regimens were used, mainly
doxycycline plus rifampicin. There was no therapeutic failure.
Relapse occurred in ﬁve of the 75 patients (6.7%).
Conclusion: Brucellosis is still endemic zoonosis in the Central
Anatolian region of Turkey. So, we think that the effective heating
of dairy products and other potentially contaminated foods is
main prevention method of the disease and others.
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P477 Comparison of proﬁciency testing among
governmental and private sector hospital microbiology
laboratories in Tehran
M. Rahbar
Tehran, IR
Objective: The aim of this study was to evaluate proﬁciency test-
ing of microbiology laboratories in governmental and private sec-
tor hospitals.
Methods: Two species of bacteria were sent to microbiology labor-
atories (71 governmental and 35 private sector) included Staphylo-
coccus epidermidis (ATCC 12228) and Bukhoderia cepacia (ATCC
2541). We asked all laboratories for identiﬁcation of each bacteria
and susceptibility testing of S. epidermidis. Scoring of results per-
formed according of WHO criteria (maximum score of point for
identiﬁcation 3 and for susceptibility testing 5).
Results: Of 111 microbiology laboratories, we received answer
from 87 (75%) laboratories. The mean score of points for identi-
ﬁcation of S. epidermidis in governmental hospital microbiology
laboratories was 2.8% (SD  0.64). The main score of point in
private hospital microbiology laboratories was also 2.8
(SD  0.7376). Statistically there was not a signiﬁcant difference
between two groups of laboratories for identiﬁcation of S. epider-
midis (P-value ¼ 0.712). Of 55 governmental hospital microbio-
logy laboratories, 22 laboratories identiﬁed B. cepacia and
obtained 3 score of points. Eleven laboratories obtained zero
score of points and other laboratories obtained 0.05–2.5 score of
points. The mean score was 1.67 (SD  1.2). Of 30 private sector
hospital microbiology laboratories ﬁve laboratories produced
correct answer for identiﬁcation of B. cepacia and obtained 3
score of points, 18 laboratories zero score of points and other
laboratories obtained 0.5–2.5 score of points. The mean
score was 0.81 (SD  1.119; P-value ¼ 0.001). The mean score
of points for susceptibility testing of S. epidermidis in govern-
mental-related hospitals microbiology laboratories was 4.8
(SD  0.38) and in private sector was 4.66 (SD  074;
P-value ¼ 0.571).
Conclusion: It is concluded that private sector hospital microbio-
logy laboratories in our county in comparison with governmental
hospital microbiology laboratories have poor proﬁciency for iden-
tiﬁcation of microorganisms such as B. cepacia. It may be due to
lack of some culture media reagents and unskilled personnel in
this sector.
P478 Implementation of particle analysers in the detection
and description of bioﬁlm formation
R. Kadlec, J. Plockova´, F. Ruzicka, V. Hola´
Brno, CZ
The growth in a bioﬁlm form enables bacteria to survive in the
environment and in human organism. Bioﬁlm bacteria are highly
resistant to host immunity and to antibiotic therapy. The ability
of bacteria to form bioﬁlm is considered to be an important fac-
tor of the pathogenicity and represents a serious medical prob-
lem. The proof of the ability and the evaluation of the dynamics
of bioﬁlm formation can be helpful for optimal therapy of the
infection. The phenotypical methods of the bioﬁlm detection are
related with subjective evaluation of the obtained results. There-
fore, we tried to ﬁnd a new method for the detection and des-
cription of bioﬁlm formation. The Staphylococcus epidermidis
strains isolated from blood cultures of patients with bacteraemia
were used in this study. Isolates were grouped on the basis of
the presence of intact ica-operon, determined by PCR reaction,
into two groups, ica-operon positive and ica-operon negative.
The phenotypical slime-positivity or negativity was performed
by two methods by Christensen tube method in brain heart infu-
sion and by the typical growth on agar with Congo red. Bacteria
with uniform (monodisperse) microparticles were cultivated
under constant stirring for different time periods. The growth of
bacterial bioﬁlm layer on the microparticles was monitored as an
increase of microparticle size. Various microparticles of
diameters ranging from 10 to 50 lm were used. The size of
bioﬁlm-covered microparticles was measured using different
independent measuring principles. Time-of-transition (TOT), low
angle laser light scattering (LALLS), gravitational ﬁeld ﬂow frac-
tionation (GFFF) and dynamic shape analysis. The total bioﬁlm
increase given by the number of particles can reach several tens
of cm2. Therefore, the changes in size distribution resulting from
the bioﬁlm growth are statistically signiﬁcant. This approach also
allows determination of the inﬂuence of various cultivation
parameters (e.g. pH and chemical composition of the medium,
properties of the particles, physical conditions and bacteria spe-
cies) on the growth and detachment of bioﬁlms. The measure-
ment of microparticle increase as a result of bioﬁlm formation
has been shown to be an effective tool for investigation of bio-
ﬁlms.
P479 Laboratory variables in selected neuroinﬂammatory
diseases
J. Bednarova, P. Stourac, H. Stroblova, A. Sevcikova
Brno, CZ
Objectives: The intrathecal synthesis of speciﬁc IgG antibodies
against the viruses of measles, rubella and varicella zoster, called
MRZ reaction (M-measles, R-rubella, Z-varicella zoster) is typical
for chronic inﬂammatory autoimmune diseases of the nervous
system. MRZ reaction is present in 89% patients with multiple
sclerosis (MS), while in patients with neuroborreliosis (NB) it
occurs very seldom (<0.1%). The aim of our study was to detect
MRZ reaction and intrathecal synthesis of speciﬁc antiborrelia IgG
antibodies and to evaluate the relevance of speciﬁc antibody
indices from ﬁrst diagnostic lumbar puncture for the differential
diagnosis between MS and NB.
Methods: We investigated a cohort of 50 patients: 21 patients were
diagnosed as multiple sclerosis, 19 patients were diagnosed as
neuroborreliosis and 10 patients with OND (other neurologic dis-
eases) served as negative controls. Serum and CSF samples were
analysed at each patient. The diagnostic kit of Human Company,
Germany (measles, rubella, varicella-zoster virus human ELISA
IgG antibody test) and the diagnostic kit of Test-Line Company,
Clinical Diagnostics, Czech Republic (EIA Borrelia garinii IgG)
were used for the detection of speciﬁc IgG antibodies. The intra-
thecal synthesis was evaluated as speciﬁc antibody index
(AI according to Reiber’s method). Values of AI > 1.4 indicated
the intrathecal synthesis.
Results: Intrathecal synthesis of IgG antibodies against measles,
rubella and/or varicella zoster viruses (AI > 1.4) was detected in
95% patients with MS. Antibody index against measles was posit-
ive in 85.7% patients, against rubella in 52.4% patients and
against varicella zoster virus in 38% patients. All these patients
had negative intrathecal antibody synthesis against Borrelia burg-
dorferi (Bb), i.e. negative Bb-IgG-AI. In patients with NB 89.5%
had positive Bb-IgG-AI. One patient (5%) only had positive anti-
measles AI. OND patients had negative MRZ reaction and
Bb-IgG-AI. The statistical signiﬁcance of MRZ reaction vs. Bb-IgG-
AI positivity was conﬁrmed by Spearman rank coefﬁcient and
Wilcoxon’s test.
Conclusion: Positive MRZ reaction is the most valuable diagnostic
parameter in diagnostically equivocal cases of MS and NB with
neurological ﬁrst symptoms. Our data emphasise the importance
of MRZ reaction and Bb-IgG-AI in differential diagnostics of MS
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and NB in early stages when other methods (MRI, oligoclonal IgG
bands) do not provide deﬁnite diagnosis.
P480 Bactericidal effect of endox against various pathogens
C. Cassanelli, S. Roveta, F. Cavallini, A. Marchese, E.A. Debbia,
R. Armanino
Genoa, I
Objectives: Endox is an instrument used for the sterilisation of
the root canal and/or periapical infections after the endodontic
treatment. The instrument applies an high frequency alternate
current (HFAC) and, for each impulse, generates an electromag-
netic ﬁeld for a short period time (140 ms) in the site of infection.
To better understand the mechanism by which sterilisation
occurs, the instrument was used to test the bactericidal effect on
different bacterial suspensions exposed to the above electromag-
netic ﬁeld.
Methods: Bacterial strains included Enterococcus faecalis, Staphylo-
coccus aureus, Actinomyces spp., Escherichia coli, Pseudomonas aerugi-
nosa and among fungi it was tested with Candida albicans. A
sample of 20 lL of a saline bacterial suspension was exposed to
the electromagnetic ﬁeld for three times. Survivors were then
counted by standard procedure.
Results: Bactericidal effect of 99.99% was found in E. faecalis,
S. aureus, E. coli and P. aeruginosa, instead in Actinomyces spp. and
C. albicans the reduction of bacterial concentration was lower
(99.9%).
Conclusions: Sterilisation effect obtained with Endox was very
remarkable (99.99%) on bacteria and, even in less extent, on fungi
(99.9%). These different results may be explained by the different
constitution of cell wall. The Actinomyces, in comparison with
other bacteria has shown a less marked reduction of bacterial con-
centration, this fact can be attributed to its characteristic to pro-
duce ‘sulphur grains’, crystalline and proteinic formations that
defend the membrane cell from the electromagnetic ﬁeld. The
extension of the area and the mode of action of the electromag-
netic ﬁeld are under investigation.
P481 Evaluation of Helicobacter pylori stool antigen test for
the detection of H. pylori infection and comparison with other
methods
M. Ozdemir, R. Kesli, B. Baysal, M. Baykan, E. Kayacetin,
M. Serdengecti
Konya, TR
Objective: Helicobacter pylori is the main cause of gastritis, peptic
ulcer and gastric cancer in adults. The measurement of H. pylori
antigens in human stools has been proposed as a valuable, nonin-
vasive diagnostic tool. The aim of this study was to evaluate the
usefulness of H. pylori stool antigen (HpSA) in diagnosis of
H. pylori infection in adult patient.
Methods: Seventy-eight patients aged 21–68 years who were
admitted to Department of Internal Medicine, Division of Gas-
troenterology with symptom of dyspepsia for whom the indica-
tion of upper gastrointestinal endoscopy was present were
included in this study. Stool samples were taken before antibi-
otic treatment. The patients were evaluated with histology,
rapid urease test and HpSA (Linear Chemicals). Urea breath
test was carried out only in 38 patients. Patients were deﬁned
as H. pylori positive, if histology, urease test or urea breath test
conﬁrmed.
Results: Fifty-nine patients were positive for H. pylori, whereas 19
patients were negative. HpSA was positive in 53 of 59. The sensi-
tivity and speciﬁcity of methods were as follows: histology 100
and 94%, urease 61 and 83%, urea breath test 100 and 100%. The
sensitivity of HpSA was 89% and speciﬁcity of HpSA was 95%.
Conclusion: Faecal tests are noninvasive, easy to perform for the
diagnosis of H. pylori infection. This test is cheap and effective for
the diagnosis of H. pylori infection in Turkish population.
P482 Comparison of the Now ICT malaria P.f./P.v. and
the OptiMAL IT rapid diagnostic tests for malaria in a
nonendemic area
F. Peyron, F. De Monbrison, P. Ge´roˆme, J.F. Chaulet, M. Wallon,
S. Picot
Lyon, F
Objectives: Malaria patients require a rapid and accurate diagno-
sis. Microscopic examination of thin or thick blood smear remains
widely used; however, such tests are time-consuming and require
experience – especially in case of low parasitaemia often encoun-
tered in nonendemic areas. Since last decade, malaria rapid diag-
nosis tests based on the detection, in blood, of soluble parasitic
antigens have been marketed. The aim of our study was to com-
pare the performance of Now ICT malaria P.f./P.v. (Binax, Port-
land, ME, USA) and OptiMAL IT (Diamed, Cressier,
Switzerland), two new versions of rapid diagnostic tests for mal-
aria.
Methods: A total of 556 consecutive patients were prospectively
enrolled in Lyon, France. The ‘gold standard’ was a combination
of results obtained by thin blood smear ﬁlm microscopic examina-
tion and QBC. PCR and anti-malarial drug assays were performed
only on discrepant samples.
Results: One hundred and nine (19.6%) patients had proven mal-
arial attacks. Sensitivity was 96.3% for Now ICT malaria
P.f./P.v. and 79.8% for OptiMAL IT (P ¼ 0.0001), and speciﬁcity
was, respectively, 98.8 and 98.4%. Likelihood ratios for positive
tests were, respectively, 86.1 and 50.9 for Now ICT malaria P.f./
P.v. and OptiMAL IT. Of 80 P. falciparum cases, Now ICT mal-
aria P.f./P.v. missed two infections. The test detected all 13 P. vi-
vax infections. Five false positive results were observed in patients
with a recent history of fever, self-treated for malaria. OptiMAL
IT misdiagnosed 10 P. falciparum infections with parasitaemia up
to 0.1%. Two P. vivax infections were not detected. We observed
seven false positive cases, with no evidence of previous malaria
attacks in six cases. During patient follow-up, Now ICT malaria
P.f./P.v. can persist positive for at least 7 days. OptiMAL IT
turned negative within an average of 3 days being more likely to
reﬂect parasite vitality.
Conclusions: Rapid diagnostic tests for malaria could be helpful
as an adjunct test, but could not replace microscopic examination
of blood ﬁlms, which remains the gold standard, including more-
over quantitative techniques.
P483 Identiﬁcation of yeasts and yeast-like microorganisms
with a colorimetric card newly developed for the VITEK 2
system
D. Pincus, J. Mills, B. Knysak, A. Bassel, A. Fothergill, M. Rinaldi
Hazelwood, San Antonio, USA
Objectives: A new colorimetric card (YST; this new card is not yet
available for commercial use) was developed for rapid automated
identiﬁcation of yeasts and yeast-like microorganisms using the
VITEK 2 system. A database created from testing well-character-
ised strains was used to optimise the computer-assisted algorithm
to achieve a high level of performance accuracy.
Methods: The YST card, containing 46 tests that measure enzy-
matic, acidiﬁcation and alkalinisation activities, was tested with
1304 isolates representing 13 genera comprised of 54 different spe-
cies. Strains included 246 recent clinical isolates tested at the Uni-
versity of Texas at San Antonio Health Science Center with the
remainder of isolates being stock cultures tested at bioMerieux.
Cards were ﬁlled with organism suspensions made in 0.45%
aqueous NaCl to a turbidity equivalent to a McFarland#2 stand-
ard. Inoculated cards were incubated in the VITEK 2 for
approximately 18 h and a computer-assisted algorithm was optim-
ised and used to generate test and identiﬁcation results.
Results: Of the 1304 isolates tested, 1249 (95.8%) gave a correct
identiﬁcation with 138 (10.6%) low discrimination results [requi-
ring supplemental testing and/or microscopic observation to
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discriminate between multiple (up to three) choices]. Twenty-six
(2.0%) of the isolates gave an incorrect identiﬁcation and 29
(2.2%) were unidentiﬁed. Results of the subset of 246 recent clin-
ical isolates showed 97.2% correct (including 8.9% low discrimin-
ation), 2.0% incorrect and 0.8% unidentiﬁed. This slightly higher
performance was due to a higher frequency of isolates of the more
common species.
Conclusion: The new YST colorimetric card used with the VITEK
2 system provides an accurate, rapid, and automated method for
the identiﬁcation of yeasts and yeast-like microorganisms.
P484 Compatibility of CPS ID 3, a new chromogenic
medium, with the VITEK 2 system
N. Fanjat, N. Garcia, S. Orenga, D. Robichon, C. Roger-Dalbert
La Balme les Grottes, F
Objectives: CPS ID 3 is a new chromogenic medium for the diag-
nosis of urinary tract infections. This new formula improves col-
our intensity for each enzymatic activity and also increases the
growth of Gram-positive bacteria and yeasts. Compatibility stud-
ies of CPS ID 3 with the bioMerieux VITEK 2 system were per-
formed. Results were compared with those obtained with colonies
isolated on CPS ID 2, the previous formula, and a nonchromogen-
ic media, both being recommended as isolation medium before
VITEK 2 testing.
Methods: A set of 180 microorganism strains representative of
those commonly encountered in urine and various mechanisms of
resistance were streaked on CPS ID 3, CPS ID 2 and a reference
medium. Isolated colonies were used to inoculate the appropriate
identiﬁcation and susceptibility card selected among ID-GNB,
ID-GPC, ID-YST, AST-N022, AST-N017, AST-P523 and AST-P524.
Results: For ID-GNB, ID-GPC and ID-YST cards the correct identi-
ﬁcation rates on CPS ID 3 were 96.7, 83.3 and 98.3%, respectively,
and statistically there was no difference with those obtained on
CPS ID 2. As regards susceptibility test results, the average MIC
agreements on AST-N022, AST-N017, AST-P523 and AST-P524
were 99.3, 99.1, 99 and 98.6%, respectively. There was no trend to
induce a higher susceptibility or resistance for speciﬁc species or
drugs. Moreover, there was no statistically signiﬁcant difference
between the MIC agreements obtained on CPS ID 2 and CPS ID 3.
Conclusion: Identiﬁcation and susceptibility testing on VITEK 2 of
common urinary pathogens isolated on CPS ID 3 correlates well
with those performed on CPS ID 2. CPS ID 3 is fully compatible
with the VITEK 2 system. Consequently, with CPS ID 3, bacteriol-
ogists will save considerable amounts of time and reagents, while
having a complete solution for the diagnosis of urinary infections,
even with the most complex specimens.
P485 New improved VITEK 2 card for identiﬁcation of
Gram-negative bacilli
B. Blanc, M. Babolat, L. Barbier, B. Celliere, L. Cordier,
M.C. Deluermoz, M. Guicherd, S. Petre, S. Chatellier, D. Monget
La Balme les Grottes, F
Objectives: A new VITEK 2 Gram-negative card (GN; this new
card is not yet available for commercial use) has been developed
recently to increase identiﬁcation accuracy of key clinical isolates
and expand the number of nonfermentative bacteria claimed by
the current ID-GNB card on the VITEK 2 system. The GN card
contains 47 biochemical tests enabling the identiﬁcation of 88 spe-
cies or groups of fermentative bacteria and 47 species or groups
of nonfermentative bacteria.
Methods: A total of 2806 well-characterised isolates from the bio-
Merieux stock collection were used to build the database. Cards
were ﬁlled with organism suspensions made in 0.45% aqueous
NaCl to a turbidity equivalent to a McFarland #0.5 standard.
Inoculated cards were incubated in the VITEK 2 instrument and a
computer-assisted algorithm was optimised and used to generate
kinetic identiﬁcation results.
Results: Of the 2806 isolates tested, 2737 (97.6%) gave a correct
identiﬁcation with 123 (4.4%) low discrimination results (requi-
ring simple additional testing). Fifty-seven (2.0%) of the isolates
gave an incorrect identiﬁcation and 12 (0.4%) were unidentiﬁed.
All the results were obtained within 2–10 h. Overall correct identi-
ﬁcation is 98.4% for Enterobacteriaceae and other fermentative
bacteria. For nonfermentative bacteria, 95.7% of the isolates gave
correct identiﬁcation.
Conclusions: The new GN card used with the VITEK 2 system
provides an accurate and rapid method for the identiﬁcation of a
wide range of Gram-negative bacteria. This updated card pro-
vides several improvements compared with the current ID-GNB
card that include:
• high level (93.2% vs. 77.5%) of one choice identiﬁcation without
any additional testing required and 97.6% vs. 96.9% overall cor-
rect when additional testing is included;
• more species claimed for nonfermentative bacteria 47 (vs. 24);
• elimination of mixed taxon ‘various nonfermenting Gram-negat-
ive bacilli’ comprising 26 taxa on the current card.
P486 Identiﬁcation of Gram-positive bacteria with a new
card developed for the VITEK 2 system
M. Desmonceaux, S. Cagne`s, N. Perrot, C.-F. Roger-Dalbert,
L. Barbier, J.-S. Bonin, R. Fillet, X. Gansel, S. Chatellier, D. Monget
La Balme Les Grottes, F
Objectives: A new card (GP; this new card is not yet available for
commercial use) was developed for rapid automated identiﬁcation
of Gram-positive bacteria using the VITEK 2 system. An expanded
database was generated by testing well-characterised strains from
clinical and industrial origin to achieve a high level of performance.
Methods: The GP card, containing 43 biochemical tests that meas-
ure enzymatic, acidiﬁcation and alkalinisation activities, was tes-
ted with 1916 routinely and less frequently encountered stock
isolates distributed into 122 species. Organisms were grown on
three different isolation media and cards were ﬁlled with bacterial
suspensions made in 0.45% aqueous NaCl to a turbidity equival-
ent to a McFarland #0.5 standard. Inoculated cards were incuba-
ted in the VITEK 2 instrument and the optimal algorithm was
established to generate kinetic identiﬁcation results.
Results: Of the 1916 isolates tested, 1882 (98.2%) gave a correct
identiﬁcation with 99 (5.2%) low discrimination results. Twenty-
eight (1.5%) of the isolates gave an incorrect identiﬁcation and six
(0.3%) were unidentiﬁed. All the results were obtained within
2–8 h.
Conclusion: The new GP card used with the VITEK 2 system pro-
vides a rapid and accurate method for automated kinetic identiﬁca-
tion of a wide range of aerobic Gram-positive species. Compared
with the existing ID-GPC card, the main improvements include:
• more species claimed: 122 vs. 57;
• higher level of single-choice identiﬁcations for the clinical spe-
cies of coagulase negative staphylococci: 95.8% vs. 85%;
• less inaccurate results for nonreactive organisms.
P487 The IDEIA Norwalk-like virus enzyme immunoassay
– a rapid method for screening outbreaks of nonbacterial
gastroenteritis
L. Butcher
Norwich, UK
Norwalk-like viruses (NLVs), initially known as small round
structured viruses (SRSVs) and now classiﬁed as noroviruses
(NoVs), are a group of genetically diverse, single stranded RNA
viruses belonging to the family Caliciviridae that are recognised
as a major cause of nonbacterial gastroenteritis. This study was
performed with a view to implementing the DakoCytomation
IDEIA NLV EIA within a routine diagnostic laboratory in order to
provide a more rapid response to outbreaks of gastroenteritis
within the region.
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Objectives: To evaluate the DakoCytomation IDEIA NLV EIA as
an alternative to screening by electron microscopy (EM) and the
Lordsdale SRSV EIA.
Methods: A faecal suspension of each clinical sample was pre-
pared according to the manufacturer’s instructions. A 100 lL of
faecal suspension was added to coated microwells and incubated
with NLV-speciﬁc genogroup 1 or 2 conjugate. After incubation,
the microwells were washed and the presence of speciﬁcally
bound conjugate was determined by the addition of a chromogen
and enzyme substrate. Clinical specimens with an absorbance
value greater than the cut-off values were regarded as positive.
All samples were sent to Bristol for conﬁrmation by EM, Lords-
dale SRSV EIA and reverse transcription polymerase chain reac-
tion (RT-PCR). Discrepant samples were sent to a second
laboratory and resubmitted to Bristol for further analysis by
RT-PCR.
Results: A total of 93 faecal samples collected from patients
involved in 28 outbreaks of gastroenteritis were tested. The Dako-
Cytomation EIA detected 24 positives and 45 negatives, conﬁrmed
by EM, Lordsdale SRSV EIA and RT-PCR. Detection of NLV anti-
gen in 13 faecal specimens by the DakoCytomation EIA were not
conﬁrmed by Bristol. Seven faecal samples found to be negative
by the DakoCytomation EIA were positive by the Lordsdale SRSV
EIA. Further analysis of these discrepant samples was sought by
RT-PCR at a second laboratory. The results obtained were in
agreement with those obtained by the DakoCytomation EIA. Of
the original 20 discrepant samples, 17 were resubmitted to Bristol
for RT-PCR. The results obtained for 11 samples were consistent
with those obtained by the DakoCytomation EIA and RT-PCR at
the second laboratory. However, six samples remained discrepant.
Conclusions: The results of the study indicated that the DakoCyto-
mation IDEIA NLV EIA is a rapid, reliable alternative to EM and
the Lordsdale SRSV EIA. The assay was subsequently introduced
into routine testing.
P488 Blind-protected telescopic catheter: a simple, reliable
and cost-effective method for the diagnosis of the ventilator-
associated pneumonia
V. Koulourida, E. Martziou, K. Arvaniti, D. Lathyris,
M. Drouggos, D. Matamis, M. Moskoﬁdis
Thessaloniki, GR
Objective: Ventilator-associated pneumonia (VAP) is a serious
infection in the ICU (elevated mortality, cost of the diagnostic pro-
cedures and the antibiotics). In our hospital, broncoscopic proce-
dures for the diagnosis of the VAP are rarely used. This study
evaluated the utility and cost-effectiveness of the blind PTC in the
diagnosis of the VAP in a 10-bed ICU.
Methods: In a 2-year prospective study, PTC was performed and
found positive in 57 patients with a clinical suspicion of VAP
(new pulmonary inﬁltrate, purulent secretions, hypoxaemia, fever,
leucocytosis). We compared these protected telescopic catheter
(PTC) patients to 98 others (matched for age and APACHE II
score) who were treated empirically for a VAP but did not have a
PTC (non-PTC patients). We evaluated (i) the time needed for the
quantitative culture of the PTC, (ii) the time necessary for the
report of the results, (iii) the accuracy and ability of the method to
safely guide a de-escalation strategy.
Results: (i) Approximately 30 min were needed for the culture
(desinfection and vortexing of the tip, dilutions, susceptibility
tests according to the NCCLS); (ii) results were communicated to
the ICU physicians in 48–72 h; (iii) mean age (55  14 years) and
APACHE II score (19  8 years) were comparable between the
two groups as well as the duration of antibiotics before the VAP
(5.8  3 days vs. 6.7  4 days). Two of the 57 PTCs were contam-
inates (3.5%), 52 of 55 PTC patients were treated for VAP (94.5%
clinical relevance, 5.5% false positives). Finally, in 22 of these 52
PTC patients, Imipenem was switched to Piperacilin/Tazobactam
(42.3%). Vancomycin was withdrawn from the empirical antibiotic
regimen in 20 of the 52 PTC patients (38.5%). No change was
attempted in the empirical antibiotic regimen of the 98 non-PTC
patients. The number of patients died was comparable in the
groups (13 PTC vs. 24 non-PTC patients; P > 0.5).
Conclusions: PTC is a simple and reliable method for the diagno-
sis of the VAP. Guided by the PTC, physicians can safely discon-
tinue large-spectrum antibiotics. Any additional cost of its use can
be easily waged by the discontinuation of unnecessary antibiotics.
P489 Diagnostic and prognostic value of serum adenosine
deaminase activity in scrub typhus
H.Y. Kim, J.K. Kim, Y. Uh, W.Y. Lee, S.J. Yong, K.C. Shin
Wonju, KOR
Objective: Scrub typhus is a common endemic febrile illness
together with haemorrhagic fever with renal syndrome (HFRS)
and leptospirosis in Korea. The aim of the present study was to
assess the diagnostic and prognostic value of serum adenosine
deaminase (ADA) activity in scrub typhus.
Methods: Serum ADA activity was determined by colorimetric
method. A total of 108 cases of serologically conﬁrmed scrub
typhus were compared with 16 cases of HFRS and 16 cases of
leptospirosis. Indirect immunoﬂuorescence assay was performed
for scrub typhus and leptospirosis, while HFRS was diagnosed by
particle agglutination test.
Results: Serum ADA levels were signiﬁcantly higher in scrub
typhus (92.46  33.89 U/L) than HFRS (44.19  12.36 U/L) or
leptospirosis (24.92  7.92 U/L) (P < 0.0001). Serum ADA2 isoen-
zyme levels also were higher in scrub typhus (70.15  21.65 U/L)
than HFRS (33.16  10.47 U/L) or leptospirosis (18.96  9.27 U/
L) (P < 0.0001). Five patients who died of scrub typhus have more
high levels of serum ADA than survived patients
(151.3  60.62 U/L vs. 89.6  29.7 U/L; P ¼ 0.002). Severe scrub
typhus patients (n ¼ 32) complicating with renal failure, respirat-
ory failure, shock, encephalitis and myocarditis have higher levels
of serum ADA than nonsevere patients (115.78  47.04 U/L vs.
82.64  19.83 U/L; P < 0.0001).
Conclusion: Serum ADA value is sufﬁciently useful in early differ-
entiation of scrub typhus from other febrile illness and may prove
to be useful as prognostic marker of scrub typhus.
P490 Early diagnosis of CJD: detection of 14-3-3 proteins in
the CSF of genetic form
D. Slivarichova, E. Mitrova, V. Verchovodkova, V. Jovankovicova
Bratislava, SK
Creutzfeldt–Jakob disease (CJD) belongs to a family of fatal neuro-
degenerative diseases called transmissible spongiform encephalo-
pathies (TSE). CJD is distributed worldwide and it occurs in
sporadic, genetic, iatrogenic forms as well as a variant CJD. The
deﬁnite diagnosis of CJD is performed usually post-mortem by
the detection of prion by several speciﬁc methods (Western blot,
ELISA, immunohistochemistry). Nonspeciﬁc, but sensitive test for
diagnosis of CJD which can be positive even in early stages of the
clinical course of the disease is the detection of protein 14-3-3 in
the cerebrospinal ﬂuid (CSF) using Western blot. This test shows
different sensitivity in individual forms of CJD, the highest was
demonstrated in the most frequent sporadic CJD, less efﬁcient
appears to be the method in human genetic TSEs. In Slovakia,
75% of all CJD patients belong to the most frequent genetic form
with mutation of prion protein gene at codon 200 (mutation
E200K). Frozen CSF samples have been stored in our laboratory
since 1978. The aim of our study, performed on 125 CSF samples,
was to determine: (i) the sensitivity of the protein 14-3-3 test in a
large, homogenous group of described genetic CJD, and (ii) the
time interval of storing, during which the sensitivity of CSF for
described test is preserved. Obtained results demonstrate that CSF
of deﬁnite CJD patients stored more than 15 years showed no
positivity for protein 14-3-3 at all. CSF samples frozen longer than
10 years showed positivity between 28.6% (sporadic CJD) and
33.4% (genetic CJD). Standardised method of protein 14-3-3
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detection in the CSF of tested genetic CJD cases with E200K muta-
tion (CJD E200K) showed as much as 92.3% sensitivity. Detection
of protein 14-3-3 was included into WHO diagnostic criteria con-
sidering mainly results obtained in sporadic CJD. Presented results
demonstrate that in CJD E200K (the most important genetic CJD) a
combined genetic testing (positive CJD-speciﬁc mutation) and
detection of protein 14-3-3 represent a very reliable marker of early
CJD diagnosis, not available in other human TSEs.
P491 A simple, isocratic reverse-phase ion-pair high
performance liquid chromatography assay for cidofovir in
human body ﬂuids
M. Darville, A. Lovering, A. MacGowan
Bristol, UK
Objectives: Cidofovir (1-[(S)-3-hydroxy-2-(phosphonomethoxy)pro-
pyl]cytosine dihdrate, HPMPC, GS-0504) is an acyclic nucleoside
analogue active in vitro and in vivo against a range of herpesviruses,
poxviruses, adenoviruses and some RNA viruses. Cidofovir is a
phosphonate and is phosphorylated to its active diphosphate form
(analogous to a nucleoside triphosphate) by cellular enzymes. Not
requiring activation by a virally coded enzyme, it can protect unin-
fected cells. Cidofovir is usually a second line drug for patients
suffering severe, life-threatening viral infection. By 24 h after dose
90% is excreted unchanged in the urine, although the intracellular
half-life of the diphosphate is between 17 and 65 h. Being nephro-
toxic, it should be administered with probenecid. It is not clear
whether this toxicity depends on peak levels of the drug or on time
above a given level. In order to help to answer this question and to
conduct pharmacokinetic studies we have developed a HPLC assay
for the detection of cidofovir in human body ﬂuids.
Methods: Chromatography was performed on a stationary phase
of Hypersil 5 ODS with a mobile phase of 2.8 mM sodium phos-
phate and 1.2 mM tetrabutyl ammonium hydroxide, pH 7.5. The
mobile phase was pumped at 1 mL/min and Cidofovir detected
by UV absorbance at 275 nm. Serum and plasma samples were
prepared by deproteinising with equal volumes of methanol,
urine samples by 10-fold dilution in mobile phase. An injection
volume of 10 lL was used.
Results: In this assay the retention time of Cidofovir is approxi-
mately 13 min and it is well resolved from the components of
biological ﬂuids and from other drugs. No interference was
seen with 31 other antimicrobial agents. The apparent concen-
tration of Cidofovir preparations is unaffected by heat (>22 h in
water or urine, >6 h in serum) and freezing and thawing (>18
cycles in water or urine, >8 cycles in serum). The assay is lin-
ear over the range of 0.03–8 mg/L. The limits of detection and
quantiﬁcation are 0.03 and 0.06 mg/L (aqueous) and 0.06 and
0.12 mg/L (serum). Recovery from serum is approximately
90%.
Conclusion: This assay is suitable for measuring Cidofovir levels
in biological ﬂuids.
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P492 The activity of some quinolones against
Stenotrophomonas maltophilia and Pseudomonas aeruginosa
clinical isolates in the presence of pump inhibitors
A.E. Laudy, I. Wojtal, A. Orzeszko, B.J. Starosciak
Warsaw, PL
Objectives: The most common cause of multidrug resistant strains
is the efﬂux mechanism. The presence of such efﬂux systems was
described for Pseudomonas aeruginosa and Stenotrophomonas malto-
philia. In P. Aeruginosa, the presence of three efﬂux systems (Mex-
AB-OprM, MexCD-OprJ and MexEF-OprN) responsible for
quinolones resistance was described. These MDR pumps belong-
ing to the RND family are inhibited by Phe-Arg-b-naphthylamide.
On the contrary, reserpine does not inhibit RND pumps. The
presence of similar efﬂux systems was shown also in S. maltophilia
(MexAB-OprM and SmeDEF). Probably, S. maltophilia has also
other efﬂux pumps.
Methods: In our study, activity of some quinolones (nalidixic acid,
ciproﬂoxacin) against S. maltophilia and P. aeruginosa clinical iso-
lates in the presence and absence of pump inhibitors was deter-
mined. The following pump inhibitors in two concentrations
(20 mg/L and 80 gm/L) were used: Phe-Arg-b-naphthylamide,
reserpine and omeprazol. We also looked for a new inhibitors
among newly synthesised compounds, 6-(adamant-1-yl)pyrimi-
dines.
Results: From the studied inhibitors only Phe-Arg-b-naphthyla-
mide affected the susceptibility of tested strains to quinolones,
ﬁrst of all to nalidixic acid. Generally, the presence of higher con-
centration of inhibitor pump (80 mg/L) increased most effectively
sensitivity to nalidixic acid both S. maltophilia and P. aeruginosa. In
90% of S. maltophilia and 80% of P. aeruginosa the MIC decreased
from threefold to 20-fold in the presence of Phe-Arg-b-naphthyla-
mide. On the contrary, this inhibitor affected the MIC of
ciproﬂoxacin only for a few strains. Moreover, Phe-Arg-b-naph-
thylamide alone has shown the activity against three strains of
P. aeruginosa (MIC 20, 40 and 160 mg/L). The other studied pump
inhibitors did not change generally the MIC of both quinolones.
Unlike the inhibitory activity of Phe-Arg-b-naphthylamide agents
as reserpine and omeprazole increased slightly the MIC of tested
quinolones for some strains of S. maltophilia.
Conclusions: Our data conﬁrm that opposed to reserpine the sec-
ond tested agent Phe-Arg-b-naphthylamide inhibited efﬂux
pumps not only on P. aeruginosa but also on S. maltophilia. More-
over, obtained results indicated that depending on the structure
of antibiotics the quinolones are maybe transported with different
effectiveness through the efﬂux pumps. Additionally, it is possible
that in case of S. maltophilia reserpine act antagonistically to
ciproﬂoxacin.
P493 Effect of serum susceptibility on the bactericidal
activity of antimicrobials against Haemophilus inﬂuenzae
I. Morrissey, D. Cooper, L. Williams, J. Shackcloth
London, UK
Objectives: To determine the serum susceptibility of clinical iso-
lates of H. inﬂuenzae (HI) and investigate the effect of this on anti-
microbial (AM) kill.
Methods: A total of 2650 HI from various countries worldwide
were screened for serum sensitivity [fr2 log kill over 1 h in the
presence of 20% human serum (HS)]. The bactericidal activity of
moxiﬂoxacin (MFX), levoﬂoxacin (LFX), telithromycin (TEL),
clarithromycin (CLA), azithromycin (AZI) and amoxicillin-clavula-
nate (AMC) was then evaluated at 0.25x, 1x and 4x MIC over 6 h
against four serum-resistant (SR) and ﬁve serum-susceptible (SS)
isolates in haemophilus test medium in the presence of HS or
heat-inactivated HS (I-HS). Kill was compared by plotting log 10
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reduction in viable count over time and measuring the area under
the curve (AUC) of each graph.
Results: The majority of isolates (82.1%) were found to be SR.
The sample subset of ﬁve SS isolates was all killed by HS alone
without AM (data not shown). Average AUC data for AM at 4x
MIC against the four SR HI with HS and for all nine HI with I-HS
are shown below. All AM were bactericidal against the SR HI in
the presence of HS, with the ﬂuoroquinolones (FQs) MFX and
LFX being the most active. For one SR HI, only MFX was bacteri-
cidal. In contrast, CLA and AMC were not bactericidal and TEL
showed weak kills with I-HS. MFX and LFX remained the most
active AMs even with I-HS.
Conclusions: The activity of HS alone cannot be relied upon to
eradicate clinical isolates of HI because the majority of HI are SR.
FQs were the most intrinsically bactericidal AMs against HI and
only MFX was active against all HI. Most other classes of AM
were poorly bactericidal or merely bacteriostatic in the absence of
active HS. Eradication of HI may be important for the treatment
of chronic infections and the use of highly bactericidal agents
unaffected by serum susceptibility such as the FQs may be beneﬁ-
cial in this regard.
P494 Assessment of in vitro telithromycin activity against
recent Haemophilus inﬂuenzae isolates recovered from adult
patients in Spain
M.I. Morosini, E. Loza, M. Garcı´a Castillo, F. Almaraz, F. Baquero,
R. Canto´n
Madrid, E
Background: Telithromycin is a ketolide compound with proven,
improved activity against Streptococcus pneumoniae isolates. How-
ever, its activity against Haemophilus inﬂuenzae isolates has been
studied to a lesser extent. This study assessed the in vitro activity
of telithromycin against recent H. inﬂuenzae isolates recovered
from adult patients in Spain.
Material and Methods: A total of 246 H. inﬂuenzae isolates obtained
from adult patients (¼16 years), one isolate per patient, suffering
respiratory tract infections during the 2003 respiratory disease sea-
son were studied. Isolates were recovered from 10 Spanish hospi-
tals in different geographic areas. Susceptibility testing was
performed as recommended by the NCCLS using microdilution
panels (Trek Diagnostic, UK).
Results: Telithromycin activity (MIC range, MIC 50 and MIC 90:
0.25–16, 2 and 4 lg/mL, respectively) was similar to that of azith-
romycin (0.12–16, 1 and 2 lg/mL), and clearly higher than that of
clarithromycin (0.5–64, 8 and 16 lg/mL) and erythromycin (0.5 to
>32, 8 and 16 lg/mL). Using 4 and 16 lg/mL to deﬁne the sus-
ceptible and resistant category for telithromycin, 98.4 and 0.8% of
isolates, respectively, were included within each category. The
corresponding values within the susceptible category for azithro-
mycin and clarithromycin using the NCCLS criteria (M100-S13)
were 98.4% (4 lg/mL) and 68.3% (8 lg/mL), respectively. One
isolate was resistant to azithromycin (MIC, 16 lg/mL) but sus-
ceptible to telithromycin (4 lg/mL) and two isolates were resist-
ant to telithromycin (MIC, 16 lg/mL) but susceptible to
azithromycin (4 lg/mL). These three isolates were resistant to
clarithromycin (32–64 lg/mL). Overall b-lactamase production
was 20%. Less than 3% of isolates were b-lactamase negative and
resistant to ampicillin. It is of note that three (1.2%) isolates were
resistant to amoxicillin/clavulanate (MIC, 8/4 lg/mL) and one
(0.4%) isolate were resistant to levoﬂoxacin (2 lg/mL), all remain-
ing susceptible to telithromycin (MIC range, 1–2 lg/mL).
Conclusions: In vitro telithromycin activity against H. inﬂuenzae
isolates was comparable with azithromycin and higher than
clarithromycin. Moreover, telithromycin was active against
H. inﬂuenzae isolates with emerging resistance mechanisms to
amoxicillin/clavulanate or ﬂuoroquinolones.
P495 Bactericidal activity and synergy of rifampin alone
and in combination against pan-resistant Acinetobacter
baumannii
M.E. Pacho´n-Iban˜ez, J. Paneque, F. Docobo-Perez, L. Arroyo,
M. Ruiz, C. Llanos, A. Garcia-Curiel, M. Rodriguez
Seville, E
Objectives: The purpose of this study was to know the bacteri-
cidal activity and synergy of rifampin (RMP) alone and in combi-
nation with imipenem (IMP) and sulbactam (SB) against two
clinical strains of panresistant Acinetobacter baumannii, including
resistance to colistin.
Methods: MIC and MBC (mg/L) were performed using microdi-
lution method (NCCLS). Time-kill curves were used to evaluate
the bactericidal activity and the synergy of antimicrobial combina-
tions (RMP + IMP, RMP + SB and IMP + SB) against the strains
99 and 113. For the time-kill curves antibiotics concentrations used
were equivalent to the respective MIC and the Cmax of RMP, IMP
and SB obtained in C57BL/6 mice (RMP 25 mg/kg, IMP 30 mg/
kg, and SB 60 mg/kg) in time points from 10 to 150 min after a
single dose; antimicrobial levels were determined by bioassay
method. Antibiotics were considered to be bactericidal when there
was a reduction of the original inoculum fr3 log CFU/mL. Syn-
ergy was deﬁned as fr2 log decrease in CFU/mL when using the
drug combination, relative to the most active component alone.
Results: MIC/MBC: RMP (128/>128) for both strains; IMP (128/
>256) for the strain 99 and (256/>256) for the strain 113; SB
(>256/>256) for both strains. Cmax: RMP (13.4 mg/L), IMP
(16.7 mg/L) and SB (81.5 mg/L). Bactericidal activity: RMP (MIC)
was bactericidal for both stains and not with Cmax. IMP was not
bactericidal for any of the strains using MIC or Cmax. SB (MIC
and Cmax) was bactericidal for the strain 99 and it was not bacteri-
cidal against the strain 113. The following combinations were sy-
nergistic: RMP + IMP (MIC and Cmax) and RMP + SB (MIC and
Cmax) for both strains.
Conclusions: The combination of RMP plus IMP or SB is synergis-
tic against selected clinical strains of panresistant A. baumannii.
These results suggest that these combinations may be useful in
the treatment of experimental infections caused by this agent.
P496 Synergistic activities of nontraditional antibiotic
combinations against multiresistant Pseudomonas aeruginosa
and Acinetobacter baumannii strains
F. Can, F. Ergin, M. Demirbilek, O. Kurt Azap, H. Arslan
Ankara, TR
Objectives: Multiresistant Pseudomonas aeruginosa and Acinetobacter
strains are increasingly cause of life-threatening infections and
leads to limitation of the therapy. This study was designed to
determine the synergistic activity of colistin with rifampicin,
doxycycline, meropenem and azithromycin against multidrugre-
sistant (MDR) P. aeruginosa and A. baumannii clinical isolates.
Methods: The synergistic activity in combination of colistin with
rifampicin, doxycycline, meropenem and azithromycin was inves-
tigated against randomly selected ﬁve A. baumannii and ﬁve
P. aeruginosa isolates by using chequerboard titration method.
Results: The combination of colistin and rifampicin was fully
synergistic against four of A. baumannii and two of P. aeruginosa
strains. Colistin with meropenem and colistin with azithromycin
combinations showed synergistic activity against three of
A. baumannii isolates, while resulted in additive or indifferent effects
on P. aeruginosa strains. Colistin and doxycycline combination was
AUC MFX LFX TEL CLA AZI AMC
HS (SR only) 20.1 19.4 10.1 8.1 15.1 17.6
I-HS (SR& SS) 14.1 15.1 2.0 0 8.9 0
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generally partially synergistic and additive effects against all of
the isolates.
Conclusions: The results of this study demonstrate that against
MDR P. aeruginosa and A. baumannii, synergy may occur between
nontraditional antibiotics. As P. aeruginosa and A. baumannii have
become to resistant to commonly used antibiotics, it is necessary
to test various drugs alone and in combinations to ﬁnd treatment
choices for the infections that these organisms can cause.
P497 Cell surface hydrophobicity and adherence of
Pseudomonas aeruginosa to abiotic surfaces: effect of
subinhibitory concentrations of piperacillin/tazobactam
A.P. Fonseca, P. Correia, C. Extremina, A. Bento, M. Martins,
A. Fonseca, R. Tenreiro, J.C. Sousa
Porto, Lisbon, P
Objectives: Pseudomonas aeruginosa is a human opportunistic
pathogen that colonises biotic or abiotic surfaces and has been
emerging as the primary source of nosocomial infections. Cell sur-
face hydrophobicity (CSH) of bacteria is a very important physico-
chemical feature, which has a great inﬂuence on the ability of
bacteria to adhere to the surface of host cells or medical devices.
It has been reported that subinhibitory concentrations (sub-MICs)
of antibiotics are able to affect the bacterial surface properties and
various phenotypic traits. In this study, the effects of sub-MICs of
Piperacillin/Tazobactam (P-T) on bacterial surface hydrophobicity
as well as the effect on bacterial adhesion were analysed, using P.
aeruginosa strains.
Methods: In vitro antimicrobial activities were evaluated by micro-
dilution method (NCCLS) against three reference strains (ATCC
27853, PAO1 and AK1), three deﬁned PAO1 mutants with devi-
ating surface characteristics (MT1562, PT623 and PAO1algC) and
ﬁve P. aeruginosa clinical isolates (CIs). Selection of CIs was based
on minisatellite-primed MSP-PCR ﬁngerprinting of 100 isolates
obtained from patients hospitalised at a Portuguese Central Hospi-
tal. The hydrophobicity assay was performed by growing the 11
strains in LB in presence and absence of P-T. The changes on CSH
were estimated by calculating the percentage of cells adhering to
n-hexadecane (1). The effects of 1/2 MIC on bacterial adhesion
(1 h) were studied using a modiﬁed microtitre-plate assay (2).
Results: There was a signiﬁcant decrease in CSH of all the strains
tested that could explain a decrease in adhesion values in CIs and
controls (reference and mutant strains). Treatment of the bacterial
cells with subinhibitory concentrations (1/2 MIC) of P-T changed
signiﬁcantly the CSH towards the hydrophilic state compared
with nontreated cells, and was found to be strain dependent.
Conclusion: As CSH and Adhesion ability are considered patho-
genic traits, these data indicate the potential effectiveness of sub-
MIC P-T for the treatment of patients with P. aeruginosa infections.
Acknowledgements: This study was supported by a research grant
from Fundac¸a˜o Calouste Gulbenkian.
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P498 In vitro activity of antimicrobial drugs against
Brucella melitensis strains in an endemic area
N. Elaldi, M.Z. Bakici, M. Bakir, I. Dokmetas, M. Sencan
Sivas, TR
Objectives: In human beings, brucellosis caused by Brucella meli-
tensis is the most important clinically apparent disease and
remains a major problem in the Mediterranean region including
Turkey. Despite clinical and laboratory studies, the optimum anti-
biotic therapy for brucellosis is still unclear. There are few reports
(mainly from endemic regions) in the literature about the sensitiv-
ity studies of Brucella spp. Furthermore, these studies still have
not been standardised and interpretative standards are not avail-
able. The in vitro activities of antimicrobial drugs against B. meli-
tensis strains isolated from blood and body ﬂuids cultures of the
patients with brucellosis were investigated in an endemic area.
Methods: A total of 63 B. melitensis strains were collected between
January 1998 and November 2003 from 63 patients with brucello-
sis at Cumhuriyet University Hospital, Sivas, Turkey. Only one
strain per patient was included. The isolates were tested for sus-
ceptibility to various antimicrobial agents by using the Sceptor
(Becton Dickinson Diagnostic Instrument Systems, Towson, MD,
USA) automatic system. This is a broth microdilution system that
uses plastic microtiter plates with doubling dilutions of desiccated
antimicrobial agents.
Results: The aminoglycoside-structured antibiotics generally had
good activity. Ceftriaxone had active against 59 of 63 (93.6%)
strains (MIC <8 lg/mL). Carbapenems (imipenem, meropenem)
showed good activity towards all strains of B. melitensis with
MICs of 4 lg/mL. All strains tested were susceptible to cefepime
(MIC <8 lg/mL) and 62 (98.4%) of 63 strains were susceptible to
ciproﬂoxacin (MIC <1 lg/mL). Fifty-nine (93.6%) strains were
inhibited by rifampicin at 1 mg/mL. Sixty-one (96.8%) were sus-
ceptible to tetracycline and 58 (92.1%) were to trimethoprim-sulfa-
methoxazole at concentrations of 4 and 0.5/9.5 lg/mL,
respectively. Strains were also tested with other antimicrobials.
Conclusion: In order to reduce the incidence of complications of
brucellosis and the development of drug resistance by the patho-
gen, it is necessary that proper treatment be instituted, following
antimicrobial susceptibility testing.
P499 Thermophilic Campylobacter resistance to ﬁve
antimicrobial drugs
B. Miljkovic-Selimovic, M. Mraovic, B. Potkonjak, T. Babic,
B. Kocic, L. Ristic
Nis, Belgrade, CS
Although Campylobacter enterocolitis is often self-limited diseases,
in prolonged diarrhoea, severe clinical presentation, immuncom-
promised patients and postinfective sequels, treatment is neces-
sary. However, appearance of Campylobacter spp. strains resistant
to erythromycin and also increasing resistance to quinolones may
be treat to efﬁcient therapy. The aim of the study is to evaluate
sensitivity of thermophilic Campylobacter strains to drugs used in
therapy of enterocolitis as well as to nalidixic acid used in identi-
ﬁcation. We investigated sensitivity of 76 thermophilic campylo-
bacter strains isolated from stool of patients with diarrhoea.
Sensitivity of Campylobacter spp. was tested by agar dilution
method in microaerophilic atmosphere for 48–72 h on Columbia
agar supplemented with 5% deﬁbrinated horse blood and antimi-
crobial agent: erythromycin (0.06–4 mg/L), gentamicin
(0.25–8 mg/L), ciproﬂoxacin (0.25–16 mg/L), tetracycline
(0.25–16 mg/L), chloramphenicol (1–32 mg/L) and nalidixic acid
(4–64 mg/L). The NCCLS interpretative standards for Enterobac-
teriaceae were used as a tentative breakpoints in MIC determin-
ation. For erythromycine sensitivity testing as a breakpoint MIC
of 4 mg/L was used. As a quality control, strain C. jejuni NCCLS
11951 was included. The resistance to erythromycin was low (4%
strains) with MIC50 of 0.5 mg/L and MIC90 of 1.0 mg/L. Strains
resistant to gentamicin were not detected. For gentamicin MIC50
of 0.5 mg/L and MIC90 of 1.0 mg/L were determined. Resistance
to ciproﬂoxacin was detected in 38.2% of investigated strains with
MIC50 of 0.5 mg/L and MIC90 of 8 mg/L. Resistance to nalidixic
acid was higher (42.1%) with MIC50 of 8 g/L and MIC90 64 g/L.
Strains resistant to tetracycline were detected in 15.8% of investi-
gated strains with MIC50 of 0.5 mg/L and MIC90 16 mg/L. All
investigated strains were sensitive to chloramphenicol with
MIC50 of 4 mg/L and MIC90 of 8 mg/L. Occurrence of strains
resistant to erythromycin and ciproﬂoxacin may restrict its effect-
iveness in thermophilic Campylobacter infection therapy and
requests its permanent investigation. Resistance to nalidixic acid
may diminish the value of the test for preliminary identiﬁcation
of thermophilic campylobacters.This work is a part of the project
‘The role of Campylobacter jejuni in etiology of some autoimmune
diseases’ (1612) and supported by the Ministry of Science, Tech-
nology and Development, Republic of Serbia.
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P500 In vitro activity of 12 anti-anaerobic agents against
clinical Bacteroides fragilis group strains isolated over a
7-month period
L. Alcala´, T. Pela´ez, N. Garcı´a-Escribano, O´. Pe´rez-Olaso,
J. Martı´nez-Alarco´n, J. Guinea, E. Bouza
Madrid, E
Objectives: Surveillance for antimicrobials resistance of clinical
Bacteroides fragilis group isolates is necessary for help guide empi-
ric therapy of anaerobic infections. We determine the antimicro-
bial susceptibility pattern of clinical B. fragilis group strains
isolated in our institution from May to November 2003.
Methods: Susceptibility testing was performed using a microdilu-
tion method according to document M11-A5 (NCCLS). Antimicro-
bials tested were amoxicillin (AM), amoxicillin-clavulanate (AC),
piperacillin (PI), piperacillin-tazobactam (PT), cefoxitin (CE), imipe-
nem (IM), chloramphenicol (CH), clindamycin (CL), metronidazole
(ME), moxiﬂoxacin (MO), tetracyclin (TE) and vancomycin (VA).
Results: A total of 182 strains from 127 specimens were tested.
The percentage of intermediate resistant strains within each spe-
cies tested were:
Conclusion: PT, IM, ME and CH were the most active agents tes-
ted, with at least 97% of susceptible strains. Moreover, AC and
CE had also a good activity with a susceptibility rate ranging
from 72.5 to 90.0%. The remaining antimicrobials had a poor
activity. In spite of the growing use of broad-spectrum antimicro-
bials, most of these agents remain active against clinical strains of
B. fragilis group isolated in our institution.
P501 The effect of sub-inhibitory concentration (sub-MIC)
of amikacin and ciproﬂoxacin on the loss of capsular antigen K1
by Escherichia coli strains
D. Wojnicz, A. Cisowska, S. Jankowski
Wroclaw, PL
Objectives: The aim of this investigation was to examine the inﬂu-
ence of 1/2 MIC of amikacin (AN) and ciproﬂoxacin (CIP) on the
loss of capsular antigen K1 by Escherichia coli strains.
Methods: Four E. coli K1 strains (315, 353, 418 and 662) isolated
from urine of children with urinary tract infections were used.
The bacteriophage K1A for detecting the capsular antigen K1 was
used. The MICs of AN and CIP for each strain in Mueller–Hinton
broth were determined by using microdilution method. The fre-
quency of occurrence of surface antigen K1 among 100 clones of
each E. coli K1 strains (without antibiotics and with 1/2 MIC of
AN and CIP) was detected by the method described earlier (1).
Results: In controls, all tested E. coli K1 strains revealed the occur-
rence of 93–96% clones with K1 antigen. The exposure of E. coli
K1 strains to 1/2 MIC of CIP signiﬁcantly decreased the percent-
age of clones with K1 antigen. Only 13% clones of E. coli 418
strain possessed K1 antigen. In cases of E. coli strains 353, 662 and
315, the presence of K1 antigen was found in 28, 37 and 40% per
100 clones, respectively. We observed that after exposure all E. coli
K1 strains to 1/2 MIC of AN, the percentage of clones with K1
antigen corresponded to the percentage observed in control.
Conclusions: The ﬁndings indicate that only sub-MIC of CIP
caused decrease in the percentage of clones sensitivity to K1A
phage.
Reference
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P502 Antibiotic susceptibilities and extended-spectrum
b-lactamase production of Enterobacteriaceae from urinary tract
infections
B. Kocic, S. Antic, B. Tiodorovic, T. Babic, L. Ristic, V. Mladenovic
Nis, YU
Objectives: ESBL producing Enterobacteriaceae have compromised
therapy with b-lactam antibiotics, including third generation of
cephalosporins. The objective of this study was to determine the
occurence of ESBL phenotypes among different isolates of Entero-
bacteriaceae and their susceptibility to antimicrobial agents.
Materials and Methods: A total of 1000 strain of Enterobacteriaceae
were isolated from urine samples during 1-year period. Suspected
strains are presumptively deﬁned as ESBL producers according to
result of disk diffusion method, using ESBL marker antibiotics-
ceftazidim, ceftriakson and cefotaksim. Those isolates were retest-
ed with double-disc sinergy test (DDST)-CAZ, CTR, CTX and
amoxicillin-clavulanic acid disks implementation. Enhancement of
inhibition zone (or so-called ghost zone) indicated presence of
ESBL strain. Antimicrobials susceptibility to b-lactam antibiotics,
aminoglikosides, quinolones and trimetoprim-sulfametoxazol
evaluated by disc-diffusion method, and the ESBL detection was
performed by the DDST, according to NCCLS criteria (2002).
Results: The species distribution as follows: Escherichia coli
(63.9%), Klebsiella spp. (30%), Enterobacter spp. (11.1%), Proteus
vulgaris (2.3%), P. mirabilis (11%), Providencia spp. (0.8%), Morga-
nella morgani (0.2%) and Citrobacter spp. (2.6%). Total number of
isolates (21.4%) was multiresistant for more than three groups of
antibiotics: E. coli were 44.39%, Klebsiella spp. 8.41%, Enterobacter
spp. 26.63%, P. vulgaris 5.14%, P. mirabilis 10.28%, Providencia
spp. 2.33%, M. morgani 0.46% and Citrobacter spp. 35%. Thirty-
three per cent of all isolates were from hospital samples; 4.3% of
all isolates were producing ESBL, and included four different spe-
cies. Escherichia coli (4.06%), Klebsiella (23.3%), Enterobacter (8.1%)
and Proteus mirabilis (0.2%). The majority of producers were from
clinical specimens (63%).
Conclusions: Gram-negative rods were responsible for high per-
centage of urinary tract infections. Escherichia coli was the most
common uropathogen. Multiresistant strain represent 21.4% from
Enterobacteriaceae implicated in UTI. The resistance to ampicilin
was the most frequent and concerned 62.6% of isolates of all indi-
cated species.
P503 Agreement between disc diffusion and E-test
methods to assess the carbapenem susceptibility of four
Gram-negative nosocomial pathogens
B. Cakir, S. Unal, O. Uzun
Ankara, TR
Objectives: The aim of this study was to assess the carbapenem
susceptibility of four nosocomial pathogens and to evaluate the
reliability of the susceptibility results determined by E-test and
disc diffusion (DD) methods.
Methods: Escherichia coli (n ¼ 73), Klebsiella pneumoniae (n ¼ 60),
Pseudomonas aeruginosa (n ¼ 70) and Acinetobacter spp. (n ¼ 70)
isolated from nosocomial infections in 2002–2003 were included in
the study. Thirty-ﬁve per cent of the strains were isolated from
intensive care units. After determining antimicrobial susceptibility
against imipenem and meropenem by DD (10 lg; Oxoid, UK) and
Etest (AB Biodisk, Solna, Sweden) methods, the results were cate-
gorised as susceptible (S), intermediate (I) and resistant (R)
according to the NCCLS criteria. For statistical analyses, the
Species (number) AM AC PI PT CE IM CL ME MO TE
B. fragilis (76) 100 7.9 28.9 2.6 6.6 1.3 46.1 1.3 26.3 81.6
B. thetaiotaomicron (38) 100 7.9 28.9 0 52.6 0 73.7 2.6 31.6 84.2
B. uniformis (18) 94.4 0 16.7 0 16.7 0 55.6 0 72.2 66.7
B. vulgatus (15) 100 6.7 40.0 0 13.3 0 46.7 0 46.7 8.0
B. ovatus (14) 100 28.6 50.0 14.3 64.3 0 71.4 0 50.0 14.3
Other (21) 100 23.8 57.1 4.8 52.4 0 71.4 0 33.3 90.5
Overall (182) 99.5 10.4 33.5 2.7 27.5 0.5 57.7 1.1 36.3 83.0
*All strains well resistant to VA, and susceptible to CH.
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intermediate group was included in the resistant category because
of the low numbers of bacteria in the former group.
Results: None of E. coli or K. pneumoniae strains were resistant to
carbapenems, whereas, resistance reached up to 59.0% in Acine-
tobacter spp. and P. aeruginosa isolates. By either method, the pat-
tern of the susceptibility of the four bacteria was not statistically
signiﬁcantly different for imipenem vs. meropenem. Total agree-
ment of DD and E-test methods for susceptibility to imipenem
was 95.7%, and 90.0% in Acinetobacter spp. and P. aeruginosa,
respectively; and susceptibility to meropenem was 90.0% for both
bacteria. However, the difference of the results obtained by either
method was statistically signiﬁcant for Acinetobacter spp.
Conclusion: Study results suggest a high resistance rate for Acine-
tobacter spp. and P. aeruginosa strains against carbapenem antibiot-
ics in our hospital. Further studies are needed to clarify whether
E-test should be used to conﬁrm meropenem resistance of Acine-
tobacter spp. determined by DD method.
P504 Gram-negative nosocomial pathogens in Estonian
intensive care units
K. Lo˜ivukene, E. Sepp, V. Adamson, U¨. Kallandi, K. Otter,
P. Naaber
Tartu, Tallinn, EST
Objective: While the most important reasons of mortality and mor-
bidity in intensive care units (ICUs) are nosocomial infections
caused by Gram-negative pathogens, our objective was to evaluate
susceptibility pattern of those pathogens comparatively in Esto-
nian ICUs by similar protocol. To clear up methodological discrep-
ancies, data of E-test and disk diffusion method were compared.
Methods: During April–November 2003, a total 105 Acinetobacter
baumannii, 92 Pseudomonas aeruginosa and 96 Klebsiella pneumoniae
strains were collected from clinical specimens from ICUs of North
Estonian Regional Hospital, East Tallinn Central Hospital and
Tartu University Clinics. For susceptibility testing, E-tests and
antibiotic disks (meropenem, imipenem, ampicillin/sulbactam, ce-
fepime, amikacin, piperacillin/tazobactam, ciproﬂoxacin and ceft-
azidime) were used accordingly to NCCLS guidelines.
Results: Ninty-ﬁve per cent of A. baumannii strains were sensitive
to meropenem, 98% to imipenem, 61% to ampicillin/sulbactam,
56% to cefepime and 72% to amikacin (MIC50/90 values, respect-
ively, 1/3, 0.75/2, 6/32, 8/32 and 6/64); 80% of P. aeruginosa
strains were meropenem, 70% imipenem, 78% piperacillin/tazo-
bactam, 68% ciproﬂoxacin, 75% ceftazidime and 98% amikacin
sensitive (MIC50/90 values 1/16, 3/>32, 6/>256, 0.25/12, 1.5/64
and 4/12). The susceptibility of K. pneumoniae isolates to merope-
nem and imipenem were 99%, to ciproﬂoxacin 92% and to amika-
cin 97% (MIC50/90 values 0.023/0.19, 0.19/0.5, 0.023/1 and 2/3).
Generally, MIC50/90 for meropenem was 0.38/4, imipenem 0.75/
6, ampicillin/sulbactam 6/32, cefepime 8/32, amikacin 3/8, pip-
eracillin/tazobactam 6/256, ciproﬂoxacin 0.125/1.5 and ceftazi-
dime 1.5/64. In all three ICUs, the sensitivity among A. baumannii,
P. aeruginosa and K. pneumoniae strains was similar, exept higher
resistance to cefepime of A. baumannii strains in Tartu University
Clinics. Discordance between E-test and disk-diffusion was patho-
gen speciﬁc. In K. pneumoniae, one major and seven minor errors
were found, whereas in A. baumannii/P. aeruginosa testing,
respectively, 2/4 very major, 13/12 major and 69/33 minor errors
occurred. Carbapenems test results correlated better than compari-
sons of other agents.
Conclusions: Most active agents against all pathogens were carb-
apenems and amikacin, whereas meropenem and ciproﬂoxacin
had lowest MICs than others. For empirical treatment meropenem
is preferred due to high activity against all Gram-negative patho-
gens and the lowest MIC values. In case of A. baumannii and
P. aeruginosa, E-tests are needed for susceptibility testing.
P505 Effects of subminimal inhibitory concentrations of
three antimicrobials on the virulence factors and growth of
Proteus mirabilis
M. Ucar, S. Ozden, Y. Dogan, S. Kirdar, O¨. Yilmaz, H. Baskin
Izmir, TR
Objectives: Proteus is the second bacteria only to Escherichia coli
as a cause of nonhospital acquired urinary tract infections. The
enzyme urease causes the pH of urine to rise, allowing unchecked
growth of the bacteria. Adherence to uroepithelial cells and the
organisms rapid motility are also involved in the pathogenesis of
the urinary tract infections. Antimicrobial treatment is often cho-
sen after determination of the minimal inhibitory concentrations
(MIC). Although antibiotics are often present in subinhibitory con-
centrations (sub-MICs) and may still be effective in reducing bac-
terial virulence.
Methods: Subminimal inhibitory concentrations of ciproﬂoxacin,
gentamicin and ampicillin-sulbactam at 1/2–1/32 X MIC levels on
growth, adherence, urease and swarming characteristics of Proteus
mirabilis (ATCC 14153) were studied.
Results: Minimal inhibitory concentrations values were 0.125 lg/
mL for ciproﬂoxacin, 0.25 lg/mL for ampicillin-sulbactam and
1 lg/mL for gentamicin. These three antimicrobials had no signi-
ﬁcant effect on swarming and urease production at the sub-MIC
levels. Ciproﬂoxacin and ampicillin-sulbactam had no inhibitory
effect on growth at sub-MIC levels whereas gentamicin inhibited
the colony counts at 1/2 X MIC level. We also observed that
ciproﬂoxacin, gentamicin, ampicillin-sulbactam inhibited the
adherence to uroepithelial cells at 1/2–1/8 X MIC.
Conclusion: Proteus mirabilis causes urinary tract infections in the
complicated urinary tracts, especially in indwelling catheters,
presence of the structural abnormalities or in elder patients.
Ciproﬂoxacin (quinolone), ampicillin-sulbactam (b-lactam) and
gentamicin (amino glycoside) have different effect mechanisms,
and side effects. In this study, it was interesting to see that there
were no differences on the swarming and urease production of
these three antibiotics whereas gentamicin still inhibited bacterial
growth at 1/2 X MIC levels. Gentamicin was more effective in
1/2–1/4 X MIC levels on adherence of the pathogen that is
known to be the most important virulence mechanism. In conclu-
sion, we may suggest that gentamicin is more effective antibiotics
among these three agents.
P506 In vitro susceptibility of Pseudomons aeruginosa
isolated in a burn centre in south Iran, to silversulfadiazine and
silver nitrate
M. Hayati, A. Japoni, A. Alborzi, M. Kalani
Shiraz, IR
Objectives: Development of microorganisms resistant to antisep-
tics may increase with the widespread use of these agents. Silver
salts and compounds (AgNO3, silversulfadiazine) are among these
agents. Silversulfadiazine (SSD) is extensively used in our burn
centre in south of Iran (Ghotbedin Hospital, Shiraz). This study
was carried out to determine and compare the susceptibility of
Table 1. Susceptibility of Acinetobacter spp and P. aeruginosa strains to imipenem and
meropenem by comparing results of DF and Etest Methods
DD method
Etest method
R/I S McNemar test p-value
Imipenem
Acientobacter spp R/I 37 3 0.250
S 0 30
P. aeruginosa R/I 34 4 1.000
S 3 29
Meropenem
Acinetobacter spp R/I 32 9 0.021
S 1 28
P. aeruginosa R/I 30 7 0.344
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Pseudomons aeruginosa isolated from burned patients, burn wards
and nonburn patients to SSD and AgNO3.
Methods: Three groups of P. aeurginosa were isolated including
the strains from burned patients (group I), environmental strains
from burn centre (group II) and strains isolated from nonburn
patients (group III or control). The MICs of SSD and AgNO3 for
these strains were determined by agar dilution method in TYE
agar without NaCl in dark. The results were compared by ﬁsher
exact test and correlation between MICs was determined as well.
Susceptibility of these strains to SSD was also evaluated by agar
cup plate method.
Results: From 63 strains in group I, 60 strains were resistant to
SSD which 40 of them were highly resistant (MIC >10 mM) and
ﬁve of them were resistant to AgNO3. In group II, eight strains of
15 were resistant to SSD with the same range of MIC as group I
but non of them showed resistance to AgNO3. In group III, all the
strains were sensitive to SSD and AgNO3. The differences
between MIC of SSD in these groups were signiﬁcant (P < 0.001).
Correlation between MIC of SSD and AgNO3 was not signiﬁcant
in group I. The results of agar dilution tests were conﬁrmed by
agar cup plate method.
Conclusion: Pseudomanas aeruginosa, the epidemic cause of infec-
tions in our burn centre could develop a high level of resistance
to SSD (MIC >10 mM) which is an important threat for burned
patients and warns to revise the effectiveness of this drug. Only
ﬁve strains of 60 SSD resistant were cross-resistant to AgNO3
(MIC 0.75–1 mM).
P507 Antimicrobial resistance among Streptococcus
pneumoniae and Haemophilus inﬂuenzae from Africa and the
middle-east: 2002/2003 winter season
A. Shibl, J. Daniels, J. Sievers and the SOAR in AME Study Group
Objectives: Antimicrobial resistance among respiratory pathogens
exists worldwide, affecting empirical prescribing choices. Quality
surveillance data are needed to monitor the prevalence and
spread of resistance to commonly prescribed antimicrobials.
Methods: Respiratory tract isolates of Streptococcus pneumoniae
(Sp) and Haemophilus inﬂuenzae (Hi) were collected from
patients in three African countries, seven middle-eastern coun-
tries and Pakistan in the 2002/2003 winter season. MICs for
various antimicrobials were determined using E-test, and sus-
ceptibility assessed based on NCCLS breakpoints, where applic-
able. Quality control strains were tested on each day of testing.
Not all antimicrobials were tested in all countries, or against all
isolates.
Results: A total of 1154 Sp and 1091 Hi isolates were collected. In
Africa 58.6% (136/232) and in the middle-east 42.5% (349/822) of
Sp were penicillin susceptible and 4.3% (10/232) and 8.3% (68/
822), respectively, were penicillin resistant (PRSP). The highest
PRSP prevalence was in Tunisia (17.8%). No PRSP were identi-
ﬁed in Egypt, Jordan, Kuwait or Pakistan. In Africa 10.8% (25/
232), in the middle-east 12.3% (99/808), and in Pakistan 13.0%
(13/100) of Sp were azithromycin resistant. The lowest regional
prevalence of Sp resistance to a cephalosporin was to cefprozil
[Africa: 2.2% (5/232); middle-east: 1.9% (16/822)], and the high-
est was to cefaclor [Africa: 10.8% (25/232)] and cefdinir [middle-
east: 24.3% (113/465)]. Only 0.4% (1/232) of Sp in Africa and
0.5% (4/821) in the middle-east were resistant to amoxicillin/cla-
vulanic acid. In Africa, 50.0% (5/10) of PRSP were co-resistant to
azithromycin, as were 22.4% (15/67) of PRSP from the middle-
east. Of Hi isolates, 14.9% (33/221) (Africa) and 21.6% (166/768)
(middle-east) were b-lactamase positive. All Hi from Africa and
Pakistan and 99.9% from the middle-east were amoxicillin/cla-
vulanic acid susceptible.
Conclusions: Despite an overall prevalence of PRSP in Africa and
the middle-east <10%, the higher prevalence of PRSP in countries
such as Tunisia may complicate empirical prescribing in those
areas. Of further concern is the prevalence of macrolide resistance
and PRSP macrolide co-resistance. The high prevalence of b-lacta-
mase production in Hi in the middle-east may make b-lactamase-
unstable antimicrobials unsuitable in this region. Agents such as
amoxicillin/clavulanic acid, to which both Sp and Hi remain sus-
ceptible, may be most appropriate for empirical prescribing in
these areas.
Antifungal susceptibility studies
P508 Comparative evaluation of AFST-EUCAST method
and Sensititre YeastOne Colorimetric Antifungal Panel with
NCCLS reference method for susceptibility testing of Candida
species
M. Yucesoy, C. Ergon
Izmir, TR
Objectives: This study was carried out to compare the perform-
ance of two alternative methods, Antifungal Susceptibility Testing
Subcommittee of the European Committee on Antimicrobial Sus-
ceptibility Testing (AFST-EUCAST) method and a commercially
prepared Sensititre YeastOne Colorimetric Antifungal Panel with
NCCLS M27-A2 microdilution method.
Methods: Two quality controls, seven reference strains of ATCC
including various Candida species and a clinical isolate of ﬂucon-
azole-resistant C. glabrata were included. Susceptibility for ampho-
tericin B, ﬂuconazole, itraconazole and ketoconazole were
performed with AFST-EUCAST, Sensititre and NCCLS microdilu-
tion methods while the susceptibility of 5-ﬂucytosine was investi-
gated with Sensititre and NCCLS methods. AFST-EUCAST
method was performed with RPMI-1640 supplemented with 2%
dextrose, inoculum size of 0.5–2.5  105 CFU/mL and ﬂat-bottom
plates. Sensititre method was carried out according to the manu-
facturer’s instructions with an inoculum of 1.5–8  103. The end-
points were determined visually for amphotericin B, visually and
spectrophotometrically at the wavelength of 450 and 492 nm for
azoles after 48 h in the NCCLS method. The results were read
spectrophotometrically at the same wavelengths in the AFST-EU-
CAST method and only visually in the Sensititre method. The
results were compared according to the agreement of MIC values
within 2-fold dilutions and susceptibility categories.
Results: When the agreement between the results of NCCLS and
Sensititre method after 48 h was considered 8–9 of 10 strains were
within 2-fold dilutions for amphotericin B, ﬂuconazole and itrac-
onazole and 6–7 were for ketoconazole. According to the results
of NCCLS method and AFST-EUCAST method, at 24 and 48 h
8–10 of the strains were within 2-fold dilutions for all of the
agents. When the susceptibility categories were considered there
was no very major and major errors.
Conclusion: It can be concluded that both AFST-EUCAST and
Sensititre methods are potentially good alternatives for antifungal
susceptibility testing of Candida species for many antifungal
agents when tested with reference strains.
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P509 Determination of antifungal activity of caspofungin
using ﬂow cytometry
S. Costa-de-Oliveira, C. Pina-Vaz, C. Tavares,
A. Gonc¸alves Rodrigues
Porto, P
Caspofungin is an echinocandin that blocks the synthesis of
b-(1,3)-D-glucan of the fungal cell wall, which is an essential com-
ponent of the cell wall of numerous fungal species. The inhibition
of its synthesis may result in a fungistatic effect, from blockade of
the cell wall synthesis, or in a fungicidal effect, from changes in
the integrity of the cell wall. Cytometric methods allow the early
establishment of a susceptibility proﬁle and give the possibility to
evaluate functional and morphologic changes of the fungal
cells (1).
Objectives: To determine susceptibility of clinical isolates of yeast
to caspofungin by cytometric methods.
Methods: Two strains of Candida albicans with low MIC to caspo-
fungin (determined accordingly M27 A protocol by NCCLS) and
one C. guilliermondii and one strain of Cryptococcus neoformans both
with high MIC were studied. The strains were grown overnight in
Sabouraud broth and then incubated with caspofungin (Merck), at
serial concentrations (MIC, MIC/2, 2x MIC and 4x MIC) during 1,
3 and 5 h, in phosphate buffer saline (Sigma). The suspensions
were washed and stained with propidium iodide (PI; Sigma) (a
marker of cell death by cell membrane lesion), FUN-1 (molecular
probes) an indicator of metabolically integrity of yeast cells and
SYTO 16 (molecular probes) a green ﬂuorescent nucleic acid stain.
The cells were analysed on a ﬂow cytometer (Beckman Coulter
XL-MCL): the morphology (scattergram) and the intensity of
ﬂuorescence of the stained cells [FL3 (red) for PI; FL2 (green) for
FUN-1 and FL2 for SYTO 16] were evaluated.
Results: Obvious changes of the scatter were noticed from after
1 h of incubation, which increased with increasing incubation
time. Five hours of incubation with 4x MIC were necessary to
stain sensitive yeast strains with PI. Resistant strains did not stain
with this probe. Fun-1 staining increased on sensitive strain after
3 h incubation with MIC or higher concentrations; resistant strains
only increased intensity of ﬂuorescence with very high concentra-
tions. SYTO 16 did not allow to distinguish sensitive from resist-
ant strains.
Conclusions: The antigungal effect of caspofungin could be evalu-
ated by cytometric methods. The fungicidal effect was detected
with PI after 5 h incubation with the antifungal while fungistatic
effect was detected with FUN-1 sooner after 3 h incubation.
Reference
1. Pina-Vaz, C. et al. (2001). Clin Microbiol Infect 7, 609–618.
P510 Paradoxical caspofungin effect: reduced activity
against Candida albicans at high concentrations
D.A. Stevens, T.C. White, D.S. Perlin, M. Espiritu, R. Parmar
San Jose, Seattle, Newark, USA
Objective: Resistance problems with caspofungin, an echinocandin
inhibitor of fungal cell wall glucan synthesis, have been rare. We
noted and investigated paradoxical turbid growth of Candida
albicans isolates in some high, supra-MIC, concentrations of caspo-
fungin.
Methods: Broth and agar dilution, checkerboard analysis of drug
interaction, DNA sequencing, enzyme expression analysis.
Results: Among isolates submitted for susceptibility testing and
screened to 12.5 mcg/mL, the frequency was 10%. Analysis of the
turbid growth indicated slowing of growth in drug, but CFU up
to 72% of drug-free controls. Clearing of growth again by the
highest concentrations produces a quadri-phasic pattern in a tube
dilution series. Cells growing at high drug concentrations were
not resistant on retesting, but showed the paradoxical effect of the
parent. Among a selected series of isolates tested to 50 mcg/mL,
an additional 53% showed a ‘mini effect’: no turbid growth, but
incomplete killing at high, supra-MFC concentrations. These
effects were reproducible, medium dependent in extent, noted in
macro- and micro-dilution and on agar containing drug (but not
when drug concentrations were not constant, as in agar diffusion),
not seen in other Candida species or with other echinocandins,
and not due to destruction of drug in tubes with the effect or to
mutations in resistance-associated regions of the glucan synthase
complex. Co-operative enhancement of inhibition by a second
drug could eradicate the effect. Extensive studies of relationship
to azole resistance mechanisms suggest a weak association, at
most. Occasional isolated clear tubes on subculture yielded a few
viable cells in a ring-like pattern, suggesting random distribution,
in some strains, of few cells with propensity to grow in the pres-
ence of drug.
Conclusion: We postulate high drug concentrations derepress or
activate resistance mechanisms. The ability of subpopulations to
survive at high drug concentrations could have in vivo conse-
quences.
P511 Bioﬁlms of Candida albicans on silicon catheters
could be reduced by caspofungin in vitro
C. Cocuaud, S. Imbert-Bouyer, M.-H. Rodier, C. Imbert
Poitiers, F
Objectives: Some manifestations of candidiasis are associated with
the formation of bioﬁlms on inert surfaces, and the intrinsic resist-
ance of C. albicans bioﬁlms to the most commonly used antifungal
agents has been demonstrated. We studied here the effect of
caspofungin on bioﬁlms of C. albicans.
Methods: Calibrated sections of silicone catheters were incubated
with C. albicans yeasts to obtain bioﬁlms of 2, 24 and 48 h of mat-
uration. Ten strains of C. albicans were used: ﬁve strains suscept-
ible to ﬂuconazole in vitro and ﬁve strains resistant to this
antifungal agent. We report on the effect of two concentrations of
caspofungin (MIC and 2 mg/L) on these bioﬁlms. The inﬂuence
of caspofungin on C. albicans bioﬁlms was determinated by evalu-
ating a signiﬁcant decrease or increase (P < 0.0001) in the meta-
bolic activity of yeasts.
Results: The results showed that caspofungin (MIC) had no effect
on C. albicans bioﬁlms, whatever the strains and the maturation
status of the bioﬁlm. Caspofungin (2 mg/L) induced a signiﬁcant
decrease of the metabolic activity of all tested C. albicans bioﬁlms.
The efﬁciency of caspofungin (2 mg/L) was observed independ-
ently of (i) the susceptibility of yeasts to ﬂuconazole, and (ii) the
maturation status of fungal bioﬁlms.
Conclusion: Caspofungin (2 mg/L) could represent a good candi-
date in the prevention of candidiasis associated with silicone med-
ical devices.
P512 In vitro activities of ﬂuconazole and voriconazole
against Spanish bloodstream isolates of Candida glabrata and
Candida krusei
G. Quindo´s, L. Sa´nchez, M. Villar, P. Ahuad, E. Eraso,
J. Herna´ndez
Bilbao, E; Mexico City, MEX; Buenos Aires, AR; Barakaldo, E
Objective: To evaluate the in vitro susceptibility to ﬂuconazole
and voriconazole of all the Candida glabrata and Candida krusei
blood isolated during a 14-year period (1990–2003) at a tertiary
care hospital (University Hospital of Cruces, Barakaldo, Spain).
Patients and Methods: Twenty-eight C. glabrata and 15 C. krusei
blood isolates were tested. Disk diffusion was performed as des-
cribed in NCCLS document M44-P in Mueller–Hinton agar (Difco
Laboratories, USA) supplemented with 2% glucose and methy-
lene blue. Fluconazole (25 lg) and voriconazole (1 lg) disks were
obtained from Becton Dickinson (USA). Plates were inoculated by
using a swab dipped in a cell suspension adjusted to the turbidity
of a 0.5 McFarland standard, incubated at 37C and read at 24 h.
Interpretive criteria for ﬂuconazole were: (i) susceptible, zone
diameter of 19 mm or more; (ii) susceptible-dose dependent, zone
diameter of 15–18 mm; (iii) resistant, zone diameter of <14 mm.
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Interpretive breakpoints have not yet been established for vorico-
nazole an a zone diameter of <13 mm was considered as an indi-
cator of in vitro resistance. Quality control was performed by
using C. albicans ATCC 90028, C. krusei ATTC 6258 and C. parapsi-
losis ATCC 22019. E-test (AB Biodisk, Sweden) and Sensititre
Yeast One (AccuMed International, USA) were used for testing
all resistant and susceptible-dose dependent isolates and a repre-
sentative number of susceptible isolates.
Results: 14.3% C. glabrata had a decreased susceptibility to ﬂuc-
onazole, as two C. glabrata were resistant and other two iso-
lates were susceptible-dose dependent. All C. krusei were
resistant to ﬂuconazole. Voriconazole was active against 27
(96.4%) C. glabrata and 14 (93.3%) C. krusei. Both voriconazole
resistant isolates were also resistant to ﬂuconazole and were
isolated one (C. krusei) in 1991 and other (C. glabrata) in 1993.
The ﬂuconazole and voriconazole susceptibility patterns were
constant during this 14-year period. These susceptibility results
to both triazoles were conﬁrmed by the E-test and Sensititre
YeastOne methods.
Conclusion: Voriconazole was very active in vitro against C. glab-
rata and C. krusei blood-stream isolates.
Acknowledgements: This work was ﬁnanced in part by grant
1/UPV 00093.327-E-14645/2002 from the Universidad del Paı´s
Vasco.
P513 Comparison of the in vitro activity of anidulafungin
with amphotericin B, caspofungin, ﬂuconazole, itraconazole and
voriconazole against a panel of 780 yeast isolates obtained from
ﬁve European centres
E.M. Johnson, B.P. Goldstein, K.G. Davey, M.A. Fraser
Bristol, UK; Pen, USA
Objectives: To compare the in vitro activity of the echinocandin
agent anidulafungin with that of ﬁve other systemically active
antifungal agents against a total of 780 yeast isolates obtained
from ﬁve European countries.
Methods: Isolates of Candida albicans (505), C. glabrata (89), C. krusei
(53), C. parapsilosis (41), C. tropicalis (65) and other Candida species
(23) were obtained from superﬁcial and deep infections of patients
in the UK, France, Germany, Italy and Spain. All isolates were tes-
ted by the microtitre plate modiﬁcation of method NCCLS M27-A2
with results recorded after 24 and 48 h. A subset of 50 isolates was
also tested by the EUCAST method with reading after 24 h.
Results: The 24 and 48 h MIC50, MIC90 and range (mg/L) are
presented for each drug against all isolates tested by the NCCLS
method. Results of the NCCLS method read after 24 or 48 h and
results obtained by the EUCAST method read after 24 h differed
by no more than a doubling dilution. Anidulafungin was the most
potent agent overall against the panel of yeasts tested. MICs of
anidulafungin were similar for azole-susceptible and azole-resist-
ant isolates.
Conclusions: Anidulafungin was highly active in vitro against Can-
dida isolates from ﬁve European countries. These data are consistent
with previous ﬁndings in smaller studies and in a large US survey.
P514 The efﬁciency of ﬂuconazole and amphotericin B in
comparison with echinocandin micafungin and benzothiazole
APB in Candida albicans and C. dubliniensis isolated from HIV
and cancer patients
S. Melkusova´, H. Bujda´kova´, A. Vollekova´, Y. Myoken, Y. Mikami
Bratislava, SK; Hiroshima, Chiba, JP
Objectives: This work studied the efﬁciency of the experimental
antifungal agent 6-amino-2-n-pentylthiobenzothiazole (APB),
echinocandin micafungin and the conventional antifungal drug
amphotericin B in ﬂuconazole-resistant Candida albicans and
C. dubliniensis. In addition to this, the work was focused on the
study of synergy effect between APB and ﬂuconazole in both
mentioned Candida species.
Methods: For this study, 16 ﬂuconazole resistant C. albicans and
C. dubliniensis strains were selected out of 60 originally tested for
susceptibility to ﬂuconazole. Clinical isolates were obtained from
patients with diabetes, different allergy and cancer diseases and
oropharyngeal candidiasis of HIV infected patients from Slovakia,
Brazil, Japan and Thailand. All clinical isolates were cultivated on
CHROMagar Candida. Identiﬁcation was performed with com-
mercial set API 20C AUX. The discrimination between C. albicans
and C. dubliniensis was carried out by PCR assay using set primer
pair (Cd-oligo2/F and Cd-oligo2/R) speciﬁc only for C. dublinien-
sis. Standard C. dubliniensis CBS 7987 was used as positive control.
Susceptibility to ﬂuconazole, amphotericin B, APB and micafungin
was tested by broth microdilution method according to NCCLS
M27-A reference method. The synergy effect of APB with ﬂucon-
azole was investigated in selected clinical isolates.
Results: The antifungal activity was determined at both concen-
trations, MIC80 and MIC95. For ﬂuconazole, MIC80 was observed
in range from 0.25 to 8 mg/L, but MIC95 was proved higher than
64 mg/L. Benzothiazole APB showed to be less active against C.
albicans and C. dubliniensis (MIC80 ¼ 8–32 mg/L; MIC95 ¼ 16–
64 mg/L) in comparison with clinical trial amphotericin B, which
was efﬁcient at concentration range from 0.125 to 2 mg/L. Efﬁ-
ciency of micafungin was very high with MIC80, and MIC100
<0.031 mg/L. In this study, the synergy effect of APB with ﬂuco-
nazole was conﬁrmed in several selected C. albicans and C. dublini-
ensis. While MIC100 for single ﬂuconazole was over 64 mg/mL,
this agent was effective in the range from 16 to 2 mg/L in combi-
nation with APB. On the contrary, MIC100 for APB was 32 mg/
mL in single application, but in combination with ﬂuconazole, it
was markedly lower (8–2 mg/L).
Conclusion: Results conﬁrmed the high efﬁciency of echinocandin
micafungin, as well as the synergy effect between APB and ﬂuc-
onazole in ﬂuconazole resistant C. albicans and C. dubliniensis
strains.
P515 Evaluation of a colorimetric antifungal susceptibility
test by 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride
C. Chang, J. Shin, J.-C. Choi, E.Y. Lee
Busan, KOR
Objectives: Reliable susceptibility testing of pathogenic and
opportunistic fungi is of growing importance. Despite the consid-
erable progress made by using the NCCLS standard method M27-
A2 for broth dilution susceptibility testing of yeasts, problems still
arise when determining the minimum inhibitory concentration
(MIC). One of the most important is the trailing phenomenon.
2,3-Diphenyl-5-thienyl-(2)-tetrazolium chloride (STC) is an oxida-
tion-reduction indicator that, in the presence of growing organ-
isms, changes from colourless to red. This indicator has not been
explored for antifungal susceptibility testing. The present study
aimed to develop a colorimetric method of antifungal susceptibil-
ity testing using STC.
Methods: Five type strains (Candida parapsilosis ATCC 22019,
C. albicans ATCC 90028, C. albicans ATCC 64550, C. krusei ATCC
6258 and C. tropicalis ATCC 201380) and 19 clinical strains of
C. albicans were used. Antifungal susceptibility tests were
Table 1. Table of 24 and 48h MIC50, MIC90 and Range (mg/L) for each drug against
780 isolates of Candida species
Drug
Range
(mg/L) 24 h
Range
(mg/L) 48 h
MIC50
(mg/L) 24 h
MIC50
(mg/L) 48 h
MIC90
(mg/L) 24 h
MIC90
mg/L 48 h
Anld 0.03–2.0 0.03–2.0 0.03 0.03 0.06 0.12
Caspo 0.125–2.0 0.125–8.0 0.25 0.5 1.0 2.0
AmB 0.03–1.0 0.03–2.0 0.25 0.5 0.5 0.5
Fiz 0.125–>64 0.125–>64 0.125 0.25 16 32
Itra 0.03–>16 0.03–>16 0.03 0.06 0.5 1.0
Vori 0.03–>16 0.03–>16 0.03 0.03 0.25 0.5
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performed with NCCLS-recommended broth microdilution and
STC-colorimetric methods in parallel. The colorimetric method
using STC was identical to the broth microdilution method with
two exceptions: that STC was added to RPMI 1640-MOPS medium
with antifungal agents at a ﬁnal concentration of 50 lg/mL, and
that the solubilising agents were added at 48 h of incubation and
then the plates were incubated for 2 h. The wells with fungal
growth were pink to red after addition of the agent.
Results: Among 24 strains, 18 and nine strains, respectively, dem-
onstrated the trailing phenomenon with ketoconazole and itracon-
azole in the broth microdilution method. In contrast, trailing
growth was not seen in the STC-colorimetric method, and, for 22
(92%) and 20 (83%) of the 24 strains, the ketoconazole and itrac-
onazole MICs, respectively, were within two dilutions of those
obtained by the NCCLS method. Furthermore, the colorimetric
method allows stringent endpoint designation, and there is no dif-
ference between visual observation before extraction and visual
and spectrophotometric reading after extraction.
Conclusions: The colorimetric method using STC was objective
and easy to interpret and showed high levels of agreement with
the NCCLS method for ketoconazole and itraconazole. I think that
the STC-based colorimetric method is easily applicable for the
antifungal susceptibility test.
P516 Antifungal activity of Juniperus turbinata on species
of Candida and dermatophytes
E. Pinto, C. Cavaleiro, L. Salgueiro, A. Palmeira, M. Gonc¸alves,
C. Pina-Vaz, A. Gonc¸alves Rodrigues, S. Costa-de-Oliveira,
C. Tavares, J. Martinez-de-Oliveira
Porto, Coimbra, P
Dermatophytosis and candidosis are common superﬁcial infec-
tions that can be found all over the world. Recently, our group
demonstrates that some essential oils (Thymus ssp., Origanum ssp.
and Lippia ssp.) can be useful as antifungal agents (1–4).
Objectives: Continuing our research on the antifungal activity of
essential oils, we report now the activity of Juniperus turbinata
leaves and berries’ essential oils in order to support its application
as therapeutic agents in the treatment of superﬁcial mycoses.
Methods: Two samples of leaves oils from plants collected at
Algarve (A) and at Alentejo (B) and one sample of berries oil from
Alentejo (C) were assayed. Essential oils were isolated from fresh
material, by water distillation (3 h) in a Clevenger type apparatus
(5) and their compositions investigated by GC and GC-MS, as pre-
viously reported (6). Leaves oils are dominated by monoterpene
hydrocarbons (77.1–89.4%), but quantitative important differences
were found in the main compounds (a-pinene 27.8% vs. 48.2%
and b-phellandrene 28.8% vs. 23.1%, respectively, for samples A
and B). The main constituents of the berries oil were a-pinene
(66.7%) and b-phellandrene (8.4%). Antifungal activity on Candida
and dermatophytes strains was evaluated by determination of the
minimal inhibitory concentration (MIC), according to the NCCLS
protocol, M 27-A and M 38-P, respectively.
Results: Important inhibitions of the growing of dermatophytes
were observed, with MIC values ranging 0.08–0.32, 0.63–1.25 and
0.32–1.25 lL/mL for J. turbinata oils (A, B and C, respectively).
For Candida strains the oils have low activity with MIC values
ranging 0.32–2.5, 1.25–10.0 and 5.0–20.0 lL/mL for samples A, B
and C, respectively).
Conclusion: The antifungal activity of J. turbinata essential oils on
dermatophytes, may justify future clinical trials to validate their
use as therapeutic alternatives for dermatophytosis treatment.
Acknowledgements: FCT, POCTI and FEDER (POCTI/40167/ESP/
2001) for ﬁnancial support.
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P517 The effect of onion extract on ultrastructure of
Trichophyton mentagrophytes and T. rubrum
M. Shams, M. Godarzi, T. Tarihi, M. Razzaghi Abyaneh
Tehran, IR
Dermatophytes are a specialised group of fungi able to use the
keratinised tissue of skin, nail and hair as the sole nutritional
source. These fungi are classiﬁed in three major genera namely
Microsporum, Trichophyton and Epidermophyton. The various species
in each genus are the causative agents of dermatophytosis in
human and animals. Dermatophytoses usually appear as chronic
infections and do not respond well to current antifungal drugs.
These drugs also have numerous side effects and their continued
administration causes resistance against their therapeutic effects.
So there have been several attempts to discover new agents with
antidermatophytic effects and less side effects. This survey was
conducted to evaluate the effect of onion extract on growth and
ultrastructure of two important dermatophytes T. rubrum and
T. mentagrophytes. The fungi were cultured in the presence of
aqueous onion extract in sabouraud dextrose broth and the cul-
tures were incubated for 5, 10 and 15 days. Mycelial dry weight
was used as the index of fungal growth rate and a portion of
mycelia was processed for electron microscopy as mentioned in
the Materials and Methods. The results showed that aqueous onion
extract can inhibit the growth of T. rubrum and T. mentagrophytes
in a dose and time dependent manner. This inhibition is more
revealed for T. mentagrophytes compared with T. rubrum and the
maximum inhibition of growth was observed for both dermato-
phytes in 6.25% concentration of aqueous onion extract. Study of
the effect of 3% (v/v) aqueous onion extract on fungal ultrastruc-
ture showed massive changes as deformation and swelling of
mycelia, disruption of the mycelial cell wall, separation of ﬁla-
mentous material from mycelial cell wall, severe degeneration of
mycelia and conidia and disruption of intracellular organelles
especially nuclei and mitochondria. These morphologic changes
were also greater for T. mentagrophytes than T. rubrum. It is
assumed that there are some factors in T. rubrum causing its
resistance to antifungal agents. On the whole it can be concluded
that aqueous onion extract can inhibit the growth of T. rubrum
and T. mentagrophytes. This effect is probably caused by disruption
and deformation of the cell wall structure and intracellular organ-
elles. Therefore, aqueous onion extract can be used in antifungal
preparations with future determination of its effective substances.
P518 Effects of 5-hydroxytryptamine on virulence
properties of Candida albicans in vitro
A. Mayr, G. Hinterberger, M.-P. Dierich, C. Lass-Flo¨rl
Innsbruck, A
Objectives: In human beings selective serotonin reuptake inhibi-
tors (SSRIs) modify the concentration of 5-hydroxytryptamine
(5-HT) and lead to an increase of 5-HT during therapy with SSRIs.
Recently, we found that 5-HT has antifungal activity against
Candida spp. in vitro. Therefore, we investigated the direct inﬂu-
ence of 5-HT against clinical isolates of C. albicans (CBS 5982) with
regard on direct effects on virulence properties of this fungal
pathogen in vitro. We examined the inﬂuence of 5-HT on enzy-
matic activity with regard to extracellular phospholipases and the
production of secreted aspartyl proteinases (SAPs).
Methods: Serial dilutions from 25–0.09 mg/mL 5-HT were used
for testing extracellular phospholipase activity and SAPs. The
extracellular phospholipase activity of C. albicans was measured
by the egg yolk agar method. The assay for Candida secreted
aspartyl proteinases was assessed by a modiﬁed version of the
original protocol by Ollert et al.
Results: An interaction between 5-HT and virulence properties of
C. albicans in vitro could be clearly demonstrated. A signiﬁcant
decrease (P < 0.05) on phospholipase activity and SAPs of
C. albicans at 5-HT concentrations of 25–0.09 mg/mL compared
with positive control was observed. At a range of 25–12.5 mg/mL
5-HT the most strongest effect on phospholipase activity was
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determined, whereby the lowest concentration of 5-HT (0.09 mg/
mL) had no effect on enzymatic activity. The highest reduction on
SAPs was found to be at a range of 1.56–0.78 mg/mL 5-HT com-
pared with positive control.
Conclusion: An inﬂuence of 5-HT on both virulence factors of
C. albicans could be clearly observed. In conclusion, further stud-
ies are required to evaluate the potential role of 5-HT in antifun-
gal host defence.
P519 Studies on in vitro antimicrobial activity of vitreous
substitutes against Candida albicans
A. Szczepanik, E. Kosior-Jarecka, M. Wojtowicz, J. Mackiewicz,
M. Koziol-Montewka
Lublin, PL
Objectives: Vitreoretinal surgery is one of the most rapidly devel-
oping ﬁelds of ophthalmology. However, it may also be respon-
sible for serious blindness as a result of complications including
fungal endophthalmitis. Silicon oil (PDMS 5000), perﬂuorodeca-
line (PFCL) and perﬂuorohexyloctane (F6H8) have been used as
internal tamponading agents in vitreous surgery. The aim of the
study was to evaluate and compare possible antimicrobial proper-
ties of PDMS 5000, PFCL and F6H8 in vitro against Candida
albicans, which is considered one of the major causative agents of
postoperative fungal endophthalmitis.
Materials and Methods: The clinical isolate of C. albicans was selec-
ted. The fungus was separately inoculated into PDMS 5000 (pro-
duced by AcriMed, Germany), PFCL (produced by AcriMed,
Germany) and F6H8 (produced by Fluoron, Germany). Control
inoculations into physiological saline and sugar broth were per-
formed. The fungal suspensions in each vitreous substitute, phy-
siological saline and sugar broth were diluted according to serial
dilution procedure and plated in Petri dishes with Sabouraud
medium. After 48 h incubation fungal CFUs were counted.
Results: Candida albicans CFUs decreased signiﬁcantly in all used
vitreous substitutes. CFUs of C. albicans in PDMS 5000 decreased up
to the ﬁfth day of the study; afterwards no growth was observed.
Fungal growth was inhibited on the medium inoculated with Can-
dida suspension in PFCL up to the third day of the study but single
colonies appeared after the ﬁfth day. For fungal inoculations in
F6H8 single colonies on Sabouraud medium were present during
the whole period of the study. No total elimination of the fungal
growth was observed for PFCL and F6H8. CFUs of C. albicans
declined slightly in physiologic saline. A growth pattern similar to
the growth curve of microorganisms was observed in sugar broth.
Conclusion: Our study indicates that silicon oil, perﬂuorodecaline
and perﬂuorohexyloctane could have antifungal properties against
C. albicans, which is considered one of the major causative agents
of postoperative fungal endophthalmitis. Additionally, silicon oil
seems to be the most efﬁcient vitreous substitute inhibiting fungal
growth.
P520 Antifungal resistance patterns among oral Candida
species from patients receiving anticancer therapy
I. Glazar, M. Abram, S. Pezelj-Ribaric, B. Miletic, I. Brekalo Prso,
B. Matica
Rijeka, Zagreb, HR
Objectives: Oral fungal infections are frequent complications in
immunocompromised patients. This study was conducted to
understand the current status of yeast resistance to available anti-
fungal agents among patients receiving anticancer therapy.
Materials and Methods: Oral swabs were collected from 216 hospi-
talised patients receiving chemotherapy or radiotherapy treatment
for malignant disease. No patients in this series had previous epi-
sodes of oral candidiasis or had received any prophylactic anti-
fungal therapy. Yeast isolates were tested for their susceptibility
to ﬁve antifungal agents (amphotericin B, 5-ﬂucytosine, ﬂuconaz-
ole, itraconazole and ketoconazole) by the commercially available
E-test, using RPMI + 2% glucose + MOPS agar inoculated with
0.5 McFarland yeast suspension in saline and incubated at 35C/
ambient in bag, for 24 and 48 h. For interpretation we used
NCCLS M-27-A2, 2002 recommendation.
Results: At time of sampling, 46 (21.3%) patients were found to
be colonised with yeasts, of which 42 (91.3%) were Candida albi-
cans and only four (8.7%) non-albicans Candida species. Antifun-
gal susceptibility patterns showed that 100% of isolates were
susceptible to amphotericin B (mean MICs-0.098 lg/mL), 5-ﬂucyt-
osine (mean MICs 0.11 lg/mL) and ﬂuconazole (mean MICs
1.64 lg/mL) while 91.3% were susceptible to itraconazole (mean
MICs 0.058 lg/mL) and ketoconazole (mean MICs 0.029 lg/mL).
Of ﬁve resistant yeasts, three were non-albicans species showing
simultaneous resistance to both drugs.
Conclusion: The frequency of resistant Candida is still very low in
cancer patients at the Clinical Hospital in Rijeka. However, it is
important to follow continuously the distribution and susceptibil-
ity patterns of yeasts, which should contribute in developing opti-
mal prophylactic strategies, as well as, in reducing clinically
detectable oral candidiasis in this group of patients.
Antibiotic resistance in respiratory pathogens
P521 Changes in macrolide susceptibility of oral
streptococci following administration of azithromycin or
clarithromycin to healthy volunteers – a prospective randomised
blinded trial
J. Wagner, C. Klaus, H. Orawa, M. Pletz, M. Eisenblatter,
W.E. Haefeli, H. Hahn, H. Lode
Berlin, Heidelberg, D
Objective: Macrolides are the treatment of choice for many com-
munity-acquired airway infections, hence emerging resistance to
these antibiotics, which may be transmitted from oral streptococci
to pathogens such as pneumococci, poses a public health problem.
Macrolides with long half-life and high concentrations in mucosal
tissues (e.g. azithromycin, AZ) may increase compliance of
patients. However, whether they cause changes in susceptibility
of oral streptococci to macrolides more frequently than macrolides
with shorter half-life and lower tissue concentrations (e.g. clarith-
romycin, CL) is not known.
Methods: To detect possible development of microbial resistance
of oral streptococci to macrolides we performed a prospective,
randomised, evaluator-blinded trial in healthy volunteers receiv-
ing standard courses of either AZ (n ¼ 20) or CL (n ¼ 20). Throat
swabs for isolation of streptococci were taken before treatment
and on days 1, 8, 16, 32, 48, 62 and 90 of the study. Compliance
to treatment was monitored by analysis of drug concentrations in
urine. Todd–Hewitt broth was inoculated with the swabs and
0.1 mL were transferred to Columbia agar containing either 0.01%
pyridoxal and 10 mg/L gentamicin only (Col) or pyridoxal/gen-
tamicin plus 2 mg/L erythromycin (Col + E) for incubation. CFUs
on Col and Col + E were counted for each sample. Up to 10 mor-
phologically different colonies were collected from Col and
Col + E (day 1) or Col + E only (later time points) and stored at
70C. Three isolates from each sample were randomly chosen
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for determination of MICs for AZ and CL by E-test on Columbia
agar, incubated for 24 h at 37C in 5% CO2.
Results: After exclusion of one subject in the AZ- and two in the
CL-treated group who took antibiotics before completion of the
trial and correction for baseline differences, the number of macro-
lide-resistant streptococcal isolates (expressed by the ratio
Col + E/Col) did not differ signiﬁcantly between the groups.
Although higher MICs of isolates from CL-treated individuals
compared with those from the AZ-treated group on days 32, 48
and 62 (but not earlier or later) were observed, these differences
were not signiﬁcant. Two subjects from the AZ-treated group
were excluded from this analysis because no growth was found
on Col + E at day 0 or 90.
Conclusion: The long half-life of AZ does not induce higher rates
of antimicrobial resistance in oral streptococci compared with CL
with a shorter half-life and lower mucosal concentrations.
P522 Unchanged susceptibility of key respiratory
pathogens to telithromycin postintroduction in Germany
R. Reinert, A. Rodloff, D. Felmingham – The PROTEKT Study
Group
Objectives: PROTEKT – a global, longitudinal, international sur-
veillance programme established in 1999 to study the antimicro-
bial susceptibility of common bacterial pathogens associated with
community-acquired respiratory tract infections (RTIs) – has now
completed its third year. This analysis was undertaken to track
and assess the susceptibility of community-acquired RTI isolates
to the ketolide antibacterial telithromycin since its introduction in
Germany in October 2001.
Methods: MICs of community-acquired RTI isolates collected
within Germany as part of the PROTEKT programme over three
consecutive respiratory seasons (year 1: 1999–2000; year 2: 2000–
2001; year 3: 2001–2002) were determined centrally by NCCLS
broth microdilution methods.
Results: Between 1999 and 2002, 3580 Streptococcus pneumoniae iso-
lates, 2836 Haemophilus inﬂuenzae isolates and 691 Streptococcus
pyogenes isolates were collected from a total of 11 centres (seven
centres in year 1; 11 centres in years 2 and 3) and MICs were
determined. Results show no major change in susceptibility of
any of these pathogens to telithromycin over the 3 years of fol-
low-up, with >99% of pathogens susceptible to telithromycin
using breakpoints as approved by the NCCLS Antimicrobial Sus-
ceptibility Testing Subcommittee, January 2003. Telithromycin
mode MIC and MIC90 for all three respiratory seasons were,
respectively, 0.008 and 0.03 mg/L for S. pneumoniae and 1 and
2 mg/L for H. inﬂuenzae. MIC ranges for telithromycin against S.
pneumoniae in years 1, 2 and 3 were 0.004–0.5, 0.004–2 and 0.002–
0.5 mg/L, respectively. MIC ranges for H. inﬂuenzae were 0.06 or
0.12–4 mg/L. Mode MIC for telithromycin against S. pyogenes was
0.015 mg/L for all 3 years, with an MIC90 of 0.03 mg/L in year 1,
0.015 mg/L in year 2 and 0.12 mg/L in year 3, and an MIC range
of 0.008–8.0 mg/L in years 1 and 2 and 0.004–0.5 mg/L in year 3.
Conclusions: The ketolide telithromycin is highly active against
the major bacterial pathogens implicated in community-
acquired RTIs, with no change in susceptibility noted in Ger-
man clinical isolates over the 3 years of the PROTEKT study
despite widespread use of this antibacterial since its introduct-
ion in 2001.
P523 Prevalence of antimicrobial resistance and activity of
the ketolide telithromycin against Haemophilus inﬂuenzae
isolated from Japanese children
K. Sunakawa, D. Farrell
Kanagawa, JP; London, UK
Objectives: Although b-lactamase (BL) production has been the
primary mechanism of b-lactam resistance among H. inﬂuenzae,
the prevalence of BL-nonproducing ampicillin-resistant (BLNAR)
strains is increasing. This analysis – undertaken as part of the
PROTEKT Kids surveillance programme – assesses the prevalence
of BL-positive (BL+) and BLNAR strains among H. inﬂuenzae
isolated from paediatric patients in Japan, and the activity of the
ketolide antibacterial telithromycin (TEL) against these isolates.
Methods: Isolates of H. inﬂuenzae were collected over two 1-week
periods (24–30 November 2002 and 19–26 January 2003) from
children (aged <16 years) with community-acquired respiratory
tract infections (CARTIs) attending 18 centres in Japan. Isolates
were tested for BL production (by the chromagenic nitroceﬁn
method) and nonsusceptibility to ampicillin (MIC ¼ 2 mg/L).
MICs for a panel of antibacterials were determined centrally by
NCCLS broth microdilution methods and interpreted using
NCCLS breakpoints.
Results: A total of 272 H. inﬂuenzae isolates were collected, of
which 7.0% (19) were BL+, 18.8% (51) were BLNAR
(MIC ¼ 4 mg/L) and 12.9% (35) were BL-nonproducing ampicil-
lin-intermediate (MIC ¼ 2 mg/L; BLNAI). TEL showed good
in vitro activity against H. inﬂuenzae with a mode MIC and
MIC90 of 2 and 4 mg/L, respectively, irrespective of BL or
BLNAR/I status. Overall, 99.3% (270/272) of H. inﬂuenzae iso-
lates, including 85/86 BLNAR/I and 19/19 BL+ isolates, were
susceptible to TEL (MIC ¼ 4 mg/L), with the remaining 0.7%
having intermediate susceptibility (MIC ¼ 8 mg/L) (breakpoints
approved by NCCLS SAST, January 2003). A total of 238 iso-
lates of S. pneumoniae were also collected in this study, of
which 73.1% (174) were resistant to macrolides (erythromycin
MIC ¼ 1 mg/L). TEL maintained high in vitro activity against
S. pneumoniae, with 100% of isolates susceptible to TEL at con-
centrations 1 mg/L.
Conclusions: Approximately 19% of H. inﬂuenzae isolates collected
from children in Japan were BLNAR (and therefore co-resistant to
a number of other antibacterials including amoxicillin–clavulanate,
ampicillin–sulbactam and most ﬁrst and second generation ce-
phalosporins), with a further 12.9% BLNAI and 7% BL+. TEL
demonstrated good activity against H. inﬂuenzae, including BL+
and BLNAR/I strains, with a susceptibility rate of >99%. TEL has
high in vitro activity against those pathogens targeted in the empi-
ric treatment of CARTIs in Japan.
P524 Susceptibility of recent paediatric respiratory isolates
of Streptococcus pneumoniae and Haemophilus inﬂuenzae in
Spain
C. Latorre, C. Garcia-Rey, J. Barron, A. Pinedo, J.M. Nogueira,
J. Torres, L. Aguilar – The Spanish Surveillance Group for
Respiratory Pathogens
Objectives: Resistance to penicillin and/or erythromycin in Strep-
tococcus pneumoniae, and b-lactamase (BLA) production in Haemo-
philus inﬂuenzae are well-known predictor factors for treatment
failure of acute otitis media in children. It is therefore critical to
monitor rates of resistance in the community in order to tailor
empiric therapeutic recommendations.
Methods: A prospective, multicentre (25 hospitals in 13 Autonom-
ous Communities, CCAA) antimicrobial survey was carried out
between November 2001 and October 2002. A total of 373 con-
secutive S. pneumoniae and 438 H. inﬂuenzae isolates from children
with community-acquired respiratory tract infections were collec-
ted and sent to a central laboratory for further processing. Suscep-
tibility testing was performed by a semiautomated microdilution
method following NCCLS M100-S12 recommendations. Break-
points for penicillin and erythromycin were 2 and 1 mg/L,
respectively. Nitroceﬁn test was used to detect BLA production.
Results: Excluding those CCAA with less than 18 isolates (11
pneumococcal isolates: 36% penicillin resistant and 82% erythro-
mycin resistant; and 38 H. inﬂuenzae: 21% BLA producers) for the
sake of accuracy, mean penicillin resistance was 20% (95% CI 14–
26), whereas erythromycin resistance was 48% (95% CI 36–60) for
S. pneumoniae, and the MLSb phenotype was dominant (90%). As
for H. inﬂuenzae, BLA production was 14% (95% CI 9–19). Rates
by CCAA are given in the table.
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Conclusions: BLA production in paediatric respiratory H. inﬂuen-
zae was below 20% and around 15%. Currently, resistance to
penicillin does not seem to keep increasing among paediatric
respiratory isolates and remains around 20%. However, resist-
ance to erythromycin among paediatric pneumococcal isolates is
alarmingly high, with regions showing more than 60%. Only
Cantabria had <20%. Macrolides do not provide adequate cover-
age against the two key bacterial pathogens involved in infantile
respiratory infections in Spain and therefore, in the absence of
sounding reasons, empirical prescription of macrolides should be
avoided.
P525 Susceptibility of Haemophilus inﬂuenzae respiratory
isolates from adults in Spain (2001–2002)
A. Garcia-Perea, C. Garcia-Rey, C. Garcia-Riestra, R. Landinez,
M. De-la-Rosa, P. Alomar, J. Garcia-de-Lomas, L. Aguilar – The
Spanish Surveillance Group for Respiratory Pathogens
Objectives: The role of Haemophilus inﬂuenzae (and of Streptococ-
cus pneumoniae) in exacerbations of chronic bronchitis, acute otitis
media and community acquired pneumonia along with their
capability to produce b-lactamase (BL) are the rationale to add
clavulanate to aminopenicillins, to use second generation
cephalosporins or a respiratory ﬂuoroquinolone to treat these
infections. Monitoring of its rate of BL production and of the
phenotype BL-negative ampicillin resistant (BLNAR) is strongly
recommended.
Methods: A prospective, multicentre (25 hospitals) antimicrobial
survey was carried out between November 2001 and October
2002. A total of 2207 consecutive H. inﬂuenzae isolates from adult
patients with community-acquired respiratory tract infections
were collected and sent to a central laboratory for further process-
ing. Susceptibility testing was then performed by a semiautomat-
ed microdilution method following NCCLS M100-S12 guidelines
and breakpoints against antibiotics commonly used. Chromogenic
nitroceﬁn was used to test BL production.
Results: beta-Lactamase production was detected in 466 of 2207
(21.1%) isolates (95% CI 17.5–23.4). Additionally, there was 4.0%
of BLNAR isolates (95% CI 2.7–6.4). Coamoxiclav, cefuroxime,
cefonicid, ciproﬂoxacin and azithromycin displayed an excellent
in vitro activity. In contrast, full susceptibility to cefaclor and
clarithromycin was found only in 82.1 and 72.3% of isolates,
respectively.
Conclusions: b-Lactamase production seems to be decreasing
compared with previous surveillances done in Spain and cur-
rently stands around 20%, although there are hot spots in the
south-east of the peninsula (Valencia and Murcia) with rates
around 35–40% and in the north (Vizcaya) with 30%. BLNAR
phenotype appears stable around 4% of isolates, but there also
were centres with rates between 15 and 19% (Ciudad Real in
the centre and Vizcaya) that must be closely watched. The best-
tested oral anti H. inﬂuenzae agents from an in vitro point of
view were coamoxiclav, cefuroxime, azithromycin and ciproﬂ-
oxacin. Clarithromycin and cefaclor displayed the worst suscep-
tibility rates and should be avoided, as better options are
available.
P526 Antibiotic sensitivity of streptococci isolated in ear,
nose and throat diseases – development of resistance from 1999
to 2002/2003
K. Fickweiler, U. Fickweiler, A.C. Rodloff
Leipzig, D
Objective: Streptococci belong to the most frequent causative
agents of infections in the ENT area. In recent years, resistance of
this group of organisms against penicillin and macrolides has
increased worldwide. It was the aim of this study to monitor the
resistance of b-haemolytic streptococci, pneumococci and viridans
streptococci isolated from infected patients of the ENT department
of the University Hospital in Leipzig.
Methods: Since 1999, all microbiological results for patients of the
ENT department were recorded according to the clinical diagno-
sis. In addition, MIC determinations were made for all isolates
and penicillin, cefuroxime and roxithromycin. MIC values were
established employing E-test strips according to the recommenda-
tions of the manufacturer. In order to study possible trends in
resistance development, results of strains tested in 1999 were com-
pared with those obtained during 2002/2003.
Results: During the study periods, altogether 262 strains of strep-
tococci were isolated, mostly from patients with peritonsillar and
neck abscesses, acute otitis media and acute sinusitis and rhinitis
(1999 n ¼ 112; 2002/2003 n ¼ 150). Fifty-three were identiﬁed as
group A streptococci, 97 were pneumococci and 112 were other
viridans streptococci.
Results: All group A streptococci and 99% of the pneumococci
were susceptible for penicillin (MIC  0125 mg/L). An increasing
resistance rate (MIC  2 mg/L) was observed for viridans strepto-
cocci (0% in 1999 vs. 3% in 2002/2003). All streptococci tested
were susceptible for cefuroxime (MIC < 2 mg/L). Interestingly,
the resistance rate for group A streptococci and roxithromycin
(MIC  8 mg/L) was decreasing (15% in 1999 vs. 4% in 2002/
2003), while an increase was observed for pneumococci (4.5% in
1999 and 15% in 2002/2003) and for viridans streptococci (2.5%
in 1999 vs. 10% in 2002/2003).
Conclusion: We conﬁrmed that there is no penicillin resistance in
group A streptococci. In spite of worldwide reports on rapidly
increasing resistance rates for penicillin and macrolides in pneu-
mococci, we observed only limited alterations in the resistance
rate of pneumococci and other viridans streptococci. Surprisingly,
a large number of viridans streptococci were recovered from
patients with abscesses. The pathogenic role of these isolates
requires further analysis.
P527 The comparative in vitro activity of moxiﬂoxacin
against respiratory tract pathogens isolated during 2003 from
Libra-targeted surveillance
I. Morrissey, A. Colclough, L. Viljoen, K. Dowling, M. McKeon,
T. Veltman
London, UK
Objectives: To assess the antimicrobial agent susceptibility of Hae-
mophilus inﬂuenzae (HI) and Streptococcus pneumoniae (SP) isolates
causing community-acquired respiratory-tract infections from
worldwide locations during 2003.
Methods: A total of 35 centres in seven countries submitted 1530
HI and 1541 SP. Bacteria were re-identiﬁed and their susceptibility
to penicillin G (PEN, SP only), ampicillin (AMP, HI only), amoxi-
cillin-clavulanate (AMC), azithromycin (AZI), ceftriaxone (CTX),
levoﬂoxacin (LFX), gatiﬂoxacin (GFX) and moxiﬂoxacin (MFX)
was determined using the NCCLS broth microdilution method
and breakpoints at a central laboratory.
Results: All HI were fully susceptible to AMC, CTX, LFX, GFX
and MFX. AMP resistance in HI was: France (43.0%), Germany
(20.2%), Italy (11.3%), Spain (13.8%), Mexico (27.5%), South
Africa (6.4%) and USA (34.7%). Eleven AZI nonsusceptible HI
strains were found overall (0.72%). SP resistance (number of cen-
tres, number of isolates per country) is shown below. Of the 1541
CCAA
S. pneumoniae H. inﬂuenzae
N
Penicillin
resistance (%)
Erthromycin
Resistance (%) CCAA N
BLA
production (%)
Andalucia 40 20% 55% Andalucia 34 12%
Cantabria 36 17% 17% Cantabria 37 16%
Catalu~na 41 20% 42% Catalun˜a 92 17%
Galicia 20 25% 55% Galicia 19 21%
Madrid 72 25% 46% Madrid 57 18%
PaisVasco 95 7% 47% PaisVasco 68 4%
Valencia 30 17% 53% Valencia 47 19%
Murcia 28 29% 68% Aragon 29 7%
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SP, 293 (19.0%) were resistant to two or more of PEN, AMC,
CTX, LFX and AZI (GFX and MFX were omitted to avoid duplica-
tion). These multi-resistant (MDR) SP were 98.3, 92.5, 27.3, 10.9,
3.4 and 1.4 resistant to PEN, AZI, AMC, CTX, LFX and MFX,
respectively.
Conclusion: For HI, resistance to AMP was prevalent in many
countries but full susceptibility was seen with MFX and other
agents. With SP, AZI and PEN resistance was very high in many
countries. Relatively high AMC and CTX resistance was also
found in South Africa. Resistance to LFX and GFX was higher
than MFX, where <1% resistance was seen in all countries. Vir-
tually all MDR SP were resistant to PEN and AZI and over 1/4
resistant to AMC. MFX was the most active agent against both HI
and SP causing community-acquired respiratory tract infection
worldwide including MDR SP. MFX is therefore a valuable option
for the treatment of community-acquired respiratory-tract infec-
tion.
New drugs and novel therapeutic aproaches
P528 In vitro activity of synthetic peptides and
mechanisms of resistance to colistin in pan-resistant
Acinetobacter baumannii
M. Rodriguez, J. Saugar, F. Docobo-Perez, J. Paneque,
M. Pacho´n-Iban˜ez, J. Aznar, D. Andreu, L. Rivas, J. Pacho´n
Seville, Madrid, Barcelona, E
Objectives: Acinetobacter baumannii colistin resistant constitute a
severe chemotherapeutical threat for nosocomial infection. Mem-
brane-active antibiotic peptides were proposed as a good alternat-
ive. Among them synthetic hybrids cecropin A-melittin hybrids
(CAMEs) were reported among those with highest activity.
Objectives: To test the in vitro activity of CAMEs against pan-
resistant A. baumannii (AbPr) as putative alternative to colistin,
and to study the mechanism of AbPr colistin resistance.
Methods: Peptides: A ¼ CA(1–8)M(1–18), B ¼ CA(1–7)M(2–9),
C ¼ Octanoil-CA(1–7)M(2–9) and D ¼ CA(1–7)M(5–9). MIC/MBC
(NCCLS) against 13 AbPr clinical isolates. Bactericidal activity
(time-killed curves using 1 MIC, 2 MIC and 4 MIC concentrations)
with four strains (NCCLS): 208628, 201630, 183280R and 183280L.
LPS-CAME afﬁnity was determined by displacement of dans-
ylpolymixin B bound to LPS. Spheroplasts from a colistin-suscept-
ible (ATCC19606) and two colistin-resistant (208628 and 201630)
strains were prepared according to Dathe et al. (2002); their lysis
induced by the peptide, were monitored by decrease in A450.
Results: MIC50/MIC90 (mg/L) of colistin and peptides A, B, C
and D: 32/64, 4/8, 2/4, 4/4 and 4/4, respectively. MBC50/
MBC90 (mg/L) of peptides A, B, C and D: 4/8, 2/4, 4/4 and 4/8,
respectively. Time-killing curves: the four peptides were bacteri-
cidal against the four strains; ‘A’ was bactericidal with all concen-
trations against the four strains; ‘B’ and ‘D’ were bactericidal with
all concentrations against strains 183280R and 183280L, and from
concentration > MIC against strains 208628 and 201630; ‘C’ was
bactericidal with all concentrations against strains 208628, 201630
and 183280R, and from concentration > MIC against strain
183280L. LPS afﬁnity for CAMEs were very similar for all of them
and much higher than that for colistin, independently of the strain
used to obtain LPS the same resulted with permeabilisation of
inner membrane. Both, peptide A and colistin, permeabilised
spheroplasts at a similar rate, independently of their colistin sus-
ceptibility. Thus, the differences in colistin activity were solely
located at the outer membrane, mostly to LPS changes.
Conclusions: All CAMEs were bactericidal against pan-resistant
clinical isolates of A. baumannii, being CA(1–8)M(1–18) the best
one. Resistance to colistin is due to changes in outer membrane.
CAMEs act by permeabilisation of the inner membrane, and it
was achieved at much lower concentration than colistin.
P529 New antimicrobial peptide active against methicillin-
resistant Staphylococcus aureus, multi-resistant coagulase
negative staphylococci, and b-haemolytic streptococci
A. Jasir, F Kasprzykowski, V. Lindstrom, C. Schalen, A. Grubb
Lund, S; Gdansk, PL
Objectives: The main objective was to develop antimicrobial com-
pounds active against methicillin-resistant Staphylococcus aureus
and multi-resistant coagulase negative staphylococci and strepto-
cocci and to elucidate the mode of action of a new antibacterial
oligopeptide.
Methods: The synthesis of Cystapep has been outlined previously
and was prepared from Boc-L-valinol according to the general
procedure. The antibacterial activity of Cystapep was tested by
agar well diffusion. For determination of MBC and MIC concen-
trations, a broth dilution method was used.
Results: The derivative, here called Cystapep, displayed antibacte-
rial activity against several clinically important Gram-positive bac-
teria. It displayed MIC and MBC of about 16 lg/mL for both
S. aureus and S. pyogenes. In radial agar diffusion assays, groups
A, B, C and G streptococci as well as staphylococci were generally
susceptible to the action of Cystapep, whereas pneumococci and
enterococci were less susceptible. Cystapep also showed high
activity against methicillin-resistant S. aureus (MRSA) and multi-
antibiotic resistant coagulase negative staphylococci (CNS),
suggesting its mechanism of action to differ from those of most
currently used antibiotics.
Conclusion: Cystapep was apparently as effective against various
antibiotic resistant staphylococci and streptococci as against anti-
biotic susceptible strains of these species. In particular, in a
large collection of MRSA comprising many strains with addi-
tional resistance properties, the susceptibility to Cystapep
proved invariably high. Similarly, a substantial number of CNS
clinical isolates involving many multi-resistant strains also
showed high susceptibility to Cystapep. Presently, these staphy-
lococci represent leading agents in nosocomial and biomaterial-
associated infections posing signiﬁcant therapeutic problems due
to shortage of effective antibacterial agents. In addition, the
susceptibility of b-haemolytic streptococci to Cystapep may
prove important due to treatment problems both for invasive
and superﬁcially located infections. Although several hundreds
of isolates have been studied, we have not so far observed any
strains of staphylococci or b-haemolytic streptococci resistant to
Cystapep. Furthermore, the possibility to select resistant mutants
by repeated passages in media containing Cystapep is currently
being investigated but no resistant mutants have so far been
obtained.
% resistant AZI PEN AMC CTX LFX GFX MFX
France (6, 224) 46.0% 28.6% 0.9% 3.6% 1.8% 1.8% 0.5%
Germany (3, 60) 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Italy (2, 125) 41.6% 4.8% 0.8% 1.6% 1.6% 1.6% 0.8%
Spain (3, 197) 23.9% 22.3% 6.1% 0.0% 0.0% 0.0% 0.0%
Mexico (3, 145) 20.7% 20.7% 0.0% 0.7% 2.8% 1.4% 0.7%
South Africa (2, 128) 46.1% 45.3% 15.6% 5.5% 0.8% 0.8% 0.8%
USA (16, 662) 28.9% 24.9% 6.8% 2.1% 0.8% 0.6% 0.3%
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P530 Comparison of azithromycin and amoxicillin for
treatment of adult patients with solitary erythema migrans
S. Lotric-Furlan, M. Logar, V. Maraspin, J. Cimperman, T. Jurca,
F. Strle
Ljubljana, SI
Objective: To evaluate the effectiveness and side effects of azithro-
mycin and amoxicillin for treatment of adult patients with solitary
erythema migrans.
Methods: Consecutive adult patients with typical erythema
migrans were enrolled in a prospective study on early Lyme bor-
reliosis at the Department of Infectious Diseases in Ljubljana dur-
ing 1997. Patients receiving antibiotics at their ﬁrst visit, having
clinical evidence of disseminated Borrelia burgdorferi s.l. infection,
and/or being pregnant were excluded. They were randomised to
receive either azithromycin 500 mg b.i.d. for the ﬁrst day,
followed by 500 mg once a day for the following 4 days (AZT) or
amoxicillin 1000 mg t.i.d. for the ﬁrst 5 days, followed by 500 mg
t.i.d. for the following 10 days (AMO). Basic epidemiological data
were obtained by means of questionnaires. Serum IgM and IgG
antibody titre against B. burgdorferi s.l. were determined by IFA
without absorbtion. Titres equal and/or greater than 1:256 were
interpreted as positive. In all patients skin biopsy had been
accomplished prior to the institution of antibiotic treatment and
specimen cultured in MKP medium.
Results: A total of 133 patients, 77 (57.9%) females and 56
(42.1%) males, aged 16–83 (median 49) years were included in
this study. Sixty-ﬁve patients were evaluated in AZT group and
68 patients in AMO group. No differences in epidemiological and
pretreatment characteristics were present comparing the two
groups. Median duration of skin lesions after the institution of
treatment was 7 (1–60) days in the AZT group and 7 (2–180) days
in the AMO group (P ¼ 0.325). During the follow-up of
12 months none of the patients developed major late manifesta-
tions of Lyme borreliosis but in six patients severe minor manifes-
tations appeared: in two (3.1%) from AZT group and in four
(5.9%) included in AMO group. Isolation rates of B. burgdorferi s.l.
from skin before treatment (25/65 vs. 33/68; P ¼ 0.319) as well as
2–3 months after therapy (0/25 vs. 0/33) were comparable for the
two groups. Three (4.6%) AZT group patients and one (1.5%)
patient from AMO group reported mild gastrointestinal discom-
fort (P ¼ 0.358).
Conclusions: Treatment of adult patients with solitary erythema
migrans with two different antibiotics exhibited equal effective-
ness and comparable side effects. The outcome of borrelial infec-
tion after one year was favourable in both treatment groups.
P531 Comparative in vitro activity of ABT-492 and six
other antimicrobial agents against anaerobic bacteria
E. Sillerstro¨m, E. Wahlund, C.E. Nord
Stockholm, S
Objectives: ABT-492 is a new quinolone active against aerobic and
anaerobic bacteria involved in respiratory tract infections, urinary
tract infections, blood stream infections, and skin and soft tissue
infections. ABT-492, 1-(6-amino-3,5-diﬂuoropyridine-2-yl)-8-chloro-
6-ﬂuoro-(3-hydroxyazetidine-1-yl)-4-oxo-1,4-dihydroquinolone-3-
carboxy acid, is more potent in vitro than other new quinolones.
The present investigation determined the in vitro activity of
ABT-492 against anaerobic bacteria recently isolated from human
infections. The activity was compared with that of moxiﬂoxacin,
piperacillin, cefoxitin, imipenem, clindamycin and metronidazole.
Methods: The 369 anaerobic strains investigated were isolated
from respiratory tract infections, gastrointestinal infections, gynae-
cological infections and skin infections. All strains were identiﬁed
using morphological tests, biochemical tests and gas–liquid chro-
matography. The antimicrobial susceptibility tests were performed
by the agar dilution method according to NCCLS. The testing was
performed on Brucella agar supplemented with 5 mg haemin and
1 mg vitamin K per litre and 5% laked sheep blood. The plates
were read after 48 h of incubation at 37C in anaerobic jars. Four
control strains were used for monitoring the antimicrobial suscep-
tibility tests: Bacteroides fragilis ATCC 25285, B. thetaiotaomicron
ATCC 29741, Clostridium perfringens ATCC 13124 and Eubacterium
lentum ATCC 43055.
Results: ABT-492 and imipenem were the most active antimicro-
bial agents tested: Peptostreptococci (52 strains) had the following
minimum inhibitory concentrations: ABT-492, range 0.008–
0.25 mg/L; imipenem, range 0.016–0.064 mg/L. Propionibacterium
acnes (32 strains): ABT-492, 0.032–0.125 mg/L; imipenem, 0.032–
0.064 mg/L. Clostridium perfringens (50 strains): ABT-492, 0.008–
0.032 mg/L; imipenem, 0.016–0.5 mg/L. Clostridium difﬁcile (50
strains): ABT-492, 0.008–0.5 mg/L; imipenem, 8 mg/L. Bacteroides
fragilis (100 strains): ABT-492, 0.032–0.125 mg/L; imipenem, 0.064–
0.25 mg/L. Porphyromonas and Prevotella species (55 strains): ABT-
492, 0.008–0.5 mg/L; imipenem, 0.016–0.25 mg/L. Fusobacterium
nucleatum (30 strains): ABT-492, 0.008–0.125 mg/L; imipenem,
0.008–0.064 mg/L.
Conclusions: ABT-492 is active against anaerobic bacteria and
might be useful in the treatment and prophylaxis of anaerobic
infections. Clinical trials are therefore warranted.
P532 Iclaprim, a novel diaminopyrimidine antibiotic:
synergy studies with different classes of antibiotics
L. Weiss, D. Gillessen, S. Hawser, K. Islam
Munchenstein, CH
Objectives: Iclaprim (formerly AR-100) is a novel broad-spectrum
diaminopyrimidine antibiotic that exerts its antibacterial action
through the speciﬁc and selective inhibition of bacterial dihydro-
folate reductase. The in vitro synergistic potential of Iclaprim with
thirty different antibiotics was evaluated using several Gram-pos-
itive and Gram-negative pathogens.
Methods: MICs were performed using the NCCLS micro dilution
methods. Pathogens used were: Staphylococcus aureus, S. pneumoni-
ae, Haemophilus inﬂuenzae, Moraxella catarrhalis and Klebsiella pneu-
moniae. Checkerboard experiments were used to determine the
potential synergy or antagonism with 30 antibacterial agents. Syn-
ergism was calculated using the FIC index. [Synergy was deﬁned
whereby the SigmaFIC were <0.5, indifference (no synergy or
antagonism) whereby SigmaFIC was >0.5 but <4 and antagonism
whereby SigmaFIC was >4.]
Results: Iclaprim showed potent MIC against most of the patho-
gens used in this study with MICs ranging from 0.063 to 16 lg/
mL. Iclaprim was also active against Trimethoprim-resistant
strains of S. aureus and S. pneumoniae. In terms of the synergistic
potential, Iclaprim was highly synergistic with the two sulphona-
mides tested, namely sulphamethoxazole and sulphadiazine
against the majority of isolates used. By contrast, Iclaprim showed
no synergy with the other 28 antibiotics including macrolides,
aminoglycosides, quinolones, penicillins, trimethoprim, rifampi-
cin, tetracycline and vancomycin. Importantly, no antagonism was
observed between Iclaprim and the 30 antibiotics used in this
study.
Conclusions: Iclaprim was synergistic with sulphonamides and
showed neither synergy nor antagonism with other classes of anti-
biotics.
P533 Anti-pneumocystis activity of iclaprim, a reliable
therapeutic alternative against Pneumocystis pneumonia
E.M. Aliouat, E. Dei-Cas, N. Gantois, K. Islam, S. Hawser
Lille, F; Munchenstein, CH
Objective: Available drugs effective against severe forms of
Pneumocystis pneumonia (PcP) are limited; often induce adverse
reactions with treatment failure common. Moreover, recent reports
suggest the emergence of P. jirovecii resistance to sulpha drugs,
the most commonly used drugs to treat pneumocystosis. The
unmet medical need is that no reliable therapeutic alternative to
Trimethoprim/Sulfamethoxazole (TMP/SMX) is available to
119Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
physicians; pentamidine exhibits signiﬁcant toxicity and atovaqu-
one is currently used only against mild forms of PcP. Iclaprim
(formerly AR-100), a novel broad-spectrum diaminopyrimidine
compound that exerts its antimicrobial activity through inhibition
of dihydrofolate reductase, may represent a new therapy for the
treatment of this unmet medical need. For this reason the objec-
tive of the present work was to test the activity pf Iclaprim
against P. carinii using highly efﬁcient in vitro and in vivo models.
Methods: The activity of Iclaprim against P. carinii was tested
both in vitro, using an axenic culture system, and in vivo, using
P. carinii endotracheally inoculated corticosteroid-treated rats, the
most reproducible PcP model available. Animals were orally
administered with Iclaprim (5, 25 and 50 mg/kg/day), Iclaprim/
SMX (5/25, 25/125, 50/250 mg/kg/day), TMP (50 mg/kg/day)
or TMP/SMX (50/250 mg/kg/day) once a day for 10 consecutive
days.
Results: Iclaprim showed in vitro a high anti-Pneumocystis activity,
with an EC50 value of 20.3 lg/mL. Iclaprim/SMX combination
(proportion 1/5) showed a signiﬁcant synergistic activity with an
EC50 value of 13.2/66 lg/mL. TMP/SMX was the least potent
compound (EC50 of 51/255 lg/mL). In vivo, although Iclaprim
and TMP showed a similar activity, the Iclaprim/SMX combina-
tion was more potent (98.5 + 0.9% of inhibition for 25/125 mg/
kg/day) than TMP/SMX (86.6 + 7.1% of inhibition for 50/
250 mg/kg/day).
Conclusion: These data suggest that Iclaprim may constitute a reli-
able therapeutic alternative for treating severe forms of PcP.
P534 In vitro plasma ﬁbrin clot models vs. in vivo models
of experimental endocarditis: case study for diaminopyrimidine
antibiotics iclaprim and trimethoprim/sulfamethoxazole
J.M. Entenza, M. Giddey, J. Vouillamoz, S. Hawser, P. Moreillon
Lausanne, Basle, CH
Background: Iclaprim (ICL) is a novel diaminopyrimidine antibi-
otic that exhibits potent broad-spectrum activity against many
pathogens including MRSA. The drug recently completed a Proof
of Concept Phase II clinical trial exhibiting efﬁcacy in human
beings similar to vancomycin (VAN). This study was aimed to
determine the activity of ICL against MRSA AW6 in liquid med-
ium, in infected plasma-ﬁbrin clots in vitro, and in rats with
experimental endocarditis.
Methods: MICs for ICL, trimethoprim/sulfamethoxazole (TMP/
SMX) and VAN were performed in MHB (under NCCLS condi-
tions) and in MHB supplemented with 10–50% of either human
or rat serum, or 0.1 U/mL of thymidine phosphorylase (TP).
Plasma-ﬁbrin clots were made with human or rat plasma-contain-
ing MRSA and treated with homologous serum containing either
ICL (6 mg/L), TMP/SMX (8/40 mg/L), VAN (40 mg/L) or saline
for 18 h. Rats with experimental endocarditis were treated with
i.v. ICL or VAN every 12 h or TMP/SMX every 8 h at doses mim-
icking expected serum kinetics in human beings.
Results: In MHB, the MICs of ICL, TMP/SMX and VAN for the
test strain were 0.12, 1 and 1 mg/L, respectively. However, addi-
tion of 10% of rat but not human serum, selectively increased the
MIC of ICL and TMP/SMX by 2x. Addition of TP decreased MICs
by 2x. Serum did not affect the MIC of VAN. In bactericidal tests
(MBC), concentrations of ICL and TMP/SMX above the MIC
inﬂicted a loss of 0.5–1 log 10 CFU in pure MHB. However, addi-
tion of 50% of human serum increased this effect to 3 log 10 CFU.
In contrast, addition of 50% of rat serum totally abolished the
antibacterial effect of both ICL and TMP/SMX. Addition of TP to
pure MHB or to rat serum restored the bactericidal activity of
both ICL and TMP/SMX. In human plasma clots, ICL and TMP/
SMX signiﬁcantly killed MRSA within 18 h (P < 0.005 vs.
untreated clots), whereas they failed in clots made with rat
plasma and in vivo. Addition of TP to clots made with rat plasma
re-established drug activity. By contrast to ICL and TMP/SMX,
VAN was active both in terms of clot and rat endocarditis.
Conclusions: Although ICL and TMP/SMX showed good activity
in the ‘in vitro endocarditis model’ such activity was absent in the
in vivo endocarditis study in rats. These data suggest that rodent
models of endocarditis are not suitable for determining the poten-
tial of diaminopyrimidine antibiotics due to signiﬁcant antagon-
ism and that in vitro human plasma clot models may prove to be
better predictors for human use.
P535 Antimicrobial activity of the novel cephalosporin
LB11058 tested against pathogens commonly associated with
bacterial meningitis
H. Sader, D. Johnson, D.J. Biedenbach, R. Jones
North Liberty, USA
Background: The increasing prevalence of multi-drug resistance
(MDR) pathogens has jeopardised the use of extended-spectrum
cephalosporins for empiric treatment of community-acquired bac-
terial meningitis. LB 11058 is a novel cephalosporin, which has
shown broad-spectrum activity and high potency against penicil-
lin (PEN)-R streptococci. Additionally, the activity of LB 11058
against isolates from bacterial species most frequently associated
with bacterial meningitis was further assessed.
Methods: A total of 573 organisms were tested, including 63
N. menigitidis (NM), 205 Streptococcus pneumoniae [SPN; 103 peni-
cillin (PEN) nonsusceptible], 203 Haemophilus inﬂuenzae [HI; 100 b-
lactamase (BL) producers]. LB 11058 MIC values were determined
by methods recommended by NCCLS (M7-A6).
Results: LB 11058 was highly active against NM with all isolates
being inhibited at <0.008 lg/mL (see table). All PEN-R SPN (MIC
>2 lg/mL) were very susceptible to LB 11058 (MIC90, 0.12 lg/
mL; range 0.06–0.25 lg/mL). LB 11058 was eightfold to 16-fold
more potent than ceftriaxone (CRO) or cefepime (CPM) against
PEN-I and PEN-R strains. LB 11058 activity against HI (MIC90,
0.25–0.5 lg/mL) was not affected by BL production, and it was
similar to that of CPM (MIC90, 0.12–0.25 lg/mL), but inferior to
CRO (MIC90, 0.008–0.015 lg/mL).
Conclusions: LB 11058 showed excellent activity against the most
signiﬁcant pathogens causing community-acquired bacterial men-
ingitis. This compound may represent an excellent option for
empiric therapy of this infection, especially in areas with high
rates of b-lactam resistance among SPN.
P536 Gram-negative bacteria producing characterised
b-lactamases: in vitro activities of BAL 9141 and comparators
M. Kresken, M. Heep, I. Wiegand
Bonn, D; Basel, CH
Objectives: BAL 9141 is the ﬁrst of a new class of anti-MRSA
cephalosporins, which also possesses broad activities towards
most clinically relevant bacterial pathogens. This study aimed at
evaluating in vitro activities of BAL 9141 and comparators
towards b-lactamase-producing Gram-negative bacteria.
Methods: 57 strains (33 Escherichia coli, 10 Klebsiella pneumoniae,
nine Pseudomonas aeruginosa, three Klebsiella oxytoca, one Proteus
mirabilis and one Aeromonas hydrophila) with well-characterised
b-lactamases were studied. Two strains produced more than one
b-lactamase. MICs of BAL 9141, cefepime, ceftazidime, ceftriax-
one, aztreonam, piperacillin, piperacillin-tazobactam and imipe-
nem were determined by broth microdilution according to
NCCLS guidelines.
Table 1. In vitro activity of LB1 1058 and selected agents against invasive NM strains
Antimicrobial MIC50 MIC90 Range
LB1 1058 0.008 0.008 0.008
Ceftriaxone 0.25 0.25 0.25
Penicillin 0.015 0.25 0.015-0.25
Gatiﬂoxacin 0.03 0.03 0.03
Rifampin 0.25 0.25 0.25
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Results: The MICs of BAL 9141 for strains producing b-lactamases
of groups 1 (CMY-2, CMY-7, DHA-1, FOX-1, FOX-2 and LAT-1),
2b (HMS-1, LXA-1, SHV-1, TEM-1, TEM-2 and TEM-90) and 2br
(TEM-30 to TEM-36) as deﬁned by Bush et al. (1) ranged from 0.06
to 2 mg/L. However, the MIC of LAT-2 producing K. pneumoniae
strain N10 was 32 mg/L. BAL 9141 displayed inconsistent activity
against extended spectrum b-lactamase (ESBL)-producing strains
(group 2be b-lactamases) of E. coli, Klebsiella and P. mirabilis. The
MICs of BAL 9141 for E. coli strains harbouring ESBLs SHV-2,
SHV-4, SHV-5, TEM-3, TEM-21, or TEM-50 as well as those of
P. mirabilis strain 33 producing TEM-52 and K. oxytoca hyperpro-
ducers of K1 b-lactamase (range of MICs 8–64 mg/L) exceeded
those for E. coli strains producing ESBLs SHV-3, TEM-5 to TEM-10,
or TEM-20 (range of MICs 0.06–2 mg/L). BAL 9141 had also incon-
sistent activity against E. coli producing OXA enzymes. MICs were
4–8 mg/L for OXA-5 and OXA-7 compared with 0.06–0.125 mg/L
for OXA-1 to OXA-4. Pseudomonas aeruginosa strains producing car-
benicillin- or oxacillin-hydrolysing enzymes (group 2c and 2d)
were associated with MICs ranging from 1 to 64 mg/L, whereas
an MIC of 0.06 mg/L was recorded for the Aeromonas hydrophila
strain producing AER-1. In general, MICs of BAL 9141 were
comparable with those of aztreonam.
Conclusions: BAL 9141 displayed good activity against Gram-neg-
ative bacteria producing various types of b-lactamase. In addition
to its anti-MRSA activity, BAL 9141 maintains the potent activity
of third generation cephalosporins and aztreonam.
Reference
Bush et al. (1995). Antimicrob Agents Chemother 39, 1211–1233.
P537 MIC determination of the anti-pneumococcal activity
of BAL 9141 compared with other agents
P. Appelbaum, D. Hoellman, M. Jacobs
Hershey, Cleveland, USA
Background: Pneumococcal drug resistance has become a world-
wide problem.
Objective: This study examined the anti-pneumococcal activity of
BAL9141, a new broad-spectrum intravenous cephalosporin, com-
pared with those of amoxicillin, imipenem, ertapenem, cefepime,
ceftriaxone, cefotaxime, cefuroxime, cefdinir, levoﬂoxacin, moxiﬂ-
oxacin, azithromycin, clarithromycin, linezolid, quinupristin/dal-
fopristin, daptomycin, vancomycin, teicoplanin and telithromycin.
Strains included 30 PSSP, 60 PISP and 209 PRSP (n ¼ 299); of
these, 152 (51%) were macrolide-resistant and 39 (13%) were levo-
ﬂoxacin-resistant (both groups with deﬁned resistance genotypes).
Methods: Agar dilution MIC with cation-adjusted Mueller–Hinton
agar + 5% sheep blood and inocula of 104 CFU/spot were used.
The following MIC50/MIC90 values (lg/mL) were obtained:
Although MICs of all b-lactams rose with those of penicillin G,
BAL9141 had the lowest MICs of all cephalosporins tested. Using
NCCLS IV cephalosporin nonmeningeal pneumococcal break-
points, 98.3% of strains were S, 1.3% I, and 0.3% R to BAL9141;
compared with 73.2% S, 20% I, and 6.7% R with ceftriaxone and
70.9% S, 24% I, and 5% R with cefepime. All strains were S to
quinupristin/dalfopristin, daptomycin, vancomycin and teicopla-
nin, and 93.3% S to telithromycin (breakpoint 0.5 lg/mL).
Conclusions: BAL 9141 had the lowest MICs (similar to carbapen-
ems) of all IV cephalosporins tested against pneumococci irres-
pective of a strain’s b-lactam, macrolide or quinolone
susceptibility.
P538 Efﬁcacy and safety of pharmacokinetically enhanced
amoxicillin/clavulanate 2000/125 mg in adult patients with acute
bacterial sinusitis in Hungary
L. Tamas, P. Kovacs, G. Horvai, M. Twynholm
Budapest, HUN; Harlow, UK
Objectives: Recent increases in the prevalence of antimicrobial
resistance among common respiratory pathogens have caused
concern worldwide. Pharmacokinetically enhanced amoxicillin/
clavulanate 2000/125 mg was designed using pharmacokinetic/
pharmacodynamic principles to achieve eradication of common
respiratory pathogens, including penicillin-resistant Streptococcus
pneumoniae (PRSP, penicillin MICs 2 mg/L) with amoxicil-
lin  clavulanate MICs of up to and including 4 mg/L.
Methods: In this multicentre, international, open-label, noncom-
parative study, patients with acute bacterial sinusitis (ABS) were
given amoxicillin/clavulanate 2000/125 mg as two 1000/62.5 mg
tablets twice daily for 10 days. Diagnosis of ABS was based on
clinical and radiological ﬁndings. Patients were required to have
sinus aspiration for bacteriological assessment at screening and,
for patients in whom treatment failed, at the time of treatment
failure. Treatment success was based on eradication of the initial
infecting pathogen or, in the absence of an evaluable repeat sam-
ple, clinical evidence of eradication. Data from a subset of patients
recruited in Hungary are presented here.
Results: A total of 222 patients received study medication. The
mean age of patients was 40.2 years and the majority of patients
were female (59.5%). Overall, 127 isolates were cultured from 109
patients [bacteriology intent-to-treat (bITT) population]. Streptococ-
cus pneumoniae was the most frequently isolated pathogen, identi-
ﬁed in 40.4% (44/109) of patients in the bITT population. Success
in the bITT population at follow-up (days 17–28, primary efﬁcacy
endpoint) was 87.2% (95/109). Of 14 patients who were not suc-
cesses, seven were conﬁrmed bacteriological failures and seven
had a response of ‘unable to determine’. In patients with S. pneu-
moniae infection, 93.2% (43/44) were successes at follow-up. Two
patients had PRSP identiﬁed at screening, and both patients were
successes at follow-up. Adverse events (AEs), due to any cause,
were reported by 25.2% (56/222) of patients. Diarrhoea was
reported as an AE by 12.6% (28/222) of patients. The majority of
AEs were mild to moderate in severity. Only 2.7% (6/222) of
patients withdrew from the study due to AEs.
Conclusion: Amoxicillin/clavulanate 2000/125 mg was highly
effective in treating patients with ABS, particularly cases caused
by S. pneumoniae, including two patients with PRSP infection, and
was generally well tolerated.
P539 An in vitro evaluation of the antimicrobial activity of
a novel ﬂuoroquinolone
M.J. Robbins, D. De Rubeis, C. Dencer, L. Williams, M. Harrison,
A. Bryskier, D. Felmingham
London, UK; Romainville, F
Background: Since the introduction of the ﬂuoroquinolones,
ciproﬂoxacin and oﬂoxacin over 10 years ago, there has been a
small but signiﬁcant increase in the number of resistant clinical
Drug Pen S Pen I Pen R Macrolide R Quinolone R
BAL9141 0.016/0.016 0.06/0.5 0.5/1 0.5/1 0.5/1
Amox 0.016/0.03 0.25/2 2/8 2/8 2/4
Imipen 0.004/0.03 0.03/0.12 0.25/0.5 0.25/0.5 0.25/0.25
Ertapen 0.004/0.12 0.12/0.5 0.5/1 0.5/1 0.5/1
Ceﬁpime 0.03/0.12 0.5/1 1/2 1/2 1/2
Ceftriax 0.016/0.12 0.25/1 1/2 1/4 1/4
Cefurox 0.016/0.25 0.5/4 4/16 4/16 4/16
Cefotax 0.016/0.03 0.25/1 1/2 1/2 1/2
Cefdinir 0.06/0.25 0.5/8 8/16 8/16 8/16
Levo 0.5/32 1/2 1/4 1/2 16/32
Moxi 0.06/4 0.12/0.25 0.12/0.5 0.12/0.5 2/8
Azithro 0.06/>64 0.25/>64 4/>64 >64/>64 0.12/>64
Clarithro 0.016/>64 0.06/>64 1/>64 >64/>64 0.06/>64
Linez 0.25/2 1/2 1/2 1/2 1/2
Quin/Daf 0.12/1 0.5/1 0.5/1 0.5/1 0.5/1
Dapto 0.06/0.25 0.12/0.25 0.12/0.25 0.12/0.25 0.12/0.25
Vanco 0.12/0.5 0.25/0.5 0.25/0.5 0.25/0.5 0.25/0.5
Teico 0.016/0.12 0.03/0.06 0.06/0.12 0.06/0.12 0.06/0.12
Telithro 0.008/1 0.03/0.12 0.03/0.5 0.12/1 0.016/0.25
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isolates of species previously susceptible to these agents. More
recent ﬂuoroquinolones have better activity against Gram-positive
species while retaining activity against Gram-negative species.
The comparative in vitro activity of the novel ﬂuoroquinolone
WCK 1152A was determined against a range of clinical isolates.
Methods: MICs were determined for 1007 clinical isolates, the
majority using the NCCLS agar dilution method. The microbroth
method was performed when testing isolates of Streptococcus pneu-
moniae, Haemophilus inﬂuenzae and Moraxella catarrhalis.
Results: MICs of WCK 1152A, moxiﬂoxacin and ciproﬂoxacin for
respiratory tract pathogens are summarised below. Generally, the
in vitro activity of WCK 1152A was similar to that of moxiﬂoxacin.
Against isolates of S. pneumoniae of deﬁned genotype, and ‘atyp-
ical’ respiratory pathogens, WCK 1152A was some twofold to
fourfold more active than moxiﬂoxacin.
Conclusion: Improved activity against multi-resistant isolates of
S. pneumoniae and ‘atypical’ pathogens indicate a potential role for
WCK 1152A in the treatment of respiratory tract infections.
P540 Intracellular penetration and activity of cethromycin
against Legionella pneumophila in a monocytic cell line (Mono
Mac 6)
I. Garcı´a, S. Ballesta, E.J. Perea, A´. Pascual
Seville, E
Objectives: Antimicrobial intracellular penetration and activity are
important parameters in the therapy of infections due to intracel-
lular pathogens. The penetration of the ketolide cethromycin into
the mature monocytic cell line Mono Mac 6 and its intracellular
activity compared with telithromycin against Legionella pneumo-
phila was evaluated.
Methods: Uptake of radiolabeled cethromycin by Mono Mac 6
cells was determined by a radiometric assay. The cells were incu-
bated with different extracellular concentrations of cethromycin
(1–25 mg/L) and after different incubation times separated by a
velocity gradient centrifugation technique. Extracellular suscepti-
bility (MIC) was determined by microdilution susceptibility test-
ing in BYEalpha agar after 48 h of incubation. The activity of
cethromycin and telithromycin against intracellular L. pneumophila
ATCC 33152 into Mono Mac 6 cells in a 48 h assay was also eval-
uated. Mono Mac 6 cells containing intracellular L. pneumophila
were incubated with different ketolide extracellular concentrations
(0.1–10 mg/L). After 48 h of incubation, intracellular bacteria were
released and plated on BCYEa agar.
Results: The uptake of cehromycin by Mono Mac 6 cells was
rapid and not saturable. At extracellular concentration of 2 mg/L,
the intracellular concentration of cethromycin was 40 times higher
than extracellular one. Cethromycin was rapidly released from
loaded Mono Mac 6 cells (after 30 min incubation in antimicro-
bial-free medium, only 20% of accumulated-drug remained cell
associated). MIC of cethromycin and telithromycin against
L. pneumophila ATCC 33152 were 0.008 and 0.015, respectively. At
the extracellular concentrations evaluated, cethromycin impaired
signiﬁcantly the intracellular growth of L. pneumophila. At an
extracellular concentration of 0.1 mg/L (10XCMI), the percentage
of bacterial inhibition for cethromycin was 90%. Only at higher
extracellular concentrations (around 1 mg/L), a similar bacteri-
cidal effect against intracellular bacteria was achieved by telithro-
mycin.
Conclusions: Cethromycin penetrates into the mature monocytic
cell line Mono Mac 6, reaching high intracellular concentrations,
while it remains active intracellularly. The intracellular activity of
cethromycin against L. pneumophila was signiﬁcantly higher than
that of telithromycin.
P541 Phase 2 trial comparing four regimens of oritavancin
vs. comparator in the treatment of patients with S. aureus
bacteraemia
J.S. Loutit, W. O‘Riordan, J. San Juan, J. Mensa, R. Hanning,
S. Huang, S.B. Porter
Brisbane, Chula Vista, USA; Buenos Aires, AR; Barcelona, E
Objectives: The efﬁcacy and safety of four dose regimens of orita-
vancin, an investigational semisynthetic glycopeptide with bacteri-
cidal activity in vitro against gram-positive pathogens, was
evaluated in the treatment of patients with S. aureus bacteraemia.
Methods: In this Phase 2, open-label, randomised trial, patients
with S. aureus bacteraemia were randomised to receive oritavancin
(5, 6.5, 8, or 10 mg/kg IV qd for 10–14 days) or comparator
(vancomycin 15 mg/kg IV q12 h for 10–14 days or a B-lactam
agent if the organism was sensitive). Efﬁcacy and safety were
assessed at End of IV Therapy, Early Follow-Up (EFU, 5–12 days
post-therapy) and Late Follow-Up (LFU, Day 42). The primary
endpoint was the composite (combined clinical and bacteriologic)
outcome in the Evaluable population (EVAL) at EFU.
Results: 125 patients enrolled; 123 received study drug (ITT popu-
lation) and 84 met criteria for the EVAL population. The efﬁcacy
data for the EVAL population at EFU are presented. Composite
outcome success rates for the 5, 6.5, 8, and 10 mg/kg oritavancin
groups were ﬁve of six (83%), ﬁve of seven (71%), 16 of 24
(67%), and 16 of 20 (80%), respectively, and for the comparator
group, 19 of 27 (70%). Clinical cure rates were ﬁve of six (83%),
ﬁve of seven (71%), 17 of 24 (71%), 16 of 20 (80%) for oritavancin
and 20 of 27 (74%) for comparator. Bacteriologic eradication rates
were ﬁve of six (83%), six of seven (86%), 19 of 24 (79%), 17 of
20 (85%) for oritavancin and 21 of 27 (78%) for comparator. Rates
of deaths, SAEs, AEs, and discontinuations from IV therapy
because of AEs were similar across all treatment groups. The most
common AEs seen in the oritavancin vs. comparator groups,
respectively, were diarrhoea (17% vs. 19%), injection site phlebitis
(19% vs. 14%), pyrexia (19% vs. 14%), hypotension (16% vs.
16%), vomiting (10% vs. 22%), nausea (12% vs. 14%), and hypo-
kalaemia (10% vs. 13%). No increase in AEs was seen with
increasing dose levels of oritavancin.
Conclusions: Oritavancin for 10–14 days was as effective as com-
parator in the treatment of patients with S. aureus bacteraemia
with higher Clinical, Bacteriologic and Composite outcomes seen
in the 10 mg/kg cohort. Safety results were comparable across all
treatment groups with no evidence of increasing AEs with
increasing dose levels of oritavancin.
P542 Linezolid in the treatment of skin and soft tissue
infections caused by methicillin-resistant Staphylococcus aureus
N. Alikadic, D. Smrke
Ljubljana, SI
Objectives: Linezolid, the ﬁrst member of a new class of synthetic
antibacterial agents (the oxazolidinones), has demonstrated Gram-
positive spectrum of activity, involving all strains of staphylo-
cocci, including methicilin resistant Staphylococcus aureus (MRSA)
and methicilin resistant Staphylococcus epidermidis (MRSE), entero-
cocci, including vankomycin resistant enterococci (VRE), and
pneumococci (including penicillin-intermediate and penicillin-
MIC(mg/L
WCK1152A Moxiﬂoxacin Ciproﬂoxa-
cin
Species (n) 50% 90% 50% 90% 50% 90%
S. pneumoniae multi-resistant (86) 0.03 0.06 0.12 0.12 1 2
S. pneumoniae FLQ I/R (51) 0.25 1 2 4 16 64
S. pyrogenes(20) 0.06 0.06 0.12 0.12 0.5 0.5
H. inﬂuenzae (24) 0.015 0.03 0.015 0.03 0.0008 0.015
M. catarrhalis (14) – 0.06 – 0.06 – 0.06
L. Legiomella spp. (25) 0.015 0.03 0.03 0.03 0.015 0.015
M. pneumoniae (12) – 0.03 – 0.12 – 2
C. pneumoniae (5) range 0.03–0.06 range 0.12–0.25 All at 4
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resistant strains). To assess the efﬁcacy, safety and tolerance of
intravenously and orally administered linezolid in the treatment
of patients with documented MRSA skin and soft tissue infections
(SSTI) our department participated in the international multicen-
tric clinical trials.
Methods: The study was conducted in 16 patients with conﬁrmed
MRSA surgical SSTI. Patients were randomised to receive one of
the following regimens: linezolid iv 600 mg every 12 h for the
entire treatment period or switched to linezolid orally 600 mg
every 12 h; vancomycin iv 1 g every 12 h for the entire treatment
period (dose may have been adjusted by serum level determina-
tion to maintain therapeutic level) Along with linezolid the surgi-
cal procedures were performed, when necessary. Clinical and
microbiological assessments were performed throughout the
study. After completion of therapy all patients were short-term
followed-up.
Results: The treatment with linezolid resulted in resolution of
clinical signs and symptoms as well as laboratory signs of infec-
tion in all patients enrolled. No serious adverse events related to
the medication were noted. The efﬁcacy of linezolid was compar-
able with that of vancomycin, while its microbiological success
rate at the end of treatment was signiﬁcantly higher and on the
follow-up.
Conclusion: Our trials suggest that linezolid is an effective, safe
and well-tolerated option for the treatment of SSTI caused by
methicilin resistant Staphylococcus aureus. It may be regarded as a
valuable antimicrobial agent to control the increasing occurrence
and spread of infections caused by resistant Gram-positive strains
or in patients who cannot tolerate standard antimicrobial therapy.
P543 Linezolid tolerance among multiresistant
nasopharyngeal isolates of Streptococcus pneumoniae
A. Malm, I. Korona-Glowniak, A. Kalasiewicz
Lublin, PL
Objectives: Linezolid, a synthetic compound belonging to a new
class of antibiotics called the oxazolidinones, shows antipneumo-
coccal activity. Nasopharyngeal isolates of S. pneumoniae from
healthy children are useful for predicting antimicrobial suscepti-
bility of pneumococci in a given population. We assess in vitro
activity of linezolid against multiresistant strains of S. pneumoniae
isolated from nasopharynx of healthy children.
Methods: 58 strains of S. pneumoniae were tested, including 22 iso-
lates sensitive to penicillin (PSSP) and 36 – relatively resistant to
penicillin (RRSP). All strains were resistant to at least three anti-
microbials, including erythromycin, clindamycin, tetracycline, chl-
oramphenicol or cotrimoxazole. Minimal inhibitory concentraion
(MIC) and minimal bactericidal concentration (MBC) values for
linezolid were determined by broth microdilution method. The
bacteriostatic or bactericidal effects of linezolid were assessed by a
time-kill assay. Sensitivity of isolates to optochin and their bile
solubility were tested by conventional methods.
Results: Linezolid inhibited all isolates tested with MICs ranging
from 0.25 to 1 mg/L, showing similar activity against PSSP and
RRSP strains. This indicates that all strains, including those resist-
ant to all antimicrobials used, were sensitive to linezolid.
Although the majority of the tested isolates were sensitive to bac-
tericidal effect of linezolid with MBCs ¼ 8 mg/L or less, three of
them (1 RRSP, 2 PSSP) were killed at high concentrations of
linezolid – MBC ¼ 16 or 32 mg/L and had a high MBC/MIC
ratios 32 or 64. Linezolid tolerance was conﬁrmed by monitoring
viability of these strains during exposure to 20 mg/L of this anti-
biotic, that is similar to its maximal serum concentration after
standard dosing. All tolerant strains were sensitive to optochin
and lysed with desoxycholate, which indicates autolysin produc-
tion. The prevalence of linezolid tolerance among the tested multi-
resistant pneumococci was 5.17%.
Conclusions: Although it has not been found linezolid resistance
in S. pneumoniae, some pneumococcal strains were insensitive to
bactericidal effect of this antibiotic. Linezolid tolerance in clinical
isolates may represent a potential risk, especially in patients with
suppressed immune response.
P544 New penams (6-APA) and cephems (7-ACA) with
bulky T-shaped side-chains: synthesis and antibiotic activities
L. Efron, T. Happaerts, E. Sonveaux, H. Chanteux,
Y. Glupczynski, C. Behrin, F. Van Bambeke, P. Tulkens
Brussels, B
Objectives: Discovered more than 50 years ago, beta-lactam antibi-
otics remain of large interest because of their potentially large spec-
trum and low intrinsic toxicity. A large number of semi-synthetic
derivatives have been obtained, but few have explored the possibil-
ity to use bulky side chains in an attempt to more fully block the cata-
lytic crevice in PBPs. In this context, we have synthesised penam and
cephem derivatives bearing two morpholine rings attached to their
side-chains. We report here on two typical compounds (DEMO-Pen
and DEMO-Cef; see structures in the Figure) modelled after benzyl-
penicillin and the correspondingmethoxy-acetyl-cephem.
Methods: DEMO-Pen and DEMO-Cef were formed via the mixed
anhydride method. The whole side chain was ﬁrst obtained by bis-
alkylation of methyl 3,5-dihydroxybenzoate with N-chloroethyl-
morpholine, and made into a pentaﬂuorophenyl ester. The latter
was coupled with 6-APA and 7-ACA to give the corresponding
penam and cephem derivatives. MIC’s were determined by com-
mon agar dilution method in comparison with ampicillin and
cefadroxil against both collection strains and clinical isolates.
Results: The structures and stabilities of DEMO-Pen and DEMO-
Cef were conﬁrmed by 1H NMR, 13C NMR, IR, and high-resolu-
tion mass spectrometry. DEMO-Pen was active against Gram (+)
organims (S. aureus, S. pneumoniae, S. pyogenes). DEMO-Cef was
more active (8x) than cefadroxil against S. pneumoniae.
Conclusion: Bulky side-chains do not prevent penams and cep-
hems to reach the active site of PBPs and may provide increased
activity. This opens the way to renewed efforts in the synthesis of
novel beta-lactam derivatives.
P545 In vitro and in vivo activities of novel compounds
active against multiresistant strains of Mycobacterium
tuberculosis
U. Mo¨llmann, L.P. Martinova, S. Ru¨sch-Gerdes, V.A. Makarov
Jena, D; Moscow, RUS; Borstel, D
Objectives: During the past two decades the WHO indicated an
increasing number of TB patients infected by strains ofM. tuberculo-
sis resistant to most of the available drugs. In contrast it has been
nearly 30 years since the introduction of a novel compound for the
treatment of TB. We synthesised series of analogues of our newly
discovered class of antimycobacterial compounds to enhance
in vitro and in vivo activity by structure activity relationship studies.
Methods: Molecules were derived by speciﬁc methods of classical
synthesis. In vitro activity was determined in a ﬁrst screen against
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a variety of microorganisms (Gram-positive and Gram-negative
bacteria, yeast, fungi) including fast growing mycobacteria, than
against sensitive strains and drug resistant clinical isolates of Myco-
bacterium tuberculosis. In vivo activity was tested in a murine model
of TB infection. Acute and chronic toxicity were checked in mice.
Results: While starting compounds were active against Gram-posit-
ive bacteria, mycobacteria, fungi and yeast, in the course of the inves-
tigations activity was focused on bacteria andmycobacteria. Various
analogues demonstrated high in vitro activity againstM. tuberculosis
including clinical isolates and MDR strains. MIC’s of the most
advanced compounds forM. tuberculosis H37Rv and clinically isola-
ted MDR strains were <0.78 to <0.063 lg/mL. The compounds were
therapeutically active after oral application in mice infected withM.
tuberculosis H37Rv with 100% survival rates. The LD50 in mice after
oral application was >500 mg/kg for all compounds. Additionally,
synthesis of the compounds is efﬁcient and inexpensive.
Conclusions: Considering the activity of the novel compounds
against MDR strains of M. tuberculosis the mechanism of action
must be different to that of the existing therapeutics. Because of
the narrow spectrum of activity and the low toxicity this new
class of antimycobacterial compounds represents a promising lead
candidate for low cost drugs to overcome MDR-TB with reduced
side effects.
P546 Basidiomycete metabolites attenuate virulence
properties of Candida albicans in vitro
L. Pleyer, S. Ressler, A. Berg, M.P. Dierich, R. Wu¨rzner
Innsbruck, A; Jena, D
Objective: The previously used stratagem of targeting a singular
cellular metabolic or biosynthetic process in antifungal drug
design has proven inadequate, especially with regard to the
increasing drug-resistance. We therefore studied the recently dis-
covered basidomycete protease inhibitors Aureoquinone and Lacc-
aridiones A and B for their ability to block fungal adhesion and to
inhibit candidial secreted aspartate protease (Sap) release.
Methods: Inhibition of adhesion was tested on endothelial and
epithelial cells, Sap antigen concentrations by speciﬁc ELISA and
their activity by enzymatic cleavage of bovine serum albumin.
Results: The inhibition of C. albicans adhesion to the epithelial cell
line Hela S3 was shown to be dose dependant and highly signiﬁ-
cant (24% inhibition with Aureoquinone, 35% with Laccaridione
A and 56% with Laccaridione B at 10 lg/mL, respectively),
clearly marking Laccaridione B as the front runner. The inhibitory
effect of Laccaridione B on candidial adherence to the endothelial
cell line EAhy 926 was an even greater (highly signiﬁcant 66%).
Concerning Sap-release Laccaridione B also proved to be the most
effective among the substances tested, showing a signiﬁcant 50%
reduction in concentration and a reduced activity at 10 lg/mL.
The inhibitory effects observed were shown to be the result of an
inhibition of Sap-production and/or -release and not due to a
direct interaction of the basidiomycete metabolites with Sap. For
both Sap-release and activity a single application of the drug
resulted in a much less pronounced effect than regular drug addi-
tion over a period of 8 days.
Conclusion: Animal studies will show whether Laccaridione A and
especially Laccaridione B, or derivatives thereof, may also represent
potent antifungal drugs in vivo targeting fungal virulence factors
such as adhesion and protease release, without being fungicidal.
P547 Search and assessment of novel substances active
against Epstein–Barr virus
S. Zagorodnya, N. Dyachenko, N. Nesterova, V. Atamaniuk,
A. Novik, S. Rybalko, G. Baranova
Kiev, UKR
Objectives: The aim of the study was to assay the anti-EBV activ-
ity of several substances prepared from the raw material of the
plant origin, namely Proteﬂasid in the miscellaneous modiﬁed
forms (drug 11 and drug 12). Proteﬂasid (Ecopharm Research and
Production Company, Kyiv) represents the quercetin-containing
herbal extract of wild grasses Deschampsia caespitosa L. and Ca-
lamagrostis epigeios L.
Methods: PCR. An inhibition of reproduction of EBV in cell cul-
ture by Proteﬂasid was determined by reduction of number of
genome equivalents of EBV DNA on a cell in treated vs. untreated
cells. To determine it, a quantitative PCR was applied using
primes and reagents of ‘AMPLY-Senc-100R’ (Russia) and pro-
gramme ‘Biotest A’.
Results: The search for the novel antiviral substances active
against Epstein–Barr virus (EBV) is a topical problem since the
persistent EBV infection alters immune status promoting the
development of adenocarcinomas and lymphoproliferative dis-
eases. Moreover, EBV like other herpesviruses affects central and
peripheral nervous system being involved in the pathogenesis of
meningoencephalitis, arachnoencephalitis and meningitis. Anti-
EBV activity of the substances was assessed in EBV-infected
lymphoblastoid Raji cells. The substances were assayed within
broad concentration ranges. The activity of drugs was studied at
its depositing simultaneously with to infected, 24 h prior to infec-
ted and in 24 h after to infected. The maximally tolerable concen-
trations for the cell line being assayed amounted to 150 mg/mL.
Is rotined, that the depositing drug 12 in a syrup gives the best
outcomes as contrasted to by drug 11 – about it the values chemo-
therapeutic indices of an indices testify. Specially good outcomes
were obtained on medical operating preparations in two solvents
chemotherapeutic indices 350 (1) and 1250 (2). But also preventive
the processing lymphoblastoid of cages by a drug (24 h prior to
contamination) gives high enough parameters – 250 (1) and 400
(2). The inhibition of EBV reproduction was assessed by PCR
technique estimating the number of EBV DNA genomic equiva-
lents. Minimal effective concentrations amounted to 0.1 mg/mL
for Proteﬂasid for both modiﬁcations.
Conclusion: To summarise, the substances under study possess
the signiﬁcant anti-EBV activity and may be the advantageous for
the therapy of EBV-associated diseases.
P548 A phase 2 study of the toxin binding polymer
tolevamer in patients with C. difﬁcile associated diarrhoea
D. Davidson, J. Peppe, T. Louie - The Tolevamer Working Group
Background: Tolevamer sodium is a novel, nonabsorbed, nonanti-
biotic polymer that binds C. difﬁcile toxins A and B, and is being
developed to treat C. difﬁcile-associated diarrhoea (CDAD). C. difﬁ-
cile is the most common cause of infectious nosocomial diarrhea,
affecting 1% of hospitalised patients. C. difﬁcile proliferates
when normal colonic ﬂora are altered, typically by antibiotics.
Pathogenic strains of C. difﬁcile produce two toxins, A and B, that
induce colonic inﬂammation and ﬂuid loss. CDAD treatment with
metronidazole or vancomycin also disrupts normal ﬂora, and
CDAD recurs in 20% of treated patients. We have completed a
phase 2 trial demonstrating that tolevamer and vancomycin have
similar efﬁcacy in the treatment of mild-moderate CDAD.
Primary objective: To demonstrate noninferiority vs. vancomycin
with respect to time to resolution of diarrhoea (TTROD).
Methods: A randomised, double-blind, double-dummy, active-
controlled phase 2 trial was conducted to determine the safety
and efﬁcacy of monotherapy with 1 or 2 g tolevamer TID vs. a
standard oral dose of 125 mg vancomycin QID. 289 patients with
a ﬁrst episode or recurrent CDAD were enrolled at 58 US, UK
and Canadian sites.
Results: Preliminary data showed that the median TTROD in the
per protocol population (PP) was 2.0 days with vancomycin, and
2.5 days with 6 g tolevamer. Noninferiority testing demonstrated
that these response times were comparable (P ¼ 0.015), and that
the 6 g tolevamer TTROD risk ratio relative to vancomycin was
0.98 (95% CI: 0.68–1.41). In the ITT population, the median
TTROD was 3.0 days for both groups. There was no statistically
signiﬁcant difference in TTROD between vancomycin and 6 g
tolevamer in either primary or recurrent CDAD patients. The 3 g
TTROD was 4.0 days, showing a tolevamer dose response. In the
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PP, the deﬁnitive recurrence rate (DRR: conﬁrmed by a positive
toxin assay) was 19% with vancomycin and 10% with 6 g tolev-
amer, but this advantage did not achieve statistical signiﬁcance
(P ¼ 0.185). In the PP with recurrent CDAD at enrollment, the
DRR was 27% with vancomycin and 0% with 6 g tolevamer
(P ¼ 0.07). Overall rates of serious and nonserious adverse events
were similar between groups.
Conclusion: Tolevamer dosed at 6 g/day rapidly resolved CDAD
similarly to vancomycin and demonstrated a trend towards
reduced recurrence. Tolevamer may provide a nonantibiotic alter-
native for the treatment of this antibiotic induced disease.
P549 A novel antimicrobial system to treat methicillin-
resistant and glycopeptide-resistant staphylococci
B. Cookson, M. Embleton, S. Nair, M. Wilson
London, UK
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) pose
a worldwide public health problem. It has long been a major
cause of nosocomial infections and strains causing serious com-
munity-acquired infections have recently emerged. MRSA and
indeed coagulase negative staphylococci (CNS) are often multi-
drug resistant and can rapidly acquire resistance to new anti-
microbials, such as linezolid, making infections difﬁcult to treat,
costly and life-threatening. Hence, there is a real need to develop
alternative treatments. We have previously shown that MRSA
strains can be killed by photodynamic therapy (PDT) using tar-
geted photosensitizer conjugates. We describe the use of non-
strain-speciﬁc phage-photosensitizer conjugates to target and kill
MRSA, glycopeptide resistant MRSA and CNS.
Methods: The S. aureus phage 75 was conjugated to the photosen-
sitizer tin (IV) chlorin e6. The conjugate was then added to a sus-
pension of MRSA and this was exposed to red light (l 633 nm).
This activated the photosensitizer, producing highly reactive sing-
let oxygen which can exert a bactericidal effect. Following irradi-
ation, survivors were enumerated.
Results: 99.99% of MRSA in suspensions containing 1  107
cfu/mL were killed by the treatment using a conjugate/bacteria
ratio of 1:1. Furthermore, the phage-photosensitizer conjugate
could kill bacteria in exponential and stationary phases of growth.
By increasing the ratio of conjugate to bacteria to 10:1, it was
possible to achieve 100% kills. Controls showed that at the con-
centrations used phage, photosensitizer or laser alone did not pro-
duce signiﬁcant kills. We were also able to kill Glycopeptide
resistant MRSA and CNS. Calcium neutralisation showed that
these effects were because of nonspeciﬁc phage adhesion.
Conclusions: The phage-photosensitizer conjugate was very effect-
ive at killing multidrug-resistant MRSA and CNS. Because Staphy-
lococcus aureus phages have the ability to adsorb to any
staphylococcus, they make ideal targeting systems for PDT. There-
fore, phage-targeted PDT is an excellent candidate for a new treat-
ment against such infections. By selecting different phages and
photosensitizers, it may be possible to use this technique against
many species of bacteria.
P550 Novel ‘ethiological’ therapies for AIDS-related
Kaposi’s sarcoma, and possible laboratory monitoring
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
HAART changed the natural history of HIV disease, but AIDS-
related malignancies still occur, including Kaposi sarcoma (KS),
whose multifactorial pathogenesis include a deﬁnite pathogenetic
role of HHV-8, HIV infection itself, and underlying immunodeﬁ-
ciency. Five consecutive male homosexual patients (p) diagnosed
with AIDS because of cutaneous disseminated and/or visceral KS,
received HAART combined with an alternating weekly schedule
of liposomal doxorubicin or daunorubicin, and the antiviral drug
cidofovir at 5 mg/kg (preceded by probenecid administration).
Our p received four to 13 cycles of alternating chemotherapy-cid-
ofovir administered every other week, which led to a signiﬁcant
improvement of number, size, and activity of KS lesions, obtained
in all treated p at all involved body sites, since the second-third
therapeutic cycle. However, the role of concurrent HAART-related
immune recovery (45–395% increase of CD4+ lymphocyte count,
compared with baseline), has to be taken into account, as well as
the hypothetic direct or indirect activity of antiretroviral therapy
on KS evolution. Only one p with a prior, recent myocardial infarc-
tion received only four cycles of daunorubicin, because of contra-
indications indicated for p suffering from coronary heart disease;
he continued cidofovir alone, administered every other week. Four
p needed concurrent rHuG-CSF administration to control drug-
related incoming neutropenia. A drop of quantitative plasma
HHV-8 viraemia was demonstrated in four treated p, and strictly
paralleled clinical improvement. Both liposomal doxorubicin and
daunorubicin were approved for the treatment of HIV-related KS,
demonstrating a comparable effect (but less toxicity), of combined
chemotherapy based on vincristine, adriamycin, and bleomycin.
The conﬁrmed pathogenetic role of HHV-8 in KS prompts the
introduction of cidofovir (an antiviral drug with extensive activity
towards all Herpesviruses), in the ethiological KS treatment, but
neither validated schedules of administration of both drugs are
available, nor criteria for selection of a speciﬁc drug over the other
one, because of the lack of data from controlled studies. After pay-
ing careful attention to heart-kidney toxicity of doxorubicin-dauno-
rubicin, and cidofovir too, this cytotoxic-antiviral combination
therapy may become the ﬁrst-line therapeutic choice for HIV-asso-
ciated KS, waiting for controlled data. The decay of HHV-8 virae-
mia needs further investigation, as a predictor of response to
combined cytotoxic-antiviral therapy.
P551 A novel antiviral based on oral antibodies: clinical
beneﬁts in paediatric upper respiratory infections
A.V. Martyushev-Poklad, V.F. Uchaikin, M.P. Kotelnikova,
J.L. Dugina, O.I. Epstein, S.A. Sergeeva
Moscow, RUS
Objectives: High prevalence of viral upper respiratory infections
(URI) and inefﬁcacy of anti-inﬂuenza vaccination for noninﬂuenza
and mixed URIs reveal an unmet need in managing URI, most
urgent in pediatic population. A novel antiviral and immunomod-
ulating drug developed and currently marketed in Russia – Ana-
feron (AF) – contains antibodies to interferon gamma (IFNg) in
ultra-low doses intended for oral use. Animal studies showed its
therapeutic and preventive action in inﬂuenza and herpetic infec-
tion. On course oral treatment AF signiﬁcantly (three to six times)
enhanced IFNg ex vivo secretion in peripheral mononuclears.
Methods: Efﬁcacy and safety of AF for inﬂuenza and other URI
was studied in a multicentre randomised placebo-controlled trial
that involved over 400 pediatric in- and outpatients aged
6 months–14 years. AF (oral tablets) was given three to seven
times daily starting on day 1–2 of URI onset, as add-on therapy to
symptomatics and/or antibiotics (if indicated). Major clinical signs
of URI and possible adverse drug reactions were monitored dai-
ly.In a randomised study of AF as a prophylactic for URI, over
400 patients (aged 6 months–4 years) received AF/placebo, 1 oral
tablet daily for 3 months. In cases of URI, AF was given according
to treatment schedule. Points to consider were occurrence and
severity of URIs, rate of complications, tolerability.
Results: Treatment with AF provided considerable (P < 0.05)
reduction in duration and severity of major signs of URIs, and
rate of complications. Duration of fever reduced by 35–40%, of
intoxication – by 40–50%, of coryza – by 20%, of cough – by 30%.
None of AF patients showed any adverse drug-related events
(ADREs). Prophylactic use of AF caused a 2-2,3-fold drop in
occurrence of URIs. The part of children who avoided URI within
3 months of treatment rose from 3% in placebo to 24,7% in AF
group. The use of AF provided a 1.5–2-fold reduction in duration
of major signs of URI. Typical pediatric URI complications (otitis
and purulent rhinitis) were 2.3 and 2.1 times less frequent (corre-
spondingly). No ADREs were registered on AF.
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Conclusion: AF is effective and safe in prophylaxis and treatment
of inﬂuenza and other URIs in children aged 6 months and older.
Moreover, pilot studies have shown AF efﬁciency in infectious
mononucleosis and haemorrhagic fever with renal syndrome. Rus-
sian Health Ministry recommends AF as one of choice remedies
for pediatric URIs.
P552 Disruption of the interaction between the HCMV
DNA polymerase subunits: towards new anti-HCMV inhibitors
A. Loregian, B. Appleton, J.M. Hogle, H.S. Marsden, D.M. Coen,
G. Palu`
Padova, I; Boston, USA; Glasgow, UK
Objectives: The human cytomegalovirus DNA polymerase is com-
posed of a catalytic subunit, UL54, and an accessory protein,
UL44. The observations that both UL54 and UL44 are essential for
HCMV DNA replication, and that antisense inhibition of UL44
synthesis in HCMV-infected cells strongly inhibits viral DNA rep-
lication raises the possibility that the UL54/UL44 interaction
might be a valid target for antiviral drugs.
Methods and Results: To investigate this possibility, overlapping
peptides spanning residues 1161–1242 of UL54 were synthesised
and tested for inhibition of the interaction between puriﬁed UL54
and UL44 proteins. A peptide, LPRRLHLEPAFLPYSVKAHECC,
corresponding to residues 1221–1242 at the very C-terminus of
UL54, disrupted both the physical interaction between the two
proteins and speciﬁcally inhibited the stimulation of UL54 by
UL44. Moreover, to deﬁne individual residues in UL44 and UL54
that are crucial for interacting with each other, we have engin-
eered several mutations both in the C-terminal region of UL54
and in a region of UL44 identiﬁed in the crystal structure as the
‘connector loop’. Substitution of alanine for Ile135 in UL44 or for
Leu1227 or Phe1231 in UL54 greatly and speciﬁcally impaired the
UL54–UL44 interaction in both pull-down assays and assays of
long-chain DNA synthesis, identifying these residues as crucial
for subunit interaction.
Conclusions: Thus, a few speciﬁc side chains appear to be crucial
for UL54/UL44 interaction, suggesting that small molecules tar-
geting the relevant side chains could interfere with this interac-
tion. This information may aid in the discovery of new drugs for
the treatment of HCMV infection.
MRSA and staphylococci: epidemiology
P553 MRSA outbreaks in nursing homes in Central
Norway
K.W. Larssen, G. Iversen, T. Jacobsen, K. Bergh, O. Scheel
Trondheim, N
Introduction: Norway has a low prevalence of methicillin-resistant
Staphylococcus aureus (MRSA), with a rate of less than 1% of all
staphylococcal infections. Reports from the Norwegian Notiﬁca-
tion System for Infectious Diseases (MSIS) show an increase in the
number of reported cases of MRSA from 63 in 1998 to 142 in
2002. Most cases are now contracted in Norway and outside hos-
pitals. Although there have been several outbreaks of MRSA in
hospitals, this is the ﬁrst report of MRSA outbreaks in Norwegian
nursing homes (NH).
Material/methods: Since March 2003 there has been outbreaks of
MRSA at two different NH in Central Norway located 111 km
from each other. The initial detection of MRSA was performed at
a local hospital. Positive strains were sent to St Olav University
hospital for conﬁrmation and further investigation. Strains from
24 persons (Both infection and carrier strains) were analysed by
Pulsed Field Gel Electrophoresis (PFGE), and one strain from each
NH was analysed by Multi Locus Sequence Typing (MLST).
Results: NH A had 10 cases among inmates and ﬁve among
health care workers. NH B had nine cases, all among inmates.
MRSA strains were isolated from nostrils or wounds, in some case
from both locations. The nine cases in NH B had an identical
PFGE pattern. The strains from NH A were also similar except
from one band difference. The strains from NH A differed by one
or two bands from the NH B strains, thus all strains were closely
related using PFGE. By MLST both strains were found to be ST
45. The SCCmec gene has not yet been determined. (The interna-
tional strains Berlin is ST 45 type IV).
Discussion: No exchange of personnel or inmates had occurred
between the two NH, and no obvious cause of spread was found.
The close relation of the strains makes us suspect a common
source. Although both NH are served by the same hospital, this
hospital had not experienced any outbreak of MRSA. Our results
show the potential for spread of MRSA within NH. Several
authors report MRSA within NH to be an increasing problem,
and NH residency has been proven to be an independent risk
factor for MRSA carriage upon hospital admission. It is important
that health care workers at NH are aware of this. Proper infection
control must be implemented not only in hospitals but also in
NH.
P554 Prevalence and risk factors for colonisation with
methicillin-resistant Staphylococcus aureus (MRSA-C) in
residents of long-term-care facilities in Greece
V. Grammelis, K. Kanellakopoulou, A. Kapaskelis, M. Gika,
K. Volonaki, A. Merkouris, G. Greka, H. Giamarellou, M.K. Lazanas
Athens, GR
Objectives: LTCF are becoming a major component of the health
care delivery system. The high prevalence of antimicrobial-resist-
ant organisms in some LTCF has been documented for many
years. The prevalence of colonisation or infection with MRSA may
be as high as 20–30%. MRSA-C in LTCF often precedes invasive
infection and represents a reservoir for dissemination in other res-
idents or facilities. A survey was conducted to determine the pre-
valence and main risk factors for MRSA-C in residents of LTCF in
Greece.
Methods: 18 LTCF were randomly selected from the public sanita-
tion list of Attic province. Nasopharyngeal (N) and wound (W)
samples were collected from 561 residents; from each LTCF, we
chose randomly 30% of the existing population (minimum sum
25 residents). Cultures and susceptibilities were performed, fol-
lowing NCCLS guidelines. Information was collected on facility
and resident demographic data. Univariate and multivariate ana-
lyses were performed.
Results: 587 samples were collected and 22 (3.75%) MRSA were
isolated, 18 (2%) from N and 4 (0.6%) from W specimens. The
most common site was W (four of 26, 15.4%), followed by N (18
of 561, 3.2%). Variables associated with MRSA-C by univariate
analysis: recent (previous 30 days) antimicrobial use (RR 3.8,
P ¼ 0.017), indwelling urinary catheter (RR 2.2, P ¼ 0.02), recent
(previous 120 days) hospitalisation (RR 2.5, P ¼ 0.011), poor func-
tional status (RR 3.6, P ¼ 0.013) and feeding tube (RR 4.4,
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P ¼ 0.001). In multivariate analysis, only recent hospitalisation
(RR 2.5, P ¼ 0.01), poor functional status (RR 3.6, P ¼ 0.01) and
feeding tube (RR 4.4, P ¼ 0.01) were independently associated
with MRSA-C. This model had a sensitivity of 95% and an area
under the ROC of 76%.
Conclusions: MRSA-C is relatively low in Greek LTCF. According
to our survey, independent risk factors for MRSA-C in LTCF are
hospitalisation, poor functional status and usage of feeding tubes.
P555 Risk factors for nasal carriage of methicillin-resistant
Staphylococcus aureus among patients in long-term care
facilities in Korea
S.-H. Eun, Y.-S. Lee, J.-K. Lee, J.-I. Yoo, J.-O. Cha, B.-S. Kim
Seoul, KOR
Objective: As populations in Korea age, increasing numbers of
older individuals reside in long term care facilities (LTCF) such as
nursing homes and chronic disease hospitals. As antimicrobials
are frequently subscribed in LTCF, the emergence of antimicrobial
resistant organisms is a serious problem. But, little is known about
anitmicrobial resistance of LTCF in Korea. Among various antimi-
crobial organisms, Methicillin resistant Staphylcoccus aureus
(MRSA) is one of the most common pathogens causing nosocomial
infections and widely prevailing in Korean hospitals. We designed
this study to investigate the prevalence of MRSA and risk factors
associated with nasal carriage of MRSA in LTCF.
Methods: The study was performed among 632 residents in eight
geriatric care hospitals from July to August 2002. Samples were
obtained by swabbing both nares. Mannitol salt agar containing
6 mg/mL of oxacillin was used for isolation of MRSA. The anti-
microbial resistance of isolated strains was determined by the disk
diffusion method, according to the recommendation of NCCLS.
We reviewed all medical records of 632 residents to analyse varia-
bles as risk factors including demographic, hospitalisation-related
factors, antibiotic usage and comorbid conditions.
Results: Overall prevalence of nasal carriage of S. aures was 50.2%
(317 of 632). Among 317 isolated S. aureus, 64.1% was resistant to
oxacillin. Recent infections (OR, 2.79, P ¼ 0.01) and use of anti-
microbials (OR, 2.787, P ¼ 0.01), indwelling devices such as foley
catheters and tracheostomy tubes (P < 0.001) and the existence of
bedsores or wounds (OR, 2.508, P ¼ 0.02) were associated with the
isolations of MRSA. And the history of previous hospitalisation
and the duration of hospitalisation were also associated with the
isolation of MRSA but not signiﬁcant statistically.
Conclusion: We found that MRSA were spreading widely in Kor-
ean LTCF. Multiple risk factors including recent infections and
the use of antimicrobials, indwelling devices and the existence of
wounds or bedsores were associated with the nasal carriage of
MRSA in geriatric care hospitals in Korea.
P556 The prevalence of nasal colonisation with MRSA
among residents of long-term care facilities in South Korea
Y.-S. Lee, J.-O. Cha, J.-O. Ahn, J.-K. Lee, J.-I. Yoo, S.-H. Eun,
B.-S. Kim
Seoul, KOR
Objectives: The long-term care facilities (LTCFs) patients are those
with serious underlying disease, poor functional status, wounds
such as pressure sores, invasive devices of urinary catheters. Resi-
dents of LTCFs are at risk for colonisation with multidrug-resistant
bacteria including methicillin resistant S. aureus (MRSA). More
than 70% of S. aureus isolated in tertiary hospitals in Korea was
methicillin resistant. But the prevalence of antimicrobial resistance
data in elderly population has not been known yet, in Korea. To
determine the prevalence of nasal MRSA colonisation in LTCFs, we
investigated the rates of methicillin resistance among the nasal iso-
lates of S. aureus isolated from provincial hospitals for the elderly.
Methods: Nasal swab specimens were obtained from 632 patients
of eight provincial hospitals for elderly from July to August 2002.
Swab specimens were cultured on staphylococcal broth for enrich-
ment, and plated on mannitol salt agar and mannitol salt oxacillin
agar which was supplemented with 6 lg/mL of oxacillin. Species
were identiﬁed by PCR and biochemical test. Antimicrobial sus-
ceptibility tests to 12 antibiotics were performed by disc diffusion
method, MIC of oxacillin was conﬁrmed by agar dilution method.
mecA and mupA were detected by multiplex PCR. PFGE and co-
agulase typing were performed for molecular epidemiological
analysis of isolates.
Results: On admission to the LTCFs, 317 S. aureus (50.2%) were
isolated from the specimens and were identiﬁed resistant to
oxacillin in 64% of them range from 36.6 to 80.0% depends on
hospitals. mecA gene was detected in all tested 233 MRSA
isolates with MICs of 16 to >128 lg/mL. Twenty-three isolates
of MRSA were mupirocin resistant with mupA gene and MICs
of >1024 lg/mL. The majority of those showed closely genetic
relatedness with more than 75% in PFGE and coagulase
type II.
Conclusions: Methicillin resistance of S. aureus isolates in provin-
cial hospitals for the elderly was very high (64%). This study sug-
gests that the importance of infection control programmes in
preventing the spread of MRSA in LTCFs should be encouraged.
P557 Basic hospital infection control methods reduced the
isolation rate of methicillin-resistant Staphylococcus aureus
E.S. Kim, E. Heo, D.H. Whang, H. Yum, B. Shin, H. Ko, B.H. Jun
Seoul, KOR
Objectives: Methicillin resistant Staphylococcus aureus (MRSA) is
highly prevalent in hospitals in Korea. Hospital infections by
MRSA are causing serious problems, so every hospital is trying to
control MRSA by applying effective methods. Seoul Paik Hospital,
tertiary teaching 430 bed hospital, applied relatively stricter infec-
tion control methods than previous ones in March 2002. This
study was designed to evaluate the difference of the isolation rate
of MRSA from all clinical specimens before and after the applica-
tion of the infection control methods.
Methods: Each month, data of the number of MRSA was gathered
and sorted; the results of the study were reported to every ward.
All wards were supplied with Microshild (Johnson & Johnson,
Australia), Clean N’ Fresh (Carroll, USA), and standard paper
towels. Health care workers were educated about hospital infec-
tion control. The use of antibiotics was then restricted. We retro-
spectively compared MRSA isolation rate based on results
reported by the Department of Clinical Microbiology before (Sep-
tember 2001–February 2002) and after (March 2002–August 2003),
applying the new infection control methods.
Results: After starting restricting system of antibiotics, glycopep-
tides and carbapenems were prescribed 15% (81 vs. 69 vials/1000
patient-days, P < 0.01) and 35% (37 vs. 24 vials/1000 patient-days,
P < 0.01) less respectively, during the same period (September
2001–May 2002 vs. September 2002–May 2003). Methicillin resis-
tance rate of S. aureus was reduced from 78 to 69% during the
period of study (P ¼ 0.02). The isolation rate of MRSA was
reduced by 39% from 2.3 to 1.6/1000 patient-days (P ¼ 0.002)
during the same period (September 2001–February 2002 vs. Sep-
tember 2002–February 2003).
Conclusions: This study showed that the isolation rate of MRSA
was reduced by applying hospital infection control methods in
the hospital.
P558 Molecular surveillance of clinical methicillin-resistant
Staphylococcus aureus isolates in neonatal intensive care units
Y.-C. Huang, L.-H. Su
Kweishan, TW
Objects: Methicillin-resistant Staphylococcus aureus (MRSA) has
become an important nosocomial pathogen in our neonatal
intensive care units (NICUs) and accounts for almost 100% of all
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S. aureus clinical isolates. To assess the relatedness of these MRSA
strains, we conducted this molecular surveillance study.
Materials and methods: During 1998 and 2000, a total of 125 MRSA
clinical isolates, 10 isolates in 1998, 59 isolates in 1999 and 56 iso-
lates in 2000, from 107 infants hospitalised in our NICUs were
collected. Fifteen infants were with multiple isolates (two to four
isolates). The sources of specimens included blood (75), pus (23),
sputum (15), body ﬂuids (3), and catheter tip (9). The genotyping
method used was pulsed-ﬁeld gel electrophoresis with Sma I
digestion.
Results: A total of six genotypes with 23 type-subtypes were iden-
tiﬁed. Subtypes could be identiﬁed in genotypes A, C and D.
There were two genotypes in 1998, ﬁve genotypes in 1999 and
four genotypes in 2000. Seventy-seven isolates (61.6%) were
shown to belong to a major type (Genotype A, 7 type-subtypes),
while 43 isolates (34.4%) belonged to genotype C (11 type-sub-
types). Both types could be identiﬁed in each year and were the
two predominant clones in each year. The other four types were
minor. Among the 15 infants with multiple isolates, the genotype
was usually same if the isolates were from the same episode of
MRSA infection, while the genotype was different if the isolates
were from distinct episodes.
Conclusion: There were two predominant MRSA clones prevailing
in our NICUs between 1998 and 2000. Infection control measures
should be implemented to try to control the spread of MRSA.
P559 Methicillin-resistant Staphylococcus aureus
bacteraemia in neonatal intensive care units: genotyping
analysis and case–control study
P.-W. Chung, Y.-C. Huang, C.-Y. Lee, L.-H. Su, T.-Y. Lin
Kweishan, TW
Objects: To assess the relatedness of methicillin-resistant Staphylo-
coccus aureus (MRSA) isolates and to identify the risk factors for
the acquisition of MRSA bacteraemia in the infants hospitalised in
the MRSA endemic neonatal intensive care units (NICUs).
Methods: Twenty-one isolates from the bloodstreams of 21 infants
hospitalised in NICUs were genotyped by pulsed-ﬁeld gel eletro-
phoresis (PFGE) and infrequent-restriction-site polymerase chain
reaction (IRS-PCR). Other 21 infants stayed in the same NICUs
with a same gender, a similar gestational age and a similar birth
weight but without MRSA bacteraemia were matched for a case–
control study.
Results: Of the 21 MRSA isolates, two genotypes (A and C) were
identiﬁed by PFGE while three genotypes (I, II and III) by IRS-
PCR. Genotype C-III in nine isolates and genotype A-I in seven
isolates were the two most common genotypes. With multiple
logistic regression analysis, presence of skin infection at onset and
prior sepsis were the two signiﬁcant risk factors of MRSA bactere-
mia with odd ratios of 20.8 (95% CI 2.95–145.4, P ¼ 0.002) and
7.97 (95% CI 1.33–47.7, P ¼ 0.02), respectively. Both prolonged
prior duration of central venous catheter (CVC) indwelling and
prolonged hospital stay were also signiﬁcantly associated with
MRSA bacteraemia in these infants.
Conclusion: Two major clones of bacteraemic MRSA prevailed in
our NICUs in 1999 and the presence of skin infections, particularly
the insertion site of CVC, and prior sepsis were the two risk factors
for the acquisition of MRSA bacteraemia in these infants.
P560 Delineation of the endemic and sporadic clones
among methicillin-resistant Staphylococcus aureus strains in a
Czech hospital
O. Melter, M. Aires de Sousa, K. Laskafeldova´, P. Urba´sˇkova´,
M. Wu¨nschova´, H. de Lencastre
Prague, CZ; Oeiras, P; Novy´ Jie`ı´n, CZ; New York, USA
Objectives: To deﬁne the clones among methicillin-resistant Sta-
phylococcus aureus (MRSA) strains collected between September
2001 and February 2003 at the regional hospital of Novy´ Jie`ı´n,
Czech Republic.
Methods: The isolates were characterised by susceptibility tests,
HindIII ribotyping, and pulsed-ﬁeld gel electrophoresis. Repre-
sentatives of each clonal type were analysed by multilocus
sequence typing and staphylococcal cassette chromosome mec
(SCCmec) typing. The prevalence of the major macrolide (ermA,
ermB, ermC and msrA) and aminoglycoside (aac6’-aph2’’, aph3’
and ant4’) resistance genes was evaluated as well.
Results: The presence of two international MRSA clones was
documented in the Czech hospital: (i) the Iberian clone (ST247:
SCCmec IA: PFGE A: ribotype H2) endemic in the hospital and
associated with a single multiresistant phenotype and (ii) clone
EMRSA-15 (ST22: SCCmec IV: PFGE H: ribotype H7) detected
since the beginning of 2002 and associated with three pheno-
types. These two clones could be distinguished by the distribu-
tion of macrolide and aminoglycoside resistance genes (ermA,
aac6’-aph2’’, ant4’ and ermC plus msrA in a few isolates,
respectively) and the presence of enterotoxin A (in the Iberian
clone).
Conclusions: Two clones could be delineated among the strains
studied. The combination of the molecular characterisation with
chronological epidemiological data enabled following the spread
of EMRSA-15 clone in the hospital.
P561 MRSA – emerging issue in a university hospital,
Hradec Kralove
V. Dostal, K. Honegr, S. Plisek, J. Beran, M. Moravkova,
E. Mickova, J. Manak, J. Kajzr, P. Dostal, L. Prokes, P. Bradna,
A. Lukes, J. Tosner, P. Moravek, J. Harrer, J. Sykorova
Hradec Kralove, CZ
Introduction: Although the incidence of strains of methicillin-
resistant Staphylococcus aureus (MRSA), methicillin-resistant
Staphylococcus epidermidis (MRSE), and other MRS varies from
country to country and from hospital to hospital, it has been
steadily increasing worldwide in the last decade.
Objectives: In the year 2003 one of the troublesome bacteria of the
last decade, MRSA, became the emerging issue also for many
departments of the University Hospital in Hradec Kra´love´. Thus
we decided to perform analysis of MRSA incidence.
Methods: Retrospective analysis of MRSA prevalence from Uni-
versity Hospital databases.
Results: Since 1 January till 8 December 2003 was 5530 strains of
Staphylococcus aureus isolated in the Department of Clinical Micro-
biology from various samples. Eighty-nine strains resistant to
oxacilin (MRSA) were identiﬁed in 21 patients. The positive ﬁnd-
ings from sputum and/or tracheal cannulas were most frequent,
in 12 individuals, followed by skin isolates including the decubi-
tuses and surgical wounds. Positive haemocultures and isolations
from abscesses were rare. Regarding the common results of
mixed cultivation from above-mentioned samples, it was difﬁcult
to specify MRSA in all cases as a primary cause of invasive
diseases. The diagnosis related to the cultivation results of MRSA
– nosocomial bronchopneumonia, sepsis, infection of wounds,
decubitus and abscess – were determined in patients with other
underlying disease or shock. We have found no strain resistant to
vancomycin, linezolid and quinupristin/dalfopristin. Sensitivity
to the other antibiotics were rather changing in follow up each
patient, it was mostly present also for lincomycin and chloram-
phenicol.
Conclusion: Therapy of particular invasive disease caused by
MRSA was successful in most of cases. One patient aged 81 died
on septic shock (nosocomial bronchopneumonia), where we could
not exclude MRSA as causative agent. Nevertheless long term
results are left to assess, including the practice in isolation precau-
tions of these patients.
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P562 Epidemiological analysis of the incidence of MRSA
infections in hospitals in the Czech Republic
B. Mackova´, O. Melter, P. Urba´sˇkova´
Prague, CZ
Objectives: Infections caused by MRSA (methicillin-resistant Sta-
phylococcus aureus) have been historically considered as hospital
infections. Nevertheless, MRSA is becoming increasingly involved
in community infections as well. The incidence of MRSA infec-
tions varies widely with the regions and population groups.
Methods: Since 2000 the Czech Republic has been taking part in
the European Antimicrobial Resistance Surveillance System monit-
oring the incidence of ﬁve pathogens in invasive isolates from
blood. One of the causative agents under surveillance is Staphylo-
coccus aureus. The incidence of MRSA has been monitored in
blood specimens from 89 hospitals of the Czech Republic. Data on
patients, hospitals and phenotypes of antibiotic resistance in the
bacterial strains isolated have been recorded. Basic statistical
methods are used for epidemiological analysis.
Results: Between 2000 and 2002, 2804 Staphylococcus aureus strains
were analyzed. Out of these strains, 5.5% were MRSA (see Table).
The incidence of MRSA varied with types of hospitals, hospital
wards, age groups and time. Geographical distribution of MRSA
strains in the Czech Republic was mapped. Thanks to collabor-
ation of 45 laboratories, highly valid data covering 82% of the
Czech population have been available.
Conclusion: Surveillance of MRSA strains as a basis for active
antibiotic policy has become of increasing concern to both health
care providers in hospitals and community general practitioners.
There is a need for better awareness of MRSA infections among
both health care professionals and the public. The incidence of
MRSA infections in the Czech Republic shows a slightly increas-
ing trend. The development of the incidence of MRSA infections
and factors involved in their spread will be the subject of further
study.
P563 Evolution of two different clones of methicillin-
resistant Staphylococcus aureus (MRSA) isolated in Italy
F. Campanile, D. Bongiorno, S. Borbone, V. Caﬁso, F. Di Bassiano,
S. Stefani
Catania, I
Objectives: The origins of the major MRSA clones are still poorly
understood. Previous reports have suggested a common origin for
all MRSA from a single ancestral S. aureus strain that acquired the
mec complex. Recent studies have shown that some MRSA strains
are very divergent, implying that mecA has been transferred
among S. aureus lineages at different times in the past.
Methods: S. aureus MLST, together with BURST analysis and SCC-
mec-typing, has been used to probe population biology of bacteria
and to predict ancestral genotypes and evolutionary descendents
within groups of related genotypes.
Results: We explored the origin and the evolution of two novel
MRSA clones: the Rome and the Italian clones. The Rome clone,
circulating in a Rome hospital from 1997, had a characteristic clo-
nal type (II::NH::C) and was susceptible to erythromycin, clinda-
mycin, spectinomycin, vancomycin and teicoplanin. During the
last few years, a variant of this clone has appeared and undergone
evolution, consisting in the acquisition of two copies of Tn554, the
integration of the pUB110 plasmid downstream of the mecA gene
with the evolution of the SCCmec type I to IA and the consequent
modiﬁcation of mecA polymorph II to I, maintaining the sequence
type ST247 (3-3-1-12-4-4-16; CC8) and the PFGE C pattern. The
acquisition of extra-resistance genes determined erythromycin,
spectinomycin and clindamycin resistance; moreover, these strains
showed heteroresistance to glycopeptides. On the contrary, the
Italian clone has always shown the same phenotypic (susceptible
to tetracycline and rifampin) and genotypic features (II-E-E;
ST228: 1-4-1-4-12-24-29; SCCmec I), suggesting the immediate suc-
cess of these strains in the environment.
Conclusions: Our results unambiguously indicate that the Rome
clone and its variant derive from the same MRSA clone as the
‘Archaic’, the ‘Iberian’ and the ‘Brazilian’ ones (CC8). Moreover,
the ‘Italian’ clone closely correlates with that of several S. aureus
including MSSA, MRSA and GISA strains (CC5), conﬁrming the
horizontal mecA transfer among different S. aureus ancestral line-
ages. This ancestral MRSA became the successful clone that is
spreading in Italy.
P564 Methicillin resistance in Staphylococci: results of a
survey in a Northern Italian region
R. Bandettini, M. Lemmi, L. Pescetto, A. Scaramuccia, E. Debbia
for Ligurian AMCLI group
Genoa, I
Objectives: Methicillin-resistance (MR) in staphylococci represents
a major therapeutic treat in the management of nosocomial Gram-
positive infections. This parameter therefore, need a periodical
evaluation.
Methods: In this study of the Italian Clinical Microbiologist
Association (AMCLI), MR was assessed in nine Centres localised
in Ligurian area (Northern Italy). During April 2003, 476 staphylo-
coccal strains were collected from hospitalised patients in Medical
Department (64.5%), Surgery (12.2%) and high risk of infection
wards (23.3%). Samples were obtained from wound swabs
(22.3%), infections of upper (17.0%) and lower respiratory tract
(15.8%), blood (11.6%), vascular devices (8.0%) and other
(25.3%). MR was evaluated by NCCLS suggested guidelines.
Results: The strain collection included 358 S. aureus (75.2%) and
118 CNS (24.8%). S. epidermidis were 56.8% of this latter group of
strains. MR S. aureus (MRSA) accounted for 63.7% and in CNS
this trait was 66.1%. Many isolates were also resistant to other
classes of antibiotics. In particular, some representative pathogens
(among MRSA) exhibited together with MR, unsusceptible to ami-
noglycosides, MLS, ﬂuoroquinolones, and tetracycline (46.5%). All
strains resulted susceptible to vancomycin and teicoplanin.
Among CNS, concomitant resistance to methicillin and other anti-
biotics were detected in 33.3% of these pathogens. No strain was
found resistant to vancomycin and teicoplanin.
Conclusions: The present ﬁndings indicate that antibiotic resist-
ance in nosocomial staphylococci is largely diffused and need a
continuous programme of surveillance.
P565 Methicillin-resistant Staphylococci in a surgical
hospital: incidence, antimicrobial susceptibility, molecular
typing
A. Zilevica, T. Tracevska, R. Treimane, R. Paberza, I. Vingre
Riga, LV
Objectives: Monitoring of the incidence rate of methicillin-resist-
ant Staphylococcus aureus (MRSA) and coagulase-negative Staphy-
lococci (MR CoNS) in hospitalised patients in a surgical hospital,
characterising of their multiresistant nature, slime production in
CoNS and molecular types in MRSA.
Methods: A total of 165 strains of S. aureus and coagulase-negative
Staphylococci collected from clinical specimens of different hospi-
talised patients within 2002 were analysed. Microbial strains were
Year S. aureus MRSA
2000 525 20 (3.8%)
2001 109 53 (5.8%)
2002 1166 70 (5.9%)
Total 2804 153 (5.5%)
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isolated and characterised by conventional methods. An automa-
ted Crystal system was used for species’ identiﬁcation. Antimicro-
bial susceptibility was tested by the disk diffusion method
(NCCLS) and detection of the minimal inhibitory concentration
(MIC) in SCEPTOR panels. Methicillin resistance was tested by
oxacillin disks with the potency 1 lg of oxacillin and conﬁrmed
by detection of the mec A gene by PCR, the latex agglutination
test and the E-test (Bio Disk). Slime production in CoNS was tes-
ted using the tube test with tryptic soya broth (TSB) and glucose.
Molecular typing was performed by the randomly ampliﬁed poly-
morphic DNA test (RAPD).
Results: The incidence rate of MRSA and MR CoNS in 2002 was
1.64 and 30.6%, respectively. MRSA were resistant to erythromy-
cin (99%), clindamycin (71.5%), trimethoprim (35.8%), gentamicin
(25%), ciproﬂoxacin (17.9%). MR CoNS were resistant to clinda-
mycin (94%), erythromycin (92%), trimethoprim (66%), gentami-
cin (40%), ciproﬂoxacin (28%). The result among different species
of CoNS varied. 74 CoNS strains (52 S. epidermidis sensu stricto, 12
S. haemolyticus, 4. S. hominis, 3 S. capitis, 1 S. cohnii) were tested
for slime production. Twenty-three of them were methicillin-sensi-
tive, 51 – methicillin-resistant. Fifty-one (69%) of the investigated
strains did not produce slime, 10 strains (13.5%) produced slime
with a high intensity, 13 strains (17.5%) – with a moderate inten-
sity. Slime production in MRS was more intensive than in MSS
strains. Thirty-six strains of MRSA were examined by the RAPD
typing method, and the main genetic groups were differentiated.
Conclusions: The incidence rate of methicillin resistance in Staphy-
lococci in our hospital is not high. MRS are multiresistant. 13.5%
of CoNS are active producers of slime, 17.5% are moderate pro-
ducers, 69% do not produce slime. Methicillin-resistant Staphylo-
cocci produce slime more actively than methicillin-sensitive
strains. The RAPD method is a sensitive and reliable molecular
typing method.
P566 Initial molecular characterisation of the ﬁrst MRSA
outbreak at a clinical university hospital
E. Miklasevics, A. Balode, U. Dumpis, A. Martinsons
Riga, LV
Objectives: Meticillin resistant S. aureus (MRSA) is a well known
pathogen which causes severe nosocomial infections. First con-
ﬁrmed case of MRSA at P. Stradins Clinical University Hospital
(CUH) was registered in March 2003. The aims of this study were
comparison of bacteriological and molecular identiﬁcation of sta-
phylococcus isolates as well as their initial characterisation and
typing.
Methods: Staphylococcus isolates were collected at CUH in period
March–September 2003. Presence of the cﬂA, femB, mecA and
PVL genes were detected by PCR ampliﬁcation. rep-PCR and
RFLP were used for MRSA typing.
Results: Screening of 86 isolates revealed 16 MRSA (cﬂA+, femB+,
mecA+). This result was in concordance with the one obtained by
bacteriological methods. Twelve of these strains were typed by
rep-PCR and RFLP. Application of these methods generated three
groups including nine, two and one isolates, respectively. The last,
single isolate was the only one positive for Panton-Valentine leuk-
ocidin toxin.
Conclusions: The local ICU outbreak was registered and con-
ﬁrmed by molecular methods. Maintenance of vigorous surveil-
lance and prevention measures are strongly required.
P567 Clonal spread of borderline oxacillin-resistant
Staphylococcus aureus in a dermatological hospital unit
M.K. Thomsen, M. Rasmussen, K. Fuursted, L.N. Pedersen,
M. Deleuran, J.K. Møller
Aarhus, DK
Objectives: The aim of this study was to describe and investigate
a clonal spread of mecA gene-negative Staphylococcus aureus
strains with decreased sensitivity towards oxacillin (BORSA)
among patients in a dermatological hospital unit.
Methods: The medical records from patients in the dermatological
hospital unit and clinical samples received in the Department of
Clinical Microbiology were reviewed, retrospectively, from
November 2000 to October 2001. Susceptibility to oxacillin (1 lg
disk, Oxoid) was examined with either the disc diffusion method
or Etest on Iso-Sensitest Agar or Columbia agar (with 4.5% NaCl)
at 35C. The presence of the coa gene and absence of the mecA
gene was examined with a polymerase chain reaction (PCR)
method. BORSA was deﬁned as phenotypic oxacillin-resistant
S. aureus being mecA-negative. All isolates were phage-typed and
genotyping was performed with pulsed ﬁeld gel electrophoresis
(‘enzym’).
Results: Fifteen isolates from ﬁfteen patients were evaluated. All
the strains carried the coa gene, were of phage-type 95u and the
PFGE results conﬁrmed that all the isolates constituted a clone.
The median zone size from disc diffusion testing was 6 mm
(range 6–19 mm) while the median oxacillin MIC was 3.0 mg/L
(ranged from 0.25 to 6.0 mg/L). None of them carried the mecA
gene. Ten of the patients received systemic immuno-suppressive
medications, and four others used topic immuno-suppressive
agents (chlormethine and group III steroids). At least 10 of the
patients received low-dosis penicillinase-stable penicillins for lon-
ger periods of time.
Discussion: We describe for the ﬁrst time a clonal outbreak of
BORSA among patients in a dermatological hospital unit. The
clonality was conﬁrmed by means of both phenotyping (phage-
type 95u) and geno-typing (same PFGE type). It could not be
clariﬁed whether the ‘BORSA clone’ spread directly from one
patient to another or whether it was spread by a health care
worker or through shared objects. One of the patients had a
history with visits to the out-patients clinic only which may sug-
gest indirect transmission. We believe that the spread of BORSA
in our dermatological hospital unit was facilitated by longtime
(low-dosis beta-lactam) antibiotic pressure, close relationships
between patients during admission, and immuno-suppressive
treatment. The BORSA clone seems to have disappeared after
changes in hygienic measures and discussions of the antibiotic
policy in the department.
P568 The use of molecular epidemiology to monitor the
nosocomial ﬁssemination of methicillin-resistant Staphylococcus
aureus in a tertiary care university hospital during a 10-year
survey: 1991–2001
A.L. Beretta, P. Trabasso, R.B. Stucchi, M.L. Moretti
Sao Paulo, BR
Background: Methicillin-resistant Staphylococcus aureus (MRSA)
represents a severe clinical threat for patients worldwide and has
been the cause of major outbreaks and epidemics among hospital-
ised patients, with high mortality and morbidity rates.
Objectives: To study the genomic diversity of MRSA strains isola-
ted from patients with nosocomial infection assisted in a tertiary
care university hospital during a 10-year survey (1991–2001).
Methods: The study comprised two periods: the period I from
1991 to 1993 and period II from 1995 to 2001. The DNA typing
analysis was performed by pulsed ﬁeld gel electrophoresis and
the similarity among the MRSA strains was determined by cluster
analysis.
Results: In the period I, 73 strains presented ﬁve distinctive DNA
proﬁles: A, B, C, D and E. Proﬁle A was the most frequent DNA
pattern and was identiﬁed 55 (75.3%) strains; three closely-related
and four possibly-related proﬁles were also identiﬁed. During
period II, 80 (68.8%) of 117 strains had the same endemic proﬁle
A identiﬁed in period I, 18 (13.7%) closely-related proﬁles and 18
(13.7%) possibly-related proﬁles and only one strain presented an
unrelated proﬁle. Cluster analysis showed a 96% coefﬁcient of
similarity between proﬁles A from period I and proﬁle A from
period II and they were considered to be from the same clone.
The molecular monitoring of MRSA strains permitted to
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determine the clonal dissemination and maintenance of a domin-
ant endemic strain during a 10-year period and the presence of
closely and possibly related patterns to the endemic proﬁle A.
Conclusion: Further studies on virulence factors of this MRSA
endemic proﬁle and the reinforcement of strict measures of hands
hygiene and environment cleaning are necessary to improve the
understanding and control of the dissemination of the endemic
proﬁle in our hospital.
P569 Epidemiology of methicillin-resistant Staphylococcus
aureus at a German university hospital
H. Haefner, C. Bauer, S. Koch, F. Huenger, S.W. Lemmen
Aachen, D
Background: Many risk factors for acquisition of methicillin-resist-
ant Staphlococcus aureus (MRSA) infections or colonisation during
hospital stay are described in the literature. In our study we eval-
uated the risk factors of patients identiﬁed as MRSA positive at
the University hospital Aachen.
Methods: During January–November 2003 all medical records of
inpatients identiﬁed as MRSA positive from clinical species were
reviewed prospectively for demographic data and risk factors.
Whenever possible the patients were interviewed also about hos-
pital stay in the last 6 months, being a nursing home resident,
being known as MRSA positive, previous antibiotic therapy and
underlying diseases. Division for infection or colonisation was
determined by GP.
Results: During the study period 148 S. aureus strains (7.8%) were
identiﬁed as MRSA. Fifteen isolates were detected in outpatients;
133 strains in inpatients, 20 (15%) of which were known as MRSA
positive at time of admission. Until now the data of 114 (85.7%)
inpatients could be evaluated. The major sites of detection of
nosocomial acquired MRSA included the lower respiratory tract
(19%), wound (21%), urinary tract (7%), skin (17%), bloodstream
(13%) and tip of central vascular catheter (19%). Seventy per cent
of patients were colonised and 23% infected, no information was
available for 7%. Lethality rate was 30%. The demographic data
were: male: 70%, female: 30%, age 60 years (mean 64); hospital
service: surgery 48%, internal medicine 31%, other wards 21%;
44% were detected in any ICU; major admission diagnosis:
trauma (25%), acute infection (21%), previous surgery (13%), car-
diovascular disease (11%), malignancy 10%; known chronic dis-
eases (malignancy, cardiovascular disease, diabetes etc.) on
admission 67%; previous antibiotic therapy 79%; central venous
catheter 59%; hospital stay days 47 (mean 39), time until MRSA
detection 26 days (mean 20), hospitalisation in the last 6 months
34%, transmitted from other hospitals 29%, nursing home resi-
dents 6%.
Conclusions: The MRSA-rate of 7.8% in our hospital is low. The
late detection of MRSA after average hospital stay of 26 days
shows that most patients were colonised or infected during their
hospitalisation either by strain transmission or strain selection
because of shown risk factors.
P570 Nosocomial meningitis due to methicillin-resistant
Staphylococcus aureus (MRSA): review of eight cases
B. Arda, T. Yamazhan, O. Sipahi, S. Islekel, C. Buke, S. Ulusoy
Izmir, TR
Objectives: To evaluate MRSA meningitis cases in our hospital
between 1999 and 2003. Patients and method: We evaluated the
hospital charts of eight patients who had culture proven MRSA
meningitis retrospectively.
Results: Patients were six men, two women, aged 4–70 years
(mean 39). All had postneurosurgical state and two had shunt
infections. All patients were evaluated as hospital-acquired
meningitis. Fever, leucocytosis, disturbances in the consciousness
were the most common clinical and laboratory ﬁndings. One
patient had mixed infection (MRSA + Enterococcus spp.) whereas
seven were infected only with MRSA. One patient was treated
with vancomycin alone and three with teicoplanin alone. One
patient was treated empirically with cefazolin and died during
this treatment while awaiting the CSF culture results. One patient
was treated with vancomycin followed with teicoplanin + me-
ropenem because of tubulo interstitial nephritis. The last two were
treated with combined regimens one with vancomycin + chloram-
phenicol, and one with teicoplanin + chloramphenicol. Mean dur-
ation of treatment was 27.5 days (range 3–60 days). Mortality rate
was 12.5%.
Conclusions: MRSA meningitis is a rare but hard to manage
nosocomial infection. Although IV vancomycin is the mainstay of
therapy, the fact that ﬁve of these eight cases were successfully
treated with teicoplanin (alone or in combination) shows that it
may be an alternative treatment option.
P571 Effect of an intervention programme on the MRSA
outbreak in an Aberdeen inﬁrmary
J.-M. Lopez-Lozano, A. Beyaert, F.M. MacKenzie, R. Wilson,
D. Stuart, I.M. Gould
Orihuela, Murcia, E; Aberdeen, UK
Objectives: Aberdeen Royal Inﬁrmary (ARI) has experienced an
outbreak of Methicillin resistant Staphylococcus aureus (MRSA)
since 1997. We previously reported the relationship between hos-
pital use of third generation cephalosporins (3GC), macrolides
(MAC) and ﬂuoroquinolones (FQU) and the emergence of MRSA.
In May 2001, an intervention programme was introduced in the
intensive care unit (ICU) involving admission screening and body
decontamination. This study evaluated the effect of this pro-
gramme on the overall hospital outbreak.
Methods: ARI is a 1200 bed teaching hospital with 16 ICU beds.
Monthly nonduplicate MRSA data and antibiotic use data were
collected for the ICU beds and the non-ICU beds, for the period
January 96 to March 03. Time series dynamic regression models
were adjusted to evaluate the intervention effect.
Results: ICU-MRSA evolution preceded the non-ICU MRSA by a
1-month lag. ICU-MRSA was dependent on past ICU-MRSA val-
ues as well as lagged ICU use of MAC, TGC and FQU. The inter-
vention decreased the per cent monthly ICU-MRSA by the value
10.6. The impact of the ICU intervention on the non-ICU MRSA
was 5.6%, thus breaking the increasing trend of the MRSA epi-
demic.
Conclusion: The ICU can inﬂuence the prevalence of nosocomial
infections in the rest of the hospital because of the continuous
ﬂux of patients. This study promotes the beneﬁts of interven-
tions other than reducing antimicrobial use in the control of
MRSA.
Figure 1. Monthly %MRSA for ICU and Non-ICU beds. Aberdeen
Royal Inﬁrmary, January 1996-March 2003
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P572 How dangerous is the environment of a patient with
respect to transfer of MRSA
S. Maxwell, M. Wiggins
Stockport, UK
Background: Methicillin resistant Staphylococcus aureus (MRSA) is
a dangerous and persistent hospital pathogen. It is accepted that
the major source of this organism within the hospital environment
is infected and colonised patients’ themselves. However, there is
little documented fact on the relative importance of the patients’
environment in the spread of this organism.
Objectives: To assess the degree of contamination of the patient’s
immediate environment and to estimate the likelihood of spread
of MRSA from this environment to Health Care Workers and via
them to other patients.
Method: A 5-week prospective study was carried out on a variety
of wards, The environments of 29 colonised patients were sam-
pled, including 29 curtains both sides, 59 hard surfaces, and 58
samples of the gloved hands of the investigator after samples had
been taken. Curtains were sampled by direct indentation of the
curtains on to selective agar. Hard surfaces were swabbed and
hands were sampled using the ﬁnger streak method. Ten control
environments containing patients who were not known to be colo-
nised were also sampled.
Results: MRSA was isolated in 15 of the 29 environments. It was
found on the sampler’s hands on eight occasions out of the 29.
Conclusion: MRSA is a frequent contaminant of the patients’ envi-
ronment especially soft furnishings such as curtains. It is readily
transferred to the hands after minimal contact. These ﬁndings
need to be taken into consideration when cleaning protocols are
devised and are especially important in terminal cleaning after
patients’ infected or colonised with MRSA have been discharged.
P573 Antibiotic usage and environmental reservoirs
maintain methicillin-resistant Staphylococcus aureus on an
intensive care unit
K.J. Hardy, P.M. Hawkey, B.A. Oppenheim, F. Gao
Birmingham, UK
Objectives: To determine the rate of colonisation and the inci-
dence of transmission of methicillin resistant Staphylococcus aureus
(MRSA) on an Intensive Care Unit (ICU) and control MRSA trans-
mission.
Methods: A nine bed ICU was studied for an initial observation
period of 8 months, all patients admitted to ICU for >24 h were
screened for MRSA within 48 h then three times a week. Demo-
graphic data and antibiotic usage was recorded. An intervention
period of 8 months when antibiotic prescribing was restricted fol-
lowed. A second observation period (6 months) was instituted.
Monthly environmental screening (29 sites) with swabs from three
areas in each bed space (bed ﬂoor, monitor and workstation) plus
two from the nurses workstation took place. Patient and environ-
mental isolates were typed using pulse ﬁeld gel electrophoresis
(PFGE).
Results: Fifty-seven of 215 patients (26%) were colonised with
MRSA during the initial phase, 50% of these acquired MRSA on
ICU. Eighty-eight per cent of patients received >1 antibiotic, cefu-
roxime and metronidazole being the most heavily prescribed pri-
marily as prophylaxis. During the intervention period
prophylactic antibiotics were restricted to one dose and the need
for treatment antibiotics reviewed daily. Postintervention the total
antibiotics used was reduced from 132.5 to 104.1 DDD/100 patient
days and a reduction in metronidazole/cefuroxime from 33.1 to
12.0 and 20.6 to 3.8 DDD/100 patient days respectively. Despite
this there was no reduction in the number of patients colonised
with MRSA on ICU, but the percentage of patients acquiring
MRSA on ICU fell to 43.2%. Results from 19 environmental
screens of 29 sites in the ICU yielded MRSA from 1 to 11 sites on
every screen (mean 4.6). On two occasions no patients on ICU
were colonised with MRSA, but MRSA was isolated from two
and ﬁve environmental sites respectively. Typing showed
EMRSA-15 variants were predominant in patients and environ-
ment with the environmental isolates reﬂecting both the current
patient types and previously discharged patients.
Conclusion: Despite reducing the total antibiotic usage the rates of
MRSA colonisation remained the same. The continuous isolation
of MRSA from the environment together with our typing data
indicates that environmental sources of MRSA have a role to play
and are important in controlling the endemic MRSA infection in
hospitals.
P574 Monitoring outbreaks of MRSA in a university
hospital, Innsbruck by automated ribotyping
K. Grif, D. Orth, R. Wu¨rzner, M. Dierich, F. Allerberger,
C. Lass-Flo¨rl
Innsbruck, A
Objectives: Methicillin-resistant Staphylcoccus aureus (MRSA) is an
important cause of hospital- and community-acquired infections.
The aim of this epidemiological study was to elucidate the spread
of MRSA clones by means of molecular typing in the University
hospital of Innsbruck.
Methods: Positive MRSA cultures collected from clinical speci-
mens, such as blood cultures, cerebrospinal ﬂuids, sputum, drains
and various swabs isolated from patients admitted to the Univer-
sity hospital of Innsbruck were investigated from March to
November 2003. All MRSA strains (initial isolate per patient) were
typed by automated ribotyping according to manufacturer
instructions using EcoRI as restriction enzyme.
Results: 116 patients acquired MRSA in the hospital and 49 were
in intensive care units. Seventy-one MRSA strains were investi-
gated and classiﬁed in 14 different ribotyping patterns (RP 1–RP
14) using EcoRI. RP 10 was identiﬁed in 24, RP 1 in 18, RP 3 in
10, RP 7 in 7, RP 4 and RP 2 in two patients. Further eight MRSA
isolates yielded unique RPs. In the neurology intensive care unit
RP 1 strains and in the medical intensive care unit RP 10 strains
occurred constantly over a period of seven and four months,
respectively. These strains were related to colonisation (n ¼ 22)
and infections (n ¼ 20). Overall, 41 and 30 patients showed colo-
nisation and infections because of MRSA, respectively.
Conclusions: Automated ribotyping successfully fulﬁlled our aim
to study epidemiological aspects of MRSA spread. The majority of
MRSA strains were limited to three clonal groups. RP 1, 3 and 10
strains were predominant in intensive care units, yet spread and
persistence was also found within other wards. Furthermore this
study shows the importance of stringent infection control meas-
urements and the necessity of guidelines for antibiotic use to
avoid selection of antibacterial resistance.
P575 MRSA acquisition on an intensive care unit (ITU)
S. Dancer, M. Coyne, A. Speekenbrink, S. Samavedam,
J. Kennedy, P. Wallace
Glasgow, UK
Objectives: The aim of this study was to investigate MRSA acqui-
sition within a seven-bedded ITU in a tertiary hospital over a per-
iod of 5 months.
Methods: Data was collected from all patients admitted into ITU,
including microbiological results and dependency scores. This
enabled the distinction to be made between patients who were
admitted with MRSA and those who acquired it whilst in ITU.
Stafﬁng levels for trained, auxiliary and agency nurses were
plotted against bed occupancy rates and acute admissions; stu-
dent attendance and nurses from other wards were also inclu-
ded. From these, nurse–patient ratios, workload and MRSA
colonisation pressures were calculated and modelled against the
timing of MRSA clusters. Standardised environmental screening
was performed throughout the study using commercial
dipslides.
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Results: Of 162 patients admitted into ITU, 28 (17%) were found
to have MRSA. Twelve of 28 (43%) acquired MRSA on the unit in
four discrete clusters involving three patients. Each cluster
occurred within a 5-day period and was preceded by enhanced
workload, because of a shortage of trained nurses and increased
bed occupancy. There was also an association with surface level
hygiene throughout the study. Of 160 sites screened, 37 (23%)
produced quantitative growth of 2.5–12 cfu/cm2 and 26 of 37
(70%) were from hand touch sites. MRSA was found in the envi-
ronment during the most intense period of activity. Some of the
strains appeared to be related within and between clusters, and
were particularly associated with upper respiratory sites.
Conclusions: Over a 5-month period, 12 of 162 (7%) patients
acquired MRSA in this ITU, less than half of the patients shown
to have MRSA overall. Clusters of MRSA acquisition were associ-
ated with shortages of trained nurses, increase in workload and
hygiene failures predominantly involving hand-touch sites.
P576 Control of methicillin-resistant Staphylococcus aureus
transmission in an intensive care unit: evaluation of the efﬁcacy
of control practices
G. Guerrier, L. Bodin, S. Males, J.M. Ekherian, D. Resiere,
J.J. Rouby
Paris, F
Objectives: Fighting against the dissemination of methicillin resist-
ant Staphylococcus aureus (MRSA) infections depends on the under-
standing of the use of antibiotics and also the prevention of cross
contamination. We evaluate the importance of hygienic measures
in order to prevent MRSA spreading in a surgical intensive care
unit.
Methods: We compared the incidence of MRSA carriage and
infections before and after starting preventive measures among ill
patients who often experience infections caused by MRSA. Envi-
ronmental measures (technical and geographical isolation, hand
washing) and decontamination of ill patients carrying MRSA may
help improve the care of many at risk patients.
Results: Incidence of cases of nasal MRSA is relatively decrease
from 28 to 5% and 30 to 2% for acquired MRSA infections over
10-year period. Risk factors to develop pneumonia because of
MRSA is stable for chronically ill carriers through the time despite
of nasal and skin decontamination.
Conclusion: Observance of hygienic measures by the medical team
is a key to the prevention and control of the hyperendaemic estate
of MRSA. However, it seems useful a global strategy to ﬁght
against MRSA, but the beneﬁt of each measure of a global control
programme is difﬁcult to evaluate.
P577 Emergence of a VISA strain in a patient with
osteomyelitis: ﬁrst isolation reported from Austria
A. Wechsler-Fo¨rdo¨s, N. Isufovski, F. Geppert, T.R. Walsh
Vienna, A; Bristol, UK
Introduction: MRSA with reduced susceptibility to vancomycin
was ﬁrst described 1997 by Hiramatsu in Japan. So far, no MRSA
strains with intermediate resistance to glycopeptides have been
reported from Austria. We present a patient with osteomyelitis
caused by MRSA developing intermediate resistance to glycopep-
tides during therapy.
Case report: In June 1998 W.P., a male, aged 59, presented with a
polymicrobial diabetic foot infection requiring the amputation of
two toes of the right foot. After initial clinical improvement MRSA
fully susceptible only to glycopeptides and fusidic acid was isola-
ted repeatedly from the wound as well as from the bone in the
autumn of 1998. As the patient was willing to comply with a
long-term outpatient intravenous therapy teicoplanin was admin-
istered three times a week, which resulted in improvement clinic-
ally and by MRI investigations. Additionally, in May 2000 a bone
graft impregnated with vancomycin was implanted resulting in
local healing and decreased inﬂammatory activity in MRI controls.
After a traumatic injury 2001 amputation of the right lower leg
had to be performed because of a massive infection with MSSA
and Acinetobacter.
Methods: In 2001, 40 MRSA strains isolated from 1-6/2000 were
retested for vancomycin resistance with Va 5 lg disks on Mueller-
Hinton agar using McF 0.5. For all strains with a zone-of-inhibi-
tion diameter 14 mm MICs were determined by E-Test on BHI
agar using McF 2. The MICs for vancomycin and teicoplanin for
the MRSA-strain 2417/00 recovered from patient W.P. in January
2000 had increased to 12 and 16 lg/mL, respectively, thus fulﬁl-
ling the NCCLS-criteria for intermediate glycopeptide resistance.
This strain was subjected to population analysis.
Result: The population analysis performed by Dr T. Walsh con-
ﬁrmed the E-test result for strain 2417/00: Figure 1.
Conclusion: Detection of VISA is a challenge for the routine clin-
ical laboratory and requires a high level of suspicion. Prolonged
use of glycopeptides promotes the development of glycopeptide
resistance as seen in this case and in many others and should
prompt further investigation in order to identify VISA and to
enable adequate isolation precautions and efﬁcient antimicrobial
treatment.
P578 Six lethal cases of community-acquired methicillin-
resistant Staphylococcus aureus infections in young adults in
Montevideo, Uruguay
A. Galiana, W. Pedreira, K. Hiramatsu, X. X. Ma, T. Ito,
O. Bertaux, I. Constenla, I. Christophersen, H. Bagnulo
Montevideo, UY; Tokyo, JP
Objective: To describe six severe sepsis (in 6-month period) in
young immunocompetent hospitalised at ICU during an outbreak
of community-acquired methicillin-resistant Staphylococcus aureus
(CA-MRSA) infections.
Methods: Retrospective study between July and December 2003 of
CA-MRSA severe sepsis syndrome cases. Two haemoculture sets
(HEM) at admission (FAN Bact-Alert), culture of traqueal aspirate,
pleural ﬂuid(PF), drains(D) and skin lesions if present. Staphylo-
coccus aureus identiﬁed by standard methods. ‘MRSA screen’
(Oxoid) for PBP2a. Susceptibility testing NCCLS (M2-A8, M100
S13): Oxacillin(OXA), Erythromycin(E), Clindamycin(CLI), Genta-
mycin(GM), Co-trimoxazol(SXT), Ciproﬂoxacin(CIP), Vancomy-
cin(VA). Genomic typing at Juntendo University of the ﬁrst three
cases.
Results: Three females (16, 16, 45 years) and three males (15, 20,
37 years) except 1, none presented health care associated risk fac-
tors. Four patients with necrotizing pneumonia and respiratory
sepsis (RS) three complicated with empyema and during period
of more incidence of Inﬂuenza virus. One sepsis secondary to skin
infection (SI) and one surgical site infection (SSI) sepsis. Four of
them with previous superﬁcial SI. All had severe respiratory dis-
tress syndrome and haemoptysis that require ventilatory assist-
ance, refractory septic shock, kidney and haematology failure,
four liver failure, two coagulopathy. Initial empiric antimicrobial
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therapy (AT) for respiratory sepsis: Ceftriaxone and Azythromy-
cin iv; for skin associated sepsis: Cefradine iv and for SSI: Cefra-
dine and Gentamycin iv. Outcome: four died in the ﬁrst 48 h:
three RS and SI before bacteriologic culture results were available
and in the other two (RS and SSI) AT change to Vancomycin 2 gr
iv bid. These patients died 8–45 days after. CA-MRSA (PBP2a
positive) were isolated from all patients HEM, three PF from four
RS and from one D. All susceptible to VA, CIP, SXT, GM, CLI,
and resistant to OXA, E. Gene mecA positive, SCCmec type IV,
Panton Valentine leucocidine gene + (LPV), enterotoxin A-B gene
– and PFGE indistinguishable and closely related.
Conclusions: In our country like others, in a short period
CA-MRSA infections were associated with unusual rate of severe
and rapidly mortal cases mainly respiratory sepsis in young peo-
ple, probably clonally related all LPV + that challenges the current
empiric antimicrobial guidelines. Because their high virulence, this
unsuspected emergent pathogen, constitutes a health care problem
nonresolved yet.
P579 S. aureus community-acquired infections. Antibiotic
resistance rates and macrolide resistance phenotypes
Sp. Fokas, St. Fokas, F. Markatou, E. Lauranou, M. Kalkani,
M. Dionysopoulou
Sparta, GR
Objectives: To estimate the antibiotic resistance rates of S. aureus
strains isolated from community-acquired infections and to deter-
mine the macrolide resistance phenotypes.
Methods: We examined retrospectively 152 S. aureus strains iso-
lated over a 2-year period (2001–02) from 152 clinical specimens
received from patients with community-acquired infections as
follows: 99 strains (65.1%) from abscesses, 18 strains (11.8%)
from wound infections, 15 strains (9.9%) from skin and soft tis-
sue infections and 20 strains (13.2%) from various other infec-
tions. Conventional methodology was used for identiﬁcation to
the species level and the susceptibility tests were performed
using the disk diffusion method according to the NCCLS proce-
dure (2000). MRSAs detection was achieved by oxacillin 1 lg
disk and detection of PBP 2a by a slide latex agglutination
assay. The macrolide resistance phenotypes were determined by
the double disk method using erythromycin and clindamycin
disks.
Results: A total of 44 (28.9%) MRSA strains were found, the peni-
cillin resistance rate was 86.8% (132 strains) and we found no
vancomycin or teicoplanine resistant S. aureus isolates. The resist-
ance rates to other antibiotics were as follows for MRSA and
MSSA respectively: ciproﬂoxacin 22.7–3.7%, erythromycin 20.5–
13.9%, clindamycin 15.9–3.7%, cotrimoxazole 29.5–13.9%, fusidic
acid 84.1–25.9% (CA-FSM 1996 guidelines), gentamicin 11.4–1.8%.
Resistance to gentamicin was clearly associated (P < 0.05) with
methicillin resistance. The macrolide resistant phenotypes for
MRSA were cMLSB 78% – iMLSB 22% and for MSSA were
cMLSB 27% – iMLSB 73%. Multiresistant strains were isolated
among MRSA (10 strains, 22.7%).
Conclusions: In our area aminopenicillins are not useful in the
empirical treatment of community-acquired S. aureus infections
and their combinations with beta lactamase inhibitors must used
with caution. Erythromycin, clindamycin and cotrimoxazole can
be used in selected cases. The high prevalence of inducible macro-
lide resistant phenotype in MSSA raises questions about the use
of clindamycin in infections caused by these S. aureus strains.
P580 An epidemic European fusidic acid resistant strain of
Staphylococcus aureus carries the fusB determinant
A.J. O’Neill, A.R. Larsen, A.S. Henriksen, I. Chopra
Leeds, UK; Copenhagen, DK
Objectives: Fusidic acid-resistant epidemic clonotypes of Staphylo-
coccus aureus causing impetigo have recently been reported in sev-
eral European countries. The genetic basis of fusidic acid
resistance in these strains has not been determined, and it is
unknown whether they constitute a single epidemic strain under-
going inter-country spread. To address this, representative epi-
demic strains were typed by Pulsed-Field Gel Electrophoresis
(PFGE) and the genetic basis for their reduced susceptibility to
fusidic acid was established.
Methods: PFGE-typing was performed according to the HAR-
MONY protocol. Strains were examined for fusidic acid resistance
polymorphisms in the fusA drug target by PCR ampliﬁcation and
DNA sequencing. For detection of the acquired staphylococcal
fusidic acid-resistance determinant, fusB, southern hybridisation
was employed to probe both total DNA and puriﬁed plasmid
DNA preparations. Conjugational transfer capabilities were exam-
ined by ﬁlter-mating.
Results: PFGE-analysis of epidemic fusR clonotypes established
that strains from Sweden, Norway, the United Kingdom, Den-
mark and Ireland represent a single clone. No mutations were
detected in the fusA genes of this clonotype. Strains were positive
for fusB in both total and puriﬁed plasmid DNA preparations,
indicating that fusB is associated with a plasmid. Further charac-
terisation of this replicon revealed that it was 42 Kb in size, and
incapable of transfer by self-mobilisation. Development of a sensi-
tive and speciﬁc PCR-based assay for probing strains for fusB
enabled rapid detection of the fusB determinant in further mem-
bers of this clonotype.
Conclusions: The epidemic fusidic acid-resistant clonotypes of
S. aureus described in several European countries actually consti-
tute a single clonotype that is spreading in Europe. Fusidic acid
resistance in this clonotype is mediated by carriage of the fusB
resistance determinant on a large, nonconjugative plasmid.
MRSA and staphylococci: laboratory aspects
P581 Susceptibility of pulse ﬁeld characterised methicillin-
resistant Staphylococcus aureus to daptomycin
R. Smyth, G. Kahlmeter
Vxjo¨, S
Objectives: Daptomycin, the ﬁrst antibiotic in the lipopeptide
class, is in clinical development for the treatment of serious infec-
tions caused by Gram-positive pathogens. Daptomycin possesses
potent in vitro and in vivo bactericidal activity against Staphylococ-
cus aureus isolates, including those strains resistant to methicillin
(MRSA), vancomycin (VRSA), and linezolid. This study is the ﬁrst
to test the potency of daptomycin against a set of clinical MSSA
and MRSA isolates in Sweden.
Methods: The strains comprised 100 S. aureus from a reference
collection at the Swedish Institute for Infectious Disease Control
(SMI), 25 of which were MSSA (mecA-) and 75 of which were
MRSA (mecA+). The MRSA strains were clinical isolates from
single cases or minor outbreaks in Sweden (1998–99) and had had
their Harmony-type and pulse ﬁeld patterns characterised. Sus-
ceptibility testing was performed by the NCCLS broth microdilu-
tion methodology using commercial lyophilised panels.
Results: Daptomycin had a MIC90 of 1 mg/L for all strains tested
regardless of their susceptibility to methicillin. No strain exhibited
an MIC above 2 mg/L.
Conclusion: The results of this study demonstrate that daptomycin
has potent activity against Swedish S. aureus isolates, regardless of
the presence of the mecA gene. This suggests that daptomycin
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may provide an alternative to the limited antimicrobial agents
available for the treatment of serious S. aureus infections.
P582 Usefulness of mec-associated dru sequences in
monitoring the spread of highly clonal epidemic methicillin-
resistant Staphylococcus aureus isolates in Scotland
R.V. Goering, D. Morrison, K.F.C. Cooper, Z. Al-Doori,
G.F.S. Edwards, C.G. Gemmell
Omaha, USA; Glasgow, UK
Objectives: The epidemic methicillin-resistant Staphylococcus aureus
strains, EMRSA-15 and -16, initially observed in England in the
early 1990s, spread to Scotland by the mid 1990s. Since that time,
reports of MRSA in Scotland have risen dramatically from 565 in
1995 to over 12 000 in 2001. EMRSA-15 and -16 account for 70
and 20% of these isolates, respectively. While PFGE typing has
identiﬁed a number of EMRSA-15 and -16 clonal variants, epide-
miological tracking is difﬁcult because c. 50% of EMRSA-15 and
35% of EMRSA-16 isolates are indistinguishable by PFGE (pulso-
types PF15a and PF16a, respectively) and other typing methods.
We evaluated the usefulness of mec-associated dru sequences as a
more sensitive approach to tracking the persistence and spread of
these ‘clonal’ epidemic MRSA isolates in Scotland.
Methods: EMRSA-15 and -16 cultures were collected from hospi-
tals throughout Scotland. Sixty-nine isolates with PFGE pulsotypes
PF15a and PF16a were selected for analysis of the mec-associated
dru region. DNA sequences were aligned and interrelationships
analysed using BioNumerics v. 3.5 (Sint-Martens-Latem, Belgium).
Results: Analysis of dru sequences allowed separation of the 69
PF15a and PF16a isolates into 19 speciﬁc subtypes. While some
types were found in multiple hospitals, dru sequence comparisons
identiﬁed instances of speciﬁc strain movement between hospitals
in a given geographic region (i.e. hospital-speciﬁc types).
Conclusions: The mec-associated dru region has the potential for
extensive variability both in sequence and in number of 40-bp tan-
dem repeats. However, speciﬁc sequence types appear to be very
stable over time. Analysis of dru sequences thus appears very
promising as a means of identifying and tracking speciﬁc sub-
types of otherwise indistinguishable epidemic MRSA isolates in
Scotland. The ability to potentially monitor the speciﬁc movement
of these epidemic MRSA within and between hospitals is a wel-
come addition to ongoing public health and infection control
efforts to control the persistence and spread of these problem
organisms.
P583 Detection of methicillin resistance in clinical isolates
of Staphylococcus isolates: a comparative study between rapid
PBP-2a test, conventional phenotypic tests and mec A gene
detection by PCR
A.S. Abu-Aitta, I. El-Defrawy, N. Fam, H. Ahmed, M. El-Wishahy
Cairo, EGY
Objectives: The study was conducted to delineate the prevalence
of methicillin-resistant staphylococcal (MRS) nosocomial infections
particularly coagulase-negative staphylococci (CoNS) among debi-
litated subjects using indwelling foreign bodies or subjected to
repeated invasive medical procedures. Also the performance char-
acteristics of several laboratory tests for detection of MRS, which
is often heterogeneous, were evaluated.
Methods: The tests performed were the conventional phenotypic
oxacillin disk diffusion, the oxacillin-salt agar dilution using
modiﬁed National Committee for Clinical Laboratory Standards
(NCCLS) guidelines, and a novel rapid latex agglutination test
that detects penicillin binding protein (PBP-2a LA Oxoid), the
gene product of mec A. Detection of mec A gene by PCR was
used as the ‘gold standard’ for comparing the assays.
Results: Methicillin-resistance (MR) was detected in 40% of 98
staphylococcal clinical isolates (38% in 55 S. aureus strains and
42% in 43 CoNS). Among the S. aureus isolates the PBP 2a LA
test and the oxacillin-salt agar dilution test showed higher sensi-
tivity and speciﬁcity in detection of MRSA compared with disk
diffusion test (sensitivity 95, 90 and 85% and speciﬁcity 100, 100
and 88% respectively). However, among CoNS the PBP2a LA
showed a signiﬁcantly lower sensitivity but a higher speciﬁcity
for detection of MR compared with the two phenotypic tests that
demonstrated equivocal results (sensitivity 50, 83 and 83% and
speciﬁcity 88, 80 and 80% respectively). The PBP2aLA test also
correctly identiﬁed six heterogeneous strains of S. aureus isolates,
which were not likewise detected by one or both of phenotypic
tests.
Conclusion: The PBP2aLA test is recommended for reliable accu-
rate and rapid identiﬁcation of MRSA and can be easily incorpor-
ated as a routine laboratory test when PCR is not feasible. Further
evaluation is recommended for its utilisation in detecting MR
among CoNS, which is better diagnosed, by conventional pheno-
typic test as well as molecular methods.
P584 Use of polyvalent anti-staphylococcal bacteriophages
for the biocontrol of methicillin-resistant Staphylococcus aureus
and other staphylococci
A. Coffey, S. O’Flaherty, W. Meaney, M. Elbreki, R. Ross
Cork, IRL
Objectives: The emergence of drug resistant staphylococci has
prompted the need for alternate controls other than antibiotics.
The objectives of this study were to isolate and characterise anti-
staphylococcal bacteriophages and to test their host-range against
a broad range of staphylococci including antibiotic-resistant
S. aureus such as MRSA and VRSA.
Methods: General bacteriophage isolation procedures including
enrichment, ﬁltration, plaque assay and broth-culture bacterial
challenge assays were performed. This was followed by restriction
analysis and electron microscopy according to standard protocols.
Challenge experiments were carried out in vitro and anti-microbial
efﬁcacy was evaluated by plate count.
Results: A number of anti-staphylococcal phages, which effect-
ively kill documented typed isolates of MRSA, GISA, VISA, VRSA
and teicoplanin resistant S. aureus were successfully collected and
characterised. Those phages exhibiting broadest host range and
largest plaque size were retained for further use. These termed
‘polyvalent’ phages were phage K, phage CS1 and phage DW2. In
the case of phage K, the host range extends well beyond the spe-
cies S. aureus to include the coagulase-negative staphylococci S.
caprea, S. hyicus, S. epidermidis, S. captis, S. haemolyticus and
S. chromogenes. On the basis of genomic and electron microscopic
analysis, the three phages fall into the myoviridae family in the
classiﬁcation scheme of the International Committee on Virus
Taxonomy. As expected, these phages have no effect whatsoever
on bacteria outside of the genus Staphylococcus nor do they affect
eukaryotic cells. In general, phage K had the broadest host range.
In cases where phage resistance occurred in staphylococci, it was
demonstrated that this was because of indigenous staphylococcal
restriction-modiﬁcation systems. Phages could be modiﬁed to
circumvent these systems. Infusion of the phage into a bismuth-
based cream resulted in strong anti staphylococcal activity from
Summary of results
MIC (mg/L) MRSA MSSA
0.25 1 0
0.50 39 14
1.00 33 11
2.00 2 0
Total 75 25
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the cream. Similarly phages were incorporated into handwash
where they also exhibited a strong anti-staphylococcal activity.
Conclusions: The results indicate that the phages used in this study
are capable of signiﬁcantly reducing the numbers of recently-
emerged antibiotic-resistant staphylococci from Irish hospitals.
P585 Evaluation of cefoxitin MIC determination to detect
low-level methicillin-resistant Staphylococcus aureus (MRSA) by
the automatic system Phoenix
A. Felten
Paris, F
Background and objectives: Phenotypic detection of low-level meth-
icillin-resistant Staphylococcus aureus (MRSA) may fail when rely-
ing only on oxacillin susceptibility, regardless of whether
determined by disk diffusion or by broth dilution. In a previous
study, testing of cefoxitin by disk diffusion proved to be a power-
ful tool to detect MRSA. The aim of this study was to evaluate
the possibility to identify a cefoxitin concentration which would
enhance the ability to detect MRSA.
Methods: Seventy-seven Staphylococcus aureus (SA) isolates and
seven SA reference strains were tested by oxacillin disk diffusion
methods and by the Phoenix System panel PMIC/ID25 for sta-
phylococci which measures broth dilutions MICs including cefox-
itin MICs (FOX-MIC) in the range of concentrations from 1 to
64 mg/L. Isolates were classiﬁed as being MRSA or not according
to the presence or absence of the mecA gene.
Results: Eleven SA were mecA negative: nine were methicillin-
susceptible and two borderline. Oxacillin MICs (OXA-MIC) and
FOX-MICs ranged respectively from 0.25 to 1 mg/L and from 2
to 4 mg/L. Seventy-three SA were mecA positive: 38 with OXA-
MICs 4 mg/L and 35 with low-level OXA-MICs from 0.5 to
2 mg/L. For 70 of 72, FOX-MICs ranged from 8 to >64 mg/L, for
two of 72 FOX-MIC was 2 mg/L. Therefore, a 8 mg/L cefoxitin
cut-off value allowed detection of 100% of the MRSA detected by
OXA-MICs and of 94% of those with low-level OXA-MICs
(<4 mg/L).
Conclusions: Cefoxitin MIC determination increases the rate of
detection of low-level MRSA. A >4 mg/L cefoxitin cut-off MIC is
100% predictive of MRSA in low-level OXA-MICs SA according
to a yearlong practice in our laboratory.
P586 The stability of mecA genes and MIC values of
methicillin in passage-selected vancomycin-resistant EMRSA
strains isolated in the UK
I. Alshami, S.A.H. Awad, J.P. Burnie
Manchester, UK
Objectives: Nosocomial outbreaks of methicillin resistant Staphylo-
coccus aureus (MRSA) strains are associated with signiﬁcant mor-
bidity and mortality. Such strains have been characterised by their
phage type and antibiogram and, in the UK, are termed epidemic
MRSA (EMRSA). Seventeen epidemic MRSA strains (EMRSA 1-
17) have been documented. The purpose of the present study was
to ascertain if representatives of strains of EMRSA 1-17 could
grow in increasing concentrations of vancomycin and whether this
was associated with consistent changes in genotype and pheno-
type.
Methods: Vancomycin susceptible isolates previously reported
and identiﬁed to be EMRSA (1-17) and their vancomycin-resistant
derivatives were examined. Vancomycin-resistant derivatives
were obtained by serial passage of the parental strains in nutrient
broth with increasing concentrations of vancomycin producing
vancomycin- resistant isolates. Antibiotic sensitivities (vancomy-
cin, methicillin) were determined by E-test performed according
to the manufacturers recommendations. The stability of mecA
genes was examined by using PCR. Cell wall changes were dem-
onstrated by transmission electron microscopy.
Results: Six strains became vancomycin resistant, three became
vancomycin intermediate and seven remained susceptible. The
vancomycin MICs for the vancomycin resistant clones ranged
from 24 to 32 lg/mL, and were associated with decreased methi-
cillin susceptibilities and increased cell wall thickness. Four out of
the six vancomycin-resistant derivatives became sensitive to meth-
icillin (MIC 0.75–1 mg/mL) (P < 0.05) and the mecA gene could
not be detected using PCR.
Conclusions: In conclusion, we found that, in vitro, decreased sus-
ceptibility to vancomycin was readily inducible following expo-
sure to sub-inhibitory concentrations of vancomycin. This may be
a strain speciﬁc phenomenon. Development of vancomycin resist-
ance affects resistance to other antimicrobial agents, including
methicillin and affects the stability of the S. aureus mecA gene.
Southern hybridisation of mecA should be investigated to conﬁrm
the points and size of the deletion.
P587 Susceptibity of methicillin-resistant strains of
S. aureus isolates from nasal carrier to mupirocin and bacitracin
in a Tehran hospital, Iran
M. Rahbar, K. Bahar, M. Yaghobi, A. Reza Shajari
Tehran, IR
Objective: The aim of this study was to determine prevalence of
nasal colonisation with Staphylococcus aureus and susceptibility of
isolates to mupirocin and bacitracin.
Methods: Of 1000 Health Care workers (HVWs) of Milad hospital
774 participated in our study nasal swabs were taken from both
of nose of all participants. All specimen were processed in micro-
biology laboratory within 2 h. Culture performed on Manitol salt
gar. Suspected colonies of S. aureus were subcultured on sheep
blood agar. Identiﬁcation of S. aureus was based on the morphol-
ogy of colonies, a positive coagulase test and other tests. We per-
formed susceptibility testing by disk diffusion method as
recommended by National Committee for Clinical Laboratories
Standards. (NCCLS).
Results: We screened 774 HCWs for nasal carriage of S. aureus.
Among HCWs 241 (31%) were colonised by S. aureus. We found
signiﬁcantly more male HCWs with S. aureus (34.9% vs. 27%,
P < 0.05). In some department there was a high frequency for nasal
carriage of S. aureus. For example in Postintensive Care Units
(PICU) and general operating room 53 and 37% were carriage of
S. aureus respectively. About 7% of all isolates of S. aureus were
resistant to Methicillin. All strains of S. aureus were susceptible to
mupirocin (Mast Diagnostic, Mupirocin5) and bacitracin. Resist-
ance to other antibiotics was: penicillin 97% erythromycin 9.5%
gentamycin 9% tetracycline 40% clindamycin 5% co-trimoxazol
7.5%, choloramphenicol 1% ciproﬂoxacin 5.4% and vacomycin
0%.
Conclusion: This study reveals that prevalence of MRSA is not
high in HCWs and all MRSA were susceptible to mupirocin and
bacitracin. Mupirocin could be used as nasal ointment for eradica-
tion of MRSA.
P588 Aminoglycoside-resistance genes and phenotypes in
multiresistant nosocomial strains of Staphylococcus aureus
M. Malossi, S. Cresti, S. Pollini, C. Cellesi, G. Amicosante,
G.M. Rossolini
Siena, L’Aquila, I
Objectives: Aminoglycosides are potent bactericidal agents that
play a role in chemotherapy of serious staphylococcal infections.
In this study, multidrug-resistant (MDR) nosocomial strains of
Staphylococcus aureus from an Italian hospital, were analysed for
susceptibility to several aminoglycosides and for the presence of
aminoglycoside resistance genes.
Methods: Studied strains: a collection of 28 MDR strains of
S. aureus, isolated from nosocomial infections at the Siena Univer-
sity Hospital (Italy), that included representatives of genotypically
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different (as per results of spa and coa typing) S. aureus strains
circulating in the hospital (some of which had caused nosocomial
outbreaks). In vitro susceptibility testing was determined by a
microdilution method according to NCCLS guidelines. Aminogly-
coside resistance genes were detected by dot-blot hybridisation
and PCR analysis.
Results: Of the 28 MDR strains of S. aureus included in this study,
18 were methicillin-susceptible (MSSA) and 10 methicillin-resist-
ant (MRSA). The resistance rates to aminoglycosides were: gen-
tamicin and tobramycin, 50% (22% in MSSA and 100% in
MRSA); amikacin, 18% (11% in MSSA and 30% in MRSA); neti-
lmicin 7% (0% in MSSA and 20% in MRSA). All the 14 aminogly-
coside-resistant (AR) strains harbored the aac(6’)-Ie-aph(2’’)
resistance gene, encoding the bifunctional AAC(6’)-APH(2’’)
enzyme; of them, 10 (71%) also carried the aph(3’)-IIIa aminogly-
coside phosphotransferase gene, and 4 (29%) the ant(4’)-Ia amino-
glycoside nucleotidyl-transferase gene. Multiple resistance genes
were present in most AR strains (three of four MSSA AR strains,
and all 10 MRSA strains). Resistance genes were never detected in
aminoglycoside susceptible strains.
Conclusions: High resistance rates to gentamicin and tobramycin
were observed in MDR nosocomial strains of S. aureus, especially
in MRSA strains. Netilmicin was the most effective anti-staphylo-
coccal aminoglycoside, and retained activity against most gentam-
icin- and tobramycin-resistant strains, including MRSA. The
aac(6’)-Ie-aph(2’’) gene was the most common resistance deter-
minant, followed by the aph(3’)-IIIa and ant(4’)-Ia. The latter
genes were never observed alone. The distribution of aminoglyco-
side resistance genes revealed differences in comparison with
other epidemiological settings.
Acknowledgements: This work was supported by a research grant
from Essex Italia S.p.a.
P589 Frequency of glycopeptide intermediate and hetero-
glycopeptide intermediate Staphylococcus aureus among
methicillin-resistant strains isolated in 2002 in a Warsaw
university hospital
G. Mlynarczyk, A. Mlynarczyk, M. Luczak
Warsaw, PL
Objectives: The problem of glycopeptide intermediate Staphylococ-
cus aureus (GISA) and hetero-GISA was ﬁrst found by Hiramatsu
group. They showed, that in the case of infections caused by
GISA strains, glycopeptide antibiotics were not effective. The
inefﬁcacy of glycopeptides against h-GISA strains was not fully
conﬁrmed, but they were presumably precursors of GISA.
Because the usage of glycopeptides in hospitals is still very high,
it seems that monitoring of both types of S. aureus strains is
necessary.
Methods: In the presented work, the 103 methicillin-resistant
strains of S. aureus (MRSA) isolated during 1 year (2002) were
examined. All strains were isolated from patients from different
wards of the one of Warsaw University hospitals, the Center of
Injuries Treatment. The reference Keiichi Hiramatsu strains
Mu50 and Mu3 were also used, as well as reference susceptible
strain FDA 209P. First, the preliminary selection was performed,
using a sector of BHI-agar plate with 4 mg/L of vancomycin
and undiluted suspension of strain. For all strains that showed
growth, MICs for vancomycin were examined, performing
E-tests. Strains with MIC values of vancomycin <8 mg/L were
examined if they are h-VISA. The population analysis and modi-
ﬁcations of the method were performed. The consecutive dilu-
tions of bacterial strain were plated on the growing
concentrations of vancomycin. At the same time reference strains
were examined.
Results: From investigated 103 MRSA only 18 strains grew in the
preliminary selection. The MICs of vancomycin for them were
lower than 8 mg/L, but higher than 1 mg/L. For all of them the
population analysis was performed. The course of population ana-
lysis curve in the case of ﬁve of the examined strains suggested
that they are h-VISA. In the case of some clinical as well as stand-
ard strains (susceptible, GISA and especially h-GISA) the start
inoculum signiﬁcantly inﬂuenced a shape of the growth curve
obtained as a result of the population analysis. The obtained
results of frequency of VISA and h-VISA in 2002 were compared
with results obtained for S. aureus strains obtained in former years
in the same laboratory.
Conclusions: The method of detection of h-VISA still requires
improvements. There was observed no increase in the frequency
of VISA and h-VISA in the investigated hospital in last years,
despite that consumption of glycopeptides was not reduced.
P590 Methicillin-resistance expression mediated by
subinhibitory concentrations of ﬂuoroquinolones in MRSA
J.L. Mun˜oz Bellido, S. Herna´ndez Iglesias, R. Marı´n Jime´nez,
J.A. Garcı´a-Rodrı´guez
Salamanca, E
Objectives: To know how minimal ﬂuoroquinolone concentrations
modify the expression of methicillin resistance in mecA (+)
S. aureus.
Methods: Two mecA (+) S. aureus clinical strains were grown for
10 days in Mueller Hinton broth containing norﬂoxacin (NFX) at
1/8 MIC and in NFX free Mueller Hinton broth. Aliquots were
obtained from the cultured broth and inoculated to a fresh broth
every 24 h. Hundred millilitres were obtained every 24 h from
broths with and without NFX, diluted and spread onto Mueller
Hinton agar plates with 6 and 32 lg/mL of oxacillin and oxacil-
lin-free.
Results: The proportion of microorganisms expressing methicillin-
resistance (colonies on oxacillin-containing agar/colonies on oxa-
cillin-free agar), when the microorganism was grown in NFX-free
both remained stable along the whole study (3  105–3  106).
When the microorganism was grown in NFX-containing broth,
methicillin resistance expression increased during the experiment
(5  102 the second day, 1.5  101 the fourth day and 50% the
ﬁfth day. The level of resistance also increased in the second
strain. In NFX-free broth, colonies growing on Mueller Hinton
agar with 32 lg/mL of oxacillin remained <5  106. In NFX-con-
taining broth, proportion was <5  106 the ﬁrst day, 2  103
the fourth day and 3  101 the ﬁfth day.
Conclusions: Previous studies suggest the high frequency of ﬂuor-
oquinolone and methicillin co-resistance derives from the use of
ﬂuoroquinolones against MRSA, so co-resistant clona have
remained and expanded. This study show that this high fre-
quency can also derive from the increased expression of methicil-
lin resistance in MRSA.
P591 Screening criteria for glycopeptide susceptibility of
methicillin-resistant Staphylococcus aureus revisited for two
periods of blood cultures isolates
L. Bernard, P. Vaudaux, P. Rohner, E. Huggler, M. Armanet,
D. Pittet, D.P. Lew, J. Schrenzel
Geneva, CH
Objectives: Detection of methicillin-resistant Staphylococcus aureus
(MRSA) isolates exhibiting intermediate susceptibility to glyco-
peptides (GISA) is challenging for clinical microbiology laborator-
ies.
Methods: We compared three different screening assays for evalu-
ating trends in decreased glycopeptide susceptibility during two
periods. Ninety-four and 95 consecutive MRSA blood isolates
from 189 bacteremic patients collected during periods A (1989–94)
and B (1999–2001), respectively, were screened in parallel for
vancomycin or teicoplanin susceptibility by glycopeptide-contain-
ing Brain-Heart Infusion agar (BHIA) tests, Etest MICs performed
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at a standard (0.5 McFarland) inoculum on Mueller-Hinton
(MHA), or high (2.0 McFarland) inoculum or BHIA, respectively.
Any MRSA isolate yielding <50 CFU (representing <106 of the
plated inoculum) on either BHIA containing 2 mg/L of vancomy-
cin (V2-BHIA) or 5 mg/L of teicoplanin (T5-BHIA) at 48 h at 37C
was considered as fully susceptible to vancomycin or teicoplanin,
respectively. All MRSA isolates were typed by pulsed-ﬁeld gel
electrophoresis (PFGE).
Results: The proportion of MRSA isolates yielding >50 CFU on
either V2-BHIA or T5-BHIA signiﬁcantly (P < 0.01) increased from
seven of 94 (7.4%) or eight of 94 (8.5%) in period A to 16 of 95
(16.8%) or 14 of 95 (14.7%) in period B, respectively. Vancomycin
Etests MICs on MHA were of lower sensitivity (<65%), but high
speciﬁcity (99%) on period B isolates compared with those on V2-
BHIA. Vancomycin Etests MICs on BHIA were of a higher sensi-
tivity (81%) but lower speciﬁcity (65%) compared with those on
V2-BHIA, because of an unexpectedly high number of false posi-
tive isolates (28/95). Eighty-three per cent of period B isolates
(including the potential GISA isolates) analysed by PFGE
belonged to a single predominant MRSA clonototype that essen-
tially replaced all four major MRSA clonotypes formerly present
during period A.
Conclusions: Screening of decreased susceptibility to vancomycin
or teicoplanin on V2-BHIA or T5-BHIA, respectively, may repre-
sent simple low-cost alternatives to Etest MICs, minimising the
risk of missing potential GISA isolates.
P592 Sequence analysis of the polymorphic region X of
protein A in a methicillin-sensitive Staphylococcus aureus
population isolated from the airways of cystic ﬁbrosis patients
B. Kahl, A. Mellmann, S. Deiwick, G. Peters, D. Harmsen
Munster, D
Objectives: Recently, we demonstrated a high prevalence and
long-term persistence of methicillin-sensitive Staphylococcus aure-
us (MSSA) in the airways of cystic ﬁbrosis (CF) patients.
Pulsed-ﬁeld gel electrophoresis (PFGE) distinguished six preval-
ent clonal lineages (Dice similarity coefﬁcient >85%; 36 isolates)
and 35 individual clones. Single locus DNA-sequencing of the
S. aureus polymorphic region X of protein A (spa) was used to
evaluate a faster and more feasible method. The region X con-
sists of a variable number of 21–27 bp repeats. The goals of the
present study were: (i) to determine the spa-types of persistent
MSSA strains in a deﬁned patient group and (ii) to compare
PFGE and spa-typing as a tool for molecular typing for long-
term observations.
Methods: Seventy-one MSSA isolates collected during a 6-year
longitudinal study from 50 patients were analysed. The following
primers were used for ampliﬁcation and sequencing: spa-1113f
and spa-1496r. Spa-types were determined with the Ridom Staph-
Type? software (Ridom GmbH Wu¨rzburg, Germany), which auto-
matically assigns numeric spa-repeat and -type codes. The
software synchronizes with an accompanying website (http://
www.ridom.de/spaserver) to ensure a uniform terminology code.
Results: In total, 48 spa-types were distinguished by sequencing
all 71 MSSA isolates. Twenty-four spa-types occurred within the 6
-by PFGE- deﬁned prevalent clonal lineages (36 isolates). The
remaining 35 individual isolates showed 24 different spa-types.
As the overall composition of spa-types within a clonal lineage
was very similar, it is conceivable that the differing spa-types
could be explained by micro-evolution of the spa-region: deletion
of single or several repeats (11 strains), duplication of repeats
(three strains) or point-mutations (three strains). However, four
strains displayed totally different spa-types.
Conclusions: Spa-typing showed a high diversity in a MSSA pop-
ulation isolated from a deﬁned patient group. The discriminatory
power of spa-typing was comparable with PFGE results, and
overall the same clonal lineages were detected. However, gains,
losses of repeats, and point-mutations occurred in strains within
the six prevalent clonal lineages indicating micro-evolution of the
spa-region. Therefore, if spa-typing is used as a molecular typing
method, micro-evolutionary events have to be taken into account
when analyzing the data, especially if isolates from long-term
observations are to be compared.
P593 Ridom StaphType software: facing the challenge of
inter-laboratory evaluation of sequence-based MRSA typing
A. Mellmann, D. Harmsen, A.W. Friedrich, J. Rothgnger,
H. Claus, U. Vogel, H. Karch
Munster, Wurzburg, D
Objectives: Staphylococcus aureus is a major pathogen that causes a
wide range of infectious diseases. Since its ﬁrst identiﬁcation in
the early 1960s, methicillin-resistant S. aureus (MRSA) has become
a major concern. In order to manage increasing MRSA numbers
effective typing protocols have to be applied. Typing of MRSAs
by analysis of protein A (spa) gene repeat sequences is reprodu-
cible; it has a high discriminatory power; the data generated are
highly portable (digital data management), and delivers results
congruent to other typing methods (e.g. PFGE). One major draw-
back of repeat typing is that automatic Internet based repeat code
assignment has not been available until now.
Methods: In our study, we used the recently developed Ridom
StaphType software (Ridom GmbH, Wu¨rzburg, Germany; version
1.0) which meets these requirements. The performance of the soft-
ware was evaluated using spa sequences obtained from 220 inde-
pendent MRSA isolates, which were collected at the two German
university hospitals in Wu¨rzburg (n ¼ 107, collected from 7/2001–
6/2002) and Mu¨nster (n ¼ 113, 1/2002–12/2002).
Results: Assignment of spa-types by Ridom StaphType was poss-
ible for all 220 isolates tested. In total, three predominant spa-
types, two of them identical in both institutions, accounting for
about 50% of all isolates were observed. The remaining isolates
showed sporadic and different spa-types in both hospitals. The
use of Ridom StaphType greatly reduced time needed for genera-
tion of data. Furthermore, the software allowed for easy sequence
chromatogram editing and ﬂexible data management and retrie-
val.
Conclusion: In conclusion, automatic repeat assignment by Ridom
StaphType overcomes shortcomings of current spa-typing and
will promote wide-spread use of the method and inter-laboratory
exchange of data. Finally and most important the software helps
to take evidence based actions (e.g. infectious disease control
measurements) in hospital settings.
P594 Intracellular killing of drug-resistant Staphylococcus
aureus by different antibiotics
F. Rozgonyi, C. Gemmell
Budapest, HUN; Glasgow, UK
Objectives: The emergence of epidemic multiple resistant Staphylo-
coccus aureus (EMRSA) and vancomycin intermediate susceptible
(VISA) strains has heightened concerns about the treatment of
associated infections. It has also been suggested that intracellular
survival of S. aureus in phagocytic cells play an important role in
the pathogenesis of associated infections, moreover it may contrib-
ute to failure of antimicrobial chemotherapy. Therefore intracellu-
larly active antibiotics may be of value in treatment. This study
was aimed to investigate the effect of linezolid, moxiﬂoxacin and
vancomycin on the intracellular survival of S. aureus.
Methods: Two clinical isolates of methicillin resistant S. aureus
(EMRSA 16 also resistant to macrolids and VISA 3759.v with
intermediate susceptibility to vancomycin) were tested in J774
macrophage cell line. Susceptibility of the strains was determined
by NCCLS broth microdilution method. Cells were infected with
bacteria opsonised with 10% normal pooled human serum in
Hank s balanced salt solution supplemented with 1% gelatine.
After 2 h of incubation the supernatant was discarded and cells
were washed three times in the buffer. Thereafter, antibiotics were
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added to the cells at the following concentration: 0  MIC,
1/2  MIC, 1  MIC, 2  MIC in triplicate. Samples were taken
1, 2, 3, 4 h after antibiotic addition. Cells were washed three times
with phosphate buffered saline, then lysed with distilled water.
Bacterial count of the cell lysate was determined by the microdilu-
tion followed by blood agar plating. Each test was performed
three times.
Results: In the presence of vancomycin, intracellular killing was
not enhanced, as linezolid and moxiﬂoxacin facilitated the clear-
ance of live intracellular bacteria even at sub-MIC concentrations.
Discussion: Whether this enhancement is due to inhibition of
intracellular bacterial multiplication, or due to an effect on the
host cells’ killing mechanisms, or both remains to be seen.
According to our observation linezolid and moxiﬂoxacin have
been shown bioactive intracellularly against MRSA.
Acknowledgement: The project was supported by the FEMS.
P595 MRSA with Panton-Valentine-Leukocidin in
Germany
W. Witte, C. Braulke, C. Cuny, B. Strommenger, G. Werner
Wernigerode, D
MRSA containing lukS-lukF (Panton-Valentine-Leukocidin) have
been reported as community acquired MRSA from US, Australia
and Europe (France and Switzerland). The European cMRSA are
clearly different by genomic background from isolates from other
continents. Here we report on emergence and of lukS-lukF MRSA
in Germany.
Methodology: Typing of MRSA from hospital and community all
over Germany as National reference center by means of SmaI-
macrorestriction patterns, MLST (according to www.mlst.net) and
spa-sequence (www.ridom.de). PCR demonstration of lukS-lukF,
of resistance genes and the agr locus.
Results: From autumn 2002 until December 2003 there were nine
sporadic infections in hospitals and 10 cases of deep seated skin
infections with lukS-lukF MRSA in the community in different
geographical areas of Germany. The isolates exhibited an unique
typing pattern with regard to SmaI-macrorestriction, MLST (ST80)
and spa (type 46). The exhibited resistance to oxacillin, ciproﬂoxa-
cin, oxytetracycline (tetM) and fusidic acid (far-1 coded efﬂux).
They were negative for the agr-locus.
Conclusion: The typing pattern of lukS-lukF MRSA from until
now sporadic cases of infections corresponds to that known for
MRSA from France and Switzerland. Further characteristics are
far-1 mediated fusidic acid resistance (not in other MRSA from
Central Europe) and deletion of agr.
P596 Characterisation of methicillin-resistant
Staphylococcus aureus isolated at a policlinic in Bari, Italy
M. Corrente, R. Monno, M. Totaro, G. Normanno, I. De Giglio,
A. Lorusso, C. Buonavoglia
Valenzano, Bari, I
Objectives: To evaluate several methods for the detection of meth-
icillin resistance of Staphylococcus aureus (MRSA) isolated in Bari,
South Italy and to characterise the strains by genotyping methods.
Methods: Forty-eight strains of S. aureus isolated from clinical
samples and different wards of the Policlinico Hospital (Bari,
South Italy) were evaluated for methicillin resistance by the PBP
latex agglutination test (Oxoid, Milan, Italy), the oxacillin-salt agar
screen test, the results of an automated system (Microscan Pos-
Panels, Dade Behring, Milan, Italy), the determination of MIC val-
ues to methicillin by the agar dilution and the detection of the
gene MecA by PCR. The strains were also analysed by PCR for
the mec-associated hypervariable region (HVR-PCR) and by Ran-
dom Ampliﬁed Polymorphic DNA (RAPD) analysis. Thirty-one
strains were also tested for the production of enteroxins A, B, C
and D by the Reverse Passive Agglutination Assay (RPLA,
Oxoid).
Results: All the 48 strains of S. aureus resulted MRSA by the oxa-
cillin agar screen test, the PBP2a latex agglutination test, the auto-
mated system and by the mecA-PCR. The MIC90 for oxacillin was
>256 mg/L. Both RAPD and HVR-PCR clustered the strains in
three main genotypes. Eight different resistotypes were found.
The strains isolated in the surgical units belonged to the same
RAPD and HVR group and displayed the same resistotype. Fif-
teen of the 31 strains (48.4%) of S. aureus tested resulted entero-
toxins producers (11 were producers of the enterotoxin A, three of
the enterotoxin B and one of the enterotoxin D).
Conclusion: In previous studies MRSA accounted for the 40.1% of
the S. aureus isolated at Policlinico hospital. In this survey all the
methods used for MRSA detection produced concordant results
with mecA-PCR that is considered the gold standard for methicil-
lin detection. In addition RAPD and HVR-PCR resulted well cor-
related to each other in order to cluster the strains and to
correlate the groups to the different hospital wards. The methods
described and the pattern of antimicrobial susceptibility may be
useful for a rapid and inexpensive typing of MRSA in the hospi-
tal, especially for the comparison of the strains isolated from dif-
ferent wards and for identiﬁcation of clonal spread within a
hospital.
Parasitic diseases
P597 Detection of Giardia lamblia in stool samples by
enzyme immunoassays
N. Miladinovic-Tasic, S. Tasic, A. Tasic, D. Zdravkovic, I. Tasic
Nis, CS
Background: Giardia lamblia (GL) protozoa type is the most fre-
quent parasite in the digestive tract. Transmission of GL is faecal-
oral, and interhuman contact has the greatest signiﬁcance in bad
hyginenic and sanitary conditions. We made comparison of two
methods for determination of GL cyst in stool.
Methods: Three successive stool samples were examined by direct
microscopy of native preparations with Lugol and after applying
of formaline-ethyl acetate concentracion technique. Second
method for detection of GL antigens in stool specimens was
enzyme immunoassays (EIAs) (Ridascreen Giardia, R-Biopharm,
Germany). Investigation was performed in July 2003 on risk group
of patients in Special hospital for retarded children in Kulina.
Stool samples of 104 patients were examined.
Results: stool samples of all patients were examined by conven-
tional microscopy examination (CME), and by EIAs. From total
score of examined samples 101 was negative to GL, using both
methods. GL was detected at three stool samples using both
methods. Three stool samples were positive using EIAs, and neg-
ative using CME. In repeated examination of stool samples using
CME, there was no change in results. We conclude that EIAs
method is more sensitive for determination of GL cyst in stool. In
risk group of retarded children is hard to perform examination of
at least three successive stool samples using CME on presence of
GL. By using a more sensitive method one can obtain results
examining one stool sample, which has great diagnostic and epi-
demiological importance.
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P598 Epidemiological features of intestinal parasitosis in a
children’s hospital in Athens
I. Varzakakos, H. Damaskopoulou, A. Makri, L. Papavasileiou,
H. Papavasileiou
Athens, GR
Background: Intestinal parasitosis is a major problem in children,
which is responsible for diarrhoea and nutritional deﬁciencies.
Environmental, socioeconomic, demographic and health related
behavior is known to inﬂuence the transmission and distribution
of these infections.
Objective: Our goal was to determine the prevalence of intestinal
parasitic infections among patients in a children’s hospital in Ath-
ens and its possible association with demographic and socio-
economic parameters.
Material and methods: During a period of 6 years (27/9/97–27/9/
03) a total of 3022 samples were examined in our laboratory (1720
of stool specimens and 1302 of scotch tests). The study population
(both Greeks and immigrants from developing countries) was
children between 3 and 15 years old, which either examined in
the outpatient’s clinic or hospitalised. These patients had one or
more of the following symptoms: diarrhoea, abdominal pain, eosi-
nophilia, pruritus. All specimens were examined in direct micros-
copy. In addition for all stool specimens the formalin – ether
sedimentation technique and trichromic stain were used.
Results: Of the 3022 children examined, 212 (7%) were found positive
for various intestinal parasites. Six (6) different species of helminthes
and protozoa were found among the samples. By far the highest fre-
quency 162 cases (76.5%) was noted for Enterobius vermicularis, fol-
lowed by Giardia lamblia 30 cases (14.2%), Entamoeba histolytica 10
cases (4.7%), Ascaris lumbricoides six cases (2.8%), Trichuris trichiura
two cases (0.9%) and Taenia saginata two cases (0.9%).
Conclusion: The frequency of intestinal parasitic infection in
Greece, although it is relatively low, it is not rare. Fifty-ﬁve per
cent of the 212 cases that were found positive belonged to immi-
grants coming from developing countries. The above results indi-
cate that education policies should be taken and domestic and
personal hygiene should be improved as well.
P599 Survey of intestinal parasitic infections among
physical and mental retardees in a maintenance centre, Taft
M.H. Anvari Tafti, A.A. Jafarri Nodoushan, A. Fattahi Bafghi
Yazd, IR
Introduction: There are more than 453 070 individuals suffering from
physical and mental retardation in Iran, those who need expensive
health services and maintenance facilities. Because of their mental,
physiological and physical problems in handling personal health care
and also living in mass population, they are always at high risk in
acquiring contagious infections. In order to decrease their infection
rate and then to treat them, it seems that searching their intestine for
parasitic infection is highly necessary. The general purpose of this des-
criptive study was to determine the prevalence of intestinal parasitic
infections among the physical and mental retardation’s to encourage
their sponsors for controlling and more health care on them.
Material and methods: The current descriptive and cross-sectional
study was performed on 86 mental and physical retardation
patients. Following completion questionnaire form of cases, three
stool samples were collected from each case for direct examina-
tion using wet-mount and formaline–ether concentration methods.
Data was analysed using SPSS software.
Result: 54.7% of cases included female, 34.9% had more than
20 years old and 65.8% needed the camping observation. 45.3%
of cases had previous history of infectious disease, that highest
ratio was related to cutaneous fungal disease (25.6%). In total,
48.8% were infected with different types of intestinal parasites
and 18.6% had more than one parasite. The parasite frequency,
which were detected is followed: Entamoeba coli 32.6%, Giardia
lamblia 18.6%, Chilomastix mesnili 11.6%, Lodamoeba butschlii 8.1%,
Blastocystis hominis 1.2% and oxyour 1.2%. There was not seen
any statistical signiﬁcant differences of infection rate between
male and female cases. The 20-year-old and more age group
showed the highest rate of parasitic infection (16.5%). There was
seen a statistical signiﬁcant differences in infection rates between
camping and noncamping individual (P < 0.05).
Conclusion: Fifty per cent infection suggest needs of control and
supervision for health care services and facilities to improve their
personal health and also prevention of contagious contacts.
P600 Intestinal parasites in a paediatric hospital
population in Madrid (Spain), January 2002 to October 2003
A. Morente, V.M. Martı´nez, R. De Julia´n, M. Baquero, M. Subirats
Madrid, E
Objectives: Parasitic diseases are important causes of chronic diar-
rhea and low growth in childhood. The aim of this study was to
analyse and present the incidence of fecal parasites in pediatric
population in our area.
Methods: From January 2002 to October 2003 in our laboratory 2710
faecal samples were examined for the presence of parasitic patho-
gens. We studied 721 consecutive outpatients (mean age 4.8 years,
range 0.1 months–16 years) who were referred to our Paediatric
Department and considered for recruitment into this analysis.
Results: The following parasites were detected. Blastocystis hominis
(105); Chilomastix mesnilii (10); Dientamoeba fragilis (3); Endolimax
nana (88); Entamoeba coli (103); Entamoeba hartmanii (24); Entamoeba
histolytica (34); Enterobius vermicularis (3); Giardia intestinalis (156);
Schistosoma mansoni (1); Hymenolepis nana (89); Iodamoeba butschlii
(12); Isospora belli (1); Paragonimus sp. (2); Strongyloides stercoralis
(10); Taenia sp. (2); Trichuris trichiura (41); Hookworms (5); Ascaris
lumbricoides (22). Parasitologic ﬁndings were proved in 19.37% of all
examined samples (29.54% of total patients). No signiﬁcant differ-
ences was observed when we analysed per sex. In spite of the
greater number of samples was found in the range of 2 years old or
less, the highest positive rate was found in the range of 7–10 years
old. Of the total number of faecal samples, in 383 (53.7%) pathogen
parasites were detected, while in 330 (46.2%) nonpathogen parasites
were found. Giardia intestinalis was the most commonly pathogen
isolated, followed by Hymenolepis nana and Entamoeba histolytica,
whereas Blastocystis hominis and Entamoeba coli were the main non-
pathogen parasites detected.
Conclusion: From these results, we could conclude intestinal para-
sitic diseases are important causes of morbility in childhood. We
observed discrepancies between age ranges in which diarrhoeas
because of parasites are mainly suspected and age ranges in
which positive rates are higher.
P601 A 3-year descriptive study of intestinal parasite
infections in outpatients in Madrid, Spain (2000–02)
P. Tajada Alegre, M. Garcı´a-Collı´a, L. Zapatero, F. Bola´s,
M. Subirats, M. Baquero, J.L. Go´mez-Garce´s
Madrid, E
Background: Intestinal parasite infections have increased in our
country mainly because of easier access to international travel and
immigration.
Objective: To know the prevalence of intestinal parasite infections
in outpatients attending to a health area (Area 1, Madrid, Spain).
Patients and methods: 11 016 faecal samples (10 346 stools, 604
perianal swabs and 66 adhesive tapes for diagnosis of pinworms)
were processed from 5757 patients between January 2000 and
December 2002. Origin of samples and seasonal incidence of the
parasites found together with epidemiological data as gender, age
and geographical origin of infected subjects were analysed. Stools
were concentrated using a disposable parasite concentrator with
formalin-ethyl acetate (Biosepar, Germany). Coccidian oocysts
were screened on direct and concentrated faecal smears stained
by a modiﬁed Kinyoun acid-fast staining.
Results: 53.3% of parasitised patients were from foreign origin,
mainly from South America (91.7%; of which 79.8% were Ecuado-
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rian subjects). The overall prevalence of intestinal parasitisms was
15.6% (1723 faecal specimens belonging to 882 patients with 2353
parasites identiﬁed). The prevalence of the parasites found was:
Blastocystis hominis (34.1%), Giardia intestinalis (17%), Entamoeba
coli (15.6%), Endolimax nana (14.7%), Enterobius vermicularis
(4.6%), Trichuris trichiura (3.9%), Cryptosporidium parvum (2.6%),
Entamoeba histolytica/dispar (1.8%), Strongyloides stercoralis (1.3%),
Ascaris lumbricoides (1.2%), Hymenolepis nana (1.2%), Lodamoeba
butschlii (0.6%), Taenia saginata (0.5%), hookworms (0.4%) and
Chilomastix mesnili (0.2%). Considering only the pathogen species,
Giardia intestinalis was the most prevalent (48.8%) followed by
Enterobius vermicularis (13.2%), Trichuris trichiura (11.4%), Crypto-
sporidium parvum (7.6%), Entamoeba histolytica/dispar (5.3%),
Strongyloides stercoralis (3.8%), Ascaris lumbricoides (3.5%), Hyme-
nolepis nana (3.5%), Taenia saginata (1.6%) and hookworms (1.2%).
The frequency of double, triple, quadruple and quintuple infec-
tions was 19.7, 5.9, 1.8 and 0.4%, respectively. Samples processed
and parasite detected in 2002 have increased by 82.7 and 166.7%,
respectively with regard to 2000.
Conclusions: Our ﬁndings suggest that parasitic infections are still
a public health problem with a high prevalence. The knowledge of
the situation in each area facilitates its management and control.
P602 Enteropathogenic bacteria isolated from patients with
diarrhoea: frequency of isolation and susceptibility testing to
commonly used antibiotics in a Tehran hospital: a 1-year study
B. Kiadarbandisari
Tehran, IR
Objectives: The aim of this study was to determine bacterial aeti-
ology of the diarrhoea, frequency of isolated various enteric path-
ogens and susceptibility to commonly used antibiotics.
Methods: During 1 year study from November 2001 to November
2003, in total 2291 stool specimens were examined microscopically
in microbiology laboratory. All specimens inoculated to routine
microbiological cultures media including: XLD, Selenit F Mac-
Konky agar Hekton Enteric and SS agar. All isolated bacteria
identiﬁed by biochemical tests and stereotyped by relevant anti-
sera (Bahar Afshan Company) Susceptibility testing performed by
disk diffusion method as recommended by NCCLS.
Results: Of 2991 stool sample 123 enteropathogenic bacteria isola-
ted. The frequency of isolated bacteria was: Shigella spp. 58
(47.8%) strains, enteropathogenic Esherchia coli (EPCE) 28 (22.8%)
and Salmonella spp. 28 (22.8%). Shigella sonnei was the most pre-
valent serotype with 43 (74.5%) isolates followed by Shigella ﬂex-
neri 11 (12%) and Shigella dysenteriae and Shigella boydi each two
strains. Salmonella group D was the predominant serotype with
eight isolates followed by Salmonella group B and Salmonella typhi.
Susceptibility of Shigella isolates to ciproﬂoxacin, ceftrixone, ami-
kacin, nalidix acid co-trimoxazol, ampicillin and tetracycline was
98.2, 91, 88.3, 20.4, 19.3 and 15.1% respectively. All Salmonella iso-
lates were susceptible to cefotaxim, followed by gentamycin
99.6% chloramphenicol 89.6% co-trmoxazole 80% and ampicillin
19.34% and teracyclin 15.1%. About 60% of all EPCE were sus-
ceptible to ciproﬂoxacin, gentamycin, chloramphenicol co-trimaxa-
zol and cefotaxim. All isolates were resistant to ampicillin.
Conclusion: This study reveals that Shigella sonnei was the pre-
dominant serotype among Shigella isolates. The majority of Shigella
spp. and EPCE were resistant to ampicillin and co-trmaxazole.
The rate of resistance among Salmonella spp. isolates was not high
except for ampicillin.
P603 Intestinal parasites found in native and foreign
workers during a 7-year period in Greece
J. Spiliopoulou, M. Palta, V. Nickolas, V. Petrocheilou-Paschou
Athens, GR
Infections with intestinal parasites constitute both a medical and
a public health problem. The improvement of sanitation since
1960 led to a signiﬁcant reduction of parasitosis in Greece. How-
ever, the high numbers of foreign workers entering the country
have contributed to the increased numbers of faecal examination
and isolation of intestinal parasites in our laboratory. The objec-
tive of this study was to monitor the number of people carrying
intestinal parasites and to compare them with those of earlier
years.
Material and methods: During a 7-year period (1997–2003) samples
from 1879 individuals (natives and foreigners) who were exam-
ined as outpatients at the hospital, in order to obtain a heath
clearance certiﬁcate, were included in the study. Single stool sam-
ples obtained without purgatives were subjected both to macro-
scopic and microscopic examination: (1) direct unstained smears,
(2) iodine stained direct smears, (3) unstained wet ﬁlms after con-
centration (sedimentation method: Ritchie).
Results: Out of 1879 individuals who were examined, 1061 were
natives and 818 foreigners. Parasites were found in 17 natives
(1.6%) and in 97 foreigners (11.8%). The species of isolated para-
sites were: (a) Protozoa [Giardia lamblia (34), Blastocystis hominis (9),
Entamoeba histolytica/E. dispar (6), nonpathogenic Amoeba (77)] (b)
Intestinal Nematodes [Ascaris lumbricoides (5) and Enterobius vermi-
cularis (3)]. In 23 individuals a mixed infection with two species of
parasites was found while in one, three species were present.
Conclusion: The alertness of public health services is critical in order
to constrain the spreading of parasitic infections to indigenous pop-
ulations by locating and treating, if possible, foreign carriers.
P604 Prevalence of intestinal parasites in women
15–45 years old (in pregnancy age) in a healthy village (Kargan),
in Ardabil, Iran
A. Daryani, M. Dehghan
Ardabil, IR
Objectives: Intestinal parasites are one of the major health prob-
lems in developing countries and cause malnutrition, diarrhoea
and anaemia in human, especially in women. The aim of this
study was to determine the prevalence of intestinal parasites
among women 15–45 years old.
Methods: A cross-sectional study was performed on 90 women
(15–45 years old) of this village. A questionnaire was designed to
include relevant information. Faeces samples of them were collec-
ted and examined with wet mount smear and formalin-ether con-
centration methods. Data was analysed by Chi-square test.
Results: The present study indicates that 51.1% of women infec-
ted at least one type of intestinal parasites as follow: Giardia lamb-
lia 10%, Entamoeba coli 43.3%, Blastocystis hominis 28.8% and
Hymenolepis nana 3.3%. More than 27.7% of the subjects were
infected with more than one parasite: 17.7, 7.8 and 2.2% had 2, 3
and 4 parasites, respectively.
Conclusion: Because of the high prevalence rate of intestinal para-
sites among women 15–45, contact them with children and role of
them in preparing food, preventive measures and treatment seems
to be necessary.
P605 Cryptosporidiosis associated with child care settings
in Madrid, Spain
P. Tajada Alegre, M. Garcı´a-Collı´a, L. Zapatero, F. Bola´s,
M. Subirats, M. Baquero, J.L. Go´mez-Garce´s
Madrid, E
Background: Cryptosporidium parvum is a protozoan parasite trans-
mitted by ingestion of oocysts excreted in the faeces of infected
humans or animals. Cryptosporidium infection usually causes a
self-limited diarrhoeal illness but it can be life-threatening in im-
munocompromised individuals. Groups at particular risk of cryp-
tosporidiosis include immunocompromised persons, especially
those with HIV infection, family and sexual partners of infected
patients, children and caretakers in day-care centres, animal han-
dlers and travellers.
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Objective: To assess the prevalence of Cryptosporidium parvum in
outpatients attending to an urban health area (Area 1, Madrid,
Spain).
Patients and methods: A total of 1250 faecal samples from 929 out-
patients were processed between September 2000 and December
2002. All faecal samples were studied by direct iodine wet mounts
visualization followed by a concentration technique. Stools were
concentrated using a disposable parasite concentrator with forma-
lin-ethyl acetate (Biosepar, Germany). Coccidian oocysts were
screened on direct and concentrated faecal smears stained by a
modiﬁed Kinyoun acid-fast staining.
Results: During the 28-month period, Cryptosporidium parvum
oocysts were detected in 62 faecal samples from 42 patients (25
males and 17 females). All were children between 4 months and
9 years; 35 of them (83.3%) were aged <4 years, of which 27
(77%) attended to day-care centres. Of the 42 cases of cryptospori-
diosis, 20 (47.6%) exhibited an elevated excretion rate of oocysts
and 27 (64.3%) showed faeces with pasty consistency and a char-
acteristic yellow colour in the moment of diagnosis. The highest
incidence of Cryptosporidium parvum was observed in autumn and
spring (31 and 16 isolations, respectively).
Conclusions: Our data revealed that Cryptosporidium parvum
should routinely be sought in children with diarrhoea. A correct
aetiological diagnosis may permit to detect outbreaks and to avoid
spreading. A modiﬁed acid-fast stain should be performed as part
of a routine examination. Epidemiological studies are necessary to
better quantify the public health impact of cryptosporidiosis.
P606 Cryptosporidiosis in children
A.M. Garcia-Tapia, P. Marin-Casanova, C. Lopez, J. Ruiz-Aragon,
C. Fernadez, M. Martin, P. Garcia-Martos
Cadiz, E
Objectives: During an outbreak of acute watery diarrhoea among
the residents children of Cadiz (Spain) occurred from August 12
through November 18 2003, Cryptosporidium parvum oocysts were
identiﬁed on 22 stool specimens from these patients.
Methods: Stool specimens were collected from patients with diar-
rhoea, and were preserved in sodium acetate-acetic acid-formalde-
hyde. Stool were sedimented by centrifugation. The microscopic
examination of a direct smear and the cold acid-fast Kinyoun
stain were realisated. An extensive questionnaire with demogra-
phic, clinical and epidemiologic characteristics was deﬁned.
Results: Of the 22 patients with cryptosporidiosis, a 59% was
male, a 27% required hospitalization, 21 were immunocompetents
and one was HIV positive. Their mean age was 4 years. The clin-
ical manifestation included watery diarrhoea (100%), anorexia
(63%), abdominal cramps (54%), vomiting (35%), and fever(13%).
The median duration of diarrhoea was 13 days. Cryptosporidium
parvum was identiﬁed as the unique pathogen in 86% of the
cases.
Conclusion: Cryptosporidium parvum was not a common cause of
gastroenteritis in immunocompetent children resident in Cadiz.
However, we recommend that clinicians and laboratories consider
performing routine stool test for Cryptosporidium in people with
watery diarrhoea. This outbreak highlights the importance of sur-
veillance for cryptoporidiosis and the need for guide for the pre-
vention of infections among HIV infected persons. Further studies
are needed to determine the prevalence and spectrum of the clin-
ical patterns of this parasitic disease.
P607 Human and animal trichinellosis in Belgrade
Z. Dakic, Z. Kulisic, B. Antonijevic, R. Dmitrovic, M. Jovanovic,
M. Petrovic
Belgrade, CS
Objectives: To determine the number of humans infected with
Trichinella spiralis in the area of Belgrade and the kind and source
of meat contaminated with the parasite.
Methods: Epidemiologic data on the number of human trichinello-
sis in Belgrade in the period from 1996 to 2000 were collected
from the Institute for Infectious and Tropical Diseases and Insti-
tute of Public Health of Belgrade and the data on pig trichinellosis
from the Ministry of Agriculture and Forestry. We collected data
on the connection between the infected humans and source of
meat from the Food and Drinks Centre.
Results: In the period of investigation on the territory of Belgrade
399 individuals were infected with T. spiralis what makes 12.3%
of the infected individuals in Serbia. The greatest number of infec-
ted people was in 1997 and 2000 (morbidity: 6.0/10 000 and
5.1/10 000 respectively). The disease had seasonal character and
appeared in epidemics (42 epidemics with 306 patients). In this
period 77 pigs were found to harbour the parasite. Fifteen of them
were the source of infections, while the others were eliminated
thanks to the timely action of veterinary inspection. It makes
30.61% of the total of 49 pigs infected with T. spiralis that were
the source of infection for inhabitants of Belgrade. The other pigs
(69.39%) originated from the other parts of the country. The
smallest number of infected individuals was observed in central
parts of the town and the greatest number of them was in three
suburbs, where was also found the greatest number of pigs infec-
ted with T. spiralis.
Conclusion: 30.61% of all pigs that were sources of epidemics of
inhabitants of Belgrade originated from the territory of Belgrade.
There was topographic correlation between trichinellosis of pigs
and humans. The greatest number of infected humans and pigs
was observed on the territory of three suburbs, that implicates the
foci of infections in these areas.
P608 Study of rodents and their parasitic infections in
Bandar Abbas City, Southern Iran
M. Shahi, A.A. Hanaﬁ-Bojd, M. Soleimani-Ahmadi, G. Zamani,
G. Mohseni
Bandar Abbas, IR
Objectives: This investigation is conducted in Bandar Abbas City,
Southern Iran, to determine the fauna, abundance, distribution
map, ectoparasites and blood parasites of rodents, during the
basic study for their control programme.
Methods: Rodents were captured with live traps from different
parts of the city, during spring and summer of 2003 and trans-
ferred to the parasitology laboratory of Bandar Abbas training and
public health research centre. After anaesthetization six thin and
thick blood ﬁlms were prepared from the heart of each animal.
Smears were prepared from the ears of rodents to study the leish-
maniasis infection. After recording the morphometric characters,
ectoparasites were removed on water surface by combing their
hairs. Finally the head and skin of each rodent was removed and
ectoparasites were conserved in ethanol 70%. The obtained slides
were stained with Giemsa and observed with light microscope.
Results: A total of 105 rodents demonstrated four species: Rattus
norvegicus, R. rattus, Tatera indica and Mus musculus were caught
and investigated from 20 areas of Bandar Abbas city. The major
species was R. norvegicus (78%), followed by T. indica (16%),
R. rattus (3%) and Mus musculus (3%). The most frequency was
observed in Ayatollah Ghaffari quarter, 17 rodents per 24 traps.
Ectoparasites were identiﬁed as Xenopsylla cheopis, Polyplax sp.,
Ixodes sp. and Ornithonyssus sp. We found 35 rodents infected
with blood parasites. The observed parasites were Trypanosoma
sp., Babesia sp., Borrelia sp. and one unknown bacteria. The most
infection rate was due to Trypanosoma followed by Babesia (13.3%)
and Borrelia (0.95%). There was no leptomonad infection in the
studied rodents. Mus musculus (0%) and R. norvegicus (88.6%) had
the lowest and highest parasitic infection, respectively. Borrelia sp.
was only observed in the blood ﬁlms of T. indica.
Conclusion: The reason for high frequency of rodents in some
quarters of Bandar Abbas is the waste food materials, sweepings
gathered in some parts of town, illegal storing and transporting of
some food materials such as wheat, corn and so on. Removed
ectoparasites are important because of their role in transmission
of some dangerous disease agents such as plague, typhus,
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relapsing fever and also haemorrhagic fevers. The observed blood
parasites in the studied rodents show that these animals can be
potential reservoir hosts for some zoonoses in Bandar Abbas,
especially in quarters with low sanitation.
P609 Epidemiology of Blastocystis hominis and other
intestinal parasites in female marriage emigrants in Taiwan
J.W. Shin, H.S. Cheng
Tainan, TW
Background: There were 139 735 foreign marriage immigrants
(exclude the Mainland China) until the end of 2002 in Taiwan and
58.2% of them came from Vietnamese. There were several studies
mentioned about the prevalence of parasitic infection among for-
eign workers but none did concern with these marriages immi-
grants. This is the ﬁrst study about the prevalence of intestinal
parasitic infections in the female marriage immigrants from Viet-
nam in Taiwan.
Methods: The female marriage immigrants from Vietnam who
were required to take a complete physical examination for the
residence approval July 1998 to June 2001 in southern Taiwan
were included in this study. Examination for intestinal parasites
used the merthiolate-iodine formaldehyde concentration method.
Student’s t-tests and multiple regressions were used to test for
signiﬁcance and for statistical adjustment.
Results: The prevalence of intestinal parasite infection of 1434
female Vietnamese marriage immigrants was 37.3% and there
was a signiﬁcant increase from 1999 to 2001 in statistically
(P < 0.0001) but decreasing trend in the prevalence by age in sta-
tistically (P < 0.0001). There were 20 species of intestinal parasites
were found in the study. 30.5% for 12 species transmitted via fae-
cal–oral route, 11.8% for three species from soil-mediated route,
and 0.7% for ﬁve species by food-bone infection. The prevalence
of blastocystosis (20.4%) and hookworm infection (9.7%) was
remained high in the protozoa and helminthes infection in the
immigrants. The results of the prevalence of intestinal parasite
examinations were aged adjusted by using multiple regression
analysis. This also showed signiﬁcant differences in the preva-
lence of intestinal parasite infection in different annuals in statisti-
cally (adjusted with age, P < 0.001).
Conclusion: The results provide systematic information on intesti-
nal parasitic infection among female marriage immigrants in Tai-
wan and advised appropriate health care after parasite infection
conﬁrmed in these migration communities.
P610 Characterisation of casein kinase 1 in Trichomonas
vaginalis
P. Tang, C.H. Huang
Taoyuan, TW
Casien kinases (CK) are important regulators of many cellular
processes in higher eukaryotes; however, casein kinase related
genes has never been identiﬁed in Trichomonas vaginalis. The full
length cDNA of two casein kinase 1 (CK1) partial cDNA clones
isolated from a T. vaginalis expressed sequence tags (EST) library
were obtained by 5’ rapid ampliﬁcation cDNA ends (5’-RACE).
The complete open reading frames of TvCK1.1 and TvCK1.2 are
1467 bp and 1572 bp. The Trichomonads CK1-like gene encodes a
putative protein of 489- and 524-amino acid residues with a pre-
dicted molecular weight of 60 and 63 kDa, respectively. The
amino acid sequences of the trichomonal TvCK1.1 and TVCK1.2
showed only 40 and 26% identity with human CK1-delta. How-
ever, 3D structure modelling simulated by ExPASy Molecular Bio-
logy Server showed the structure of the Trichomonad CK1 are
highly conserved. The expression of TvCK1s were determined in
synchronised cell division cycle. Results from quantitative real-
time PCR showed that TvCK1.1 are highly expressed during the
cell division cycle but not TvCK1.2.
P611 Comparison of direct microscopy and in vitro cultures
in detection of Trichomonas vaginalis
G. So¨nmez Tamer, D. O¨ztu¨rk Du¨ndar, S. Caliskan, E. Doger
Kocaeli, TR
Objectives: The parasitic protozoan Trichomonas vaginalis is a com-
mon pathogen that causes trichomoniasis and has been linked to
preterm birth, acquisition of human immunodeﬁciency virus, infer-
tility and nongonococcal urethritis. Diagnosis is made by identify-
ing motile unicellular ﬂagellates on a vaginal saline wet mount, by
using different culture media and serological and molecular meth-
ods. This clinical study performed to evaluate wet mount micros-
copy and two broth culture methods for the detection of
T. vaginalis in swab specimens obtained from female patients.
Methods: A total of 128 women, ages between 18 and 48 years
with abnormal vaginal discharge who applied to Obstetrics and
Gynecology Department were enrolled to this study. The samples
of vaginal secretions from the posterior fornix collected on a sterile
cotton tipped swab. The smears were examined using wet-mount
preparations and culturing on cystein pepton maltose (CPLM)
medium and tripticase yeast extract maltose (TYM) medium in 1 h
after specimen collection. We determined the optimal days on
which to read culture tubes by inoculating aliquots of secretions in
to each medium and reading the tubes 1, 2, 3, 4 and 7 days later
and evaluated the test performance criteria of three methods.
Results: Of the 128 patients 12 (9.37%) had positive results for
T. vaginalis. All the 12 positive cases were detected in TYM med-
ium. TYM medium is accepted as gold standard. CPLM medium
detected only nine of these 12 positive cases. Sensitivity, speciﬁci-
ty, positive predictive values and negative predictive values were
75, 100, 100 and 97% respectively. Wet mount examination detec-
ted only seven of the 12 positive cases. Sensitivity, speciﬁcity, pos-
itive predictive values and negative predictive values were 58,
100, 100 and 96% respectively. One CPLM negative case was pos-
itive in wet mount examination. Optimal growth observed in
2 days for CPLM and in 4 days for TYM medium.
Conclusions: Culturing on TYM medium was the most sensitive
technique which we used in T. vaginalis diagnosis. Although vagi-
nal saline wet mount is an easy and low-cost technique, culture is
more sensitive than the direct examination and TYM medium is
superior to CPLM medium for growth of T. vaginalis. We project
to expend this study with large numbers of clinical specimens.
P612 Seroprevalance of Toxoplasma gondii infection among
some risk groups in Erzurum, Turkey
A.E. Aktas, H. Yazgi, M. Ertek, A. Ayyildiz
Erzurum, TR
Objectives: Toxoplasmosis is an infection caused by a single-celled
parasite called Toxoplasma gondii. The parasite is found throughout
the world. Toxoplasmosis can be transmitted to humans by inges-
tion of tissue cysts in raw or inadequately cooked infected meat
or in uncooked foods that have come in contact with contamin-
ated meat, by inadvertent ingestion of oocysts and sporozoites in
cat faeces, or transplacentally. Our objective was to determine the
seroprevalence of T. gondii antibody among some risk groups to
ascertain whether they have an increased risk through occupa-
tional exposure.
Methods: The blood samples collected from three different risk
groups including 30 veterinarians, 43 butchers, 43 slaughterhouses
worker and, 100 healthy people as control groups, and obtained
sera were stored at 20C until used. Anti-toxoplasma IgG and
IgM antibodies were determined by using ELISA (Trinity Biotech
USA). Data and results were analysed by software Microsta
(hypothesis test for two proportional from independent groups).
Results: The percentage of Toxoplasma Ig G seropositivity were
61.2% in the risk groups and 38% in control group. The differ-
ences between risk and control groups was found to be signiﬁcant
(P < 0.001). Toxoplasma Ig G seropositivity rates were 53.5% in
veterinarians, 60.5% in butchers, 67.4% in slaughterhouses work-
ers. Toxoplasma Ig M was negative in all groups.
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Conclusion: Given the risks to health because of T. gondii infec-
tion, prophylactic measures such as wearing gloves and mask
when handling meat and animals and washing hands after risk of
contamination from soil, raw meat etc. are warranted.
P613 Comparison of DNA extraction methods and PCR
assays for detection of Toxoplasma gondii
B. Edvinsson, S. Jalal, B. Evenga˚rd on behalf of the ESGT
Objectives: The use of PCR for detection of Toxoplasma gondii is
sensitive and more relevant to use than serological techniques as
a diagnostic tool in immunocompromised hosts. There are differ-
ent DNA extraction methods and PCR assays available. We com-
pare two different DNA extraction methods and three different
PCR assays for detection of T. gondii.
Methods: DNA from T. gondii tachyzoites extracted either with
QIAamp DNA mini Kit or MagNa pure DNA extraction methods
was analysed with LightCycler SYBR green 1. Sensitivity of a real-
time PCR TaqMan assay was determined using dilution series of
extracted DNA. Also, DNA from 2 mL blood samples spiked with
104 to 10 tachyzoites per sample was extracted using the two
extraction methods and analysed with conventional PCR, PCR in
combination with oligochromatography or real-time PCR SYBR
green 1 or TaqMan. All assays targets the B1 gene.
Results: The two DNA extraction methods showed no difference
in extracting DNA from T. gondii tachyzoites. Analysis of spiked
blood samples revealed no difference in sensitivity between the
two DNA extraction methods when followed by PCR oligochro-
matography or real-time PCR TaqMan. Conventional PCR was
more sensitive when DNA was extracted using QIAamp DNA
mini Kit. Detection limit of the TaqMan assay was one parasitic
genome in a run using dilution series of pure parasitic DNA.
When analysing DNA extracted from 2 mL spiked blood samples
a less sensitive detection limit was observed. Real-time PCR
SYBR-green 1 was unable to detect parasitic DNA in all spiked
blood samples.
Conclusions: The two DNA extraction methods are equally efﬁ-
cient in extraction of DNA from T. gondii tachyzoites. LightCycler
PCR SYBR green 1 yielded a high background signal when analy-
sing blood samples making the detection signal undistinguishable.
Presence of blood cell DNA also altered the detection limit of the
TaqMan assay. Conventional PCR and PCR oligochromatography
were more sensitive than real-time PCR TaqMan for spiked blood
samples. Our results also show that conventional PCR was more
sensitive in the spiked blood samples using QIAamp DNA mini
Kit, suggesting that the choice of extraction method may affect
different PCR assays differently.
P614 Evaluation of the ELISA IgE test for diagnosis of
acute toxoplasmosis
P. Kodym, V. Tolarova, A. Lehovcova, M. Maly
Prague, CZ
Objectives: Usefulness of the IgE ELISA test (TEST-LINE Brno,
Czech Republic) for the detection of acute toxoplasmosis was
evaluated by comparing the course of quantitative and qualitative
results after infection, and also the sensitivity, speciﬁcity, positive
and negative predictive value with parameters of other tests.
Methods: 545 sera samples taken from Toxoplasma-infected
patients with known clinical status and duration of the infection
were, besides the IgE test, tested also with ELISA IgA, IgM
(TEST-LINE, BIO-RAD), the complement-ﬁxation test (CFT-Seva-
pharma, Prague) and IgG avidity test (in-house, NRL TOXO). As
a criterion of acute toxoplasmosis, the presence of clinical symp-
toms was considered.
Results: Clinical signs persist for longer than 4 months in only
30% of patients. While low avidity of IgG prevails in samples
taken up to 4 months after onset of symptoms, IgE ELISA is pre-
dominantly positive up to month 6, IgA ELISA up to month 8,
and IgM ELISA up to month 12, like CFT (titres up to 256). Sensi-
tivity of the IgE test (94.3%) is lower than that of IgM ELISA
(98.1%), but the speciﬁcity and predictive value of a positive test
for IgE (91.7%; 75.6%, respectively) are superior when compared
with the same parameters of IgM (65%; 43.3%). No relation of
IgE positivity with an allergy in patients was found. The IgE test
showed the lowest rate (7.7%) of false positive plus false negative
results evidencing the best correlation with clinical features.
Conclusions: Similarly like the IgG avidity test, the IgE ELISA
TEST-LINE is a highly speciﬁc test which can be very useful in
combination with some sensitive test (IgM, CFT). As the increase
in IgG avidity is strictly related to the time since infection, this
method is preferred when the duration of the Toxoplasma infec-
tion is needed to be known. However, in some patients, high
avidity after 4 months can be accompanied by persisting clinical
symptoms of toxoplasmosis. If data reﬂecting the clinical state of
the patients are preferred, the IgE test is the method of choice.
P615 Effect of testing for IgG avidity for serodiagnosis of
toxoplasmosis in pregnant women
D. Findik, U. Arslan, O. Ural, I. Tuncer
Konya, TR
Objects: Measurement of Toxoplasma gondii immunglobulin G
(IgG) avidity (binding strength) is a powerful tool for distinguish-
ing recent Toxoplasma infection from past. This study was
planned to determine Toxo IgM and IgG speciﬁc antibodies
against T. gondii and IgG toxo avidity in pregnant women.
Materials and methods: Blood samples were taken from all 1363
female patients attending the gynecology and obstetric depart-
ment of Selcuk University Meram Faculty of Education’s Research
and Practice Hospital during the period 2001–03. The presence of
speciﬁc T. gondii antibodies was determined using VIDAS system;
screening test, test for screening IgM and IgG speciﬁc antibodies
and IgG toxo avidity test (bio-Merieux, France).
Results: Out of 1363 pregnant women 410 (30.08%) were found
IgG toxo antibodies positive. Thirty-two (7.8%) pregnant women
have both IgM and IgG positive tests. Four (1%) have equivocal
IgM toxo antibodies tests. Low IgG avidity (<0.200, may be seen
in acute primary infection with T. gondii) was found in 10 (2.4%)
and high IgG avidity (>0.300 excludes primary infection within
last 16 weeks) was found in 398 (97.1%) of the samples (toxo IgG
positive). In two (0.5%) sera the avidity of IgG antibodies was
borderline (0.200 to <0.300) indicating possible primary infection
during the last 6 months. In 87.5% of IgG positive and IgM posi-
tive pregnant women, we determined high IgG avidity (showing
low risk pregnancy) reducing unnecessary pregnancy termina-
tions. Besides of this; in 1.1% of IgG positive and IgM negative
women we determined low IgG (showing high risk pregnancies
that were not deﬁned before).
Conclusion: Toxo IgG avidity test is more precise test in showing
high risk and low risk pregnancies.
P616 Can free-living amoebae be an environmental niche
for Vibrio cholerae?
H. Abd, A. Weintraub, G. Sandstro¨m
Stockholm, S
Background: Vibrio cholerae is a highly infectious bacterium
responsible for large outbreaks of cholera among humans. A sea-
sonal distribution of epidemics is known but the role of naturally
occurring habitats are rather unknown. Plankton has been sugges-
ted to play a role, as bacteria can be attached to this type of
organisms forming a bio-ﬁlm. The water born free-living amoe-
bae, Acanthamoebea castellanii, is an amoeba that has been shown
to be able to ingest and promote growth of several bacteria of dif-
ferent origin. The aim of the present study was to disclose whe-
ther or not an intra-amoebic behaviour of V. cholerae exists.
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Methods: V. cholerae strains (V. cholerae O139 from the outbreak
in Bangladesh 1993, the seventh-pandemic V. cholerae O1 El
Tor-Inaba strain N16961, the sixth-pandemic V. cholerae O1 Clas-
sical-Ogawa strain 395, and the nonepidemic strain V. cholerae
O54) were co-cultivated with A. castellanii for 16 days to exam-
ine whether an interaction could be established. Each day the
number of live bacteria as well as amoebae was estimated. In-
tracellularly growing bacteria were distinguished from extracell-
ularly bacteria by gentamycin treatment to show the intra-
amoebic growth of bacteria. Bacteria were located to different
compartments of amoebae, which could be mirrored by micros-
copy.
Results: When V. cholerae strains and A. castellanii were co-cul-
tured it was found that V. cholerae O139, V. cholerae O1 El Tor-
Inaba, and V. cholerae O54 multiplied intracellularly from 0 to
105 cfu/mL, while V. cholerae O1 Classical-Ogawa strain 395 could
not grow in Acanthamoeba cells. All V. cholerae strains tested stimu-
lated growth of amoebae during the co-culturing period, as the
number of amoebae increased. Approximately 2 weeks after infec-
tion of amoebae, bacteria could be found in the inter-space
between walls of the amoeba cysts. These data show a role of
free-living amoebae as hosts for growth of V. cholerae and that this
interaction can play an important role in the ecological niche of
the bacterium.
Conclusions: Besides showing a new ecological niche of V. cholerae,
this study redirects the bacterium from being pure extracellular
parasite to the constellation of facultative intracellular bacterium
that, thus, opens new medical aspects of the disease. This will
have implications on the cholera epidemiology, immunology, and
pathogenicity.
Tropical and parasitic diseases
P617 Characteristics of 117 malaria cases in Turkey
A. Celikbas, O. Ergonul, S. Eren, N. Baykam, T. Guven,
B. Dokuzoguz
Ankara, TR
Objective: To evaluate the epidemiologic and clinical characteris-
tics of 117 adult malaria patients.
Methods: The charts of the patients, who had been hospitalized
between 1985 and 2001 in the Infectious Diseases and Clinical
Microbiology Department of Ankara Numune Education and
Research Hospital, were reviewed. Diagnosis was established by
thin and thick smears of blood preparations obtained in the febrile
period. Logistic regression was modelled to predict the factors
that could determine the presence of the classical cyclic pattern of
the malaria based on the follow up notes of the nurses.
Results All the patients were >14 years of age, 78% were male.
The mean age was 28. Travel to malaria endemic region was com-
mon (55%). Forty per cent of the patients acquired the infection
in Southeastern Anatolia, while they were performing their milit-
ary duty. Prehospital antibiotic use for any other diagnosis was
common (50%) among the patients. The most common complaints
were fever (100%), rigor (93%), sweating (90%), headache (76%),
nausea (45%) and fatigue (38%). The most common physical
examination ﬁndings were splenomegaly (86%), hepatomegaly
(62%). Fifty-one per cent of the patients were diagnosed without
demonstration of the classical cyclic pattern of fever. Herpetic
lesions were detected in 10% of the cases. Four cases needed
transfusion. Anaemia was detected in 23% of the patients, leu-
kopenia in 47%, thrombocytopenia in 73%, twofold increase in
ALT or AST level in 32% of the patients. The plasmodium was
detected in 100% of the thick smears, and 83% of the thin smears.
Plasmodium vivax was detected in 115 patients, whereas P. falcipa-
rum was detected in two patients. Chloroquine and primaquine
were given to all patients with P. vivax. One of the P. falciparum
detected case was given meﬂoquin, and the P. falciparum case was
given quinin sulfate and tetracycline. Mean length of stay was
5 days. All the patients had been discharged with cure. The previ-
ous use of antibiotics, and gender had no effect on presence of
classical cyclic pattern of fever, however the detection of the clas-
sical pattern declines by the increase in age (odds ratio; 0.8, con-
ﬁdence interval; 0.79–0.99, P ¼ 0.039).
Conclusion: Malaria is still a public health problem. The febrile
patients with a history of travel to the endemic regions should
raise the suspicion of malaria.
P618 Relapse rate of vivax malaria with shorter duration of
antirelapse treatment in Iran
M. Salehi-Shaban, M. Esmailzadeh
Zahedan, IR
Objectives: Every year thousand of malaria cases mostly the vivax
type Occur in Iran. The recommendation of WHO for antirelapse
therapy of vivax malaria is the usage of primaquine (15 mg daily)
for 14 days but in area where G6PD deﬁciency rate is high 8 weeks
therapy (each week 45 mg of primaquine) is recommended.
Considering the fact that in Iran drug therapy of malaria is imple-
mented by direct observation of health care workers, 8 weeks regi-
men of antirelapse therapy of vivax is very expensive and in some
situations impractical. In this study shorter duration of antirelapse
therapy was compared with that of 8 weeks regimen.
Material and method: In 1996 and 1997 antirelapse therapy of vivax
in Sistan & Baluchistan province in southeast of Iran was done
with different regimens according to manpower and executive
facilities. This is a cohort study that compare clinically and parasi-
tologically relapse of vivax malaria in 200 patients with one week
therapy, 200 patients with 2 weeks, 800 patients with 4 weeks and
500 patients with 8 weeks therapy by primaquine .
Results: Relapse rate of vivax malaria by each regimen were 23.8,
13.2, 5.4 and 4.6% respectively. Relative risk of relapse in compar-
ison with 8 weeks regimen were 5.2, 2.9 and 1.2 respectively.
Number need to therapy (NNT) were 5, 12 and 125. Interval of
ﬁrst relapse varied between 6 and 52 weeks with mean of
28.8 weeks. The relapse rate was not different by sex.
Discussion: The relapse rate by 4 and 8 weeks regimens were low
and there was not signiﬁcant difference of relapse rate in 4 and
8 weeks regimens. So in special situations we can use 4 weeks
therapy instead of 8 weeks therapy.
P619 Persistent HRP2 and pan-malarial antigen reactivity
after successful treatment of P. falciparum infection
J. Iqbal, N. Khlaid, P. Hira
Kuwait, KWT
Introduction/objectives: Malaria infection is still prevalent in most
of the tropical and subtropical countries of the World. More than
1.5 million people die from malaria each year. In Kuwait more
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than 700 malaria cases are detected each year by microscopy,
which is an insensitive technique.
Materials/subject & methods: In this study, 229 patients with the
microscopic diagnosis of P. falciparum infection were monitored
with microscopy, ICT Malaria Pf/Pv test and OptiMAL assay to
detect persistent antigenaemia in patients negative for asexual-
stage parasitaemia following antimalarial treatment.
Results: Following successful antimalarial chemotherapy, the ICT
Malaria Pf/Pv test detected persistent antigenaemia in 160 of the
229 (70%) patients on day 7. 144 (63%) of the patients reacted with
histidine rich protein 2 (HRP2) antigen and 110 (48%) reacted with
panmalarial antigens (PMAs). However, the reactivity to HRP2
antigen and PMAs dropped to 35 and 23% respectively on day 14.
A higher proportion of patients were positive for HRP2 antigen
than for PMAs. The majority of the patients were positive for both
HRP2 antigen and PMAs however, 16 (7%) patients were HRP2–
but PMAs+. Compared with ICT Malaria Pf/Pv test, the OptiMAL
assay detected signiﬁcantly less number of post-treatment persist-
ent reactions. Levels of parasite-speciﬁc lactate dehydrogenas
(pLDH) and panmalarial pLDH, as detected by the OptiMAL assay,
were shown to decline in parallel with clearance of asexual-stage
parasitemia. On day 7, persistent pLDH reactivity was detected in
89 (39%) and panmalarial pLDH in 34 (15%) cases that dropped
signiﬁcantly to 21 (9%) and 14 (6%) respectively on day 14.
Conclusion: Thus OptiMAL may be superior to ICT Malaria
Pf/Pv in monitoring therapeutic responses. However, a further
improvement in quantiﬁcation of current antigens is required to
further enhance the sensitivity and speciﬁcity these assays.
Acknowledgements: Financially supported was granted by Kuwait
University Grant MI 109.
P620 Drug resistance to malaria in Orissa
P. Bishnu Prasad
Bhubaneswar, IND
Objective: To ﬁnd out the resistance status of malaria parasite to
4-aminoquinolin in Orissa.
Methods: The place of study is selected on the basis of predomin-
ance of P. falciparum cases and deaths because of malaria. The
team follow the method of 28 days in vivo study prescribe by the
World Health Organization (WHO).
Results: The team carried out total 14 studies from 1998 to 2002
over a span of 5 years (see Table).
Conclusion: We get RII & RIII resistance in all most all studies.
The summary ﬁndings for last 3 years shows there is increasing
of RII & RIII in persistent areas of transmission. As per the drug
policy on malaria in the country, change of drug in resistance
areas only required when there is 25% increase of RII & RIII put
together. So these areas do not warrant change of cloroquine to
some second line drug in the region.
P621 In vitro recrudescence of P. falciparum parasites
suppressed to dormant state by atovaquone alone and in
combination with proguanil
M. Thapar, P. Gil, A. Bjo¨rkman
Stockholm, S
Objective: The primary objective was to study the viability of
Plasmodium falciparum parasites reappearing during long-term
follow up cultures after repetitive exposures to various concentra-
tions of atovaquone and proguanil.
Methods: Two P. falciparum parasite strains were used for the
in vitro experiments, i.e. F32 and FCR3 originating from Tanzania
and Thailand respectively. The parasite strains were kept in con-
tinuous culture according to known method of Trager and Jensen,
1976.
Results: Parasites (F 32 and FCR3) exposed to 100–5000 nM ato-
vaquone for 96 h were reduced to <5% of initial parasitaemia but
recrudesced after 16–21 days. Similarly, parasites exposed to
1000 nM atovaquone for 48, 72, 96 and 144 h recrudesced after 9,
14, 21 and 23 days respectively. After the removal of drug expo-
sure, only one to three parasites and only schizonts were consis-
tently found per 10 000 RBCs, apparently unable to produce
trophozoites and thus possibly adopting a ‘dormant state’. Para-
sites (F32 and FCR3) exposed to 500 nM atovaquone for 72 h,
reappeared after 14 days. These recrudescing parasites were then
similarly re-exposed and suppressed by atovaquone in three con-
secutive follow up experiments. They then reappeared after 10, 9
and 6 days respectively. No known point mutations in cyto-
chrome b gene (cytb), associated with atovaquone resistance, were
however detected in any recrudescing parasites. Finally, parasites
(F32) exposed to various concentrations of atovaquone and pro-
guanil in combination for 72 h reappeared after 9–17 days. Relat-
ively low concentrations of proguanil (0.2 times EC90) were
required in combination with atovaquone to kill more than 95%
of the parasites. The baseline susceptibilities of the parasites to
both individual drugs were similar before and after recrudescence
in all experiments.
Conclusions: In vivo, the ‘dormant state’ parasites may represent a
small fraction of cytostatic parasites, unable to grow and unsus-
ceptible to further treatment with the drug. Return from ‘dormant
state’ to normal growth within few days after removal of the drug
pressure may represent the failure of drug action.
P622 Typhoid and paratyphoid fever in the Czech
Republic, 1993–2003
H. Ambrozov, J. Vanista, M. Reisingerova, C. Benes
Prague, CZ
Objectives: Typhoid fever is endemic in many developing coun-
tries. Number of the cases is estimated between 12 and 33 mil-
lion/year in the world. In the Czech republic these diseases occur
very rarely. Since the World War II, the occurrence has decreased.
While in 1951 the incidence rate was more than 14/100 000 inhab-
itants, in 2002 was only 0.01/100 000. The incidence rate of para-
typhoid fever B decreased from 0.75/100 000 in 1951 to 0/100 000
in 2002. Almost all cases are imported. Between the years 1993
and 2003 50 cases of enteric fever were reported in the Czech
republic. In our department we admitted 20 patients with impor-
ted typhoid or paratyphoid fever during this time. Seventeen
patients had typhoid fever and three paratyphoid fever A. Seven-
teen patients were from the Czech republic, three were foreigners.
Men prevailed women (16:4). Majority of cases were from the age
group between 20 and 30 years. Eighty-ﬁve per cent of all patients
were infected in Asia, the rest in Africa and Europe. The highest
risk of infection was in India, where 13 patients travelled.
Methods: All patients were physically examined and diagnosis
was veriﬁed by haemoculture, stool culture and Widal’s test. In
all patients blood count, liver function test and other biochemical
examination were examined.
Results: Clinical picture was usually mild or moderate, only one
patient had severe course with confusion. Fever occurred in
100%, hepatosplenomegaly in 75%, diarrhoea in 70% and head-
ache in 68.4% of all patients. The other signs (hypotension,
abdominal pain, bradycardia) were less frequent. Roseola was
found only in 10% of all patients. 94.5% of patients had hepato-
pathy, 40% leucopenia. Complications occurred very rarely,
relapse was seen only once. Four patients had dual infection.
Diagnosis was usually made by haemoculture (90% positive),
stool culture was positive only in 35%. Fifty per cent of all strains
were resistant to antibiotics. Multiresistant strain occurred only
Table 1. The total number of test case were 2033
S 1722 34.60%
RI 147 7.20%
RII 121 5.90%
RIII 43 2.10%
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once from India. Patients were treated by ﬂuoroquinolones in
75%, sometimes by antibiotic combination. Corticosteroids were
used only once.
Conclusions: Typhoid and paratyphoid fever are very rare in the
Czech republic, usually are imported. In our department were
treated 41% of all cases occurring in the Czech republic between
the years 1993 and 2003. The highest risk of infection was in Asia
(India) followed by Africa and Europe. Fifty per cent of all strains
were resistant to antibiotics. Fluoroquinolones were the drug of
choice and treatment was successful.
P623 Imported dengue fever in the Czech Republic
P. Chalupa, N. Sojkova, J. Januska
Brno, Prague, Ostrava, CZ
Two institutions in the Czech Republic possess the facilities for
the diagnosis of dengue fever (DF): the National Reference
Laboratory for Arboviruses, Ostrava, and the Department of Vir-
ology, Teaching Hospital Na Bulovce, Prague. During 1997–2002,
417 patients were examined for suspected DF. Serological evi-
dence, i.e. the presence of anti-dengue IgM and IgG antibodies,
was based on ELISA using PANBIO kits. Epidemiological data
on DF have been collected by the National Reference Center for
Epidemiological Data Analysis in Prague since 1997. Up till now,
15 DF cases (diagnostic code A90) and one case of dengue
haemorrhagic fever (DHF, diagnostic code A91) have been regis-
tered.
P624 Contribution of PCR in laboratory diagnosis of
visceral Leishmaniasis
S. Mitka, L. Ftika, H. Chaidouli, P. Mamasi, D. Arvanitis,
C. Psillaki, A. Kansouzidou
Thessaloniki, GR
Background: Visceral leishmaniasis (VL) is a severe zoonotic and
often life-threatening disease caused by the protozoan Leishmania
spp. The disease is widespread in the Mediterranean region and
also endemic in many parts of the world. The aim of this study
was the evaluation and the contribution of PCR in the early diag-
nosis of VL and also the comparison of PCR to the serological
tests and the direct detection of parasite in bone-marrow aspirate
(BMA).
Materials and methods: A total of 24 patients (36 whole blood and
sera samples) with conﬁrmed VL were assessed in this study. The
patients were divided in to two groups: In group 1, 11 patients
(16 whole blood and sera samples) with deﬁnite VL conﬁrmed by
the demonstration of the parasite in BMA were included. In
group 2, 13 patients (20 whole blood and sera samples) with clin-
ical manifestations of VL (fever, enlargement of spleen, pancy-
topenia), positive results in serological tests (indirect
immunoﬂuorescent antibody test, IFA, indirect haemagglutination
test, IHA) and negative direct examination of BMA were inclu-
ded. Twenty patients with fever of other aetiology in whom
Leishmaniasis was evaluated as part of the differential diagnosis
and 20 healthy persons were also included in the study, as a con-
trol group. PCR was performed in all samples. In PCR ampliﬁca-
tion two different pairs of primers and the highly repetitive
kinetoplast DNA as target were used. PCR ampliﬁcation revealed
products of 120- and 145-bp. IFA and IHA methods were used for
the detection of the speciﬁc IgG and total antibodies of Leishmania
spp.
Results: The two PCR methods produced positive results in all 24
patients (group 1, 2). Both serological tests gave positive result in
17 of 24 patients, while only one of the two serological tests was
positive in six patients (group 1, 2). There was also one patient
with positive direct examination of BMA and low serological reac-
tivity (group 1). All healthy persons and patients of other infec-
tions were found negative for Leishmaniasis by serological
methods and PCR.
Conclusions: PCR methods contribute in the early and deﬁnitive
diagnosis of VL in areas where the disease is endemic, such as
southern Europe. The demonstration of the parasite in the direct
examination of BMA is essential for establishing the diagnosis,
but presents low sensitivity. The use and the combination of sero-
logical tests are useful in the diagnosis of VL.
P625 Haemophagocytic syndrome associated with visceral
leishmaniasis
B. Kilani, L. Ammari, S. Abdellatif, E. Chaker, F. Kanoun,
T. Ben Chaabane
Tunis, TN
Introduction: Haemophagocytic syndrome, more properly referred
to as haemophagocytic lymphohistiocytosis (HLH), is a rare dis-
tinct clinical entity of infancy and early childhood. HLH is com-
monly associated with various systemic infections and to a broad
spectrum of malignancies and genetic disorders. Although the
association of HLH and visceral leishmaniasis (VL) has been
rarely described, the diagnosis of the disease may be difﬁcult
when VL and HLH together present in adults. We report a case
of haemophagocytosis in a 34-year-old man to draw attention to
the difﬁculties in diagnosing VL when accompanied by HLH.
Case: A 34-year-old man presented with a 4-week history of
fever, malaise, poor feeding and abdominal pain. Past medical
history was unremarkable. Physical examination revealed high
fever (39.2C) with pallor, hepatomegaly and splenomegaly.
Lymph nodes were not enlarged and vital signs were normal. The
laboratory ﬁndings showed pancytopenia and elevated erythro-
cyte sedimentation rate; serum triglycerides were increased to
267 mg/dL with normal cholesterol. Transaminase activity and
total bilirubin were high, whereas serum ﬁbrinogen was low with
elevated circulating ﬁbrin degradation products. There was no se-
rological evidence for infection with cytomegalovirus, Epstein–
Barr virus and toxoplasmosis. Blood cultures were negative. The
patient symptoms deteriorated within 24 h and he was referred to
intensive care unit where intestinal bleeding with disseminated
intravascular coagulation occurred. The patient died 48 h after
admission in the ICU. Bone marrow and liver biopsy performed
after death were compatible with diagnosis of HLH, whereas per-
ipheral blood culture for parasites yielded Leishmania infantum,
identiﬁed as zymodeme MON1 which is predominant in our
country.
Conclusion: Leishmaniasis should be considered when discussing
the cause of haemophagocytosis in countries where the disease is
endemic, such as Tunisia. When revealed by haemophagocytosis,
diagnosis may be difﬁcult particularly in adults.
P626 Detection of Leishmania major in visceral infection
by a nested-PCR assay
M. Karamian, M. Motazedian, K. Gholami
Shiraz, IR
Leishmania infantum is the typical agent of visceral leishmaniasis in
Iran and middle east, but a few reports suggested that L. tropica
could cause this type of leishmaniasis too. In this study, we detec-
ted L. major in bone marrow and lymph node samples of a village
dweller from booshehr, who had kala-azar signs.A 30-year-old
man with kala-azar symptoms was bedridden in Namazi hospital.
Four bone marrow smears and two parafﬁn-embedded blocks of
him were tested. At ﬁrst, DNA extraction from smears performed
by proteinase k and from blocks DNA extracted by boiling and
proteinase k. Then variable regions of leishmania KDNA minicir-
cles ampliﬁed by CSB1XR and CSB2XF primers in step 1, 13Z and
LiR primers in step 2 of nested-PCR assay. We determined the
species of parasite by electrophoresis of PCR product on agarose
gel and comparing between their bands with marker and stand-
ards. Leishmania major has a 560 bp variable region. PCR was per-
formed several times rigorously, and in all of samples only
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L. major has be detected. All clinical signs suggested to kala-azar
and leishman bodies were seen in lymph nodes and skin lesions
of patient. The skin lesion have been appeared on the left foreleg
of this man 10 years ago and did not be cured by plastic surgery,
but began to cure contemporary with kala-azar therapy. Accord-
ing to increasingly spreading of L. major in Iran, if this parasite
can cause visceral symptoms, it could be reckoned to a major
common health problem in this country. Therefore, it is necessary
to carry out widespread molecular studies in typing of various
agents of leishmaniasis.
P627 Study of glucantime resistance in cutaneous
leishmaniasis by PCR-RFLP method in Shiraz, Iran
M. Motazedian, M. Karamian, S. Ardehali
Shiraz, IR
Glucantime is an effective drug for cutaneous leishmaniasis
(CL) therapy in endemic regions of CL including Iran. In recent
years, there are several reports of resistance to it. In this study,
PCR-restriction fragments length polymorphism (RFLP) was
used for determination of any relationship between the genome
and drug resistance of causative agents of CL in Shiraz in
southern Iran. For this purpose, Giemsa-stained positive slides
of 102 patients with different degrees of amastigote density
were used. Nineteen slides belonged to healed patients who
had been treated by glucantime and 28 slides have been pre-
pared from unhealed patients. The surface materials of these
slides scraped and DNA extraction was carried out by Protein-
ase K and ampliﬁed by CSB1XR and CSB2XF primers in step 1,
13Z and LiR primers in step 2 of nested-PCR ampliﬁcation
method. The products were characterised by agarose gel electro-
phoresis in comparison with reference strains. The ampliﬁed
fragments digested by restriction enzymes were electrophoresed
and produced schizodeme patterns were analysed. Among 19
samples from healed patients, six were Leishmania tropica and
13 were L. major. Among 28 samples from unhealed patients,
14 were L. tropica and 14 were L. major. Analysis of these
results showed that patients infected with L. tropica have more
drug resistance. Those infected with L. major have more drug
sensitivity to glucantime in this region. Schizodeme analysis
showed high genomic diversity in L. tropica and L. major in Shi-
raz. The genomic diversity of L. tropica was considered higher
than L. major. The results of this study determine a relationship
between genomic diversity and incidence of drug resistance in
patients infected with L. tropica in Shiraz.
P628 Subconjunctival Diroﬁlaria repens infection
conﬁrmed by PCR-based approach
A. Dzamic, I. Radonjic, V. Arsic Arsenijevic, S. Mitrovic,
I. Kranjcic Zec
Belgrade, CS
Objectives: Diroﬁlaria repens, a mosquito-born ﬁlaria of dogs and
cats causes subcutaneous and submucosal lesions in human
beings. More than 50% of nodules are located on the head with
the most common site being the conjunctiva and orbit. We report
a case of infection in man from Belgrade, Serbia and Montenegro
who visited Spain 6 months before.
Methods: The clearly visible, motile parasite was localised under
the right bulbar conjunctiva. The parasite was extracted intact
from the lesion and preserved in 10% formalin. One part of the
worm was examined in Mason trichrome and Movat stained sec-
tions. For detection of parasites in blood concentration tests were
used. DNA extraction and PCR for D. repens and D. immitis using
speciﬁc primers was performed according to procedure for forma-
lin preserved tissues.
Results: Macroscopically the parasite was cylindrical, whitish
measuring 90 mm in length and 0.70 mm in width. The distance
from the anterior end to vulva was 1.40 mm and the distance
from the caudal end to anus was approximately 0.08 mm. Exam-
ination of cross-sections of the parasite revealed an immature
female ﬁlaria. The microscopic features included a pseudocoelom
with intestine and two empty uteri, muscle cell layer and multi-
layered cuticle with longitudinal ridges. The distance between rid-
ges was wider than the width of the ridge itself. Previous
macroscopic and microscopic characteristics indicated that the
worm was D. repens. A PCR product of 246 bp was ampliﬁed
when speciﬁc primers for D. repens were used which conﬁrmed
morphological means in accurate identiﬁcation. No microﬁlariae
were detected in patients blood sample.
Conclusons: According to recent reports the worm appears as
an emerging pathogen in Europe, especially in Mediterranean
area. We assume the infection was contracted locally, as autoc-
hthonous cases of human superﬁcial and visceral D. repens
infections were described from urban and suburban areas in
the last few years. Molecular identiﬁcation of D. repens is of
great value in detection of parasite in removed tissue partic-
ularly when regressive phenomena render the morphological
characteristics of the parasite but according to some reports,
duration of tissue/parasite preservation in formalin (more than
20 days) could interferes with DNA ampliﬁcation. Although in
this case the worm was in ﬁxative for several months, it did
not appear to inﬂuence the outcome of our PCR-based proto-
col.
P629 First cases of Acanthamoeba keratitis in Slovakia
F. Ondriska, M. Mrva, M. Lichvar, P. Ziak, Z. Murgasova,
E. Nohynkova
Bratislava, Martin, Nitra, SK; Prague, CZ
Objectives: Two dominant risk factors are responsible for initi-
ating the amebic keratitis: wearing of the contact lenses and cor-
neal trauma. Both these factors are associated with the ﬁrst
isolations of the Acanthamoeba species as the causative agents of
human keratitis in the Slovak Republic. Three cases report are
presented here.
Results: The ﬁrst case of amebic keratitis manifested in the right
eye of a 53-year-old man after the eye injury. Amoebae were
identiﬁed as Acanthamoeba sp. of group III. The course of the dis-
ease was inﬂuenced mainly by seeing a physician at a late stage
and discovering the aetiology of disease no sooner than
10 months after the eye injury. The disease progress has not
been staunched either by itraconazole (Sporanox), or by corneal
transplantation and the patient had to undergo enucleation.
Acanthamoeba lugdunensis was identiﬁed as a causative agent of
amebic keratitis in the second case. A 39-year-old man wearing
contact lenses visited thermal swimming pool. A month later,
the ﬁrst disease symptoms occurred. The disease has manifested
as herpetic keratitis of the left eye with cloudy cornea, circular
inﬁltrate and deterioration of vision. The cultivation of the eye
swab has revealed polyresistant strain of Pseudomonas aeruginosa
and the cultivation of corneal scraping has revealed amoebae.
Due to immediate clinical and laboratory diagnosis the propami-
dine-isethionate gtt. (Brolene) therapy has signiﬁcantly improved
the eye condition. Wearing contact lenses is probably connected
also with the third case. A 15-year-old woman worn the contact
lenses during bathing in various swimming pools and in the
sea. She even cleaned the contact lens case under tap water
regularly. In the used contact lens disinfecting solution, there
were found cysts of Acanthamoeba sp. of group II and we assume
that it was the way of the eye infection. The Brolene therapy
was successful.
Conclusion: Presented cases suggest probably the glacier phenom-
enon of the occurrence of amebic keratitis in the Slovakia. Thanks
to the ﬁrst record of this disease, the amebic keratitis has attrac-
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ted attention of the ophthalmologists and resulted in successful
therapies of the following cases as well as in increased require-
ments for acanthamoebae examination in patients with eye dis-
eases.
P630 First report of human myiasis caused by Chrysomya
bezziana Villeneuve (Diptera; Calliphoridae) in Iran, May 2002
K. Akbarzadeh, A. Jahanian, M. Nateghpour, S. Tirgari
Tehran, Iranshahr, IR
A 45-year-old farmer from Espand village (located in west of Iran-
shahr county, Sistan and Baluchistan Province, south-east Iran)
with sever headache, vertigo, nosebleed, oedema in face and agi-
tation symptoms, referred to the Khatam-Al-Anbia Hospital in
Iranshahr. CT scan showed an extensive oedema in nasal and
paranasal sinuses. Endoscopy consideration revealed the presence
of numerous larvae lodged inside the nasal cavity. In the oper-
ating room, on 6 May 2002 about 60 larvae of third instar ﬂy lar-
vae were pulled out under the general anaesthesia condition.
Some of the larvae were preserved in 70% methanol and the rest
were reared on ground beef placed on the top of moist soil in a
mosquito net cage under insectry condition (RH % 70  5, tem-
perature 30  2C). The full-grown larvae crawled into the soil
and developed to adult ﬂies later on. The larvae and adult ﬂies
were identiﬁed according to James (1947), Zumpt (1965) and
Spradbery (1991) keys. Our precise identiﬁcation indicated that
the ﬂies were the Old World Screw-worm (Chrysomya bezziana).
Six adult ﬂies and six full grown larvae have been deposited in
the collection of Entomology Museum, School of Public Health,
Tehran University of Medical Sciences. The patient’s life history
implied that he usually was resting near the goats in his farm at
mid-days. On the contrary, most of the goats usually being
attacked with myasis larvae.
P631 Imported case of brucellosis complicated by liver
abscess
C. Mutini, M. Di Carlo, L. Coppolaro, A. Di Girolamo,
E. Pizzigallo
Chieti, I
Hepatic involvement is a common feature of brucella infection,
but liver abscess is a less frequent complication. We report a
case of brucellar hepatic abscess in a 42-year-old man with a
4 week complaint of fever, abdominal pain, anorexia and
weight loss. Forty days earlier, he was back from a 2 years
staying in Albania. A detailed epidemiological history showed
that he consumed, about 2 weeks before the onset of symptoms,
fresh unpasteurised cheese. At admission the patient was febrile
(39C), and tachycardic (100 bpm). Abdomen was diffusely
painful, especially in the right upper quadrant. Liver was 2 cm
below the costal margin. Blood tests showed mild neutrophilia
(6680 cells  mm3), anaemia (haemoglobin 10.6 g/dL) and
hypoalbuminaemia (3034 mg/dL), ESR 94 mm/h and C-reactive
protein 15.1 mg/dL. Abdominal ultrasound scan showed an
abscess within the VI hepatic segment of about 55 mm in diam-
eter which was promptly drained. Blood cultures were positive
for Streptococcus anginosus, but Wright test for Brucella was also
positive at high titre (>1600). Clinical course was complicated
by right sided pleuric effusion that needed evacuation. Ciproﬂ-
oxacin i.v., doxycycline p.o., and metronidazole p.o. were ini-
tially administered. Antibiotic regimen was then switched to
doxicicline p.o. and gentamicin i.v. for 6 weeks, accomplishing
a progressive improvement of general conditions. Escherichia coli
and S. anginosus were isolated from the abscess drainage. Any
attempt of isolating Brucella spp., including biomolecular
approaches, failed. Wright serology was repeated at discharge,
showing a decrement in titres. A review of published cases was
done, ﬁnding a brucellar hepatic abscess incidence of some 1%.
As the isolated strains in this patient did not clearly indicate a
brucellar aetiology, some question could be raised on the real
involvement of Brucella spp. in this case. The possibility are
that normal intestinal ﬂora could reach, by contiguity, the liver.
Otherwise, the initial brucellar colonisation could have been
replaced, during abscess evolution, by superinfecting strains
that made the speciﬁc diagnosis impossible. The latter mechan-
ism could also explain the low incidence of conﬁrmed brucellar
liver abscesses in other series.
P632 Neurobrucellosis: report of ﬁve cases
A. Yuce, B. Karaca, S. Alp Cavus, E. Idiman, F. Idiman, N. Yapar
Izmir, TR
Brucellosis is a zoonotic disease which is still a problem in Tur-
key. Neurobrucellosis is a severe complication of systemic bru-
cella infection and it can be seen 0.5–25% of the patients. The
clinical symptoms and ﬁndings are variable as follows: men-
ingoencephalitis, transient ischaemic attact, serebral infarct, sub-
arachnoid haemorrhagia, myelitis, myelopathy, cranial or
peripheric neuritis, radiculopathy, serebral abcess and progres-
sive myelopathy. There are some problems in early diagnosis of
neurobrucellosis. Systemic signs and symptoms can be indistinct
and the results of serological and bacteriological tests can make
clinicians mislead. Positive CSF cultures are difﬁcult to obtain.
We aimed to report ﬁve cases of neurobrucellosis followed in
our clinic. The mean age of our patients was 32.4 (range 11–65)
years. Of our patients, three were male and two were female.
All of the patients had neurological symptoms and ﬁndings
when they submitted to hospital. Three of the patients had sen-
sorineural hearing loss. Except one patient who has a history of
symptoms lasting 1–2 months, their symptoms began more than
2 years ago. Radiological ﬁndings were all normal except two
patients; one had ventriculer shrink and indistinct brain sulcus
at the beginning of the course of the disease and the other had
hiperintence lesions in white matter of frontal and temporal
lobes in cranial BT scanning. The biochemical results of CSF
were: the pressure and protein concentration were increased,
pandy reactions were all positive, glucose levels were decreased
in all cases, the mean cell count was 105/mm3 (mostly mono-
nuclear cells). Rose Bengal test in serum and CSF were all pos-
itive. The Wright agglutination test (SF) in serum ranged
between 1/80–1/640, in CSF 1/40–1/160. In two of the patients,
CSF cultures revealed Brucella melitensis. The other three cases‘
results for blood and CSF cultures were negative. The hearing
loss did not improved but the neurological signs and symptoms
improved in all of the patients except one patient who had
organic brain syndrome 1 year after the therapy. In conclusion;
there are still problems in diagnosis of neurobrucellosis which
can cause important neurological sequelae. In the patients who
has neurological symptoms, neurobrucellosis have to be suspec-
ted by clinicians. The clinicians must carefully evaluate clinical
symptoms and laboratory results when neurobrucellosis is sus-
pected.
P633 Evaluation of available stains for detection of
Acanthamoeba sp. from brain specimen: an assessment
G. Gonzalez Mediero, P. Santiago, M. Seijo, G. Visvesvara
Vigo, Pontevedra, E; Atlanta, USA
Objectives: Acanthamoeba sp. and others free-living amoebae are
rare cause of opportunistic cerebral and mucose disease above all
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in AIDS and usually are diagnosed post-mortem. The aim of this
study is to determine the better and more fast stain for detection
of granulomatous amoebic encephalitis (GAE) and their recuper-
ation of strain from culture.
Methods: A patient, 33-year-old was admitted to the hospital in
late January 1998 with a 2 days history of headache, confusion
and a left ﬁeld visual defect. A cranial computed tomography
scan revealed a mass in the right occipital lobe. Toxoplasmosis
was suspected. A biopsy specimen was obtained which multiple
double walled cyst-like structures and granulomatous reaction
were seen. We never has seen visualised this image but we
think in Acanthamoeba sp. or Balamuthia mandrillaris. Six weeks
after, a right parieto-occipital craniotomy was performed and
microscopical examination, wet and stained preparations was
carried out, Kop Color (Innogenetics), periodic acid-Schiff (PAS),
trichrome, haematoxylin-eosin, Gomori methenamine silver and
others.
Results: An indirect immunoﬂuorescence and culture in non-
nutrient agar plates precoated with Escherichia coli culture and
incubate at 37C about 8 days was identiﬁed as Acanthamoeba ca-
stellanii. This is the ﬁrst case of GAE identiﬁed from Spain.
Conclusions: We think as others authors that GAE is not diag-
nostic sometimes probably, special cultures are required for the
identiﬁcation. As all but a few isolations from human tissue
have yield it is generally believed that most human infections
have been due to free-living amoebae. The tissue can have por-
tion with amoebae and others without it. Fast stains including
wet mounting can do more easy the recuperation of strain.
Then a positive culture can facilitate the identiﬁcation, Balamu-
thia not grow on non-nutrient agar but can be grown on mam-
malian cell lines.
P634 Leptomeningeal form of neurocysticercosis with
chronic meningitis
S. Nikolic, G. Stevanovic
Belgrade, CS
Objectives: During 2002 and 2003, we treated 46 patients with
neurocysticercosis. Neurocysticercosis was the most frequent
parasitosis of the central nerve system. Parenchymal form was
seen in 60–90% of patients; Leptomeningeal and spinal form are
rare. We treated four patients with this form of disease. The
objective of our work was to present clinical course and thera-
peutic outcome in patients with chronic meningitis during neu-
rocysticercosis.
Methods: We present clinical, laboratory and neuroradiological
ﬁndings and therapeutical outcome in these patients.
Results: Our patients had pleocitosis in cerebrospinal ﬂuid
(CSF), average 74  20 cells, CSF proteins was elevated, more
then 6.4 g/L, and CSF glucose levels were 0–1.5 mmol/L. The
pathological ﬁndings were present in prolong time period
(6 months to 2 years). In neurological ﬁndings, all of them
have a meningeal symptoms, with neurological deﬁciencies (pa-
resis, ataxia, etc.). Duration of which was not correlated with
CSF ﬁndings. Pathological changes in CSF were present longer
then neurological problems. Serological conformation of cysti-
cercosis was performing by ELISA test from blood and CSF.
Intrathecal synthesis was positive. Tests for echinococcosis and
toxoplasmosis were negative. Magnetic resonance imaging
(MRI) was reviled in two cases parenchimal and leptomenin-
geal form of neurocysticercosis. One patient has only leptomen-
ingeal form, and one patient has parenchimal, leptomeningeal
and spinal form of neurocysticercosis.
Conclusions: Leptomeningeal form of neurocysticercosis was rare
(8%). All of our patients have chronic meningitis during 6 months
to 2 years. Neurological and laboratory ﬁndings are correlating
with MRI. Repeated treatment (3–5) was necessary for successful
cure. We used albendasol with corticosteroids. Side effects were
mild and well tolerated.
P635 Distribution of soft and hard ticks and their
association with Borrelia and CCHF in Isfahan province, Iran
M. Motavalli Emami, B. Ataei, M. Khademi, A. Omoumi,
M. Hamdi
Isfahan, IR
Objectives: A faunistic study was carried out to estimate the fre-
quency and distribution of different species of soft ticks and
Ornithodoros association with intermittent relapsing fever and
have ticks infestation with CCHF.
Methods: Ten per cent of villages in 18 county of Isfahan prov-
ince were selected randomly and ticks were collected from their
habitats from June 2002 to June 2003. All of ticks were detected
alive and studied for infection rate of Borrelia and CCHF by
RT-PCR.
Results: Overall 6600 ticks were collected in this survey. The iden-
tiﬁed adult ticks were Argas persicus, A. reﬂexus, Ornithodorous la-
horensis, O. canestrinii, O. erraticus, O. tholozani, Boophilus annulatus,
Rhipicephalus bursa, R. sanguineus, Dermacentor niveus, D. margina-
tus, Haemaphysalis inermis, Hae. Sulcata, Hae. conncina, Hyalomma
anatolicum, Hae. punctata, H. dromedarii, H. asiaticum, H. deritum, H.
marinatum, H. schulzei, H. Aegyptium and Ixodes ricinus. The soft
ticks were infested to Borellia in Isfahan, Fereidan, Fereidonshahr,
Semirum and Aran-Bidgol county. No infestation by CCHF were
observed.
Conclusions: This study conﬁrm infestation by Borrelia–Persica and
Microti in Isfahan province that take advantage of them for con-
trol planning of arthropod diseases, and no building in and over
rodent colonies, and so physicians must pay attention to this dis-
ease in contaminated regions.
P636 The occurrence of Entamoeba gingivalis in patients
with periodontal diseases
D. Wojnicz, J. Sarowska, Z. Kozlowski
Wroclaw, PL
Objectives: The aim of this study was to assess the frequency of
occurrence of Entamoeba gingivalis in patients with periodontal dis-
eases and the correlation between the prevalence of these proto-
zoans in relation to clinical symptoms.
Methods: Diagnostic material in the form of swabs collected from
dental plaques, pockets and periodontium were used. The diag-
nostic material was collected from 20 patients with periodontal
diseases The way of detecting E. gingivalis was based on making
microscopic preparations using a special liquid, which extends
the vitality of protozoa. Next these specimens were examined in a
contrast phase. Entamoeba gingivalis was identiﬁed by characteris-
tic movement of pseudopodia.
Results: The presence of E. gingivalis was found in 60.5% of
examined patients. Among this group of patients the characteristic
indicators of periodontal diseases such as: oral hygiene index (PI,
PI%, API%), gingival index (GI, GI%), bleeding index (PBI,PDJ)
and deepness of gingival pockets (GK2, GK4, L>5) were analysed.
The statistical analysis of these results indicated the correlation
between the occurrence of E. gingivalis and PI, PI% and L > 5.
Conclusions: Our clinical and microscopic observations led us to
consider that infection with oral protozoans should be regarded
as an important factor associated with the pathological changes
occurring in patients with periodontal diseases.
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Meningitis
P637 Demographic, clinical and laboratory data in 140
meningococcal disease cases
A.R. Emami Naeini
Isfahan, IR
Introduction and Objective: Meningococcal diseases occur in a
worldwide distribution as endemic or in epidemics. The overall
mortality is 8–10% with deaths occurring mainly in patients pre-
senting with signs and symptoms of meningococcaemia. Several
investigators have devised scoring systems using clinical and
laboratory parameters available at the time of presentation to
prognosticate the outcome of the infection. We conducted this sur-
vey to determine the prevalence of demographic, clinical, laborat-
ory data in our patients.
Methods: This was a prospective descriptive study performed
upon patients with deﬁnite diagnosis of meningococcal infection
(blood or cerbrospinal ﬂuid positve culture) in St Zahra Hospital,
Isfahan (centre of Iran) during October 1996 till September 2001.
The subjects were comprised 140 patients [99 (70.7%) males and
41 (29.3%) females] aged 1–50 years. The data were achieved by
checklist and analysed by using SSPS software.
Results: Upon this study, 99 (70.7%) were males and 41 (29.3%)
females, and among them 75 (53.6%) were aged between 11 and
20 years. In the study population, 57 (40.7%) were students, 39
(27.8%) workers, 20 (14.3%) infant and children and 24 (17.2%)
other jobs. Seasonal frequency: winter 49 (35%), spring 37
(26.4%), summer 30 (21.4%), fall 24 (17.2%). Iranian 92 (65.7%)
and Afghan refuges 48 (34.3%). Clinical presentation: pure men-
ingitis 40 (28.6%), meningitis with meningococcaemia 62
(44.3%), meningococcaemia alone 33 (23.5%) and meningoen-
cephalitis ﬁve (3.6%). The ﬁve most clinical symptoms and signs
were: fever 131 (93.6%), vomiting 107 (76.4%), neck stiffness 105
(75%), headache 96 (68.5%), skin rash 92 (65.7%). Paraclinical
data: leucocytosis 99 (70.7%), normal range 25(17.8%) and leu-
copenia 16 (11.5%). The predominant white blood cell was poly-
morphonuclear 134 (95.7). Thrombocytopaenia 27 (19.3%).
Abnormal prothrombin time 46 (32.85%). The mortality rate was
15 (10.7%). All of our patients had the ﬁrst episode of meningo-
coccal infection. Fifteen (10.7%) had deﬁciencies of terminal com-
plement components C5–C9. Lumbar puncture was carried out
in 121 (86.4%) patients, and the abnormal results were observed
in 107 (76.4%).
Conclusion: Meningococci is still a killer, it affects males more
than females, the highest age-related attack rate occurs in teenag-
ers and young adults. Afghan refugees were a source of infection
in our survey that may be due to crowded and low socioeconomic
state of them. Central nervous system is a target organ in men-
ingococcal infection. Our mortality was higher than what to be
suggested.
P638 Laboratory surveillance of meningococcal disease in
Portugal
M.J. Simo˜es, L. Brum, C. Furtado on behalf of the Laboratory
Meningococcal Disease Network
Objectives: In 2002, the control of meningococal disease (MD) was
considered a priority in Portugal and a new surveillance system
was introduced. Since October 2002, a laboratory-based surveil-
lance system for MD (VigLab MD) started based on a laboratory
network, which includes all laboratories from hospitals with MD
inpatients. Laboratories notify to the National Institute of Health
(INSA) all suspected cases received for laboratory conﬁrmation,
make Neisseria meningitides isolation and send the strains for fur-
ther characterisation (antigenic and molecular). Besides, they also
should notify all culture negative cases of CSF having previously
established criteria, and sent them to INSA where the conﬁrma-
tion is made by non-cultural methods (PCR). The aim of this
study was to determine the number of clinical or laboratory sus-
pected cases of MD in which N. meningitis was detected.
Methods: Neisseria meningitides strains were isolated in hospital
laboratories according to their own protocols. Direct DNA detec-
tion in clinical samples with negative cultures was performed by
real time PCR (Light Cycler System, Roche, Germany) amplifying
a 111-nucleotide sequence of gene ctrA. In a screening test, we
used the ﬂuorochrome SYBR Green and, in a conﬁrmatory test, a
ﬂuorescent dye-labelled-speciﬁc probes. The melting temperature
was used for identiﬁcation of amplicons. Strain group determin-
ation was performed by direct agglutination (Difco) or, when non-
reactive, by PCR using primers speciﬁc of siaD gene for group B,
C, Y and W135, and orf-2 gene for group A. Group determination
of noncultural strains present in clinical samples, was also per-
formed by PCR. For serotyping and subtyping, we used monoclo-
nal antibodies from National Institute for Biological Standards
and Control in an ELISA technique.
Results: In a 14-month period, we received 181 clinical samples
and 118 strains. In 155 cases, we had conﬁrmed MD and charac-
terised serogroups as follows:
• 144 – culture negative + PCR negative;
• 37 – culture negative + PCR positive;
• 118 – culture positive.Seventy-nine strains were in group B, 57
strains group C and seven strains group W135
Conclusion: PCR is a very important tool for detection and charac-
terisation of N. meningitides. This network has greatly contributed
for clarifying the Portuguese situation in what concerns the MD.
P639 Multidisciplinary research of meningococcal invasive
disease in the Czech Republic
E. Kasal, V. Struncova, P. Krizova, I. Chytra, I. Martinkova,
I. Subrt, O. Dzupova, V. Dostal, L. Roznovsky, T. Habanec,
P. Chalupa, D. Barnetova, L. Nalos
Pilsen, Prague, Hradec Kralove, Ostrava, Brno, CZ
Objectives: Changing severity of MID in the Czech Republic (CR)
being related to the high incidence of invasive strain of Neisseria
meningitidis (NM), belonging to ET-15/37 complex, constrains to
elaboration of diagnostic, therapeutic and severity assessment
algorithms. High incidence of sepsis initiated our intensive study-
ing of prognostic factors of MID on admitting to the hospital,
properties of NM and other factors of MID.
Methods: A new grant project being further to our previous grant
researches started in 2002, concentrates complex of MID data from
eight departments in CR to the database including haematological
and genetic research results. The research of NM in NIPH – iden-
tiﬁcation of electrophoresis genotype ET by multilocus electro-
phoresis (MLEE) and identiﬁcation of sequence type (ST) by
multilocus sequence typing (MLST) is carried out in all patients
as well. NM strains were isolated from patients and/or from PCR
products in patients with negative cultivation. Belonging to
hyper-virulent complexes (HC) is assessed together with prognos-
tic factors and contextualised with the genetic familiar predisposi-
tion to the pathological pathway of ﬁbrinolysis (due to mutation
of promoter gene for PAI-1), and polymorphism G 308A in the
promoter gene for tumour necrosis factor (TNF). Within
15 months, we have got data from 78 patients (53.4% of MID
in the CR). Group characteristics: median of age 17.5 years,
male:female ¼ 42:36, mortality ¼ 10.3%.
Results: Data analyses show 6.4% incidence of benign meningo-
coccaemia, increasing incidence of sepsis (33.3%) with mortality
30.7%, decreasing incidence of sero-group B (42.5%) with 53% of
HC (20.6% without), increasing incidence of serogroup C (34.6%)
with HC in 92.5%. Serogroup was not identiﬁed in 16.6%. HC
could not be proved in two cases with group C and in seven cases
with group B due to the PCR detection only. Relationship among
three above-mentioned areas of investigation is evaluated.
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Conclusions: High incidence of hyper-virulent strains proved
almost in all cases with NM group C and in majority of cases
with group B does not correspond with only 33.3% incidence of
sepsis. High incidence of proved benign meningococcaemia indi-
cates good awareness of MID in the CR. Complete multidiscipli-
nary approach to the MID research can contribute to get
explanation for not yet answered question, why MID sometimes
kills and sometimes has a benign course.
Acknowledgements: This study was supported by grant IGA Min-
istry of Health NI-7109-3 (http://www.neisseria.mlst.net).
P640 Community-acquired enterococcal meningitis caused
by Enterococcus casseliﬂavus: ﬁrst case report
A. Iaria, G. Stassi, R. Di Leo, A. Toscano, A. Cascio
Messina, I
Background: Enterococcal meningitis accounts for only 0.3–4.0%
of cases of bacterial meningitis. Enterococcus faecalis and E. faecium
are the most frequent meningeal isolates accounting for 76–90 and
9–22%, respectively. Enterococcus casseliﬂavus is a motile enterococ-
cus that produces a yellow pigment in agar and has a VanC phe-
notype (intrinsic low level resistance to vancomycin and
susceptibility to teicoplanin). It has been implicated in a wide
variety of infections in human beings, especially immunocompro-
mised persons, but never in meningitis.
Case Report: A 77-year-old female presented for evaluation of
fever, stupor, diarrhoea and vomiting of 3 days duration. There
was no history or head injury or any surgical procedures. She had
been suffering from rheumatoid arthritis for 30 years for which
she was in treatment with steroids and methotrexate, diabetes in
treatment with insulin and moderate renal failure. On admission
she had a temperature of 38.0C. She was alert but not oriented to
time and place. Her neck was stiff, and she had a positive Ker-
nig’s sign. WBC 15 100/mm3, 70% neutrophils and 23% lympho-
cytes. CSF was opalescent, glucose: 14 mg/dL, protein: 472 mg/
dL, white cell counts: 200/mm3. CSF was processed using BAC-
TEC 9120. Enterococcus casseliﬂavus was identiﬁed using the
VITEK-2 system and on the basis of motility and yellow pigmen-
tation testing. The isolate was (i) susceptible to penicillin, ampicil-
lin, ampicillin-sulbactam, imipenem, teicoplanin, tetracyclines and
linezolid; (ii) low level resistant to vancomycin (MIC > 8 mg/L),
trimethoprim-sulfamethoxazole, levoﬂoxacin, ciproﬂoxacin and
quinupristin-dalfopristin; and (iii) high level resistant to gentami-
cin, streptomycin and kanamycin and clindamycin. Echocardio-
gram revealed no isolates. Colonoscopic examination revealed
two ulcerative lesions covered by ﬁbrin in the rectal mucosa and
multiple punctuate erosions in the sigma mucosa. She was suc-
cessfully treated with meropenem and ampicillin–sulbactam.
P641 Factors predicting fatal outcome of purulent
meningitis
N. Dzupova, J. Benes, M. Helcl, J. Prihodova
Prague, CZ
Objectives: To deﬁne the most accurate factors predicting in-hos-
pital mortality of patients with purulent meningitis.
Methods: Retrospective study of patients hospitalised between
1997 and 2001 in an infectious diseases department of a tertiary
care hospital. Records of 149 consecutive patients, older than
15 years with community-acquired purulent meningitis were
reviewed. The following data were selected and further analysed:
age, sex, duration of symptoms to diagnosis, underlying debilita-
ting conditions, GCS score, APACHE II score, cerebrospinal ﬂuid
(CSF) leucocyte count, CSF protein level, CSF glucose level,
CSF/blood glucose ratio and aetiology. Each parameter was tested
in univariate logistic regression analysis and furthermore all signi-
ﬁcant variables were tested in multivariate analysis.
Results: There were 30 fatal cases with the overall mortality rate
20.1%. Neisseria meningitidis meningitis possessed the lowest mor-
tality rate (2/37 ¼ 5.4%), compared with Listeria monocytogenes
(2/10 ¼ 20%) and Streptococcus pneumoniae (12/39 ¼ 30.8%). The
risk of death was signiﬁcantly higher in older age (P ¼ 0.002),
presence of underlying condition (P ¼ 0.005), lower GCS score
(P < 0.001), higher APACHE II score (P < 0.001), lower CSF/blood
glucose ratio (P ¼ 0.001).
Conclusion: Signiﬁcant prognostic factors indicated by univariate
logistic regression analysis were age, underlying debilitating
condition, GCS score, APACHE II score and CSF/blood glucose
ratio. Sex, duration of symptoms to diagnosis, CSF leucocyte
count, CSF protein level and CSF glucose level had no signiﬁ-
cant prognostic value. In multivariate analysis only age and
APACHE II score were signiﬁcant predictors of fatal outcome.
These results are in agreement with previously published stud-
ies.
P642 Dexamethasone therapy for bacterial meningitis in
south-eastern Anatolia region of Turkey
C. Ayaz, M.K. Celen, S. Hosoglu, M.F. Geyik, M. Ulug
Diyarbakir, TR
Objectives: Routine use of steroids as adjunctive treatment of
bacterial meningitis remains controversial. We have carried out a
retrospective, placebo-controlled, double-blind study of dexameth-
asone in 145 adult with acute bacterial meningitis in Dicle Univer-
sity of Turkey.
Methods: The patients were randomly assigned to receive either
ceftriaxone (n ¼ 72) or dexamethasone (n ¼ 73) in addition to
optimum antibiotic treatment (4 g every day ceftriaxone). Dexa-
methasone therapy (16 mg every day) was started 10 min before
the ﬁrst dose of ceftriaxone and has given every 6 h for 3 days.
Results: Baseline dermographic, clinical and laboratory features of
the two groups were similar. The mean age of the patients was
30.2  15.3 years. The sex of the patients was 91 males and 54
females. We have growth in 23 patients (15.9%) Streptococcus pneu-
moniae, in 12 (8.3%) Neisseria meningitis, in three (2.1%) S. aureus
and 107 (73.7%) patients had no growth in cerebrospinal ﬂuid
cultures. CSF glucose concentration signiﬁcantly increased in dex-
amethasone therapy than the other group after 24 h treatment
(P ¼ 0.01). However, other indices of inﬂammation showed sim-
ilar changes in both groups. Addition of dexamethasone did not
affect the rate at which CSF became sterile. When we compared
two group the fatality rate was observed in patients with acute
bacterial meningitis which were receiving dexamethasone; only
seven of 73 patients died, 12 of 72 patient died which were not
receiving dexamethasone.
Conclusion: Acute bacterial meningitis still remains a serious
infection. Early diagnosis and treatment may reduce fatal outcome
and improve the course of the disease. We conclude that dexa-
methasone is beneﬁcial in the treatment of adults with bacterial
menengitis, particularly in preventing deafness.
P643 Serologic evidence of Borrelia burgdorferi infection
among patients hospitalised with tick-borne encephalitis
S. Grygorczuk, M. Kondrusik, S. Pancewicz, J. Zajkowska,
T. Hermanowska-Szpakowicz
Bialystok, PL
Objective: The purpose of this work was to evaluate serum and
cerebrospinal ﬂuid presence of antibodies against Borrelia burgdor-
feri of patients with diagnosed tick-borne encephalitis.
Methods: Sera and cerebrospinal ﬂuid of 90 patients with diag-
nosed TBE were analysed. The diagnosis of TBE was based on
anamnesis (reported tick bites or endemic area dwelling) clinical
symptoms (fever, headache and neurological signs) and results of
laboratory tests (inﬂammatory changes of CSF parameters, sero-
logically conﬁrmed serum/CSF presence of IgM, IgG antibodies
against TBE virus). Patients were divided into two groups: group
I: 28 patients with severe clinical course of TBE with paresis and
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unconsciousness; group II: 62 patients with mild course of TBE.
Serological diagnosis of IgM, IgG antibodies against B. burgdorferi
was performed with use of ELISA recombinant kit. CSF and sera
were collected during ﬁrst days of hospitalisation when diagnosis
was established.
Results: In group I, IgM antibodies against B. burgdorferi in CSF
were detected in two (7.14%) patients and IgG in six (21.42%).
One patient showed presence of IgM and IgG simultaneously. In
group II, IgM in CSF was not present in any patient but IgG was
found in CSF of eight (12.9%) patients. Serum IgM antibodies
among patients from group I were detected in two (7.14%)
patients and IgG in seven (25%) patients. Patients with CSF anti-
bodies against B. burgdorferi showed their presence in serum as
well. In sera of group II patients, presence of IgM antibodies was
detected in four (6.45%) patients and IgG in 12 (19.35%).
Conclusion: The diagnosis of tick-borne encephalitis should not
exclude infection with B. burgdorferi. Patients with severe course
of TBE showed more frequent presence of antibodies against
B. burgdorferi in CSF and serum.
P644 Spinal epidural abscess in the MRI age
F.J. Ferna´ndez-Ferna´ndez, S. Pe´rez-Ferna´ndez,
J. de la Fuente-Aguado, B. Sopen˜a-Pe´rez Argu¨elles,
C. Martı´nez-Va´zquez
Vigo, E
Objectives: To evaluate the clinical, microbiological and prognos-
tic characteristics of patients who were seen in our hospital with
spinal epidural abscess (SEA).
Methods: Retrospective and descriptive study of patients who
were diagnosed of SEA at our institution between January 1998
and November 2003 was used in this study.
Results: During the period of study 11 patients (nine males, mean
age 58  14 years) were diagnosed of SEA. The most common
symptoms at presentation were fever (100%) and radicular pain
(82%). There were signs of cord compression in 55%. In seven
patients, the origin was community acquired. Seven patients had
comorbid conditions (three alcoholism, two diabetes mellitus and
two cancer); two cases presented a potential source of infection
(vascular catheter); and in three cases, there was a direct spread
from contiguous sources (epidural catheter, previous laminectomy
and thoracic empyema). The isolated microorganisms were Sta-
phylococcus aureus (six patients), Streptococci (two patients) and
polymicrobial (one patient). The aetiological agent was not identi-
ﬁed in two patients. Bacteraemia was documented in six patients.
The lumbar spine was most commonly involved (seven patients),
followed by thoracic (ﬁve patients) and cervical (two patients)
regions. In three patients, there were multiple segments affected.
In ﬁve patients, the abscess was circumferential, and in four cases
was posterior. Spondylodiscitis was associated in ﬁve patients.
The treatment was laminectomy and antibiotics in eight cases,
and three patients were treated only with antibiotic therapy. Two
patients died. In the univariated analysis the advanced age was
the only variable associated with worse outcome.
Conclusions: In our experience the SEA is essentially produced by
S. aureus. A high index of clinical suspicion should be kept in
mind in patients with fever and spinal pain to avoid the progres-
sion and development of cord compression. Less than half of the
cases have spondylodiscitis associated. In selected patients, the
antibiotics alone can be effective.
HIV
P645 Genotype-guided treatment change in previously
heavily antiretroviral treatment HIV patients
D. Arroyo, C. Tampe, G. Gonzalez, S. Saavedra,
C. Rivera-Vazquez, C. Ramirez-Ronda
San Juan, PR
Objective: To study HIV resistance in Hispanic antiretroviral ther-
apy (ART)-experienced patients, and response after genotype
(GT)-guided ART changes.
Methods: A retrospective analysis of ART-experienced patients
seen in an outpatient clinic in Puerto Rico, assessment of resist-
ance by GT, and evaluation of virological response after GT-
guided ART change.
Results: A total of 84 patients, all ART-experienced Hispanic men,
had 92 GTs performed for ART failure. Seventy-three per cent
had >1 prior change in their ART, 89% were using >3 ART drugs.
Prior exposure to all three drug classes was seen in 35% patients,
to NRTI + PI in 38%, to NRTI + NNRTI in 18% and to only NRTI
in 9%. Mean ART length was 38 (range 3–60) months. Mean VL
was 40 000 (811–750 000). Resistance by GT to all three drug clas-
ses was seen in 26% of patients, to two classes in 48% and to one
class in 14%. Twelve per cent of patients had wild-type virus;
86% had resistance to NRTI, 55% to PI, and 46% to NNRTI.
Fifty-eight patients had a GT-guided ART change. VL decrease
>0.5 log was seen in 57% patients within 16 weeks. Thirty-four
per cent reached VL <400. New ART included two sensitive drugs
in 69% patients, only 26% had >2 sensitive drugs. Success in
patients having used <3 drugs in the past was 100%, those having
used 3–7 drugs 59%, and those having used >7 drugs 20%
(P ¼ 0.05). Patients with resistance to <2 drug classes were more
likely to have virological success vs. those with higher resistance
(71% vs. 57%), but not signiﬁcantly so. Success did not depend
on the number of sensitive drugs or on the number of new drugs
added.
Conclusions: Genotype-guided ART change was associated with
59% virological success in this clinic, despite having a heavily
ART-experienced and heavily resistant population. Success was
predicted by the number of drugs the patient had previously
used. There was a trend to better success in those with <2 ART
drug class resistance. Success was not predicted by the number of
sensitive drugs nor the number of new drugs in the patient’s
ART.
P646 Lipodystrophy as paradoxically marker of efﬁcacy of
antiretroviral therapy in AIDS patients: our experience
L. Terra, S. Pellican, R. Calzone, A.C. Del Giudice, D. Teti,
F. Rombola`, S.N. Bertuccio, L. Terra
Crotone, I
Background: After antiretroviral therapy are described lipidic
alterations of metabolism and lipodystrophy with peripheral loss
of fat and central accumulation.
Objective: To evaluate prevalence of lipodystrophy and its corre-
lations with lipidic alterations.
Patients and Methods: Between 1998 and 2002, 203 AIDS patients,
125 males (62%), 78 females (38%), age 23–71 (mean
47  24) years were hospitalised.
Results: Seventy-three patients (46%) had lipidic alterations: 35
patients (22%) had hypercholesterolemia, 29 patients (18%)
hypertrigliceridemia and nine patients (6%) both. Fifty patients
(68%) had lipodystrophy. Hypercholesteraemia was associated at
age, lamivudine (P ¼ 0.033), ritonavir (P ¼ 0.002), whereas hyper-
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trigliceridaemia at age, sex, time of diagnosis, lamivudine, stavu-
dine, ritonavir and saquinavir.
Conclusions: In our study, lipidic alterations were associated with
lipodystrophy especially but there was a better immune-virologi-
cal answer to antiretrovirals. Lipodystrophy paradoxically can be
considered marker of efﬁcacy of therapy.
P647 Head-to-head comparison between ﬁrst-choice
HAART in antiretroviral-naı¨ve patients with HIV infection:
lopinavir/ritonavir-versus efavirenz-based therapy
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
The updated international guidelines of antiretroviral therapy
pose lopinavir/ritonavir (L)- or efavirenz (E)-based HAART as
the ﬁrst-line choice in naı¨ve patients. Aim of our study is to
review retrospectively the efﬁcacy and tolerability of L- vs. E-
based HAART in 67 naı¨ve patients who started HAART since
2002; 36 consecutive patients treated with L plus two nucleoside
analogues (NA) were compared with 31 consecutive patients
who received E and two NA. At baseline, the two study groups
were matched as to demographic and epidemiological features,
as well as mean viral load (4.5  1.3 vs. 4.3  1.7 Log 10 HIV-
RNA copies per millilitre, for L and E). However, the L group
included a greater number of patients with prior-concurrent
AIDS (P < 0.03), and showed a lower mean CD4þ count at base-
line (P < 0.004). The number of early (ﬁrst month) interruptions
due to poor tolerability proved similar: ﬁve cases in the L group
vs. four among E-treated patients, although untoward events
involved the gastrointestinal tract and the CNS, respectively, for
L and E. During the subsequent follow-up (9–21 months), labora-
tory examinations were performed at least quarterly, and
showed a comparable virological response (as to mode of decay,
and time and rate of viral suppression), in the presence of only
one case of virological failure in the E group. Conversely, a
more rapid immune recovery occurred in L-treated patients,
regardless of the more compromised mean initial CD4þ count of
this last patients group. Mid-term toxicity was signiﬁcantly dif-
ferent, with L-treated patients who experienced an altered serum
lipid proﬁle in over 40% of cases vs. <10% recognised in the E
group. The overall need of change of antiretroviral regimen due
to toxicity, poor adherence, patient’s request, or failure, was
comparable in the two examined patient groups. When consider-
ing our experience on 67 antiretroviral-naı¨ve patients treated
with either L- or E-based HAART, more potent and rapid
immunological effects were achieved in the L group, which
started from a deeper immunodeﬁciency, while E-treated
patients experienced more rare adverse events and had less com-
pliance problems with pill burden and subjective tolerability.
Virological efﬁcacy did not prove remarkably different between
L- and E-treated patients. Pending the approval of other agents
useful for ﬁrst-line HIV infection therapy, the selection of L- vs.
E-based regimens has to take into account of the initial immuno-
logical and disease status, while more data are needed on long-
term outcome, role of emerging resistance and toxicity, as well
as targeted pharmacoeconomic evaluation.
P648 Polyunsaturated fatty acid ethyl ester as therapy of
hypertriglyceridaemia related to HIV infection treated with
antiretrovirals
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Aim of our study is to assess prospectively the efﬁcacy and safety
proﬁle of polyunsaturated fatty acids ethyl ester (PFAEE) in the
control of hypertriglyceridaemia complicating antiretroviral-trea-
ted HIV disease. Forty-three patients aged 38–61 years (29 males)
with a diet- and exercise-resistant hyperlipidaemia and a mean
triglyceridaemia of 298.3  42.2 mg/dL, received PFAEE at 1 g
twice daily, and were followed quarterly for at least 1 year. A
hypercholesterolaemia (mean value 245.0  29.6 mg/dL), con-
curred in 11 cases only. The dylipidaemia was prompted by a
combined highly active antiretroviral therapy (HAART) lasting
from 16 to 119 months (mean 47.2  21.7 months), and based on
protease inhibitors in 30 cases, and non-nucleoside reverse tran-
scriptase inhibitors in 11 patients. Continued PFAEE administra-
tion led to a signiﬁcant decrease of triglyceridaemia of 24.1, 34.3,
36.8 and 39.2%, after 3, 6, 9 and 12 months, respectively
(P < 0.001 vs. baseline levels), while negligible changes occurred
in serum cholesterol levels. Normal serum triglyceride levels
(<172 mg/dL) were reached by 14 patients (34.1%), who contin-
ued PFAEE at 500 mg/day after 6–9 months, while ﬁve patients
had persistently elevated triglyceridaemia (<300 mg/dL), and
after 6 months signiﬁcantly beneﬁted from increased PFAEE
dosage up to 1.5 g/day (reaching a mean 31.2% reduction of
serum triglyceride levels vs. baseline). Mild and transient gastro-
intestinal disturbances (possibly attributable to concurrent medica-
tions) were referred by 12 patients, but no treatment
discontinuation became necessary. Treatment with PFAEE pre-
vented from changes of antiretroviral regimen and its composi-
tion, directly caused by persisting dyslipidaemia. Dyslipidaemia
is a mounting problem in long-term management of HIV infec-
tion, and cardiovascular damage is of particular concern. In our
experience (1–3), all administered ﬁbrates and statins showed a
similar efﬁcacy in the therapy of HIV-associated dyslipidemia, but
signiﬁcant side effects and drug–drug interactions may occur,
especially when antiretroviral drugs and other underlying phar-
macological therapies are of concern. For isolated or predominant
hypertriglyceridaemia, PFAEE may represent an effective and safe
alternative to ﬁbrates and/or statins, to be conﬁrmed in enlarged,
randomised, dose-ﬁnding comparative trials.
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P649 Pharmacokinetics of non-nucleoside inhibitors of
HIV-1 reverse transcriptase of the DATA/DAPY classes of
compounds
P.J. Lewi, K. Andries, A.I. Archakov, E. Arnold, H.H. Bohets,
A.D. Clark, F.F.D. Daeyaert, K. Das, M.-P. de Be´thune,
M.R. de Jonge, Y. Frenkel, J. Heeres, Y.D. Ivanov,
L.M.H. Koymans, A.V. Lisitsa, J. Peeters, P. Timmerman,
G. van’t Klooster, H.M. Vinkers, P.A.J. Janssen
Vosselaar, Mechelen, B; Moscow, RUS; Piscataway, USA; Beerse, B
Objectives: Diaryl-triazine (DATA) and diaryl-pyrimidine ana-
logs (DAPY) are potent nonnucleoside inhibitors of HIV-1
reverse transcriptase (NNRTIs) in cell-based assays on wild-type
virus and also in a large panel of clinically relevant single and
double mutants. Most NNRTIs assume a butterﬂy conformation
within the lipophilic binding pocket of reverse transcriptase
(RT). In the case of DATA/DAPY compounds, the two wings
of the butterﬂy conformation are composed of aromatic rings,
while the central part contains hydrogen bridge forming frag-
ments. Hence, it is not surprising that these compounds are
highly lipophilic with log P-values often in excess of 5. In spite
of their lipophilicity, these compounds show moderate to good
bioavailability in animal species and man. As can be expected,
they are also absorbed to some extent through the lymphatic
pathway.
Methods: We have investigated the possible causes of this seem-
ingly paradoxical relationship between antiviral activity, lipophi-
licity and bioavailability. This comparative pharmacokinetic study
of DATA/DAPY compounds involves various cell-based assays
and physicochemical as well as computed parameters.
Results: A surprising ﬁnding is that highly potent and bioavaila-
ble DATA/DAPY analogues also form aggregates with radii
between 34 and 100 nm. This has been conﬁrmed by means of
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dynamic light scattering, electron microscopy and atomic force
microscopy.
Conclusion: We propose that aggregate formation can be an
important factor in absorption and cell-mediated activity of lipo-
philic drugs.
P650 Restoration of complement-mediated phagocytosis in
HIV-1 infected macrophages by 20,50-dideoxyadenosin
E. Doischer, A. Jaworowski, U. Frank, S. Crowe
Freiburg, D; Melbourne, AUS
Background: Using cAMP analogues, evidence has been obtained
that complement-mediated phagocytosis (CMP) by human mono-
cyte-derived macrophages (MDM) is impaired by cAMP. During
HIV-1 infection, increased intracellular concentrations of the nuc-
leotide cAMP may occur which could have negative effects on
CMP in macrophages.
Objective: To examine the effect of an activator of adenyl cyclase
on CMP and the effect of inhibition of adenyl cyclase on CMP by
MDM infected with HIV-1Ba-L.
Materials and Methods: Using a colorimetric assay, sheep-erythro-
cytes (E) opsonised with human serum as a source of complement
components were used as targets to quantify CMP by MDM infec-
ted with a laboratory adapted, M-tropic strain of HIV-1 for 7–
10 days. Complement receptors were activated using 200 nM phor-
bol myristyl actetate for 15 min, and E uptake measured in the
presence of varying concentrations of forskolin, a potent stimula-
tor of adenylate cyclase, or dideoxyadenosin (ddAD), an inhibitor
of adenylate cyclase. HIV-1 infection was assessed by retroviral
reverse transcriptase activity, whereas immunolabelling of p24
viral antigen and the cell surface marker CD64 allowed quantiﬁca-
tion actively infected macrophages by microscopy and digital ima-
ging.
Results: Consistent with results obtained using cAMP analogues,
forskolin (100 lM) strongly inhibited CMP by 80% (P < 0.0016) in
uninfected MDM. A signiﬁcant increase in phagocytic activity
was observed when erythrocytes were incubated with increment-
ing levels of 2¢,5¢-ddAD (up to 10 lg/mL) in both HIV-1 infected
cells and controls (57  20%, and 30  6%, respectively). In the
presence of 10 MIC/mL 2¢,5¢-ddAD, particle ingestion by HIV-1
infected macrophages reached levels (97%) of complement-medi-
ated phagocytosis of untreated, HIV-negative controls.
Conclusions: In HIV-1 infected MDM, integrin-dependent phago-
cytosis can be restored by 2¢,5¢-ddAD to levels of uninfected macr-
ophages suggesting that elevated cAMP levels in these cells may
contribute to decreased complement receptor function.
P651 CD4þ T-lymphocytes counts at AIDS among patients
treated by highly active antiretroviral therapy or other
antiretroviral regimens
A. Gayet-Ageron, N. Voirin, D. Peyramond, C. Chidiac, C. Trepo,
J.-L. Touraine, B. Issartel, B. Ponceau, P. Miailhes, J.-L. Livrozet,
J. Fabry, P. Vanhems
Lyon, F
Objectives: Opportunistic infections (OI) seem to occur at higher
CD4 count, as the use of HAART. We reported and compared the
CD4 count at four AIDS-deﬁning events for patients receiving
HAART or other regimens. The risk to present OI at higher CD4
count was calculated according to HAART or other regimens.
Methods: Data of 405 patients enrolled prospectively from July
1992 to December 2002 in the Lyon section of the French Hospital
database on HIV were analysed. The following OI were studied:
pneumocystis jiroveci pneumonia (PCP), oesophageal candidiasis
(EC), cytomegalovirus disease (CMV) and Kaposi’s sarcoma (KS).
Patients were stratiﬁed by treatment at OI onset. The CD4 count
100 days before to 15 days after the diagnosis was compared by
treatment group at diagnosis (HAART vs. bi or mono, B + M,
therapy) using Mann–Whitney test (MW). Linear mixed model
(LMM) was used to estimate mean CD4 at OI by treatment group,
taking into account confounders and CD4 counts within 2 years
before the diagnosis. The risk to present OI at higher CD4 count
by treatment group at diagnosis was calculated using multiple
logistic regression by OI and was quantiﬁed by odds ratio (OR)
with their 95% conﬁdence interval (95% CI).
Results: A total of 84 PCP, 173 EC, 206 CMV and 145 KS were
analysed. The follow-up duration, CD4 count at baseline and at
treatment initiation was similar for each treatment group. Median
CD4 counts were signiﬁcantly higher among patients on HAART
at onset of EC, CMV infection, KS but not for PCP (see table).
Mean of CD4 estimated with LMM conﬁrmed these results (see
table). The risk of OI at higher CD4 count was increased for all
OI, except PCP, in patients receiving HAART compared with
those on B + M: at PCP with CD4 > 100, OR 5.8 (95% CI 0.9–
33.9); at EC with CD4 > 100, OR 2.4 (95% CI 1.1–5.3); at CMV
with CD4 > 100, OR 8.4 (3.1–23.0) and at KS with CD4 > 200, OR
7.7 (95% CI 2.9–20.1).
Conclusions: The risk of OI at higher CD4 count was increased for
patients receiving HAART compared with those on B + M. That
could be explained by an incomplete restoration of CD4 function
in spite of an increase of the CD4 count. OI occurring at higher
CD4 count since the use of HAART emphasises the need of
appropriate follow-up to detect and prevent OI. Results from
other cohorts would be helpful to conclude.
P652 Gender differences in HIV RNA and CD4 counts, but
not in AIDS-deﬁning illnesses and CD4-based HAART
initiation threshold, in new entrants to HIV care in Cleveland,
Ohio
C.V. Loupa, B. Rodriguez, H. Valdez, R.A. Salata, M.V. Lisgaris,
B. Gripshover, G. McComsey, S. Fulton, M.M. Lederman
Cleveland, Ridgebury, USA
Objectives: To examine possible differences between HIV-infected
men and women new to HIV care at University Hospitals of
Cleveland between 1995 and 2002.
Methods: Through database extraction, we identiﬁed 1066 patients
who sought treatment for the ﬁrst time at our Special Immuno-
logy Unit between 1995 and 2002. Of these, 806 (80.1%) with no
history of AIDS-deﬁning illnesses more than 3 months prior to
presentation and no prior antiretroviral exposure are included in
this analysis. Data were analysed using t-test for independent
groups and chi-square (SPSS version 11.0).
Results: Six hundred and thirty-two (78%) of our patients were
men. Women had higher CD4 counts and lower HIV RNA than
men at baseline (mean: 388  282 vs. 310  242 cells/lL,
P ¼ 0.003, and 89 396  168 223 vs. 126 537  200 540 copies/mL,
P ¼ 0.048, respectively). The proportion of entrants with CD4 cell
counts <200/lL did not differ signiﬁcantly between sexes (37.8%
vs. 30.4%, P ¼ 0.11). There was no difference in the proportion of
patients presenting with category C AIDS-deﬁning illnesses, cate-
gory B symptomatic conditions and STD history between men
and women (15.8% vs. 12.0%, P ¼ 0.23; 27.8% vs. 29.8%,
P ¼ 0.63; and 17.7% vs. 14.9%, P ¼ 0.42, respectively). Seropreva-
lence of hepatitis B (HbsAg) was higher in men (8.7% vs. 0.6%,
Table 1. Median and mean CD4 counts at OI onset by treatment
groups.
Treatment at
OI onset
HAART (n¼114) B+M (n¼291) p-value
OI Median CD4 Mean CD4 Median CD4 Mean CD4 MW1 LMM2
PCP (n ¼ 84) 18 57 29 49 0.62 0.61
EC (n ¼ 173) 59 96 21 48 <103 <101
CMV (n ¼ 206) 48 73 13 36 <101 <104
KS (n ¼ 145) 155 161 28 58 <101 <103
1Median comparison
2Mean comparison
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P < 0.001), but there was no difference in hepatitis C Ab (18.8%
vs. 15.6%, P ¼ 0.40).
Conclusions: In Cleveland, female new entrants to HIV care had
higher CD4 cell counts, lower HIV RNA levels and were less fre-
quently seropositive for hepatitis B infection. Whether women
here seek HIV care earlier in the course of disease or whether
early markers of HIV disease differ between sexes in this popula-
tion remains to be determined.
P653 Incidence and predictors of opportunistic infections
and mortality in HIV/AIDS patients admitted to a university
hospital: a 16-year follow-up
F. Sain Gu¨ven, N. Aydemir, B. Cakir, O. Uzun, S. U¨nal
Ankara, TR
The study aimed to determine the incidence and signiﬁcant risk
factors of opportunistic infections in HIV/AIDS patients fol-
lowed in the Department of Internal Medicine between 1986 and
2002, and to investigate predictors of mortality in this group.
The charts of all HIV-AIDS patients (n ¼ 110) were retrospec-
tively examined. Data were collected on patients’ sociodemo-
graphic characteristics, morbidity features at admission, presence
and type of opportunistic infections, antiretroviral treatment
modalities used and outcomes as of 31 December 2002. The
mean (SD) age was 37.1  12 years and 68% were men. Het-
erosexual contact was the major route of transmission (68.2%).
According to CDC-93 classiﬁcation (modiﬁed in 1997), 36, 38
and 33 patients were at categories A, B and C, respectively, and
42 patients had CD4þ cell count of <200/mm3 at the ﬁrst visit.
Forty-two patients experienced at least one opportunistic infec-
tion. The most common AIDS indicator condition was pneumo-
cystis carinii pneumonia (n ¼ 17, 15.5%), followed by
tuberculosis (12.7%), CMV infection (9.1%), toxoplasmosis
(8.2%), cryptococcal meningitis (2.7%) and PML (1.8%). Ninty-
one patients (82.7%) received at least one antiretroviral drug.
Twenty-four (21.8%) patients died during therapy. Cox propor-
tional hazards modelling was conducted to identify statistically
signiﬁcant predictors of opportunistic infections: adjusting for
initial CD4þ cell count, antiretroviral therapy and route of trans-
mission, patient’s age at admission (HR ¼ 1.03, 95% CI 1.01–
1.06) was the only signiﬁcant predictor of opportunistic infection.
In the study group, mortality was signiﬁcantly associated with
age at admission (HR ¼ 1.06, 95% CI 1.02–1.10) and presence of
at least one opportunistic infection (HR ¼ 2.58, 95% CI 1.01–
6.58). Study ﬁndings conﬁrmed that opportunistic infections are
signiﬁcant predictors of mortality in HIV/AIDS patients. In the
study, age at admission was indicated as a signiﬁcant predictor
of both occurrence of opportunistic infections, and subsequent
mortality.
P654 Venezuelan HIV patients and prevalence of HPV
infection in anal samples
M. Correnti, M.E. Cavazza Porro, R. Alfonso, E. Arias, M.P. Avila,
M. Uribe
Caracas, VE
Objective: The aim of the study was to characterise HPV infection
in a group of HIV positive male patients to determine the associ-
ation between HIV infection, anal squamous intraephitelia lesions
(ASILs) and HPV genotypes.
Methods: Twenty HIV positive and 9 HIV negative men were
enrolled after informed consent and complete physical examina-
tion. Anal exfoliated cells were collected for PCR assay. The HPV
typing were performance by using FRLP (HPV fast, Pharmagen,
Spain).
Results: In the group of HPV positive patients, 10% had ASCUS
lesions, 35% low grade anal squamous inthraepitelial lesion (LgA-
SIL), 15% high grade ASIL (HgASIL) and 5% presented HgASLI/
invasive anal cancer. In the HIV negative patients 67% had nor-
mal cytology, 11% with ASCUS and 22% with LgASIL. The over-
all prevalence of HPV infection was higher in HIV positive group
(95%) the negative HIV patients (78%) (P < 0.001). The HPV type
16 was the most frequent genotype in HIV positive male (55%)
associated with ASCUS, LgASIL and in all cases of HgASIL/anal
cancer; only 33% of HIV negative patients presented this HPV
type. A high spectrum of HPV genotypes in the HIV positive
group: 6, 11, CP8304, 70, 58, 31, 33, 61 and 83. A high prevalence
of oncogenic HPV types (30%) was found in the group of HIV
positive patients with normal anal cytology.
Conclusions: The results in this study shown both high rate anal
HPV infection and anal disease in the HIV positive patients
(95%). The HPV 16 is the most frequent genotype in our HIV pos-
itive men population and another common feature of HPV infec-
tion in this group was the mix viral genotypes observed in the
anal samples. In the HIV positive patients with normal anal cytol-
ogy, we found a high prevalence of high-risk oncogenic types of
HPV. This group represents a high-risk population for develop-
ment anal diseases.
Acknowledgements: This study was supported by grant FONA-
CIT-S12000000643.
P655 HCV viraemia and the degree of hepatic affectation
in HCV-HIV co-infected patients
S. Garcinun˜o, I. Guilabert, T. Alvarez Gago, M.A. del Pozo,
J. Arias, B. Sa´nchez Borge, M.A. Manteco´n, M.A. Bratos,
A. Ordun˜a, A. Rodrı´guez Torres
Valladolid, E
Objective: We study the relationship between HCV viraemia
(determined by quantitative-PCR) and the degree of hepatic ﬁbro-
sis in patients with HCV-HIV co-infection prior to treatment.
Materials and Methods: Twenty-three sera from 23 patients with
chronic hepatitis C were studied. The level of RNA HCV was
determinate by PCR, previous reverse transcription RNA-DNA
complementary (Cobas Amplicor; Roche Diagnostics). The degree
of hepatic ﬁbrosis was studied by histological activity rate (HAR-
Metavir) in hepatic biopsy.
Results: Nine (39.2%) patients have RNA levels lower than
500 000 IU/mL; ﬁve of these have a severe hepatic affectation;
three have a severe HAR-Metavir (3) and two have cirrhosis
HAR-Metavir (2). In the remaining four patients, three have a
moderate HAR-Metavir (2) and one has a slight HAR-Metavir (1).
Eight (34.8%) patients have RNA levels from 500 000 to
1 000 000 IU/mL: one patient has a slight HAR-Metavir (1), four
patients have a moderate HAR-Metavir (2) and three patients
have a severe HAR-Metavir (3). Six (26%) patients have RNA lev-
els higher than 1 000 000 IU/mL: two patients have a slight HAR-
Metavir (1), and four patients have a moderate HAR-Metavir (2).
Conclusion: In patients HCV-HIV co-infected there is an associ-
ation between viraemia and degree of hepatic affectation (HAR-
Metavir).
Table 1. Distribution of patients by viremia level and degree of
hepatic affection
Q-PCR
(IU/mL)
HAR-Metavir
Slight
(1) No.
Moderate
(2) No.
Severe
(3) No.
Cirrhosis
(4) No.
0–500 000 1 3 3 2
500 001–1 000 000 1 4 3 0
>1 000 000 2 4 0 0
Spearman’s Rho: )0.522
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P656 Prevalence of GBV-c/HGV in HIV-infected patients
and potential inﬂuence of co-infection on the course of the
disease
V. Aster, J. Ko¨nig, M. Stankova´, H. Rozsypal, B. Prochazka
Prague, CZ
Objectives: Assessment of prevalence of GBV-c/HGV infection in
HIV-infected patients and evaluating of a possible inﬂuence of
GBV-c/HGV on the course of HIV infection by assessment of
immunological and virological markers of progression of HIV
infection.
Methods: We have investigated sera of 273 HIV-infected patients
from AIDS Center of the University Hospital Na Bulovce Prague
during 2002–2003. Our target was to assess the presence of mark-
ers of GBV-c/HGV infection by semiquantitative HGV PCR evalu-
ation and anti-E2 antibodies by ELISA testing. 271 of serum
samples were tested for HGV PCR and 269 samples were tested
for anti-E2 antibodies. HIV viral load and CD4 count were tested
concurrently. We used Spearman’s test to rule out the dependency
of CD4 count and HIV viral load on HGV infection.
Results: Eighty-nine (33.3%) of patients were positive in PCR
HGV test and 101 (38.5%) of patients were positive in anti-E2-
ELISA. No statistically signiﬁcant effect of GBV-c/HGV infection
was observed on CD4 count and HIV viral load in our cohort of
patients.
Conclusion: The effect of GBV-c/HGV infection on predictive
laboratory markers of HIV infection was not conﬁrmed in our
study. Further investigations regarding this subject seem to be
necessary.
Acknowledgements: Our study is constituent of the grant project
no.7509-3/2003 IGA MH CR.
P657 Cardiovascular neurovegetative dysfunction in
HIV-infected patients
S. Cicalini, G. Raimondi, P. Noto, E. Boumis, S. Sacco, C. Saltini,
N. Petrosillo
Rome, I
Objectives: Spectral analysis of heart rate variability (HRV) is a
sensitive technique for measurement of cardiovascular neurovege-
tative function, which also allows differential assessment of para-
sympathetic and sympathetic components. Moreover, spontaneous
baroreﬂex sensitivity (BRS) is a simple and non-invasive method
for the study of the baroreﬂex function. The objective of this study
was to evaluate the presence, nature and degree of cardiovascular
neurovegetative dysfunction in HIV-infected patients compared
with HIV-negative controls, and to correlate the dysfunction with
stage of HIV infection and antiretroviral treatment.
Methods: A total of 57 HIV-infected patients (29 men), aged 34–58
(median 38) years, were enrolled in the study. Twenty-two
patients were at stage A, 22 patients at stage B and 13 patients at
stage C, according to the CDC classiﬁcation system. Forty-seven
patients were receiving highly active antiretroviral therapy (HA-
ART), and half of them were on treatment with protease inhibi-
tors. Cardiovascular neurovegetative function was assessed by
spectral analysis of HRV and by BRS method. Blood pressure and
consecutive R–R intervals were recorded continuously for 20 min
on supine resting, and for 20 min during a passive tilt-test. Data
obtained from each CDC stage group were compared with those
obtained from 14 HIV-negative controls recruited from patients
and medical staff at the hospital.
Results: HRV parameters were not statistically different among
patients at CDC stages A and B in comparison with controls;
when compared with controls, patients at stage C had: (i) a
reduced BRS in baseline condition (8.5  1.7 ms/mmHg vs.
21.8  4.1 ms/mmHg; P < 0.015); (ii) a reduced increase of systo-
lic arterial pressure during tilt-test (8.2  2.0 mmHg vs.
17.0  3.2 mmHg; P < 0.03); (iii) a signiﬁcant difference in the low
frequency (LF)/high frequency (HF) ratio (3.9  1.3 vs. 13.0  5.4;
P < 0.019) during tilt-test, related to a different LF component
(44.8  6.3 vs. 75.6  4.7 normalised units; P < 0.001). No differ-
ences were observed between HIV-infected patients with respect
to HAART regimen.
Conclusions: Cardiovascular dysfunction is common in associ-
ation with HIV infection and occurs more frequently and with
greater severity in patients with AIDS. However, it may be pre-
sent in the early stages of HIV infection and progress during the
illness.
Acknowledgements: This work was funded by Ricerca Corrente IR-
CCS.
P658 Pancreatic abnormalities during HIV infection. What
about epidemiology, management and outcome?
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
HIV-infected patients on HAART are exposed to direct and indi-
rect (hyperlipidaemia-mediated) pancreotoxicity and multiple
predisposing conditions (biliary-liver disorders, alcoholism). In
order to assess frequency and signiﬁcance of pancreatic anomal-
ies, a case–control study involved 976 HIV-infected patients fol-
lowed for 1.5 years. Octreotide  gabexate administration was
carried out in patients with severe, prolonged or symptomatic
abnormalities. In our single-centre cohort, 349 of 976 (35.7%)
patients experienced altered amylase and/or lipase at least once.
Compared with the remaining 627 patients without pancreatic
alterations a multivariate analysis detected a relationship with
duration of HIV infection, AIDS, a CD4þ count <200 cells/lL,
duration of a protease inhibitor-based HAART, hypertriglycerid-
aemia and underlying acute-chronic hepato-biliary diseases
(P < 0.01–0001), while no association was found with nucleoside
analogues. Only 36 of 349 (10.3%) patients had signs and symp-
toms of pancreatic involvement and a frank pancreatitis occurred
in only nine (2.6%) patients. A speciﬁc treatment with gabexate
(46 patients), octreotide (17 patients), or both (35 patients) was
performed when pancreatic enzymes were greater than threefold
normal values for >6 months, and when signs-symptoms of pan-
creatitis became evident. A drop of pancreatic enzymes >50%
vs. baseline, combined with improvement-cure of clinical-instru-
mental picture, was achieved in 68 of 98 (69.4%) patients treated
for 13–35 days, in absence of untoward events. A more rapid
and effective response was obtained in the 35 patients treated
with gabexate + octreotide vs. 63 patients who received a single
drug (P < 0.05). A further case–control study compared the 98
treated patients with 76 HIV controls with matched pancreatic
abnormalities, but followed with dietary-conservative measures:
a signiﬁcantly better short- and long-term evolution was seen in
patients treated pharmacologically as found by a more frequent-
rapid drop of pancreatic enzymes, improvement of clinical-
instrumental alterations, reduced relapse rate, and better HAART
tolerability. Limited literature data are available about pancreatic
abnormalities and their management during HIV disease and
HAART. However, a crude 35.7% rate of patients in our cohort
had laboratory alterations, while pathogenetic pathways are
broadening, owing to emerging dysmetabolism and mitochon-
driopathy. Further studies are needed to give reliable estimates
of both frequency and evolution of HIV-associated pancreatic
abnormalities, their consequences on HAART administration and
speciﬁc treatment.
P659 Laboratory and clinical pancreatic abnormalities
during HIV infection treated with antiretroviral therapy
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
The epidemiological and clinical features of HIV-associated pan-
creatic abnormalities are changing in the HAART era. Their fre-
quency, risk factors and clinical and therapeutic features were
assessed in an observational case–control study involving 986
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patients, assessed for pancreatic anomalies in a case–control com-
parison including the whole follow-up period of each patients;
149 patients with high and prolonged laboratory abnormalities
underwent further assessment. Compared with controls, the 352
patients (35.7%) who experienced greater than one episode of
conﬁrmed pancreatic laboratory abnormality had a longer dur-
ation of seropositivity, exposure to protease inhibitors, a more fre-
quent immunodeﬁciency, AIDS diagnosis, liver-biliary disease,
and hypertriglyceridaemia (P < 0.04–0.001), while no relation was
found with type and duration of antiretroviral combinations (as
well as speciﬁc nucleoside analogue use). Among these 352
patients, high and prolonged laboratory alterations eventually
associated with signs of organ involvement occurred in 149 cases,
and seemed related to the administration of didanosine, stavu-
dine, lamivudine, pentamidine, cotrimoxazole, or anti-tubercular
therapy, substance or alcohol abuse, opportunistic infections,
liver-biliary disease, a protease inhibitor-based HAART, and
hypertriglyceridaemia (P < 0.02–0.001). However, no difference
was noticed between the 39 patients with clinical and/or imaging
evidence of pancreatic involvement and the remaining 110 asymp-
tomatic patients, as to the same risk factors. Although recurrences
of enzyme alterations involved >70% of patients, in only 33.8% a
change of antiretroviral or antimicrobial therapy became neces-
sary. An acute but uncomplicated pancreatitis occurred in eight of
29 overall symptomatic patients (27.6%). A 2–4 weeks gabexate
and/or octreotide administration (performed in 68 patients of
149), attained a signiﬁcant laboratory, clinical and instrumental
cure or improvement in 73.5% of patients, with a better success
rate of combined versus single therapy, a reduced tendency to
disease relapses in the subsequent 6–42-month follow-up, and a
better tolerability of antiretrovirals (P < 0.05–0.004). Epidemiologi-
cal and pathogenetic studies are warranted to re-evaluate pancrea-
tic abnormalities in the HAART era, and their consequences on
continued anti-HIV and antimicrobial therapy. The management
of antiretroviral therapy and the indication to gabexate and/or
octreotide administration in the different clinical and laboratory
settings, deserve controlled investigation.
P660 Antiretroviral treatment and gynecomastia: which
correlations?
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Aim of our study was to recognise all episodes of gynecomastia
occurring during anti-HIV therapy in our patient (p) cohort, and
to search for all correlations with several demographic–epidemio-
logic variables, clinical-laboratory markers, prior-underlying ther-
apy, metabolic anomalies, and subsequent evolution. A cross-
sectional survey of 988 p treated with antiretrovirals for >1 year
(661 males:66.9% of p), allowed us to retrieve all p with ultraso-
nography-conﬁrmed, true gynecomastia, considered after exclu-
sion of all potentially involved conditions. Particular attention
was deserved to metabolic alterations, including the lipodystro-
phy syndrome, dysmetabolism, and administered antiretrovirals.
A complete hormonal workout failed in detecting signiﬁcant
abnormalities (i.e. hypogonadism) in all p but one, and hyperpro-
lactinemia was not found. Fifteen p of the 513 evaluable males
(2.92%), developed gynecomastia when aged 12–58 years. The
duration of HIV-infection, antiretroviral therapy, and HAART,
varied signiﬁcantly in our p group, and no correlation was found
with clinical-laboratory markers of HIV disease, but ﬁve of 15 p
(33.3%) never received protease inhibitors (PI), while an efavi-
renz-based therapy apparently prompted gynecomastia in four p
who were naı¨ve for PI, and worsened this sign in three more p
who switched from a PI-based HAART towards efavirenz. One p
developed gynecomastia while on prolonged, isolated dual nucle-
oside analogue (NA) therapy, without administration of PI and
non-NA reverse transcriptase inhibitors. A concurrent lipodystro-
phy was present in all p who developed gynecomastia, while
hypertriglyceridemia, -cholesterolemia, and -glycaemia were
found in 11, six, and three p, respectively. Among NA, stavudine
represented the more frequently used drug, administered during
a more prolonged time in all p with gynecomastia. During the
subsequent follow-up (7–23 months), no signiﬁcant clinical amel-
iorament of gynecomastia was observed, despite therapeutic chan-
ges (determined by regimen failure and/or toxicity), but surgery
never proved necessary. Gynecomastia, as an emerging untoward
event of HIV infection treated with antiretrovirals, warrants inves-
tigation, from an epidemiologic, clinical, and pathogenetic point
of view. The apparently frequent association with other metabolic
anomalies suggests some common pathway with other HIV- and
antiretroviral-associated disturbances, so that special attention
should be deserved to anti-HIV therapy, and the role of single
and associated antiretroviral compounds.
P661 Lipomatosis and HIV disease during antiretroviral
therapy
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Objective: The fat redistribution syndrome and its variably associ-
ated metabolic abnormalities, emerged as a result of the adminis-
tration of potent anti-HIV combinations. Local fat accumulation
may present as central adipositiy, increased breast dimension,
gynecomastia, lipomastia and the so-called buffalo hump. Lipo-
mas and other benign tumours of fatty tissue have not been yet
reported during HIV disease, and the HAART era.
Methods and Results: Eight of approximately 1000 HIV-infected
patients (p) experienced multiple lipomas since the year 2000. All
p suffered from ultrasonography-conﬁrmed multiple lipomatous
lesions (3 to >20), predominantly involving limbs, thorax, and
anterior abdomen, associated with limited local discomfort. Six p
were male and two were females, with age ranging from 36 to
58 years, and duration of seropositivity between 38 and
116 months. Risk factors for HIV disease included iv drug use and
heterosexual contacts in three p each, and homo–bisexual trans-
mission in two p. At the time of onset of lipomas, all p were on a
protease inhibitor (PI)-based HAART regimen since 17-56 (mean
24  14) months. Our p experienced four to nine different anti-
HIV therapeutic lines: almost all available PI and nucleoside ana-
logues (NA) had been used, while these p never took non-NA
reverse transcriptase inhibitors. Laboratory markers of HIV disease
tested satisfactory:mean viral load 3.1  0.6 log10 HIV-RNA cop-
ies/mL, and mean CD4+ count 432  146 cells/lL. Lipoatrophy
was present in six of eight p, associated with central adiposity in
four p, while no localised fat accumulation was present (i.e. breast
enlargement, buffalo hump).Increased triglyceridemia, cholester-
olemia, and glycaemia were detected in ﬁve, three, and one p,
respectively, with some correlation with the onset of signs of the
fat redistribution syndrome. The 15–31-month follow-up allowed
us to identify the appearance of further lesions in four p, and a
substantially stable disease in the remaining four p, while sponta-
neous regression never occurred,as well as resort to surgery.
Conclusion: The relationship between lipomas, HIV infection, and
HAART is a novel entity, but the frequent association with other
clinical and metabolic disturbances possibly related to antiretrovi-
ral therapy should prompt further epidemiological, pathogenetic,
and clinical studies. Malignant degeneration should be rare, but
careful surveillance seems recommendable. The possible patho-
genetic role carried out by antiretrovirals, and the concomitant
occurrence of lipodistrophy and dysmetabolism, warrant investi-
gation.
P662 Drug-induced alopecia after Lopinavir/ritonavir
(Kaletra) treatment
G. Chrysos, A. Pastelli, S. Mikros, F. Stasini, E. Friligou,
L. Karampali, P. Spyropoulou
Athens, GR
The most commonly reported side effects related to Kaletra are:
diarrhoea, vomiting, headache, nausea, increases in triglycerides
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and cholesterol. About 4% stopped taking Kaletra because of
side effects. Alopecia is a well-recognised adverse effect of che-
motherapy, but is uncommon with antiretroviral therapy. Alope-
cia, generally involving the scalp, has been reported in patients
with HIV infection treated with Indinavir but not with Kaletra.
Hair loss has been linked to certain other drugs.We present a
62-year-old man with HIV infection, stage B2, CD4 count 432
and plasma viral load <50 copies/mL experienced alopecia tota-
lis of his scalp, eyebrows and eyelashes beginning 18 months
after initiating antiretroviral treatment including Kaletra. No hair
loss of arms, legs and pubic area was observed. Our patient’s
drug regimen consisted of Lopinavir/Ritonavir (four caps bid),
Efavirenz (600 mg qd) and Stavudine (40 mg bid); in addition,
the patient was receiving treatment for diabetes with Glivencla-
mide and Metformin for the last 3 years. These drugs have not
been shown to cause alopecia. The alopecia reversed completely
2 months after Kaletra substitution by Nelﬁnavir without any
other change of treatment and his eyelashes and eyebrows grew
back as well.To our knowledge, alopecia totalis has not been
reported in patients with HIV infection treated with Kaletra. In
conclusion, the course of alopecia related to Kaletra seems to be
reversible.
P663 Modiﬁcation of lipid parameters during structured
interruptions of treatment in HIV chronically infected patients
M. Montes de Oca Arjona, R. Garcı´a Jua´rez, A. Martin-Aspas,
R. Pe´rez-Cano, F. Brun Romero, C. Fernandez Gutierrez,
J. Giro´n-Gonza´lez
Cadiz, E
Objective: Analysis of the modiﬁcations of anthropometric, bio-
chemical and lipid parameters as well as those molecules implied
in the lipid metabolism (leptin, tumor necrosis factor alpha –
TNF-a) in patients with chronic infection by human immunodeﬁ-
ciency virus (HIV) during structured interruptions of antiretrovi-
ral treatment (STI).
Patients and Methods: Forty chronically HIV infected patients were
evaluated (CD4 cell count, nadir 374; at the beginning of STI 968;
viral load, VIH nadir 41521; at the beginning of the STI < 50
copies; the median duration of antiretroviral treatment at entry of
the study was 60 months). The STI consisted of HAART
2 months, nontreatment 1 month. Patients were evaluated at the
end of each period and after four STI, with particular attention to
the following parameters: CD4 cell count, viral load, waist and
hip circumference, tricipital fold, arm circumference and serum
concentrations of cholesterol, triglycerides, leptin levels, TNF and
its soluble receptors (TNFR1 and TNFR2).
Results: There were no signiﬁcant modiﬁcations in lymphocyte
T CD4 counts or in the viral load at the end of 4 STI. Viral
load persisted undetectable in the patients who completed the
study. Likewise, signiﬁcant differences were not detected
between values observed at the beginning of STI and at the
end of the intervention with reference to the anthropometric
parameters (waist circumference 84 vs. 87; hip circumference
92 vs. 100 cm; tricipital fold 14 vs. 21 cm; arm circunference
31 vs. 31 cm, P > 0.05 in each case), serum cholesterol (173 vs.
226 mg/dL) or triglycerides levels (124 vs. 144 mg/dL). Never-
theless, a signiﬁcant increase in the concentration of leptin (15
vs. 66 pg/mL, P 0.043) and a diminution of the TNFR1 (100
vs. 80 vs. pg/ml, P 0.0017 ) and TNFRII (253 vs. 185 vs. pg/
mL, P 0.093) levels were detected.
Conclusions: The STI is associated to signiﬁcant modiﬁcations in
lipid markers receptors (TNF and leptin), suggestive of an
increase in lipogenesis without signiﬁcant changes in the anthrop-
ometric parameters during the 12 months of follow-up.
P664 Metabolic changes in HIV-infected patients on
HAART
E. Valadas, H. Chaves Ramos, J. Cruz, C. Ribeiro, L. Caldeira,
F. Antunes
Lisbon, P
Objective: The use of highly active antiretroviral therapy (HA-
ART) has dramatically improved the prognosis of HIV infected
patients, but it has been associated with various adverse effects. A
number of metabolic disorders have been reported among
patients on HAART, such as high serum lipids and elevated liver
enzymes. However, results are still limited and controversial. To
assess the impact of NNRTI on serum lipids and liver enzymes in
HIV infected patients.
Methods: The study was conducted during the year 2001 at a
large outpatient clinic, in Lisbon (Portugal). Clinical charts from
695 consecutive HIV infected patients were analysed. Total and
high-density lipoprotein (HDL) cholesterol, triglyceride levels,
and AST/ALT were determined. Values represent the average of
at least four time-points through the 12 months of the study.
Data from patients who were either taking nevirapine or efavi-
renz-based regimens was compared with patients treated with
other combinations, as well as with nontreated HIV infected
patients.
Results: Data from 25 patients was excluded from analysis,
because of the poor quality of the data. Complete records were
available from 670 patients: 175 patients (26.1%) were on a com-
bination of NNRTI and NRTI: 68 patients were taking efavirenz
(10.1%, Group EFV), and 107 patients were taking nevirapine
(16.0%, group NVP); 418 patients (62.4%) were on other drug
combinations (group O), and 77 HIV patients (11.5%) were not
taking antiretroviral treatment (group X) (Table 1). No age or
gender differences between the groups were noted. Group NVP
had lower triglyceride levels and higher HDL cholesterol when
compared with group O (triglyceride: 1.63 vs. 1.70, P < 0.001;
HDL cholesterol: 1.36 vs. 1.07, P < 0.001), and higher HDL cho-
lesterol when compared with group X (1.36 vs. 1.03, P < 0.001).
Group EFV had lower HDL cholesterol than group X and group
O (HDL cholesterol: 1.24 vs. 1.03, P ¼ 0.01; 1.24 vs. 1.10,
P < 0.001). No signiﬁcant differences were found in other vari-
ables.
Conclusion: Our data show that there is an association between
the use of NNRTI and better lipid proﬁles (higher HDL choles-
terol and lower triglycerides). No increase in liver enzymes was
found on association to NNRTI. The use of nevirapine improved
the lipid prole both by reducing the triglycerides and increasing
the protective HDL fraction. These changes are expected to con-
tribute to the reduction of cardiovascular disease in HIV-1-infec-
ted patients on HAART.
P665 Nephrolitiasis induced by indinavir plus boosting
dose of ritonavir in a Belgrade study population
G. Dragovic, D. Jevtovic
Belgrade, CS
Objectives: Efﬁcacy of Indinavir (IDV) has been known for more
than 6 years. Its major disadvantages are limited absorption, a
short elimination half-life and adverse events such as nephrolithi-
asis. IDV in combination with ritonavir (RTV) is believed to ameli-
orate these disadvantages. We investigate if the use of IDV singly
or with boosting dose RTV in combination with nucleoside
reverse transcriptase inhibitors (NRTIs) was associated with a
higher risk of nephrolithiasis.
Methods: We performed prospective, open-label study and con-
tinuously monitored drug naı¨ve patients for incidence cases of
nephrolithiasis. The patients received IDV alone (400 mg bid) or
IDV plus RTV (400 mg + 100 mg bid) in combination with NRTIs.
The prevalence of nephrolithiasis between groups of patients on
IDV alone (IDV arm) and on IDV with boosting dose RTV
(IDV+RTV arm) was compared using the chi-square test. The
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probability of developing nephrolithiasis was estimated by Univa-
riate and stepwise Multivariate logistic regression.
Results: There were 189 patients; 99 patients were included in the
IDV arm and 90 patients in the IDV + RTV arm. Nephrolithiasis
developed in 38 (26.57%) patients in total. The prevalence of
nephrolithiasis was 26.97% on IDV arm and 25.93% on
IDV + RTV arm, respectively (P < 0.001; d.f. ¼ 1). Multivariate
logistic regression shown that the relative risk of developing
nephrolithiasis is 1.9-fold greater (RR ¼ 1.9; 95% CI 0.88–2.48) in
IDV arm and 6.6-fold greater in IDV + RTV arm (RR ¼ 6.2; 95%
CI 1.68–17.12).
Conclusion: We demonstrate that boosting IDV with RTV
increased the risk of developing nephrolithiasis by 6.2-fold. We
support the need for therapeutic drug monitoring in patients
using IDV with or without RTV in order to monitor the number
of patients who discontinued IDV due to toxicity.
P666 Prevalence of resistance mutations in subtype F
strains isolated from Romanian naı¨ve children
D. Otelea, S. Manaila, M. Dinu, D. Banica, M. Tinischi, D. Maxim
Bucharest, RO
With the advent of highly active antiretroviral therapy (HAART)
the life expectancy of HIV infected patients have been substan-
tially prolonged. However, it is now clear that mutations accu-
mulate in treated patients, limiting the efﬁcacy of the therapy
and requiring a change in the existing medication. Resistance
genotyping has become a SOC in HIV infection management.
Furthermore, resistance mutations are more and more encoun-
tered in recently diagnosed/newly infected individuals. Informa-
tion has accumulated so far mainly on type M clade B strains
which are dominantly circulating in Western Europe and North
America. Sporadic communications have suggested that resist-
ance mutations can occur spontaneously in the genome of vir-
uses of other subtypes isolated from untreated patients.In this
study we present data coming from strains from Romanian chil-
dren obtained before the onset of the treatment. Most of the
samples had viral loads over 10 000 copies/mL. The genotyping
has been performed with the ViroseqTM (Applied Biosystems)
kit according to the manufacturer’s recommendations. Previous
anecdotal information suggested that subtype F strains are rather
common in Romania. Our ﬁndings have conﬁrmed these obser-
vations (all strains tested so far belonged to the clade F),
although the strains displayed several dissimilarities with sub-
type F strains available from databases. In order to show the
relatedness of the Romanian and international strains phylo-
genetic trees are being displayed. Bearing in mind that resistance
mutations are more readily selected in subtypes other than B,
we evaluated several genomic positions belonging to the RT and
protease genes. Our results reveal that while the reverse tran-
scriptase gene are relatively stable in respect to the resistance
mutations, the frequency of the resistance mutations is signiﬁ-
cantly higher in the protease gene. Some of the genomic posi-
tions seem more prone to evolve towards a resistant genotype.
These ﬁndings suggest that some resistance calculation algo-
rithms of clinical interest might need to be revised for other sub-
types than B – taking in consideration that the virological
response of these patients was good.
P667 Phylogenetic analysis of subtype F HIV 1 strains
isolated in Romania
D. Otelea, G. Oprisan, M. Dinu, S. Manaila, D. Banica, M. Tinischi,
D. Maxim
Bucharest, RO
One of the particularities of the HIV epidemics in Romania is the
high prevalence of subtype F strains. Virtually all of the strains
that have been tested so far have the closest relationship to refer-
ence and ﬁeld clade F strains. Several epidemiological explana-
tions have been proposed so far which took in account local
factors: the relatively closed status of the country in the late
1980s, the explosion of the epidemics in closed institutionalised
children communities, etc., were supposed to allow a cuasi clonal
expansion of a limited number of original HIV strains. Few – if
any – of the approaches used so far have relied on molecular epi-
demiology tools. Phylogenetic trees are a powerful tool that
allows to evaluate the relatedness of ﬁeld strains. The purpose of
our study was to use this tool in order to analyse the strains ori-
ginating from children infected in orphanages between 1987 and
1990, and currently circulating subtype F strains from Romania as
well as from neighbouring countries (Moldavia). Sequence infor-
mation was generated for the protease and partially for the
reverse transcriptase gene by using the commercial ViroseqTM kit
(Applied Biosystems), following the manufacturer’s protocol.
Every new sequence was analysed against the available sequences
in the major databases. The relationship of the sequences was
then analysed using some of the available phylogenetic software
(PHYLIP, PUZZLE, etc.). As possible recombinant strains were
encountered we performed separately for the reverse transcriptase
and protease comparison as well as the analyses of the entire
ampliﬁed segment. Subtype F strains have been reported to circu-
late in different parts of the world as well; such regions are South
America (Brazil, Argentina), Portugal, Central Africa. Our analy-
ses assess the genetic relatedness of the Romanian subtype F
strains with such other strains isolated worldwide.
P668 Comparison of line probe assay vs. sequence analysis
for detection of human immunodeﬁciency virus type 1 (HIV-1)
mutations conferring resistance to antiretroviral drugs
S. Garcı´a-Bujalance, C. Ladro´n de Guevara, A. Sa´nchez-Maroto,
A. Gutie´rrez
Madrid, E
Objective: To compare the line probe assay (LiPA) vs. sequence
analysis for detection of mutations conferring resistance to nucleo-
side (NRTI) and non-nucleoside inhibitors (NNRTI) of HIV-1
reverse transcriptase and protease inhibitors (PI).
Material and Methods: In a retrospective study, 54 plasma samples
from 54 HIV-1 infected patients were analysed for drug resistance.
All the patients were followed in our hospital. Baseline character-
istics of the patients were studied. Forty-nine patients received
antiretroviral therapy. The more frequently treatment was two
NRTI plus a PI in 42.6%, and two NRTI plus a NNRTI in 33.3%
of the patients. Sequencing of the protease (PR)gene and the
reverse transcriptase (RT) gene was performed by the TruGene
HIV-1 assay (Visible Genetics, Canada). The new version of the
LiPA test, LiPA HIV-1 RT and Protease assay v 2.0 (Innogenetics,
Belgium) was compared with the reference method: the sequence
analysis. The LiPA assay allows the study of wild-type and
mutant sequences at codons 41, 69, 70, 74, 75, 184, 215, 103, 106
and 181 of the RT gene (LiPA RT) and at codons 30, 46, 48, 50, 54,
82, 84 and 90 of the PR gene (LiPA P). A descriptive study was
carried out with the aid of the statistical program SPSS for Win-
dows version 9.0. Each codon was scored as wild type, mutant, a
mixture of both or uninterpretable results. Concordance was
deﬁned as the same interpretable results obtained by the two
methods. Discordances were deﬁned as minor or major.
Results: LiPA gave uninterpretable results for 36 (5,95%) of 605
analysed codons in the RT gene and for 13 (3.77%) of 344 ana-
lysed codons in the PR gene. The concordance between LiPA and
sequence analysis was 97.6% for codons of the RT gene and
96.7% in the PR gene. Minor discordances was 1.2% in the RT
gene and 2.4% in the PR gene.
Conclusions: (1) The LiPA HIV-1RT and Protease assay v 2.0 give
a high rate of codon hybridisation failures and it’s do not improve
the previous version. It is unacceptable in the clinical practice. (2)
LiPA to detect more minority mutant-wild-type mixtures than
DNA sequencing. It is useful for the screening of primary HIV-1
resistance.
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P669 Evaluation of the Roche COBAS TaqMan 48 HIV-1
test
J. Djupsjo¨backa, K. Sopenlehto, H. Piiparinen, M. Lappalainen,
J. Suni
Helsinki, FIN
Objectives: Analytical and clinical performance of the real-time
based Roche COBAS TaqMan 48 HIV-1 Test was evaluated and
compared with the Roche COBAS AMPLICOR HIV-1 MONITOR
UltraSensitive Test, v1.5.
Methods: HIV-RNA puriﬁcation for the COBAS TaqMan HIV-1
test was conducted by using glass ﬁbre-based High Pure System
Viral Nucleic Acid Kit. Plasma panels for intra-assay, linearity
and analytical performance studies were obtained from AcroMe-
trix Corporation. Genotype panels (A–H) were obtained from Bos-
ton Biomedica Inc. Plasma specimens for speciﬁcity, linearity and
competitive sensitivity for low viral titres and high titre viral
quantitation of clinical performance were obtained from our pre-
viously well-characterised HIV-1 positive plasma panel deposit-
ory. For analytical performance the specimens were tested by
both methods either in duplicate or triplicate. Clinical perform-
ance samples for speciﬁcity and linearity were tested in singlicate,
for competitive sensitivity in duplicate and for high titer quantita-
tion in quadruplicate.
Results: Intra-assay results showed good correlation (R ¼ 0.996)
between the two methods and CV%s were similar, 2–44% within
detection range of the assay. Similar correlation and CV%s were
obtained in linearity studies. However, COBAS TaqMan HIV-1
test proved to give slightly higher copy numbers, especially
within low copy number range. This was observed also when
studying competitive sensitivity for low viral titres in clinical per-
formance. Testing quantitation equality across different genotypes
COBAS TaqMan HIV-1 Test showed slightly better sensitivity in
all genotypes compared with the COBAS AMPLICOR HIV-1
MONITOR UltraSensitive Test, v1.5. The spciﬁcity of the COBAS
TaqMan HIV-1 Test, when testing negative sample panel, was
100%. In quantitation of high titer specimens the CV%s varied
between 6 and 19%. When using COBAS TaqMan HIV-1 Test
there was no need for reruns.
Conclusion: The analytical and clinical performance of the Roche
COBAS TaqMan HIV-1 Test is comparable with the Roche COBAS
AMPLICOR HIV-1 MONITOR UltraSensitive Test, v1.5 depicting
better sensitivity especially with low copy numbers. Wider detec-
tion range of 40–10  107 copies/mL and shorter assay run time
of the COBAS TaqMan HIV-1 Test are considerable improvements
in HIV RNA-quantitation.
P670 Comparison of two commercial assays for the
quantiﬁcation of HIV-RNA
L. Valde´s, S. Garcı´a-Bujalance, M.P. Romero,
C. Ladro´n de Guevara
Madrid, E
Objectives: In this study we compared two of the commercially
available assays for the measurement of HIV-1 RNA, the QUAN-
TIPLEX HIV RNA 3.0 (Bayer) which uses the branched DNA sig-
nal ampliﬁcation technique (v3bDNA) and the AMPLICOR HIV-1
MONITOR TEST 1.5 (Roche) which uses reverse transcription
(RT-PCR) to assess their quantitative relationship. It is useful to
ﬁnd a quantitative relationship between these two assays because
patients may be monitored with more than one assay over the
course of their treatment.
Methods: Total of 44 plasma samples from 44 antiVIH-1 infected
patients monitored at the specialised unit of HIV at our hospital,
were tested with v3bDNA and RT-PCR. Both are ultrasensitive
assays with lower detection limits of 50 copies/mL.
Statistical analysis: for the correlation analyses, the intraclass corre-
lation coefﬁcient was calculated. Wilcoxon test was used to deter-
mine the statistical signiﬁcance. Assays values were transformed
to common (log10) logarithms and expressed as log 10 v3bDNA
or log10 RT-PCR. These assays were also expressed by groups.
Three groups (A, B and C) were classiﬁed based on numbers of
copies/mL.
Results: The data are shown in the following table:
The undetectable samples were 19 (43,18%) tested by RT-PCR
and 24 (54, 5%) tested by v3bDNA. The two assays were found to
be signiﬁcantly correlated (P ¼ 0.002) coeff. ¼ 0.976. Statistical sig-
niﬁcant differences were observed among the A group (P < 0.035)
and B group (P < 0.021). No statistical signiﬁcant differences were
observed in C group (P > 0.263).
Conclusions: (1) Both test are highly correlated and are used to
monitor patients. (2) In patients with low viral load it is not
recommended to mix both techniques. (3) These results indicate
that variability between assays increases as values approach the
lower detection limit.
P671 Evaluation of a simpliﬁed protocol of the Versant
bDNA HIV 3.0 for HIV-1 viral load quantitation
F. Salva´, M. Rotger, E. Ruiz, H. Machado, M. Gaya, C. Alonso,
J.L. Perez
Palma de Mallorca, E
Objectives: In this study, we evaluate the validity of a new proto-
col that simpliﬁes and shortens the standard procedure of the
Versant bDNA HIV-1 RNA 3.0 for viral load (VL) quantitation
using the System 340 instrument (S340).
Methods: A total of 252 samples were studies in parallel by the
standard (SP) and alternate (AP) procedures. Frozen aliquots
stored at 70C were used for performing the AP. SP implies
manual vortexing of RNA extracts (x96), incubation for 2 h in
thermal block, and then run the S340 HIV program; in contrast,
only direct incubation of the nucleic acid extracts in the S340 was
required for AP, but running the HCV program (the same. Sam-
ples were allocated in groups A–F according to their respective
VLs determined by SP: A (n ¼ 50) <50 RNA copies/mL (c/mL); B
(n ¼ 50) 50–100 c/mL; C (n ¼ 47) 100–1000 c/mL; D (n ¼ 45)
1000–10 000 c/mL; E (n ¼ 30) 10 000–100 000 c/mL; F (n ¼ 30)
>100 000 c/mL.
Results: Mean log-transformed values between SP and AP dif-
fered in 0.05 log units. As for groups B–F, these differences were
0.14, 0.01, 0.07, 0.06 and 0.04, respectively. Eight samples in
group A (below the limit of quantitation of the SP) gave detect-
able VL with the AP (range 51–143 c/mL); conversely, seven sam-
ples from group B (range 53–75 c/mL) were undetectable by AP.
An excellent correlation between SP and AP values were
observed, either considering the numeric VLs (R ¼ 0.936;
P < 0.001) or log-transformed values (R ¼ 0.987; P < 0.001). The
AP numeric values of the VL appear to be an overall 1.5% lower
than the corresponding SP quantitations.
Conclusion: (1) Both procedures gave comparable VL values, but
the alternate protocol is simpler and less time-consuming than the
standard procedure. (2) A trend towards lower values was
observed for the alternate procedure. (3) Overall differences were
far below the 0.2 log units accepted as the normal technical vari-
ability.
bDNA
A
< 1000
B
1000-40000
C >
40000 Totals
ROCHE
A < 1000 27 27
B 1000–40000 2 7 9
C > 40000 4 4 8
Totals 29 11 4 44
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P672 HIV-1 viral load by NucliSens EasyQ HIV-1 v1.1 in
combination with the NucliSens mini MAG instrument
P. van Deursen, T. Oosterlaken, T. Cuypers, A. Verhoeven,
P. de Bie, R. Bosch, I. Berghuis, M. Jacobs, P. van de Wiel
Boxtel, Amsterdam, NL
Objectives: bioMe´rieux has developed a new nucleic acid isolation
method (NucliSens Magnetic Extraction Reagents) that uses Boom
chemistry in combination with magnetic silica particles. The Nu-
cliSens mini MAG instrument is used to wash and collect the sil-
ica particles in a user friendly and efﬁcient way. In principle, the
extraction method is generic and can be applied for a broad range
of different sample types. The objective of this study was to verify
this new extraction platform for the isolation of HIV-1 RNA from
plasma samples in combination with the NucliSens HIV-1 v1.1
assay.
Methods: Spiked plasma samples were used to measure the ana-
lytical sensitivity of NucliSens EasyQ HIV-1 v1.1 in combination
with the new extraction method. The extraction performance on
clinical samples was measured by using 123 EDTA plasma sam-
ples obtained from HIV-1 infected individuals. As a reference
extraction method the NucliSens Extractor was used. Testing was
performed on two different sites. In this study also carry over
was addressed by processing high positive samples (spiked with
>1 000 000 HIV-1 IU/mL) and negative samples obtained from
healthy blood donors in the same run.
Results: The analytical sensitivity of NucliSens EasyQ HIV-1 was
53 IU/mL and 92 IU/mL for the new extraction method and the
reference method, respectively. In the clinical samples, HIV-1
RNA was detected in 121 of 123 (98%) and 115 of 123 (93%) of
the clinical samples for new extraction and the reference method,
respectively. In addition, for both extraction methods, excellent
correlation was found in the quantiﬁcation results, the overall R-
value was 0.94. No case of sample-to-sample carry over during
extraction was observed. With the new extraction method 24 sam-
ples were processed within 90 min.
Conclusion: The NucliSens mini MAG instrument was success-
fully used to isolated HIV-1 RNA from plasma samples for deter-
mination of viral load. Compared with the reference extraction
method (NucliSens Extractor) an improved analytical sensitivity
was obtained in combination with NucliSens EasyQ HIV-1 v1.1,
and a good clinical reactivity was measured. The sample through-
put time is <90 min for 24 samples. Moreover, not a single case of
sample-to-sample carry over was detected.
P673 Comparative study of two techniques to measure
HIV-1 viral load in a French commercial laboratory
G. Kreplak, R. Legouge
Paris, F
Objectives: The aim of the study was to compare the performance
of the NucliSens EasyQ HIV-1 V1.1 assay (bioMe´rieux, Boxtel,
The Netherlands), a real time NASBA ampliﬁcation assay for the
quantitative determination of HIV-1 RNA in clinical specimen
with the Versant HIV-1 RNA 3.0 (bDNA, Bayer Diagnostics) tech-
nique routinely used in our laboratory.
Methods: A total of 221 plasma samples were collected from HIV
positive/AIDS patients. For each sample, HIV-1 viral load was
measured using the NucliSens EasyQ HIV-1 V1.1 assay and the
assay we use for routine i.e. Versant HIV-1 RNA 3. An eight-
member calibration panel from Versant was used to check for
proper set-up and functioning of both systems.
Results: Concordant results were obtained in 202 of 221 samples
(91.40%). Seventeen results were found to be discordant. Among
them, six were negative with Versant HIV-1 RNA 3 and quanti-
ﬁed with EasyQ HIV-1 V1.1 and 11 were negative with EasyQ
HIV-1 V1.1 giving a quantiﬁcation result with Versant HIV-1
RNA 3. These discordant results showed very low values of viral
load, always inferior to 2.89 log, corresponding to <776 copies/
mL. Two EasyQ HIV-1 V1.1 results were considered as invalid.
The results obtained demonstrate a good correlation between the
two techniques for both low and high viral loads.
Conclusion: Analysis of a set of 221 clinical routine samples
revealed that EasyQ HIV-1 V1.1 has a comparable performance
to the Versant HIV-1 RNA 3 assay used in our laboratory. No
difference in quantitation was observed between NucliSens
EasyQ HIV-1 and Versant HIV-1 RNA 3.These performance
results would enable us to switch from our routine method to
NucliSens EasyQ HIV-1 without any impact on patient follow-
up.
P674 Evolution of hypervariable region 1 of hepatitis C
virus in HIV–HCV co-infected patients after treatment with
highly active antiretroviral therapy
M. Solmone, E. Lalle, E. Girardi, G. Antonucci, P. Pizzaferri,
G. Migliorino, M. De Marco, M.R. Capobianchi, A. D’Arminio
Monforte – I.Co.N.A. Study Group
Objectives: HCV variability is mainly attributed to virus ability to
respond to host immune pressure. This study was aimed at study-
ing the effects of highly active antiretroviral therapy (HAART) on
heterogeneity HCV quasispecies in HIV/HCV co-infected
patients.
Methods: Sixteen HIV/HCV co-infected patients were selected
from I.Co.N.A. Cohort. The selected patients harboured HCV
genotype 1, were not co-infected with HBV, and had been on HA-
ART for at least 1 year. With respect to HAART, eight patients
showed stable or increasing CD4 counts (immunological respond-
ers, I-R) after 1 year of therapy, and eight showed decreasing CD4
counts (I-NR); 11 patients showed HIV viral load <400 cp/mL
after therapy (virological responders, V-R), and ﬁve showed HIV
viral load >10 000 cp/mL (virological nonresponders, V-NR). For
quasispecies investigation, plasma samples at baseline (T0) and
after 1 year HAART (T1) underwent clonal analysis of HVR-1
region of HCV (10–16 clones per patient per time point). Com-
plexity (Shannon entropy) diversity (mean genetic distance), ratio
synonymous to nonsynonymous substitutions (Ka/Ks) was consid-
ered, as parameters representative of quasispecies herterogeneity
at T0 and T1.
Results: All parameters of quasispecied heterogeneity showed sig-
niﬁcant correlation, but did not correlate with HCV viral load, as
already shown for patients mono-infected with genotype 1 HCV.
Mean values of HVR-1 complexity and diversity were comparable
at T0 and T1, in patients classiﬁed on the basis of either virological
or immunological response. However, when analysing the indi-
vidual variations of complexity, diversity and Ka/Ks, a general
tendency was observed, with increasing values in V-R and
decreasing values observed in V-NR. This behaviour reached high
statistical signiﬁcance for complexity (P ¼ 0.005), was signiﬁcant
for Ka/Ks (P ¼ 0.045), and approached statistical signiﬁcance for
diversity (P ¼ 0.082). No correlation was observed for the vari-
ation of heterogeneity parameters according to immunological
response.
Discussion: In HIV-infected patients undergoing HAART, control
of HIV replication and not CD4 cell count restoration is predictor
of increased HVR-1 quasispecies heterogeneity after 1 year of
therapy. This is rather surprising, and warrants further investiga-
tion on the relationships between HIV and HCV viral replication
dynamics.
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P675 Development of endogenous resistance by
staphylococci to BAL9141 and comparators
S. Heller, E. Marrer, M.G.P. Page, S. Shapiro, L. Thenoz
Basle, CH
Introduction: BAL9141 is a novel broad-spectrum cephalosporin
strongly cidal towards homogeneous MRSA and vancomycin-
resistant staphylococci. As emergence of resistance to antibiotics
inevitably follows their clinical use, we examined the proclivity of
MR staphylococci to develop high-level endogenous resistance to
BAL9141 and comparators.
Materials and Methods: MICs (mcg/mL) towards linezolid, moxiﬂ-
oxacin, and BAL9141 of three staphylococcal strains were as fol-
lows: MRSA strain 745: 4, 0.06, 4; MRSA strain P8(+)-Hom: 1,
0.06, 4; MRSE strain CNS 184: 1, 2, 1. Each strain was serially pas-
saged (108 CFU/passage, 48-h intervals, 35C) on Mueller–Hinton
agar (MHA) containing linezolid, moxiﬂoxacin, or BAL9141 for 50
passages or until the MIC stabilised at 64 mcg/mL. Cells harves-
ted from the last BAL9141 passage were subsequently passaged
on MHA without antibiotic, and their MICs towards the cepha-
losporin checked periodically by agar dilution. BAL9141-passaged
cells were also examined by DNA sequencing of the mec operon
and by QRT-PCR to assess changes in structure and expression of
genes involved in beta-lactam resistance.
Results: Cells transferred in the presence of linezolid achieved
MICs of 64 mcg/mL after 27 (MRSA strain 745), 28 [MRSA
strain P8(+)-Hom], and 28 (MRSE strain CNS 184) serial passages.
Cells transferred with moxiﬂoxacin achieved MICs of 64 mcg/
mL after eight (745), 22 [P8(+)-Hom], and four (CNS 184) serial
passages. In contrast, the MICs of cells transferred in the presence
of BAL9141 reached a plateau level of 32 mcg/mL after, respect-
ively, 37 (745), 32 [P8(+)-Hom], and 15 (CNS 184) serial passages.
The MICs towards BAL9141 remained at this value through the
50th passage. When isolates of BAL9141-acclimated MR staphylo-
cocci were passaged subsequently on antibiotic-free MHA, their
MICs towards BAL9141 fell from 32 to 8 mcg/mL within 1–2
transfers and remained at 8 mcg/mL through 30 serial passages
in the absence of antibiotic pressure.
Conclusions: The frequency of chromosomal mutations conferring
resistance in MR staphylococci follows the order moxiﬂoxa-
cin >> linezolid > BAL9141. Emergence of endogenous resistance
during a course of treatment with BAL9141 is considered exceed-
ingly unlikely.
P676 Emergence and dissemination of glycopeptide- and
high-level quinupristin-dalfopristin resistant Enterococcus
faecium clones in various wards of a tertiary hospital
S. Pournaras, M. Kanellopoulou, A. Ikonomidis, E. Papafrangas,
A.N. Maniatis
Larissa, Athens, GR
Objectives: To investigate the dissemination of quinupristin/dal-
fopristin- and glycopeptide-resistant Enterococcus faecium isolates
in a tertiary Greek hospital prior to the clinical use of quinupris-
tin/dalfopristin and their resistance mechanisms.
Materials and Methods: Twenty quinupristin/dalfopristin resistant
vanA gene carrying Enterococcus faecium (glycopeptide-resistant E.
faecium, GREF) isolates were recovered during a 10-month period
from clinical infections of separate patients in various depart-
ments of Sismanoglion General hospital (Athens, Greece). The iso-
lates were tested phenotypically for their MICs to multiple
antimicrobials used against enterococci, by PCR for genes enco-
ding glycopeptide and streptogramin resistance, by pulsed-ﬁeld
gel electrophoresis (PFGE) and by plasmid analysis.
Results: The MICs of the isolates for quinupristin/dalfopristin
ranged from 4 to >32 mg/L. All isolates carried the gene erm(B)
but not genes vat(D), vat(E) or other known genes encoding strep-
togramin A acetyltransferases, efﬂux pumps or rRNA methylases
[vat(D), vat(E), vat(A), vat(B), vat(C), vga(A), vga(B), vgb(A),
vgb(B), and erm(B)]. Macrorestriction analysis of the isolates
showed that the highly quinupristin/dalfopristin GREF isolates
ﬁtted to two genetic lineages, while the remaining isolates
belonged to various unrelated clones. Plasmid analysis of the
highly streptogramins resistant isolates showed that some isolates
did not carry any visible plasmid, possibly suggesting a chromo-
somal location of the resistance mechanism(s).
Conclusions: The absence of detectable genes encoding streptogr-
amin resistance indicates that further unknown mechanisms con-
fer the high level resistance to quinupristin/dalfopristin. The
emergence of clonally unrelated GREF isolates resistant to qui-
nupristin/dalfopristin prior to its clinical use in Greece suggests
the circulation of such isolates in the community and represents a
potential threat for the usefulness of quinupristin/dalfopristin in
the clinical practice.
P677 Evidence of reserpine-affected mechanism of
resistance to tetracycline in Neisseria gonorrhoeae clinical
isolates
J. Ruiz, A. Ribera, A. Jurado, F. Marco, M.T. Jime´nez de Anta,
J. Vila
Barcelona, E
Objective: To analyse the effect of reserpine in the MIC of tetra-
cycline in N. gonorrhoeae.
Methods: Seventeen clinical isolates of N. gonorrhoeae and three
strains with a characterised mutation in the mtrCDE operon were
analysed. The MIC of tetracycline both in the absence or the pres-
ence of reserpine was performed by E-test and read both at 24
and 48 h. Moreover, the MIC of erythromycin was performed fol-
lowing the same methodology in the three control isolates. Pres-
ence of tetA and tetM were established by PCR. To discharge a
direct effect of reserpine the MIC of this compound was calculate.
Results: Twelve intermediate and ﬁve tetracycline-resistant iso-
lates were studied. All tetracycline-resistant strain carried the tetM
gene (Dutch variant) whereas none presented the tetA gene. Nor
tetA neither tetM genes were present among the intermediate iso-
lates. In all strains the MIC of tetracycline was affected by reser-
pine. Thus, among intermediate isolates the MIC in presence of
reserpine decreased from 4 to >62-fold (from 0.5 to 1 mg/L to
<0.016 to 0.25 mg/L), without differences when the plates were
read at 24 or 48 h, while those strains carrying tetM gene pre-
sented a MIC ranged from 12 to 16 mg/L and 1–1.5 mg/L at 24 h
which was determined in the absence and the presence of reser-
pine, respectively, and of 32 mg/L, and 6–8 lg/ml when read in
absence and presence of reserpine at 48 h. The isolates were
able to grow on concentrations of reserpine higher than
100 mg/L. The effect of reserpine on mtrCDE system was
discharged due to its null effect inhibiting the MIC of erythromy-
cin.
Conclusion: Our results suggest an intrinsic mechanism of resist-
ance to tetracycline in Neisseria gonorrhoeae clinical isolates prob-
ably associated with the basal expression of some reserpine
inhibitable efﬂux pump different from mtrCDE.
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P678 Distribution of ermA, ermC, msrA and linA genes in
methicillin-resistant staphylococci in the Czech Republic
G. Novotna´, J. Janata, J. Spizek
Prague, CZ
Objectives: The aim of this study was to investigate an incidence
of different resistance mechanisms to macrolides and lincosamides
in methicillin-resistant coagulase-negative staphylococci in the
Czech Republic.
Methods: Phenotypes were determined by triple-disc diffusion
method. The presence of the genes ermA, ermC (resistance by tar-
get site alteration) msrA (efﬂux resistance) and linA (resistance by
antibiotic inactivation) was tested by Southern blot analysis. A
bioassay for the detection of lincomycin inactivation mechanism
was performed in lincosamide-resistant strains, where none of the
resistance genes was detected.
Results: In 99 clinical isolates in vitro resistant to one of erythro-
mycin, lincomycin or clindamycin, triple-disc diffusion method
reveals seven different phenotypes corresponding with resistance
mechanisms. The resistance was mainly because of the presence
of msrA gene, which was detected in 53 strains. Genes ermC and
ermA were detected in 42 strains and the linA was detected in 28
strains. In 15 lincosamides-resistant strains no resistance gene was
detected. Lincosamides were not inactivated in those strains indi-
cating a new type of resistance different from inactivation.
Conclusion: The dissemination of resistance types differs strongly
from the published data. While in other countries cross-resistance
to macrolides and lincosamides conferred by ermA and ermC pre-
dominates, in the Czech Republic the gene msrA is the most fre-
quent genetic determinant conferring resistance to macrolides
only. It follows that one third of macrolide-resistant staphylococci
remains lincosamide sensitive. A group of lincosamide-resistant
strains with unknown resistance mechanism was newly deﬁned.
P679 Fluoroquinolone-selected resistance among
Pseudomonas aeruginosa: impact on susceptibility to imipenem,
ertapenem and meropenem
P. Lister, A. Hossain, J.A. Black, E. Smith-Moland, N.D. Hanson
Omaha, USA
Objectives: Fluoroquinolone-selected mutants of Pseudomonas aeru-
ginosa can exhibit signiﬁcant changes in carbapenem susceptibil-
ity. However, little is known about which ﬂuoroquinolones are
more likely to select for carbapenem resistance. This study
assessed the occurrence and mechanism(s) of altered carbapenem
susceptibility among P. aeruginosa mutants selected with levoﬂoxa-
cin and ciproﬂoxacin.
Methods: Pseudomonas aeruginosa PAO1 and a clinical isolate
P. aeruginosa 164 were the parent strains, and single-step mutants
were selected in-agar with 1X–4X MIC of ciproﬂoxacin and levoﬂ-
oxacin. Conﬁrmed mutants were evaluated for changes in suscep-
tibility to imipenem, ertapenem and meropenem. Mutants with
signiﬁcant changes in carbapenem susceptibility were evaluated
for changes in transcriptional expression of four efﬂux pumps
and oprD.
Results: Fifty-six conﬁrmed ﬂuoroquinolone-resistant mutants
were selected, with none exhibiting decreases in imipenem sus-
ceptibility or changes in expression of mexEF-oprN. In contrast,
four mutants demonstrated signiﬁcantly decreased susceptibility
to meropenem and ertapenem. However, these four mutants did
not alter their expression of the four efﬂux pumps or oprD, and
they were selected with both ﬂuoroquinolones from both parent
strains. The small numbers prevented meaningful comparisons
between the ﬂuoroquinolones. Three additional mutants exhibited
hypersusceptibility to imipenem and ertapenem, with associated
six- to 11-fold overexpression of mexCD-oprJ. One of these
mutants was hypersusceptible to all three carbapenems, and me-
ropenem hypersusceptibility was associated with fourfold
decreased mexAB-oprM expression.
Conclusions: Ciproﬂoxacin and levoﬂoxacin exhibited a propensity
to select for both dual resistances to ﬂuoroquinolones and merope-
nem/ertapenem, as well as carbapenem hypersusceptibility. The
mechanism(s) of meropenem and ertapenem resistance remain
unknown and warrant further investigation. Furthermore, similar
studies using in vitro pharmacodynamic models should be conduc-
ted to determine if pharmacokinetically relevant exposure to levoﬂ-
oxacin and ciproﬂoxacin provides different selection pressures for
mutant selection compared the static conditions used in this study.
P680 High prevalence of macrolide resistance in
Streptococcus mitis from neutropenic patients
W. Achour, O. Guenni, B. Malbruny, A. Canu, R. Leclercq,
A. Ben Hassen
Tunis, TN
Background: The purpose of this study is to determine antibiotic
susceptibility of Streptococcus mitis and to characterise the mecha-
nisms of macrolide resistance.
Material: In 2002, 169 isolates of S. mitis were recovered at the
Tunisian Bone Marrow Transplant Centre. A total of 120 (70%)
strains were nonsusceptible to erythromycin. From this collection,
33 strains were randomly chosen and studied.
Methods: Susceptibility of erythromycin-resistant isolates to anti-
biotics was tested by agar dilution technique (CA-SFM). Ampliﬁ-
cation of ermB and mefE genes was carried out by multiplex PCR
technique. For strains harbouring ermB genes, ampliﬁcation of
int-Tn genes encoding the integrase of the Tn916–Tn1545 family
of conjugative transposons was carried out by PCR technique.
Results and Discussion: The rate of macrolide resistance was
impressive and remarkably higher than those in previous studies.
In neutropenic cancer patients, exposure to antimicrobial pressure
is high and selection of resistant strains may occur. Of the 33 eryth-
romycin-resistant strains studied, 14 were cross resistant to erythro-
mycin, spiramycin and lincomycin, including 10 strains containing
ermB genes and four containing a combination of ermB and mefE
genes. Fourteen strains displayed M phenotype contained mefE
genes. Five strains were apparently susceptible to lincomycin but
resistant to spiramycin, four contained ermB genes and one a com-
bination of ermB and mefE genes. In our study and in Canada,
ermB and mefE genes are prevalent. However, ermB genes are pre-
valent in Japan and mefE genes in Spain. The duplicity of genes has
not been described in S. mitis but already been identiﬁed in
S. pneumoniae, S. agalactiae, S. oralis and S. pyogenes. A correlation
was found between lower erythromycin MIC (4–64 mg/L) for iso-
lates carrying mefE and higher level (MIC of 4 to >1024 mg/L) for
those carrying ermB genes.The int-Tn gene, was detected in all
strains harbouring ermB genes indicating that this gene is dissemin-
ated by conjugative transposon to different strains.
Conclusion: This study shows high erythromycin resistance rate
among S. mitis isolates with prevalence of mefE and ermB genes
in our centre, which argue against the clinical usefulness of eryth-
romycin to prevent viridans group streptococcal bacteraemia in
neutropenic cancer patients.
P681 Frequency and stability of mutants selected with
ﬂuoroquinolones from Klebsiella pneumoniae containing the
plasmid-mediated resistance determinant QNR
J.M. Rodriguez-Martinez, A. Pascual, I. Garcia, E. Jime´nez-Mejias,
J. Pacho´n, L. Martı´nez-Martı´nez
Seville, E
Objectives: To evaluate the frequency and stability of mutants
derived from a porin-deﬁcient Klebsiella pneumoniae (Kp) strain
KpIMP17 (wild-type strain) containing the Ser83Phe mutation in
gyrA and its derived transconjugant KpIMP22 containing plasmid
pMG252, which codes for the plasmid-mediated ﬂuoroquinolone
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(FQ) resistance determinant qnr. MICs (mg/L) of ciproﬂoxacin
(CIP), levoﬂoxacin (LEV) and moxiﬂoxacin (MFX) against
KpIMP17 and KpIMP22 were 0.5/0.5/0.25 and 4/4/8, respect-
ively. Moreover, the presence of mutations in the genes gyrA and
parC, in these mutants, were studied.
Methods: Mueller–Hinton (MH) agar plates containing 4x MIC of
CIP, LEV or MOX were inoculated with bacteria grown in vivo
(pneumonia model in mouse) or in vitro (MH broth), and incuba-
ted at 35–37C for 48 h. Mutants (up to eight from each plate)
were subcultured at least twice in MH agar without antibiotics,
and MICs of the selecting quinolones were determined by micro-
dilution (NCCLS guidelines). True mutants were deﬁned as those
for which the MIC has increased greater than or equal to fourfold
with respect to the parental strain. Mutations in the quinolone
resistance determining region (QRDR) of the genes gyrA and
parC were evaluated by PCR and sequencing.
Results: All mutants selected on agar plates containing FQ
showed stable increased resistance to the selecting agent. Fre-
quencies of mutation of KpIMP17 were 5  107 (in vitro
grown bacteria) and 5  104 (in vivo grown bacteria), respect-
ively. For KpIMP22, these values were 106 and (in vitro grown
bacteria) and 103 to 104 (in vivo grown bacteria), respectively.
MICs of FQ against mutants from KpIMP17 were 16 to 64-folds
higher than against KpIMP17. In the case of KpIMP22-derived
mutants MICs increased eight- to 16-fold. None of the mutants
presented any additional mutation in the QRDR of gyrA or
parC.
Conclusions: In KpIMP22, pMG252 coding for qnr increases 10
times the emergence of mutants with increased resistance (eight-
to 16-fold) to FQ. This increase is not caused by additional
mutations in the QRDR of gyrA or parC. One hundred per cent
of the selected mutants presented stable resistance to ﬂuoroqui-
nolones.
P682 Resistance mechanisms of ﬂuoroquinolone-resistant
clinical isolates of Streptococcus pneumoniae collected in
Belgium, 1999–2003
S. De Craeye, R. Vanhoof, N. Celio, S. Dame´e, E. Vanbossuyt,
J. Content
Brussels, B
Objectives: Study of point mutations in the quinolone resistance
determining regions (QRDR) i.e. gyrase and topoisomerase IV,
and the role of pmrA efﬂux or other efﬂux pumps.
Methods: Different centres collected clinical strains of S. pneumoni-
ae during the winters of 1999 (205), 2001 (314) and 2003 (394).
These strains were screened for ciproﬂoxacin (CIP) resistance by
the NCCLS microdilution technique. Streptococcus pneumoniae R6
was used as a susceptible reference strain. As positive control the
strains F4 and J5 from A. Dickens (UK) were used. The QRDR
regions of gyrA, parC and parE of each strain were ampliﬁed
with the corresponding primers by PCR and then sequenced
using the ABI PRISM 3100 Avant Genetic Analyzer. To determine
the contribution of efﬂux to the FQ-resistance, the strains were
cultured on blood agar, with or without reserpine. E-test for CIP
and moxiﬂoxacin (MOX) were used to determine the MIC values
on both media. A PCR for the pmrA-gene and its regulator (mta1)
was carried out on each strain.
Results: Resistance caused by QRDR mutations: of a total of 913
clinical isolates, 89 (10.2%) were intermediate resistant (I) and 29
(3.2%) resistant (R) to CIP. All the resistant strains, 38 intermedi-
ate and four susceptible (S) strains were sequenced (SIR: 1999: 3-
15-3; 2001: 1-5-9; 2003: 0-24-17). Of a total of 71 strains, 16.9% had
mutations in gyrA, 0% gyrB, 29.6% parC and 74.6% parE. Com-
bined mutations: 1999: 38.9% with two mutations and 5.6% with
three. For 2001: 28.6, 7.1 and 14.3% with 2, 3 and 4 mutations,
respectively. For 2003: 7.7, 10.2 and 2.6%, respectively. Only
30.4% of the multiple mutations resulted in I or R to CIP and
8.7% to MOX.
Efﬂux resistance: All strains were positive for pmrA. An efﬂux
activity for CIP was found in 46 strains (64.8%) while only one
strain (1.4%) had a low efﬂux activity for MOX. In eight strains
with no mutation, a high efﬂux activity for CIP was found.
Conclusions: The relative prevalence of mutations did not increase
through the years. Multiple mutations did not necessarily result
in more resistant strains and only the nature of the mutation is
important. Efﬂux pumps were present in all strains but efﬂux
activity was only detected for CIP and not for MOX.
P683 Inducible metronidazole resistance in nim-positive
clinical Bacteroides fragilis group strains
M. Hedberg, H. Fang, C. Edlund
Stockholm, S
Objectives: To survey the incidence of nitroimidazole resistance
(nim) genes among 1502 clinical strains of Bacteroides fragilis group
species originating from a pan-Europe study. Selected nim-posit-
ive metronidazole susceptible strains were tested for inducibility
of metronidazole resistance.
Methods: All strains were screened for nim-genes by PCR. Deter-
mination of speciﬁc nim-genes (A-F) was carried out by RFLP.
Presence of insertion sequence elements in the nim-positive
strains was detected using PCR. Seven randomly chosen nim-pos-
itive clinical strains (B. fragilis, B. thetaiotaomicron and B. ovatus)
with low initial MIC values (0.25–8 mg/mL) were assayed for
induction using metronidazole E-test strips. Micro colonies were
picked within the ellipse area of the E-test strips for three pas-
sages, followed by testing of the stability of the resistance by
inoculation on blood agar plates without exposure to metronidaz-
ole over three additional passages. Bacteroides fragilis ATCC 25285
B. thetaiotaomicron CCGU 29741 and three clinical strains (B. fragil-
is, B. thetaiotaomicron and B. ovatus) all lacking nim-genes, were
used as control strains.
Results: Two per cent (n ¼ 30) of the isolates tested harboured
nim-genes. These strains belonged to four species, B. thetaiota-
omicron, B. vulgatus and B. ovatus and to the highest extent by
the clinically most important species B. fragilis. The nimA was
detected in 16 of the strains two had nimB, two nimC, seven
nimD, two nimE and one nimF. In 23 of the 30 nim-positive
strains an IS element possibly involved in regulation of the
nim-gene expression was identiﬁed. All seven nim-positive
strains tested for inducibility of metronidazole resistance could
be induced to express high levels of resistance (MIC 64 to
256 mg/mL) after three passages on subinhibitory concentra-
tions of metronidazole. After three subsequent passages without
metronidazole, the resistance was maintained at the same
induced level only in one strain. The other six strains yielded a
lower stability of resistance and had lower MIC-values after the
three ﬁnal passages. However, four of these strains still had
elevated MIC-values compared with preinduction. In contrary,
the ﬁve nim-negative control strains demonstrated no signiﬁcant
increase of resistance.
Conclusion: The fact that nim-positive strains were easily induced
to high levels of resistance is of great clinical concern and empha-
sises the importance of acknowledging metronidazole resistance
in the clinical setting.
P684 Diversity of the mechanisms involved in imipenem
resistance in Acinetobacter baumannii
S. Bourdon, M.L. Joly-Guillou
Angers, F
Objectives: Acinetobacter baumannii (Ab), a nosocomial pathogen,
is often resistant to multiple antibiotics now including ip. At this
time, ip resistance represents about 5% of the strains, when sev-
eral mechanisms have been described already. These strains are
more often involved in hospital outbreaks. The diversity of the
mechanisms involved in ip resistance was studied in nine clinical
isolates of Ab.
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Methods: The minimal inhibitory concentrations (MICs) of ip
(MSD Laboratory) were determined by E-test method (AB Bio-
disk) and serial dilutions (1–128 mg/L) in Muller–Hinton broth
(MHB). Susceptibility testing of seven beta-lactams (amoxicillin,
piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavula-
nate, ceftriaxone, ceftazidime) was performed by the agar diffu-
sion method in accordance with the French committee of
antibiogram guidelines. Including cloxacillin in agar medium that
is known to inhibit cephalosporinase revealed cephalosporinase
activity. The presence of a metallo-enzyme responsible for imipe-
nem resistance was studied, comparing the MICs of ip with and
without EDTA. Enzymes probably produced by the strains were
characterised by isoelectic-focusing method with precast poly-
acrylamid gels containing ampholines with pH range 3.5–9.5
(Amersham Bioscience).
Results: MICs of ip, obtained with E-test method, were ranged
from 4 to 128 mg/L. Discordance was noted between E-test
method and susceptibility testing in MHB: four strains had ip
MICs ﬁrst considered superior or equal to 32 mg/L because of
the presence of mutants when MICs in MHB were 4 mg/L.
Other beta-lactams also showed a decreased activity. Cephalo-
sporinase activity was involved in imipenem resistance in two
strains for which, inhibition of the cephalosporinase activity by
cloxacillin not only restore activity to ureidope´nicillin, carboxy-
penicillin or cephalosporins but also to ip. Imipenemase activity
was found in four strains: the MIC of ip plus EDTA was lower
than the MIC of only ip. Electro-focusing showed one or two
enzymes with alkaline pI, consistent with those described for
IMP-1 and IMP-4 (pI 8–9). For three strains no enzyme were
produced. A modiﬁcation of the PLP or an impermeability
mechanism was suspected.
Conclusions: In this study, we conﬁrmed that multiple mecha-
nisms should be involved in the resistance of Ab to ip. Neverthe-
less, this is the ﬁrst time that some cephalosporinase produced by
Ab are suspected to be responsible for this resistance.
P685 Cross-resistance between voriconazole and
ﬂuconazole due to the expression of efﬂux pumps
S. Costa-de-Oliveira, C. Pina-Vaz, A. Gonc¸alves Rodrigues
Porto, P
Voriconazole (Vor) is a new triazole antifungal agent, structurally
related to ﬂuconazole (Flu), with improved potency and spectrum
of activity.
Objective: To evaluate the activity of Vor on clinical resistant
strains to Flu.
Methods: Thirty-six resistant and 20 susceptible strains to Flu
were used. Minimal inhibitory concentration (MIC) to Flu and
Vor were determined according the NCCLS protocol M27-A. Flow
cytometry analysis of conidia stained with FUN-1 after 1 h incu-
bation with Flu (1) and 2 h with Vor allowed us to determine a
staining index (SI), a ratio between the intensity of ﬂuorescence of
treated conidia and the control (nontreated conidia). These assays
were repeated after incubating the conidia with sodium azide and
with four modulators of efﬂux pumps (verapamil, b-estradiol,
progesterone and ibuprofen), at a concentration able to block
efﬂux pumps. High MIC values to Flu, a SI < 1 and a reversion of
resistance following the reduction of the energetic pool with
sodium azide or with the modulators was suggestive of resistance
of efﬂux pumps (2).
Results: Sixteen resistant strains to Flu showed very high MIC to
Vor (>4 lg/mL), and evidence of active efﬂux. Low MIC values
to Vor and no evidence of efﬂux were found on the remaining
resistant strains to Flu, including ﬁve C. krusei strains (known as
intrinsically resistant to Flu). All susceptible strains to Flu showed
low MIC to Vor.
Conclusions: Vor is a more active compound on Candida strains
than Flu. The presence of efﬂux pumps seems to be responsible
for the cross resistance between the two antifungals.
References
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P686 Substrate inhibition of the Pseudomonas aeruginosa
metallo-beta-lactamase, SPM-1, in acidic and alkaline conditions
T.A. Murphy, J. Spencer, R.N. Jones, T.R. Walsh
Bristol, UK; North Liberty, USA
Objectives: To date, there is limited information on the mechan-
ism of hydrolysis for metallo-beta-lactamases (MBLs) with thera-
peutic beta-lactams. Recently, we described a new-type of MBL,
SPM-1, which has unusual kinetics. Accordingly, in order to pro-
vide an insight into the mechanism of hydrolysis by SPM-1, a
detailed kinetic analysis under different pH conditions was
undertaken.
Methods: SPM-1 was puriﬁed from a recombinant plasmid using
a periplasmic preparation followed by a two-stage puriﬁcation
process. SPM-1 was 98% pure, conﬁrmed by SDS-PAGE. Beta-lac-
tamase assays for pH 4.5–5.5 were carried out in acetate buffer,
pH 6.0–7.5 in cacodylate buffer and pH 8.0–9.0 in Tris–HCl buf-
fer. The puriﬁed enzyme was transferred to the relevant pH by
ultraﬁltration and enzyme concentration determined for each pre-
paration. Kinetic parameters (kcat/Km) were determined for peni-
cillin G, cefuroxime, meropenem and nitroceﬁn at each pH from
the initial rates of hydrolysis for different substrate concentra-
tions.
Results: Substrate inhibition is seen for penicillin G and cefuroxi-
me at high substrate concentrations under acidic conditions and is
particularly marked for penicillin G. As the pH values increase,
substrate inhibition is reduced. No substrate inhibition is observed
between pH 6.0 and 7.5 but once again becomes apparent for
penicillin G and cefuroxime in the alkaline pH range. No sub-
strate inhibition is seen for cefuroxime or meropenem. The hydro-
lytic efﬁciency (kcat/Km ratio) of SPM-1 for all beta-lactams is
optimal between pH 6.0 and 6.5. The hydrolytic efﬁciency of
SPM-1 decreases towards the acidic and alkaline pH ranges. Over-
all, pH has a limited effect on the hydrolytic activity of SPM-1.
The greatest effect being seen for meropenem where a 20-fold
order of magnitude between pH 4.5 and 6.5, and pH 9.0 and 6.5
is observed.
Conclusion: SPM-1 shows substrate inhibition for penicillin G and
cefuroxime at acidic and alkaline pH only, indicating a mechanis-
tic explanation for these effects. The lower hydrolytic efﬁciency at
acid and alkaline pH’s has previously been seen for both IMP-1,
with similar orders of magnitude to SPM-1, and BcII where
greater orders of magnitude were seen between pH 4.5 and 6.5. In
contrast to these enzymes, the effects of pH on the efﬁciency of
SPM-1 are substrate dependant.
P687 Class 1 and class 2 integrons among ESBL and non-
ESBL Escherichia coli isolates recovered from nosocomial and
community environments
E. Machado, R. Canto´n, J.C. Gala´n, A. Rolla´n, L. Peixe, F. Baquero,
T.M. Coque
Madrid, Porto, E
Objectives: To analyse the overall prevalence of integrons among
E. coli (EC) isolates from different environments, phylogenetic
groups and susceptibility proﬁles.
Methods: We studied 135 isolates: (i) 52 PFGE ESBL(+) clonal
types from hospital setting (16 TEM, nine SHV, 22 CTX-M-9, one
CTX-M-14 and four CTX-M-10) (1987–2000); (ii) 43 ESBL() iso-
lates causing bacteraemia (1987–2000); and (iii) 40 ESBL() iso-
lates from faecal samples of healthy volunteers (HV) living in
Madrid (2000–2001). EC phylogenetic groups were determined by
a multiplex PCR assay. Class 1 and 2 integrons were detected by
PCR, typed by RFLP using AluI and HaeIII as restriction
enzymes, respectively, and identiﬁed by sequencing (one per
RFLP type).
Results: Class 1 were most prevalent than class 2 integrons (48%
vs. 14%). Class 1 integrons were more commonly found among
ESBL than non-ESBL from blood or HV isolates (69, 40 and 30%)
due to the high prevalence of EC containing blaCTX-M-9, which
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is located in an In6-like class 1 integron. Class 2 integrons were
more common among community than nosocomial isolates [18, 7
and 7% for ESBL()HV, blood ESBL() and ESBL(+), respect-
ively]. A number of integrons did not contain gene cassettes (nine
of 65 of class 1 and one of 19 of class 2). Presence of integrons
was more frequent among group D than A, B1 or B2 phylogenetic
EC groups (39, 25, 11 and 25% for class 1, and 61, 22, 11, and 6%
for class 2). Seven class 1 integron types and three class 2 integron
types were detected. Among them, class 1 integrons aadA1 (15 of
56), dfrA1aadA1 (12 of /56) and dfrA16aadA2 (13 of 56) were the
most frequently found. Class 2 integrons were mainly associated
to Tn7 (15 of 18).
Conclusions: Integrons are widely distributed among EC isolates
from both community and nosocomial environments, being fre-
quently associated to EC group D. The low diversity of integrons
found might indicate a wide dissemination of other elements
(plasmids or transposons) in which they are located. The capture
of genes as blaCTXM-9 from the metagenome community pool
might be facilitated by the potentially adaptive functions encoded
in its genetic neighbourhood.
P688 Induction of the Acinetobacter baumannii RND efﬂux
pump AdeB with ciproﬂoxacin and gentamicin
H. Seifert
Cologne, D
Objectives: The Acinetobacter baumannii RND efﬂux pump AdeB
has been shown to confer resistance to gentamicin (GEN) and is
involved in reduced sensitivity to the ﬂuoroquinolones. AdeR is
the putative regulator of adeB, however, expression levels of the
genes encoding the pump and regulator is at present unknown.
We investigated the effect of ciproﬂoxacin (CIP) and GEN on
expression of these genes by growing isolates in subinhibitory
concentrations of the agents and looked at mRNA expression lev-
els quantitatively by RT real-time PCR.
Methods: The standard A. baumannii laboratory strain ATCC
19606 (CIP/GEN MICs 1 and 4 mg/L, respectivley) and a multi-
drug resistant clinical isolate SB13 (CIP/GEN MICs 8 and
128 mg/L, respectively) were used for this study. Log-phase
cells were challenged with a subinhibitory (1/2) MIC of CIP or
GEN and aliquots extracted at time t ¼ 0, 1, 3, 5 and 10 min.
RNA was stabilised before extraction and treatment with DNase.
RNA (1 lg) was reverse transcribed into cDNA template with
random hexamers. Quantitative real-time PCR was performed in
a LightCycler with primers for internal sequences of adeB and
adeR. 16sRNA was used as a housekeeping gene for internal
control.
Results: Quantitative real-time PCR against 16sRNA conﬁrmed
that samples had equal concentrations of cDNA; 3–4E + 07 tran-
scripts/ng RNA. At t ¼ 0, ATCC 19606 expressed a higher
number of adeB transcripts than SB13; 1.7E + 04 vs.1E + 03 tran-
scripts/ng RNA. Levels of adeR were lower than those of adeB
by 1E + 02. Ten minutes after addition of CIP there was no dif-
ference in adeB levels with ATCC 19606. However, strain SB13
showed a 13-fold increase in adeB transcripts over 10 min.
ATCC 19606 adeR levels dropped 80% after 3 min and
increased back up to prechallenge levels by 10 min. With SB13,
levels of adeR decreased by 50%. A similar but weaker
response in adeB expression was seen after challenge with
GEN; no change with ATCC 19606 and a sixfold increase with
SB13. ATCC 19606 adeR levels decreased by 50% but rose two-
fold with SB13.
Conclusions: The gene encoding AdeB is induced in a multidrug
resistant clinical isolate by ciproﬂoxacin and gentamicin but is not
induced in a sensitive strain. Total levels of adeB or adeR tran-
scripts may not be an indicator of reduced sensitivity whereas in-
ducibility is. This suggests that other factors such as stability of
transcripts may play a greater role in A. baumannii drug resist-
ance.
P689 Detection of carbapenemases in Pseudomonas
aeruginosa clinical isolates resistant to imipenem
E. Sevillano, M. Canduela, A. Umaran, F.E. Calvo, L. Gallego
Bilbao, E
Objectives: The aim of this study was to detect and identify the
presence of carbapenemases in clinical isolates of Ps. aeruginosa
resistant to imipenem.
Methods: The study included all resistant and intermediate iso-
lates (33 and 15, respectively) obtained at a Hospital from Bilbao
(Northern Spain) during 2002. Phenotypic detection was carried
out using the Hodge and EDTA tests. Genetic experiments to
detect bla-OXA 40, bla-IMP and bla-VIM genes were performed
by DNA ampliﬁcation with the primers P1/OXA-24: 50-GTAC-
TAATCAAAGTTGTGAA-30 and P2/OXA-24: 50-TTCCCCTAACA-
TGAATTTGT-3¢), BLAIMPF: 50-CTACCGCAGCAGAGTCTTTG-3¢
and BLAIMPR 5¢-AACCAGTTTTGCCTTACCAT-3¢) and VIM-
DIA/f 5¢-CAGATTGCCGATGGTGTTTGG-3¢; VIM-DIA/r 5¢-AGG-
TGGGCCATTCAGCCAGA-3¢; VIM1-upv 50-GTCGCAAGTCCGT-
TAGCCCAT-3¢ and VIM 2-upv 5¢-GATTCTAGCGGTGAGTATC-
CG-3¢. To detect class 1 integrons, primers 3¢CS and 5¢CS were
used in ampliﬁcation experiments.
Results: Results with Hodge and EDTA tests were as follows: (a)
Hodge+ and EDTA+, nine isolates; (b) Hodge+ and EDTA, six
isolates; and (c) Hodge and EDTA+, four isolates. The inhibiton
of the growth of the control strain and the mucoidity of the clin-
ical isolates tested did not allow the correct interpretation of the
results in many experiments.All bla-IMP experiments were negat-
ive but some fragments were obtained when the bla-VIM genes
were ampliﬁcated. OXA-40 gene was detected in two isolates
(both were Hodge+ and EDTA), which also bored integrons of
1500 and 850 bp.
Conclusions: Phenotypic methods did not allow the correct detec-
tion of carbapenemases in the majority of the Ps. aeruginosa iso-
lates tested. Genetic experiments showed the presence of OXA-40
gene in two isolates resistant to imipenem, enzyme ﬁrstly identi-
ﬁed in A. baumannii isolates from the same hospital.
P690 Nonenzyme-mediated imipenem resistance in a
clinical isolate of Citrobacter freundii from Trondheim, Norway
M. Castanheira, B. Haldorsen, A. Sundsfjord, T. Jacobsen, J. Afset,
T. Walsh
Bristol, UK; Tromso, Trondheim, N
Objectives: Citrobacter freundii K2-23 was recovered from a surgi-
cal site infection of a 39-year-old kidney-transplanted male during
treatment with imipenem and was shown to possess high-level
resistance to third and fourth generation cephalosporins as well
as imipenem (MIC 8 mg/L). Initial phenotypic screening for
extended spectrum beta-lactamases (BL) using Etest (AB biodisk)
showed that the resistance was not sensitive to clavulanic acid.
Therefore, we molecularly investigated the mechanism of this
broad-spectrum beta-lactam resistance.
Methods: Genetically screening for ESBL genes (TEM, SHV, CTX-
M and OXA-type) and CMY-type BL genes involved PCR. Degen-
erate primers used were designed on the conserved regions of the
genes and often more than one primer set was required. PCR
amplicons of the desired size were sequenced by a AB sequencer.
Crude cell extracts for BL hydrolytic activity were prepared by so-
nication and centrifugation. Assays were carried out in a Perkin
Elmer Lamda 35 spectrophotometer with a range of b-lactams.
Isoelectric focusing (IEF) was determined using a Novex (Invitro-
gen, CA, USA) vertical gel system. Outermembrane preparations
were carried out on K2-23 and 5 C. freundii b-lactam sensitive
strains by standard extraction methods and visualised using SDS-
PAGE (Invitrogen). N-terminal protein sequencing was performed
on those outermembrane differentially expressed in K2-23.
Results: PCR amplicons were obtained for CTX-M-type and
CMY-type BL genes but only the sequence of the latter was credit-
able and that was of the nascent C. freundii AmpC. IEF revealed
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only a single weak band with a pI of 8.0 and the BL assays dem-
onstrated no signiﬁcant hydrolysis with cefotaxime, ceftazidime,
cefepime or imipenem. SDS-PAGE on the C. freundii isolates
revealed that only K23 had a band missing at a molecular weight
of 43 kDa. Another protein of a similar size also appeared to be
weakly expressed. Preliminary sequencing of the N-terminus of
this and revealed the amino acid sequence of AEIYNK. These
sequencing residues showed similarity with the ompK35 of Klebsi-
ella pneumoniae indicating that the protein missing in strain K2-23
is likely to be an OMP-like outermembrane protein.
Conclusion: The data arising from these studies would indicate
that key beta-lactam resistant determinant from C. freundii K2-23
is not over-production of the nascent AmpC but down-regulation
in one or more of its outermembrane proteins.
P691 Extended spectrum beta-lactamase (ESBL) producers
among enterobacteriaceae from patients in Bulgarian hospitals
R. Markovska, E. Keuleyan, M. Sredkova, D. Ivanova, B. Markova,
P. Sotirova, E. Dragijeva, T. Kostyanev, I. Mitov
Soﬁa, Pleven, Stara Zagora, BG
Objective: To preliminary characterise the main types of ESBLs
among Bulgarian Enterobacteriaceae strains and to determine
their rate of resistance.
Methods: A total of 427 Enterobacteriaceae (K. pneumoniae – 238,
K. oxytoca – six, E. coli – 129, C. freundii – ﬁve, E. cloacae – eight,
E. aerogenes – seven, Proteus – ﬁve, Serratia – three, Salmonella
– one) strains identiﬁed as ESBL producers were collected from
seven medical centres in Soﬁa, Pleven and Stara Zagora during
1996–2003. They were conﬁrmed by phenotypical tests (DDS,
NCCLS method). MICs were determined by an agar dilution
technique (NCCLS, 2002). Conjugative plasmid transfer was
performed, followed by an isoelectric focusing according to
Mathew/Bauernfeind. The hydrolytic activity of the bands was
proved by Bioassay (Bauernfeind).
Results: The rate of resistance was: amoxicillin/clavulanate
– 86%, ceftazidime – 85%, cefotaxime – 95%, ceftriaxone – 94%,
aztreonam – 74%, cefoxitin – 14%, ceftibuten – 19%, cefepime
– 37%, imipenem – 0%, tobramycin – 95%, gentamicin – 84%, ami-
kacin – 41%, ciproﬂoxacin – 56%, tetracycline – 86%, co-trimoxaz-
ole – 53% chloramphenicol – 58%. MIC of ceftazidime (CAZ)
ranged 1 to >512 mg/L and of cefotaxime (CTX) – 2–512 mg/L. The
strains were divided into two main groups: the ﬁrst one: MIC-
CAZ > MICCTX – 251 strains and the second: MICCAZ < MICCTX
– 161. In all strains sulbactam in combination with CAZ and CTX
showed an inhibitory effect. CAZ and/or CTX resistance was trans-
ferable in 91 from 100 mating experiments. IEF analysis of 91 strains
showed the presence of three clusters. One cluster (42 strains Klebsi-
ella and 4 E. cloacae) presents CAZ hydrolytic bands with isoelectric
points (pI) 8.2 (SHV type). The second cluster (18 strains Klebsiella,
two C. freundii, 1 E. coli) demonstrated enzymes focusing at pI 6.3,
which suggests TEM type. The strains with MICCTX > MICCAZ –
(11 K. pneumoniae, 12 E. coli, 1 S. marscescens) showed CTX hydro-
lytic bands with pI 8.4 or 8.8 (CTX-M type). The pI data were from
transconjugants and wild type strains.
Conclusion: The SHV type was predominant among ESBLs
Enterobacteriaceae producers in Bulgarian hospitals. TEM type
was proved in one hospital. CTX-M types ESBLs have increased
from 2001 after their ﬁrst detection and become emerging problem
in Bulgaria. All strains were highly polyresistant.
P692 Temporal trends of Streptococcus pneumoniae isolates
with dual resistance to beta-lactam and macrolide antibiotics
J. Fuller, J. Powis, P. Tang, K. Green, D. Low and the Canadian
Bacterial Surveillance Network
Objectives: Streptococcus pneumoniae (SPN) is a leading cause of
pneumonia, meningitis, and otitis media. The evolution of antimi-
crobial resistance and concomitant clinical failures has become a
global concern. Recent mathematical modelling predicted that the
resistance to both penicillin and erythromycin antibiotics will
increase signiﬁcantly faster than resistance to either agent alone.
We examined the longitudinal changes in dual resistance to these
agents in clinical isolates collected by an ongoing Canadian sur-
veillance programme.
Method: The Canadian Bacterial Surveillance Network (CBSN) is
comprised of private and hospital-afﬁliated laboratories from
across Canada. Laboratories were asked to collect a deﬁned num-
ber of consecutive clinical isolates followed by all sterile site iso-
lates of SPN. In vitro susceptibility testing was performed by
broth microdilution using NCCLS guidelines.
Results: In our population, penicillin-nonsusceptibility and eryth-
romycin resistance in SPN is presently 16.25 and 16.46%, respect-
ively. The proportion of these isolates dually resistant to these
antibiotics has slowly increased at a rate of approximately 1% per
year since 1993. Analysis of the subpopulation of penicillin-non-
susceptible isolates revealed that erythromycin resistance has
increased dramatically (rate approximately 5.5% per year). Con-
versely, among erythromycin-resistant isolates, the acquisition of
penicillin nonsusceptibility occurred at a much slower rate (rate
approximately 1.3% per year).
Conclusion: Ten years of surveillance of clinical isolates in Canada
indicates that the increase in penicillin and erythromycin dual
resistance in SPN is largely attributed to an increased propensity
for penicillin-nonsusceptible isolates to acquire resistance to
macrolide antibiotics. At the present rates of increase, all penicil-
lin-nonsusceptible isolates will be erythromycin-resistant within
several years, at which point additional increases in dually resist-
ant isolates will be limited by the increase of SPN isolates resist-
ant to penicillin alone.
P693 CdeA of Clostridium difﬁcile, a new multidrug efﬂux
transporter of the MATE family
J. Tankovic, L. Dridi, F. Barbut, D. Decre´, J.-C. Petit
Paris, F
Introduction: Clostridium difﬁcile is a Gram-positive spore-forming
anaerobic bacterium that is the major cause of nosocomial diar-
rhoea. Its habitat is the human gastrointestinal tract, an environ-
ment rich in lipophilic inhibitors such as bile salts and fatty acids.
Furthermore, this species is intrinsically less susceptible to antibi-
otics, notably to beta-lactams, ﬂuoroquinolones, chloramphenicol,
and lincosamides, than the other clostridia. It is likely that active
efﬂux may be a crucial mechanism implicated in survival in the
gastrointestinal tract and intrinsic antibiotic resistance of this spe-
cies.
Methods: We tried to clone in Escherichia coli and Clostridium
perfringens an efﬂux gene from total DNA of C. difﬁcile strain 714
responsible for norﬂoxacin or ethidium bromide resistance. Ethi-
dium bromide accumulation was measured by a whole-cell
ﬂuorometric assay in the presence or in the absence of sodium
ions.
Results: We cloned a gene, cdeA, that made E. coli and C. perfrin-
gens resistant to ethidium bromide and acriﬂavin but had no
effect on the susceptibility of the hosts to the antibiotics tested:
norﬂoxacin, ciproﬂoxacin, gentamicin, erythromycin, tetracyclin,
and chloramphenicol. It caused ethidium bromide energy-
dependent efﬂux in whole cells of E. coli. The deduced protein
was homologous to the protein sequences of known efﬂux pumps
from the third cluster (the so-called DinF branch) of the multi-
drug and toxic compound extrusion (MATE) family. Efﬂux activ-
ity was stimulated by addition of Na+ ions suggesting that CdeA,
like other pumps of the MATE family, is a Na+-coupled efﬂux
pump.
Conclusion: CdeA is the ﬁrst multidrug efﬂux transporter of the
third cluster of the MATE family identiﬁed in gram-positive bac-
teria. It did not cause signiﬁcant resistance to antibiotics when
cloned in E. coli and C. perfringens. Gene inactivation would be
helpful to appreciate its exact role in C. difﬁcile but this experi-
ment could not be performed due to incapacity of the transforma-
tion in that species.
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P694 First appearance of the CﬁA metallo-beta-lactamase
gene in Norway and its association with a novel insertion
element
M. Toleman, A. Sundsfjord, A. Onken, B. Haldorsen, T. Walsh
Bristol, UK; Tromso, Oslo, N
Objectives: A Bacteroides fragilis blood culture isolate (K2-28) was
recovered from a 61-year-old man with severe general atheroscler-
osis, 7 days after amputation of both lower extremities and during
treatment with meropenem. K2-28 was shown to possess high-
level resistance (MIC > 128 mg/L) to carbapenems and most other
beta-lactam antibiotics. This resistant pattern, indicative of a met-
allo-beta-lactamase (MBL), is unique in Norway where resistance
to antibiotics is extremely low. Accordingly, we molecularly
investigated the precise mechanism of this broad-spectrum beta-
lactam resistance.
Methods: Production of a MBL was veriﬁed using the Etest MBL
strips (AB biodisk, Solna, Sweden) plated onto Columbia blood
agar with 5% blood. Genetically screening for the B. fragilis MBL
gene was undertaken using primers based on the cﬁA gene using
standard PCR techniques. Primers were also designed against
upstream insertion elements known to provide a strong promoter
for the expression of the cﬁA gene. Degenerate primers used were
designed on the conserved regions of the genes and often more
than one primer set was required. PCR amplicons of the desired
size were sequenced. The entire sequence of the gene and the
insertion element was obtained by the ‘primer-walking’ strategy.
Results: E-test results conﬁrmed the presence of a functional
MBL with a reduction in MIC from 256 to 3 mg/L in the pres-
ence of EDTA. Sequence analysis of the cﬁA revealed it was
100% identical to previously described sequences, presenting
with the principal zinc binding sequence of HWHGDC. Sequen-
cing of the upstream region of cﬁA revealed a novel insertion
sequence (IS) element, being most similar (94% identity) to IS612
recently described from Japan. These data designates the element
within the IS4 family. The element had a typical imperfect ter-
minal inverted repeat sequences at the distal ends of the IS ele-
ment. This IS614-like element demonstrates regions homologous
to the 10 and 35 promoter regions of the nascent cﬁA gene.
However, the 10 was most similar to that of IS613 (100%) and
the 35 to IS612 (100%) indicating the plasticity of these
regions.
Conclusion: This is the ﬁrst report of a Bacteroides spp. possessing
an active cﬁA gene within Scandinavia and the unique insertion
sequences associated with this gene testiﬁes to the plasticity of
these genetic resistant elements.
P695 Molecular analysis of linezolid resistance in
Staphylococcus aureus
T.A. Wichelhaus, S. Besier, V. Brade, A. Ludwig
Frankfurt am Main, D
Objectives: Linezolid, the ﬁrst oxazolidinone in clinical use, is
effective in the treatment of severe staphylococcal infections.
Resistance of S. aureus to linezolid recently has been shown to be
associated with point mutations within the domain V region of
the 23S rRNA gene, which is present in multiple copies in the
genome of this pathogen. Here we studied whether there is a cor-
relation between the level of linezolid resistance in S. aureus and
the presence of mutations in the different copies of the 23S rRNA
gene.
Methods: Linezolid-susceptible parental strain was subjected to
daily serial subcultivation in Mueller–Hinton broth containing
increasing linezolid concentrations for 40 days. The minimal
inhibitory concentration (MIC) of linezolid was determined for
the parental strain and for descendants by the agar dilution
method. Domain V of the different 23S rRNA gene copies of the
parental strain and of derivative isolates were ampliﬁed by PCR
and sequenced.
Results: The linezolid MIC was 2 mg/L of the parental strain and
increased gradually to 128 mg/L within 40 days of linezolid selec-
tion. Derivatives with elevated linezolid MICs revealed the substi-
tution G2447T in the 23S rRNA gene. The level of linezolid
resistance within derivatives correlated with the number of the
23S rRNA gene copies carrying this mutation.
Conclusions: The data suggest that the level of linezolid resistance
in S. aureus is dependent on the number of the 23S rRNA gene
copies carrying a speciﬁc resistance-associated point mutation. As
linezolid-resistant S. aureus mutants can be selected in vitro under
selection pressure, a cautious and judicious use of linezolid in vivo
is strongly recommended in order to maintain the valuable status
of this class of antibiotic agents.
P696 Characterisation of the ﬁrst CTX-M14-producing
Salmonella enterica serotype Enteritidis isolate
L. Romero, L. Lo´pez, L. Martı´nez-Martı´nez, B. Guerra,
J.R. Herna´ndez, A. Pascual
Seville, E; Berlin, D
Introduction: We describe the ﬁrst infection caused by a CTX-M-
14-producing Salmonella enterica serotype Enteritidis isolate.
Although reports of ESBL associated with Salmonella are relatively
rare, the number of reported cases in this organism has been
increasing in recent years in numerous countries.
Materials and Methods: Clinical samples were processed according
routine and identiﬁcation was carried out with VITEK 2 system.
The screening of ESBL was achieved by disk diffusion with discs
of third cefalosporins with and without clavulanic acid according
to manufaturer’s instructions. Cefotaxime-resistant transconju-
gants were obtained. MICs were evaluated for the isolates and
their transconjugants by microdilution in broth according to
NCCLS and 4 mg/mL ﬁxed concentration of beta-lactamase-inhib-
itor was added to third generation cephalosporins, aztreonam and
piperacillin. PGFE was performed for Salmonella strains using
XbaI endonuclease. Isoelectrofocusing was realised with Phast
System. bla CTX-M gene was ampliﬁed from all cefotaxime-resist-
ant isolates and their trasnconjugants and sequence was analysed.
Results: An susceptible Salmonella isolate (no. 1) was isolated from
a blood culture from a 10-month-old girl admitted in Paediatric
wards Then, two control faeces samples from the same patient
yielded a cefotaxime-resistant Salmonella (isolate nos 2 and 3) and
a cefotaxime-resistant Escherichia coli (isolate no. 4). The three
resistant isolates and their transconjugants showed synergism
with clavulanic acid compatible with ESBL phenotype and they
also produced beta-lactamase with a pI of 8.0, which suggests a
CTX-M9-type enzyme. It was possible to amplify the blaCTX-M
fragment and the analysis of deduced amino acid bla sequences
showed that the corresponding gene encoded the CTX-M-14 beta-
lactamase. The three Salmonella isolates belonged to serogroup D,
serotype Enteritidis, phage type PT1 and showed identical PFGE-
patterns except for one extra band of 75 kb in the cefotaxime-
resistant isolates 2 and 3.
Conclusions: Our ﬁndings provide the ﬁrst evidence of CTX-M-14
associated with Salmonella enterica serotype Enteritidis. The
molecular epidemiologic study showed that the child was infected
with the same Salmonella strain, which developed ESBL phenotype
during the episode. The ﬁnding of a intestinal E. coli strain with
the same ESBL indicates a possible intestinal bla gene transmis-
sion between both species of Enterobacteriaceae.
P697 OmpK37 and reduced susceptibility to imipenem and
meropenem in Klebsiella pneumoniae
H. Segal, B.G. Elisha
Cape Town, ZA
Objectives: The aim of the study was to investigate the reduced
carbapenem susceptibilities in clinical isolates of Klebsiella pneumo-
niae.
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Methods: K. pneumoniae strains were initially isolated from blood
obtained from two patients at Groote Schuur Hospital, Cape
Town. The isolates were susceptible to amoxicillin-clavulanate,
imipenem (MIC, 0.125 mg/L), and meropenem (MIC, 0.032 mg/
L) but resistant to amoxicillin, cefuroxime, cefotaxime, ceftazi-
dime, cefepime, and cefoxitin. Extended spectrum beta-lactamase
activity was detected using the double disc technique. Both
patients were treated with meropenem. Subsequently, K. pneumo-
niae was isolated from faeces from the same two patients. These
isolates displayed a similar susceptibility proﬁle, except that they
were resistant to co-amoxiclav, and had reduced susceptibilities
to meropenem (MIC, 3–6 mg/L) and imipenem (MIC, 1–2 mg/
L). The relatedness of the strains was investigated using pulsed
ﬁeld gel electrophoresis (PFGE). E-test strips were used to detect
the presence of metallo-beta-lactamases (MBLs) with activity
against carbapenems. To study the porin content of the strains,
outer membrane proteins (OMPs) were extracted, separated by
SDS-PAGE and, where necessary, identiﬁed by Maldi-TOF analy-
sis.
Results: Each of the strains had an identical PFGE proﬁle,
showing that the strains were related. No MBLs were detected
in the strains with reduced susceptibility to the carbapenems. A
comparison of the porin proﬁles identiﬁed a 40 kDa protein in
the strains with reduced carbapenem susceptibilities, which was
not present in the susceptible isolates. Maldi-TOF analysis indi-
cated that the protein was most similar to the E. coli OmpG.
The most likely counterpart of OmpG in K. pneumoniae is
OmpK37, the absence of which probably accounts for the
reduced susceptibility to meropenem and imipenem. OmpK35
and OmpK36 were not observed in any of the preparations.
This ﬁnding is consistent with the cefoxitin resistance pheno-
type of all four strains.
Conclusion: Meropenem susceptible and resistant K. pneumoniae
were isolated from blood and faeces, respectively, from two
patients. Reduced susceptibility to meropenem and imipenem
was associated with the loss of OmpK37. Both patients were trea-
ted with meropenem, which may have inﬂuenced the selection of
OmpK37-deﬁcient strains.
P698 In vitro sequential development of gene mutations in
ﬂuoroquinolone-resistant salmonellae
J.M. Ling, Y. Jin
Hong Kong, HK
Objectives: (1) To investigate the development of ﬂuoroquinolone-
resistant salmonellae in vitro; (2) to characterise the sequential
accumulation of target gene mutations leading to high-level ﬂuor-
oquinolone-resistance.
Methods: Fluoroquinolone-resistant mutants of Salmonella enterica
serotype Typhimurium and S. Hadar were obtained by plating
sensitive strains on agar containing increasing twofold concentra-
tions of ciproﬂoxacin, gemiﬂoxacin, levoﬂoxacin, moxiﬂoxacin,
norﬂoxacin or oﬂoxacin. Mutants thus obtained were again subjec-
ted to selection to obtain nth-step mutants (where n stands for the
number of times the mutants had been subjected to selection).
Susceptibilities of the mutants were determined and mutations of
target genes were detected by multiplex PCR amplimer conforma-
tion analysis and conﬁrmed by direct DNA sequencing.
Results: First-step mutants of S. Typhimurium usually harboured a
gyrA mutation (Asp87!Asn/Gly/His/Tyr), the MICs were 4–16
times higher than those for the parent strains and were below the
sensitive breakpoint of ﬂuoroquinolones. One mutant harboured a
gyrB (Glu466!Asp) mutation and the MICs were 2–8 times lower
than those for the parent strain. Only three second-step mutants
harboured an additional gyrA mutation (Ser83!Phe) while two
2nd-step mutants from the parent with a gyrB mutation har-
boured a gyrA mutation (Asp87!Gly or Ser83!Phe). Mutations
in parC (Glu51!Asp, Gly78!Asp, Ser80!Arg/Ile or
Glu84!Gly/Lys) were ﬁrst observed in third-step mutants.
Although most fourth-step mutants were resistant to high concen-
trations of ﬂuoroquinolones as were third-step mutants, no addi-
tional mutation was found.Fewer mutations were detected in
mutants of S. Hadar: First-step mutants harboured a gyrA muta-
tion (Asp87!Asn/Gly/Tyr or Ser83!Phe) and a gyrB
(Glu466!Asp) mutation. No additional mutation was found in
second-step mutants although MICs were higher than those for
the parents.
Conclusions: Low-level ﬂuoroquinolone-resistant salmonellae
which evolved by development of a gyrA mutation became high-
level resistant by developing additional gyrA and parC mutations.
Such sequential development of ﬂuoroquinolone-resistance varied
among Salmonella serotypes.
P699 Biochemical characterisation of IMP-16, a novel IMP
variant harboured in a class I integron of a Pseudomonas
aeruginosa clinical isolate from Brazil
R.E. Mendes, M.A. Toleman, H.S. Sader, R.N. Jones, T.R. Walsh
Bristol, UK; North Liberty, USA
Objectives: Several variants of IMP-type enzymes have been iden-
tiﬁed and they are from 1 to 17% amino acid residues divergent
from IMP-1. In some cases, they also present with different kinetic
properties. Here we report the biochemical characterisation of a
new IMP variant, IMP-16, that was found in Pseudomonas aerugi-
nosa index strain (101-4704) clinical isolate from Brasilia (Brazil).
Methods: Primers targeting the 5’CS and 3’CS regions of class 1
integron were used to amplify the blaIMP-16 containing integron.
These primers yielded PCR products, which were sequenced on
both strands using DuPont Automated systems. After integron
sequence analysis, the blaIMP-16 gene was subcloned into expres-
sion vector pPCRScriptCam SK+ and overexpressed in Escherichia
coli DH5alfa. The IMP-16 protein was puriﬁed by Fast Perform-
ance Liquid Chromatography. Kinetic properties were determined
with several beta-lactam substrates measuring hydrolytic activity
under initial rate conditions.
Results: The N-terminus of the IMP-16 showed typical features of
bacterial signal peptides that target proteins to the periplasmic
space and the most likely cleavage site is located between the
alanine at positions 18 and glycine at position 19. This produces a
mature protein of 25 266 Da with a theoretical pI of 6.5. IMP-16 is
a new IMP variant that differs from IMP-1 by 15% amino acid
residues, being one of the most divergent variants so far identi-
ﬁed. It is more similar to IMP-8 and IMP-11 (89.8 and 90.3%,
respectively) at the level of mature protein. E. coli DH5alfa har-
bouring the blaIMP-16 recombinant plasmid showed a similar
beta-lactam resistance proﬁle when compared with the index
strain (101-4704), being resistant to nearly all beta-lactam tested,
apart from aztreonam and carbapenems. The IMP-16 enzyme was
overproduced in E. coli and puriﬁed (>95%). Preliminary kinetic
analysis revealed Km values of 38, 98, 0.05 and 10 lM, and Kcat
values of 0.05, 0.24, 2.0 and 1.2 /s for meropenem, imipenem,
penicillin and nitroceﬁn, respectively.
Conclusions: IMP-16 is a new highly divergent IMP variant detec-
ted in P. aeruginosa. Kinetic parameters showed the great struc-
tural and functional plasticity among this group of clinical
important enzymes.
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P700 Pyrosequencing at the Health Protection Agency, UK
C. Arnold, S.E. Gharbia
London, UK
One of the remits in the Genomics, Proteomics and Bioinformatics
Unit (GPBU) of the UK Health Protection Agency is to utilise ge-
nomics in infection control by the use of accelerated genomic
information and enhanced biotechnological methods to streamline
the traditional approaches used in classical molecular genetics to
instigate advances in Public Health Protection.Alteration in gene
expression patterns or DNA sequence can have profound effects
on biological functions and pathological processes. In GPBU, sys-
tems are developed for identifying genetic variations and gene
expression and our key developmental objectives are to reformat
sequence-based typing into fast, high throughput systems, to
explore microbial genome sequences for VNTRs and SNP targets
as tools for high resolution strain comparison and to provide tools
for molecular-based surveillance of high priority infections.To this
end, Pyrosequencing technology has been evaluated for its utility
in SNP characterisation (including antibiotic/drug resistance) and
genotyping in Public Health Microbiology in the UK. An over-
view of applications will be presented including:
HIV-1
– drug resistance
– subtyping
Hepatitis C virus
– genotyping
– minor genotype analysis
Antibiotic resistance
– Neisseria gonorrhoeae
– Salmonella enterica
– Mycobacterium tuberculosis
Mycobacterium tuberculosis
– screening from sputum samples
– VNTR typing
H antigen typing of Salmonella
P701 Universal 16S rDNA PCR and sequencing in the
diagnosis of infective endocarditis directly from heart valve
tissue
M. Marı´n, P. Mun˜oz, M. Rodriguez-Cre´ixems, L. Alcala´, J. Silva,
E. Bouza–Endocarditis Study Group
Madrid, Spain
Background: The microbiological diagnosis of infective endocardi-
tis (IE) is based on positive culture of heart valve tissue or blood
culture but cultures remain negative when IE is caused by fastidi-
ous micro-organisms or antimicrobial treatment is started before
cultures are obtained.
Objective: To evaluate the usefulness of a universal 16S rDNA
PCR method followed by direct sequencing in heart valve tissue
for IE diagnosis in the routine of a clinical microbiology laborat-
ory, compared with traditional heart valve culture (HVC) and
blood culture (BC).
Methods: Heart valves received for culture over a ten-month per-
iod were studied by 16S rDNA PCR with primers PSL and P13P.
Positive samples were subsequently sequenced for identiﬁcation.
HV were cultured by conventional methods. BCs were performed
by the BACTEC 9240 system. Sensitivity of the assay was assessed
by obtaining DNA from 10-fold dilutions of Streptococcus oralis.
After molecular analysis, clinical records of patients and results of
conventional cultures were consulted.
Results: Twenty-four samples of HV (24 patients) were studied.
In 10 patients IE was clinically rejected and their valves were
included in the study as negative controls. Their HVC, BCs and
PCR were negative. The remaining 14 cases had either proven
(13) or possible (1) IE. Overall, BCs were positive in 11 patients
but HVC remained positive at the moment of resection in only
four patients. Of the 14 cases, 12 were microbiologically documen-
ted by conventional cultures. PCR was positive in the 12 con-
ﬁrmed cases. Micro-organisms identiﬁed by PCR matched those
cultured by conventional cultures except in one case in which the
valve was inadequately remitted to the microbiology laboratory.
In the 2 cases with IE and with no micro-organisms demonstrated
by conventional cultures, PCR was also negative. The median
time of analysis to a PCR result was 1 day and to a sequence and
bacterial identiﬁcation in PCR-positive samples, 3 days. The ana-
lytical sensitivity of this assay was 100 CFU/mL.
Conclusions: Universal 16S rDNA PCR followed by sequencing
applied to resected heart valves seems to be a reliable test for
diagnosis of IE. Our study suggests its applicability to patients
with conventional negative microbiology, mainly those studied
during the course of antimicrobial therapy.
P702 Clinical importance of PCR diagnosis in bacterial
meningitis and sepsis
S. Plisek, L. Pliskova, V. Dostal, V. Stepanova, E. Pozlerova,
J. Blazkova
Hradec Kralove, CZ
Objectives: The importance of the detection of bacterial DNA by
PCR in laboratory diagnosis of invasive bacterial infections has
been increasing. PCR represents the rapid, sensitive and speciﬁc
method, which provides the possibility to detect bacterial DNA in
cases of application of few doses of ATB therapy. In such cases
the classical microbiology methods often fail.
Methods and Materials: After DNA extraction PCR for determin-
ation DNA of N. meningitidis, Haemphilus inﬂuenzae, Streptococcus
pneumoniae, Staphylococcus aureus and Listeria monocytogenes was
used. In 2001–2003, 92 patients (CSF, blood and urine) with sus-
pected invasive bacterial infection (sepsis or bacterial meningitis)
were examined for the presence of mentioned bacterial DNA in
case of negative microscopy and agglutination examinations.
Results: Invasive meningococcal disease (IMD) was diagnosed by
clinical and laboratory methods in 20 of 60 examined patients. In
10 patients N. meningitidis was detected by classical microbiology
methods, in 10 patients N. menigitidis DNA was found only by
PCR (7x in CSF; 3x both in CSF and blood; 1 only in urine). In
50% of patients with the diagnosis of IMD the presence of N.men-
ingitidis was not detected by classical microbiology methods, only
by PCR. Of the rest of 72 patients bacterial DNA was detected in
28 patients (4x Haemophillus inﬂuenzae, 15x Streptococcus pneumoni-
ae, 6x Listeria monocytogenes and 3x Staphylococcus aureus).
Conclusion: The decline of positive ﬁndings of bacterial DNA by
classical methods (microscopy, agglutination, cultivation) may be
caused by the administration of the ﬁrst doses of ATB in the onset
of non-speciﬁc symptoms of disease. The detection by very sensi-
tive PCR enables to detect DNA not only from live but also disin-
tegrated bacteria. The signiﬁcance of PCR diagnosis in these cases
has increased very much because of its speed, sensitivity and spe-
ciﬁcity.
P703 A new scoring method for molecular diagnostic kit
users
H. Staines, P. Wallace, R. Pogathota, E. Buultjens
Dundee, Glasgow, UK
Objectives: A proposed score provides informative, intuitively
appealing feedback to molecular diagnostic kit users. The colour-
coded score [green (¼ highly satisfactory) to red (highly
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unsatisfactory)] is presented for individual samples and overall
performance. Simple graphical presentations compare perform-
ances within and between ampliﬁcation methods.
Methods: The score uses the log copies/mL reported from quanti-
tative assays. Analysis of Variance using the ampliﬁcation method
for each panel sample is used to: check for normality, identify out-
liers and estimate the standard deviation. The difference between
the participant’s result and target value is divided by the standard
deviation. A participant’s score for an individual sample is deﬁned
as the integer part of the absolute value of this value (max 3).
Scores of 0, 1, 2 and 3 are colour-coded green, yellow, amber and
red, respectively, for participant feedback. Assuming independ-
ence, normality and no ampliﬁcation method effect, the distribu-
tion of scores are approximately 68, 27, 4.5 and 0.5%.The overall
performance for an individual participant is the sum of the indi-
vidual samples scores. Monte Carlo methods determine the prob-
ability distribution of the overall performance score. These scores
are colour coded from green to red in proportions approximately
equal to individual samples (e.g. 68% green). Feedback for a parti-
cipant’s overall performance is the same as for individual samples.
Results: Scores have been found for the 2002 QCMD panels for
hepatitis B, C and HIV. For each sample log results were normally
distributed within each ampliﬁcation method with few outliers
detected.Scores frequencies varied amongst individual samples
within each panel. For many samples, the proportion of scores
were not consistent with that predicted by independent observa-
tions from a normal distribution. This was conﬁrmed by ANOVA
that showed signiﬁcant differences in the mean log observations
amongst ampliﬁcation methods. Graphical representations
showed pronounced differences amongst the methods within and
across panels.
Conclusions: The new scoring scheme is based on well-known
statistical properties and techniques. The colour coded perform-
ance scores are readily interpretable and simple graphical out-
put also allows participants to gauge their performance against
other users of the same method and to help choose amongst
methods.
P704 Application of TaqMan probes in end-point
ﬂuorimetry for detection of pathogenic bacteria by polymerase
chain reaction
K. Oravcova´, E. Kaclı´kova´, T. Kuchta
Bratislava, SK
Objectives: 5’-Nuclease polymerase chain reaction in a conven-
tional thermal cycler and a subsequent ﬂuorescence measurement
in a 96 well ﬂuorimeter were developed and successfully carried
out in ﬂat-bottom microtubes.
Methods: Complete reaction system was simply transferred from
real-time PCR to new instrumental conditions. Speciﬁc primers
and speciﬁc TaqMan probes (ﬂuorescent dye 6-FAM, quenching
dye TAMRA) for Salmonella sp. and E. coli strains were used.
When ﬁnishing the PCR, the ﬂuorescence was measured in end-
point mode in ﬂuorescence reader equipped with an excitation ﬁl-
ter with a pass maximum of 492 nm and an emission ﬁlter with a
pass maximum of 520 nm from the bottom orientation. To deﬁne
the positivity threshold, three negative control samples (contain-
ing no DNA template) were used. Mean value and the standard
deviation (SD) were calculated and the positivity threshold was
set to (mean + 2 SD).
Results: In these conditions, consistent results were obtained
when PCR was done with puriﬁed Salmonella enteritidis and E. coli
DNA or with culture lysates. When lysates of series of decimally
diluted cultures were analysed a detection limit of 10exp4 CFU/
mL was determined, the same sensitivity as with real-time PCR
and the same or one order of magnitude higher than with the gel
electrophoresis were determined.
Conclusion: The method proved to be a fast and contamination-
free alternative to gel electrophoresis and an inexpensive alternat-
ive to real-time PCR.
P705 Usefulness of the MicroSeq 500 16S rDNA-based
method for identiﬁcation of bacterial isolates unidentiﬁed by
commercial automated systems
C. Fontana, M. Favaro, M. Pelliccioni, E.S. Pistoia, C. Favalli
Rome, I
Objective: Reliable automated identiﬁcation and susceptibility test-
ing of clinically relevant bacteria is very important for routine
microbiology laboratories, thus improving patients’ care. Examples
of automated identiﬁcation systems are: the Phoenix (Bec-
ton&Dickinson) and the Vitek2(bioMe´rieux). Both systems claim to
provide accurate and rapid identiﬁcation as well as susceptibility
results with substantially easy workﬂow. However, more and more
frequently microbiologists isolate ‘difﬁcult’ strains, particularly
those isolates from patients who have undergone repetitive antibio-
tic treatment and which consequently exhibit biochemical charac-
teristics that do not ﬁt into patterns of any known genus and
species. The identiﬁcation of these pathogens is normally failed by
automated systems. An alternative could be the genetic identiﬁca-
tion; the latter based on the 16S rDNA sequencing and analysis, as
16S is highly conserved within a species and among species of the
same genus. Aim of the present work is to evaluate the possible
use of the MicroSeq (Applera), sequencing 16S rDNA, as the new
gold standard for identiﬁcation of isolates whose identiﬁcation is
not obtained or results inadequate with conventional systems.
Methods: In the present work we have analysed 83 difﬁcult iso-
lates: 25 Gram+ and 58 Gram strains. The isolates were contem-
poraneously identiﬁed by using both automated systems such as:
Vitek2 and Phoenix. The phenotypic identiﬁcations were con-
ﬁrmed by genetic analysis performed by using MicroSeq system.
Results: The results have shown that the phenotypic identiﬁcation
provided by Vitek2 and Phoenix was remarkably similar, in par-
ticular: 74% of the identiﬁcation obtained for the Gram, and
80% for the Gram+ resulted to be in concordance with both sys-
tems, and was also concordant with genetic characterisation. The
exception was represented by 15 Gram and nine Gram+ isolates
whose phenotypic identiﬁcations were contrasting or not conclu-
sive. For these strains the use of MicroSeq demonstrated to be
fundamental to achieve the species identiﬁcation.
Conclusion: The use in clinical microbiology of MicroSeq, partic-
ularly for those strains with ambiguous biochemical proﬁles
(including slow-growing strains), results to be helpful allowing to
better achieve identiﬁcations as compared with conventional sys-
tems. Moreover, the system appears easy to use and cost effective,
making MicroSeq reasonably applicable also in clinical laboratory.
P706 Facts, feasibility and future of bacterial load of
bloodstream infections
R.P.H. Peters, T. Schuurman, R.F. de Boer, A.M.D. Kooistra,
S.A. Danner, C.M.J.E. Vandenbroucke-Grauls, M.C.J. Persoons,
A.A. van Zwet, P.H.M. Savelkoul, M.A. van Agtmael
Amsterdam, Groningen, NL
Real-time PCR is becoming more and more a standard technique
in many laboratories for the detection of micro-organisms in clin-
ical samples. This closed PCR system enables rapid clinical
molecular diagnostics in the medical microbiological laboratory.
In blood samples, pathogen-speciﬁc PCR is of additional value to
conventional blood culture in case of prior use of antibiotics or
when slow-growing organisms like mycobacteria are involved.
Although there are many reports on pathogen-speciﬁc applica-
tions, a more general approach with broad-range detection based
on the 16S gene has only been described a few times, with inter-
esting results. None of these broad-range studies has been des-
cribed so far with real-time PCR that enables quantiﬁcation of
initial DNA with deduction of a ‘bacterial load’ that can possibly
be used for monitoring antimicrobial therapy.In this study real-
time PCR (TaqMan 7000) was combined with an automated DNA
isolation robot (MagNA Pure LC) in order to standardise en
optimise DNA isolation and subsequent ampiﬁcation. Ninety
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blood samples from patients with fever were evaluated. PCR
showed ampliﬁcation of 10/13 samples with positive concurrent
blood cultures; the three that remained negative in PCR all grew
coagulase-negative staphylococci. Other PCR results were in con-
cordance with blood culture outcome and/or clinical data. How-
ever, sequence-analysis showed cross-contamination with
Burkholderia species DNA that could be traced to buffers of the
DNA isolation kit, although a second (mixed) sequence could be
recognised. The concordance of clinical data and PCR results may
be explained by the presence of blood components related to
infection that function as PCR-enhancer, like serum-proteins.In
conclusion, real-time PCR seems a promising addition to the spec-
trum of diagnostic possibilities for bloodstream infections, especi-
ally in case of pathogen-speciﬁc detection of bacteraemia. To
develop a real-time broad-range PCR for detection of bloodstream
infections with determination of a ‘bacterial load’, attention
should be given to optimisation of DNA isolation and DNA-free
nucleic acid isolation kits and PCR reagents.
P707 Broad-range polymerase chain reaction based
bacterial and fungal molecular assays improve the diagnostic
ability of the Duke scheme in suspected cases of infective
endocarditis
M. Slany, M. Grijalva, J. Cerny, T. Freiberger
Brno, CZ
Objectives: The diagnosis of infective endocarditis (IE) may become
sometimes a difﬁcult one, particularly when blood cultures are neg-
ative or in cases in which the course of the disease is insidious. The
Duke scheme has improved the diagnostic ability of clinicians deal-
ing with suspected cases of IE. However, reaching a precise micro-
biological diagnosis may be a challenge in clinical situations such as
those mentioned above. Molecular approaches have helped on this
task and a few reports have been published regarding the clinical
validation of these methods and techniques in IE settings. We
hypothesised that the molecular microbiological diagnosis of IE
may improve the diagnostic ability of the Duke scheme.
Methods: To test this hypothesis, we deﬁned a group of IE
patients in which microbiology results from traditional methods
(blood and valve cultures) as well as from molecular testing
(broad range PCR-based 16S rDNA bacterial detection and 28S-
5.6S-IS2 rDNA fungal detection assays from valve samples) were
available. Then we compared the diagnostic performance (in
terms of Duke classiﬁcation) of the Duke criteria alone and after
the inclusion of microbiological molecular data. Forty-nine suspec-
ted IE patients were included in the study.
Results: The Duke scheme alone classiﬁed the patients as follows;
25 (51%) as ‘deﬁnite IE’, 22 (45%) as ‘possible IE’, and two (4%)
as ‘rejected IE’. When we applied the molecular microbiological
data as an additional major criterion, 19 ‘possible IE’ cases were
reclassiﬁed as ‘deﬁnite IE’ and the two ‘rejected IE’ cases were
reclassiﬁed as ‘possible IE’. Overall, 43 patients (88%) were con-
sidered as ‘deﬁnite IE’ and six as ‘possible IE’, while no cases
remained classiﬁed as ‘rejected IE’.
Conclusions: Broad-range bacterial and fungal PCR-based assays,
when considered as part of the Duke scheme improve its diagnos-
tic ability and might be a useful tool in the microbiological diag-
nosis of infective endocarditis. This study was supported by the
grant of MZ CR No. CEZ MZ 00000209775.
P708 Direct detection of the most important bacterial
pathogens from blood cultures using nucleic acid based
techniques
U. Eigner, M. Weizenegger, M. Holfelder, A.-M. Fahr
Heidelberg, D
Introduction: Bacterial bloodstream infections are cause of high
mortality rates in patients. Therefore rapid and accurate detection
of the bacterial pathogens is of high importance for successful
patient therapy. We developed a nucleic acid based hybridisation
assay using a set of oligonucleotide probes targeting different
DNA-regions for the differentiation of 15 Gram-negative species
and 18 different Gram-positives including the van and mecA anti-
biotic resistance-associated genes. A challenge set of 220 bacterial
isolates belonging to the genera staphylococci, streptococci,
enterococci, members of the family of the Enterobacteriaceae and
nonfermenting Gram-negative rods were selected to evaluate the
speciﬁcity of the selected primers and the oligonucleotide probes.
The strains were chosen from routine samples and reference
strains provided by different collections (ATCC, USA; DSMZ,
Germany; RKI, Germany). Species conﬁrmation of the routine
samples was done using the apistrep and the VITEK2 -system
(bioMe´rieux, France). Discrepancies were resolved by direct
sequencing a 16S rDNA fragment. Van- and mecA genotype con-
ﬁrmation was performed by an in house PCR-assay. A total of 75
bacterial DNAs were directly extracted from positive BACTEC
9260 (BD Diagnostic Systems, USA) blood culture bottles, ran-
domly collected at our laboratory.
Methods: DNA-Isolation from bacterial cultures: A loop of bacter-
ial cells or up to ﬁve colonies from an agar plate were suspended
in 150 lL distilled water and 15 min heated at 95C and sonicated
15 min. DNA isolation from blood cultures: 15 lL of the positive
blood culture was spotted on paper. After drying of 10 min at
95C, 100 lL distilled water was added. DNA was released by a
15 min heating step at 95C and 10 min soniﬁcation.
DNA-Ampliﬁcation: PCR-ampliﬁcation was done using a Perking-
Elmer 9600 thermocycler (Applera, Germany) with one cycle
5 min at 95C, 30 cycles 30 s at 95C, 30 s at 45C, 30 s at 72C
and a ﬁnal elongation step with 7 min at 72C.
Hybridisation: Hybridisation and detection were performed on an
automated system (Tecan, Germany).
Results/conclusion: With regard to the 220 bacterial isolates and
the 75 isolates from blood cultures tested the hybridisation assay
so far showed excellent results. Differentiation results were
obtained in about 4 h from the time the blood cultures gave a
positive signal, including DNA extraction, PCR and the hybridisa-
tion procedure.
P709 Development of a multiplex real-time PCR for
detection and differentiation of Chlamydiaceae species which
are pathogenic for humans
I. Edelstein, A. Narezkina, M. Edelstein
Smolensk, RUS
Objectives: Real-time PCR (RT-PCR) offers many advantages over
conventional PCR methods for detection of microbial pathogens.
The aim of our study was to develop and evaluate the perform-
ance of a multiplex 5’-nuclease-based RT-PCR assay for direct
detection and differentiation of Chlamydia trachomatis (CTR),
Chlamydophila pneumoniae (CPN) and zoonotic agents [Chlamydo-
phila psittaci (CPS), Chlamydophila abortus (CAB) and Chlamydophila
felis (CFE)] in clinical specimens.
Target
Probe
IS
FAM
CTR
JOE
CPN
ROX
CPS+
Cy5
Detection limit,
copies/reaction
IS + – – – 600
C. trachomatis – + – – 1–2
C. pneumoniae – – + – 2–4
C. psittaci – – – + 2–4
C. abortus – – – + 2–4
C. felis – – – + 2–4
173Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
Methods: The 5’-end sequence of the omp1 gene which is well
characterised in all chlamydial species was selected as a PCR tar-
get. It was ampliﬁed using the family-speciﬁc primers CM1 and
CM2 (H. Yoshida et al., 1998) on a Rotor-Gene 2000 system (Corb-
ett research). Three probes containing different ﬂuorescent dyes,
JOE, ROX and Cy5 (Biosearch Technologies) were designed to tar-
get the signature sequences in the ampliﬁed omp1 region, which
are highly conserved within CTR, CPN and zoonotic agents and
are distinctive between them. The fourth FAM-labelled probe was
used for the detection of a heterogeneous internal standard (IS).
The analytical sensitivity of the assay was determined by testing
peripheral blood leucocyte specimens spiked with chlamydial ele-
mentary bodies or recombinant plasmids containing omp1 frag-
ments of the following strains: CTR L2, CPN Kajaani 7, CPS 6BC,
CAB B577 and CFE FePn. In addition, a panel of 219 genital swab
specimens was used to assess the sensitivity and speciﬁcity of
CTR detection using RT-PCR in comparison with a commercial
PCR assay targeting the cryptic plasmid of this species.
Results: As shown in the table, the multiplex RT-PCR was able to
detect speciﬁcally and reprodce single DNA copies of each chla-
mydial species in the presence of IS and excess of human DNA.
When compared with monoplex PCRs, multiplexing of four
probes did not decrease sensitivity, while no cross-detection
between CTR, CPN and zoonotic species was observed. In testing
clinical specimens, RT-PCR detected CTR DNA in 44 of the 46
samples that were positive and in one sample that was negative
by commercial PCR. The lack of ampliﬁcation of IS indicated the
presence of inhibitors in two samples. Consequently, with com-
mercial test used as a reference, the sensitivity and speciﬁcity of
RT-PCR were 95.7 and 99.4%, respectively.
Conclusion: The developed method enables rapid, sensitive and
speciﬁc detection of all members of Chlamydiaceae which are
pathogenic for humans.
P710 Detection of Chlamydia trachomatis and Neisseria
gonorrhoeae in Tripath SurePathTM Pap samples using the
Gen-Probe Incorporated APTIMA Combo 2 Assay
R. Johnson, R. Pilla, M. Alvarez, M. Shih, C. Eng, B. Weinbaum
San Diego, USA
Objectives: To determine the suitability of TriPath SurePathTM
(TriPath Imaging) medium for detection of Chlamydia trachomatis
(CT) and Neisseria gonorrhoeae (GC) using the Gen-Probe APTI-
MA Combo 2 (AC2) Assay.
Background: Because the cervix is a site of infection for CT and
GC, Pap specimens may also be appropriate for detection of these
sexually transmitted bacteria. By testing Pap specimens for CT
and GC with AC2, multiple test results (CT, GC, Pap) can be
obtained from one specimen. SurePath medium was evaluated for
the detection of CT and GC with the AC2 assay using a protocol
in which an aliquot is transferred to a tube containing Gen-Probe
transport medium. The AC2 assay was then performed on the
SurePath/transport medium sample using the standard AC2 pro-
tocol for endocervical swab and urine specimens.
Methods: For analytical sensitivity, 14 CT serovars and 20 GC
clinical strains were diluted in the SurePath medium to 0.01 CT
IFU and 0.5 GC CFU per AC2 reaction. Speciﬁcity was evaluated
with three Chlamydia and 51 Neisseria nontarget species. Stabilities
of samples in SurePath vials and in the SurePath/transport med-
ium mixture were monitored at 4–35C. Cross-contamination due
to Pap sample processing on the TriPath PREPmateTM instrument
was determined by processing alternating negative and high titre
GC samples and then running them in the AC2 assay. Potentially
interfering substances evaluated included whole blood and com-
monly used feminine hygiene products at usage levels higher
than those expected in normal usage.
Results: All CT serovars were detected at 0.01 IFU/AC2 reaction
and all GC strains were detected at 0.5 CFU/AC2 reaction. Specif-
icity was 100%, with no cross-reactions observed with non-CT
and non-GC species evaluated. Stability study results indicated
that CT and GC can be detected from SurePath vials stored for
7 days at 35C and for 30 days when stored at 4–10C. CT and
GC were detected in SurePath/transport medium mixtures stored
at 4–35C for 30 days. Following processing of high titre positives,
false-positive results in known negative samples were <1%. None
of the potentially interfering substances affected assay results.
Conclusion: These results indicate that the SurePath Pap medium
is compatible with the APTIMA Combo 2 Assay for CT and GC
detection.
P711 Detection of Chlamydia trachomatis and Neisseria
gonorrhoeae in Cytyc Preservcyt Pap samples using the
Gen-Probe Incorporated APTIMA Combo 2 Assay
R. Johnson, R. Pilla, M. Alvarez, M. Shih, C. Eng, B. Weinbaum
San Diego, USA
Objectives: To determine the suitability of Cytyc Preservcyt (R)
(Cytyc Corp.) medium for detection of Chlamydia trachomatis (CT)
and Neisseria gonorrhoeae (GC) using the Gen-Probe APTIMA (R)
Combo 2 (AC2) Assay.
Methods: Because the cervix is a site of infection for CT and GC,
Pap specimens may also be appropriate for detection of these sex-
ually transmitted bacteria. By testing Pap specimens for CT and
GC with AC2, multiple test results (CT, GC, Pap) can be obtained
from one specimen. Preservcyt medium was evaluated for the
detection of CT and GC with the AC2 assay using a protocol in
which an aliquot is transferred to a tube containing Gen-Probe
transport medium. The AC2 assay was then performed on the
Preservcyt/transport medium sample using the standard AC2
protocol used for endocervical swab and urine specimens. For
analytical sensitivity, 14 CT serovars and 20 GC clinical strains
were diluted in the Preservcyt medium to 0.01 CT IFU and 0.5
GC CFU per AC2 reaction. Speciﬁcity was evaluated with three
Chlamydia and 51 Neisseria nontarget species. Stabilities of samples
in the Preservcyt vial and in the Preservcyt/transport medium
mixture were monitored at 4–35C. Cross-contamination due to
Pap sample processing on the Cytyc ThinPrep2000 (TP2K) instru-
ment was determined by processing alternating negative and high
titre GC samples and then running them in the AC2 assay. Poten-
tially interfering substances evaluated included whole blood and
commonly used feminine hygiene products at usage levels higher
than those expected in normal usage.
Results: All CT serovars were detected at 0.01 IFU/AC2 reaction
and all GC strains were detected at 0.5 CFU/AC2 reaction. Specif-
icity was 100%, with no cross-reactions observed with non-CT
and non-GC species evaluated. Stability study test results indica-
ted that CT and GC can be detected from Preservcyt and Preserv-
cyt/transport medium mixtures stored at 4–35C for 30 days.
Following TP2K processing of high titre positives, false-positive
results in known negative samples were 1%. None of the poten-
tially interfering substances affected assay results.
Conclusion: These results indicate that the PreservCyt Pap med-
ium is compatible with the APTIMA Combo 2 Assay for CT and
GC detection.
P712 Chlamydophila pneumoniae-speciﬁc mRNA is present
in aortic wall biopsies of patients suffering from stable or
unstable angina pectoris
M. Edvinsson, E. Hjelm, S. Thelin, G. Friman,
C. Nystro¨m-Rosander
Uppsala, S
Objectives: Chlamydophila pneumoniae (Cp) might somehow be
involved in the pathogenesis of atherosclerosis. Several studies
have demonstrated a serological association between Cp and cor-
onary artery disease and DNA from the bacteria has been found in
various atheromatous vessels. However, only a few investigators
have managed to culture Cp from atheromatous plaques. Instead
of culturing, viable bacteria could be demonstrated by reverse tran-
scriptase PCR (RT-PCR) against bacterial mRNA. We investigated
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the presence of Cp DNA and mRNA in aortic wall biopsies,
obtained at surgery, from 24 patients with stable angina pectoris
(SAP) and 20 patients with unstable angina pectoris (UAP).
Methods: DNA and RNA were extracted from the same biopsy
using the RNA/DNA mini kit (Qiagen). cDNA was made using
the SuperScript First-Strand Synthesis System for RT-PCR (Invitro-
gen). Real time PCR directed against the MOMP gene was used
to detect the presence of Cp DNA and mRNA in the biopsies.
Patient sera were tested for Cp-speciﬁc IgM, IgG and IgA antibod-
ies by the microimmunoﬂuorescence technique.
Results: Thirteen (30%) of the biopsies (six SAP; seven UAP) were
positive for Cp DNA, eight (18%) were positive for Cp mRNA
(ﬁve SAP; three UAP) and six (14%) were positive for both DNA
and mRNA (4 SAP; 2 UAP). All biopsies but one were positive
for human cDNA encoding the GAPDH gene. That biopsy was
negative also for Cp DNA and Cp mRNA. Results from the serol-
ogy will be presented on the poster.
Conclusion: We have demonstrated the presence of Cp in the aor-
tic wall of patients suffering from stable (SAP) or unstable (UAP)
angina pectoris. Also, we have demonstrated Cp mRNA in 17%
of these patients indicating that the bacteria were metabolically
active. There were no signiﬁcant differences in the frequencies of
positivity for Cp DNA or Cp mRNA between the SAP and UAP
groups. The results support the hypothesis of an active role for
Cp in the pathogenesis of atherosclerosis.
P713 Rapid identiﬁcation of HACEK group of bacteria by
16S rRNA gene PCR and restriction fragment length
polymorphism analysis
Y. Kodama, M. Sasaki, S. Tajika, Y. Ohara-Nemoto, C. Yamaura,
Y. Shimoyama, S. Kimura
Morioka, JP
Objectives: Although infective endocarditis due to HACEK
group of bacteria (Haemophilus spp., Actinobacillus actinomycetem-
comitans, Cardiobacterium hominis, Eikenella corrodens and Kingella
spp.) is a rare occurrence, the identiﬁcation of the organisms is
still important diagnostically for the speciﬁc therapy. The
HACEK bacteria are classiﬁed as fastidious Gram-negative coc-
cobacilli, and the biochemical characteristics resemble each
other. Thus, the identiﬁcation of HACEK bacteria has been
rather hard and sometimes inconclusive. In this study, we
developed a rapid and highly sensitive identiﬁcation method
for HACEK bacteria by means of 16S rRNA gene PCR ampliﬁ-
cation followed by restriction fragment length polymorphism
analysis (PCR-RFLP).
Methods: H. aphrophilus ATCC 33894, A. actinomycetemcomitans
ATCC 33384, C. hominis ATCC 12826, E. corrodens ATCC 23834
and K. kingae ATCC 23330 were used. DNA samples were pre-
pared by a DNA puriﬁcation kit. After PCR ampliﬁcation using
the primers corresponding to Escherichia coli 16S rRNA gene, the
PCR products were digested with 4 U of either f HinfI and f MspI
at 37C for 1.5 h. The samples were then separated on 1.8%
agarose gel, and the restriction patterns were recorded.
Results: The RFLP patterns of ﬁve species of HACEK bacteria
obtained by combing use of HinfI and MspI digestion were
readily distinguished from each other and from other pathogens
of infective endocarditis including viridans streptococci. Further-
more, the PCR-RFLP analysis yielded a deﬁnitive identiﬁcation
of C. hominis from one of the blood samples of the patients
with infective endocarditis in which causative pathogens could
not be unidentiﬁed by biochemical identiﬁcation kits. The result
was conﬁrmed by a 16S rRNA gene sequence analysis of the
isolate.
Conclusion: The PCR-RFLP analysis developed in this study was
a rapid and highly sensitive identiﬁcation method for HACEK
group of bacteria, and could be applicable for a deﬁnitive diag-
nostic detection of HACEK group of bacteria.
P714 Same day molecular diagnostic test result for atypical
and difﬁcult to grow respiratory pathogens including
M. tuberculosis complex by combining automated DNA
extraction with real-time PCR
K. Jaton, C. Andre´, A. Wenger, G. Prod’hom, J. Bille
Lausanne, CH
Background: Real-time PCR is a powerful method for detecting
bacteria in clinical samples, but DNA extraction is still a crucial
and cumbersome step when performing such tests.
Objectives: (i) Establish a 1-day TAT result for the molecular
diagnosis of tuberculosis using a combination of an automated
DNA extraction method with real-time PCR (RT) (ii) test its
performance for other bacterial respiratory pathogens (M. pneu-
moniae, C. pneumoniae, L. pneumophila, B. pertussis and B. paraper-
tussis (iii) assess its performance on clinical samples for M.
tuberculosis.
Methods: (i) The automated DNA extraction procedure, Magna-
PureR, Roche (MP) was compared with a conventional home-
made extraction procedure (Boom et al.) using silica particles (SI)
for 10 stored specimens positive by culture for M. tuberculosis. The
extracted DNA were ampliﬁed and the amplicons detected by
real-time PCR (RT) using the ABI 7700, Applied Biosystems; (ii)
MP and SI were compared for diluted positive-specimens for the
other bacteria; (iii) to assess the performance for the diagnosis of
tuberculosis on clinical samples, two different periods of
14 months were compared in terms of sensitivity, speciﬁcity, PPV
and NPV using culture results as gold standard. A: (March 2001–
May 2002) 710 specimens (513 patients) with 76 positive cultures
for M. tuberculosis (10.7%) with SI-RT; B: (May 2002–July 2003)
817 specimens (619 patients) with 88 positive cultures for M.
tuberculosis (10.7%) with MP-RT.
Results: (i) Eight of 10 specimens were positive for M. tuberculosis
with SI-RT and nine of 10 with MP-RT (the three discordant
results were weak-positive specimens upon culture); (ii) 100%
concordance between the two procedures for the ﬁve different
bacterial respiratory specimens, even better for the MP-RT when
considering the cycle threshold (Ct) results; (iii) the A vs. B (A/B)
results were very similar (%): global sensitivity: 90/89; sensitivity
for the Ziehl-Neelsen (ZN)-positive samples: 100/100; sensitivity
for the ZN-negative samples: 77/ 80; speciﬁcity: 99/ 99; PPV: 95/
95 and NPV: 99/ 99.
Conclusions: One-day TAT molecular diagnostic test results are
now possible for several atypical or difﬁcult to grow respiratory
bacterial pathogens including M. tuberculosis complex by combi-
ning automated DNA extraction with real-time PCR.
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P715 Reliable and rapid detection of clinically relevant
Mycobacterium and Nocardia species using a multiplex-PCR
with genus- and species-speciﬁc primers
A. Roth, O. Landt, S. Andrees, H. Mauch
Berlin, D
We report a rapid and reliable multiplex PCR assay to identify
13 clinically relevant Mycobacterium species (including M. bovis)
and seven of the most frequently occurring Nocardia species. The
method includes two genus-speciﬁc and six species-speciﬁc pri-
mer mixtures for identiﬁcation to the species level. Additional
genus-primers for closely related actinomycetes such as Streptom-
yces and Tsukamurella were included also. The primers were
designed from nucleotide sequences of the 16S rDNA, the 16S–
23S rDNA intergenic spacer region and part of the 23S rDNA.
The established multiplex PCR identiﬁcation scheme was applied
to the identiﬁcation of 131 reference strains and clinical isolates
that were previously identiﬁed to the species level by 16S rDNA
sequencing or 16S–23S rDNA spacer RFLP. The new scheme was
very reliable and speciﬁc concerning the intra-species stability of
the primers: all strains were identiﬁed correctly, although not all
strains within a few genetically heterogenous taxa such as M.
kansasii or N. abscessus were detected by this PCR method. This
will make the inclusion of further primers necessary for some
groups. Furthermore, we tested this multiplex PCR with 45 spec-
imens from the respiratory tract from patients with suspected
mycobacteriosis or nocardiosis (42 specimens were positve for
acid fast rods, three contained branched Gram-positive rods).
Since only microscopically positive specimens were tested, the
negative predictive value and the sensitivity were very high.
This multiplex-PCR represents a cost-effective, rapid and easy to
perform method for the identiﬁcation of mycobacteria and nocar-
dia from cultures and for the direct detection of these rare but
important pathogens in microscopically positive clinical speci-
mens.
P716 Identiﬁcation of Mycobacterium gordonae clinical
isolates with the use of four molecular methods
F. Kontos, M. Maniati, Z. Gitti, E. Petinaki, P. Papageorgiou,
S. Anagnostou, S. Kanavaki, S. Nikolaou, C. Kostopoulos,
I. Tselentis, A.N. Maniatis
Larissa, Crete, Athens, GR
Objective: The aim of our study was the evaluation of the
PCR-RFLP analysis of hsp65 and rpoB genes, a PCR-based assay
and the Accuprobe tests (Gene-Probe Inc.) for the identiﬁcation of
clinical M. gordonae isolates.
Methods: Thirty seven, of the 42 M. gordonae isolates studied,
were recovered from clinical specimens of different patients and
ﬁve strains obtained from the collection of the Greek National
Mycobacterium Reference Unit. A segment of the RNA polymerase
gene (rpoB) was ampliﬁed by PCR and the products (342 bp)
were digested with the restriction enzymes HindII, HaeIII, MvaI
and AccII. A segment of the heat shock protein gene (hsp65) was
ampliﬁed by PCR and the products (440 bp) were digested with
the restriction enzymes HaeIII and BstEII. The digested products
were electrophoresed and the results were analysed using the
PCR-RFLP algorithms. PCR-assays were performed using a pair
of M. gordonae-speciﬁc primers that ampliﬁed a fragment of
152 bp of the internal transcribed spacer region. The results of
identiﬁcation were compared with those obtained by conventional
biochemical and AccuProbe tests.
Results: All the 42 M. gordonae isolates included in this study
have been correctly identiﬁed by the four molecular methods
tested. The PCR-RFLP analysis of rpoB gene generated the typ-
ical pattern of type A, B and D for 12, and 12 isolates respect-
ively. However, the PCR-RFLP analysis hsp65 gene generated
the typical pattern of type I, II, III, IV for 27, and iso-
lates,respectively. After the combination of patterns 25 isolates
had patterns of type A and I, three isolates had patterns of type
A and II, three isolates had patterns of type B and II, three iso-
lates had patterns of type D and III and nine isolates had pat-
terns of type D and IV.
Conclusions: The PCR-based assay method is faster than the con-
ventional methods, technically more simple than PCR-RFLP ana-
lysis, less expensive than Accuprobe tests. However, the use of
PCR-RFLP analysis methods we discover heterogeneity between
the isolates of our collection indicating that the combined use of
these molecular markers would be useful for typing of M. gordo-
nae isolates. Therefore, we recommend the use of the PCR based
assay or Accuprobe tests for the rapid identiﬁcation and the com-
bined use of PCR-RFLP analysis methods for typing of M. gordo-
nae isolates and for identiﬁcation of other clinical mycobacterial
isolates.
P717 Evaluation of the BD ProbeTecTM ET Mycoplasma
pneumoniae ampliﬁed DNA assay
S.S. Nielsen, S.A. Uldum, B. Dohn, J.S. Jensen
Copenhagen, DK
Objectives: New assays for diagnosing atypical pneumonia caused
by Chlamydiaceae family, Legionella pneumophila and Mycoplasma
pneumoniae from throat swabs and lower respiratory samples are
currently under evaluation on the BD ProbeTecTM ET system.
These assays are based on real-time homogenous strand displace-
ment ampliﬁcation (SDA) and detection technology. It has been
reported that molecular methods have increased sensitivity and
shorter time to results vs. culture. For this study, we took part in
the evaluation of BD ProbeTec ET Mycoplasma pneumoniae (MP)
Assay with previously collected throat swabs expressed in 2SP
medium and stored frozen.
Methods: Specimens (78) were included in this study – 15 speci-
mens were negative by PCR and 63 specimens were previously
conﬁrmed positive for Mycoplasma pneumoniae by our in-house
PCR method. Nineteen of the PCR-positive specimens were cul-
ture positive for Mycoplasma pneumoniae. Sensitivity of the MP
assay was calculated against the gold standard (culture) and
against our in-house PCR method. For samples with discrepant
results, the PCR assay was repeated from the original 2SP media
if available and also from the BD ProbeTec ET processed sam-
ples.
Results: Gold standard (culture): Of 19 culture-positive speci-
mens, 16 were MP Assay positive (sensitivity 84.2%). The three
culture-positive MP Assay negative specimens could not be tested
by PCR on the original 2SP media due to insufﬁcient volume, but
were tested from the BD ProbeTec ET processed sample. Only
one of the three specimens was positive by PCR.
PCR: Of 63 PCR-positive specimens, 52 were MP Assay positive
(sensitivity 82.5%) and 11 were negative. Three of these 11 speci-
mens were culture positive, but could not be tested by PCR as
mentioned previously. Eight of the 11 PCR-positive MP Assay
negative specimens were tested by PCR on the original 2SP media
and six were found to be positive. When PCR was performed on
the BD ProbeTec ET processed sample, only four of the 11 speci-
mens with PCR positive, MP Assay negative results were positive.
All 15 PCR-negative specimens were also negative by the MP
Assay (speciﬁcity 100 %).
Conclusion: The BD ProbeTec ET MP Assay is a sensitive and spe-
ciﬁc assay for the rapid identiﬁcation of M. pneumoniae in throat
swabs expressed in 2SP media. The MP assay may be useful in
situations where culture is time consuming and difﬁcult to per-
form.
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P718 Quantiﬁcation of Salmonella by 5’-nuclease
polymerase chain reaction targeted to ﬁmC gene
E. Kaclı´kova´, D. Pangallo, T. Kuchta
Bratislava, SK
Objectives: A new 5’ nuclease PCR system for the quantiﬁcation
of Salmonella spp. using the primers and the probe oriented to Sal-
monella-speciﬁc region of the ﬁmC gene was developed.
Methods: The sequence of the ﬁmC gene was carefully checked
and Salmonella-speciﬁc region was identiﬁed, and primers and a
5’-nuclease probe oriented to it were designed with a theoretical
melting temperature of 60C. To determine the exclusivity of the
primers, 45 non-Salmonella strains were tested by conventional
PCR. To determine the inclusivity of the PCR system consisting of
the primers and the probe, 48 Salmonella clinical and food isolates
of 34 various serotypes were tested by real-time PCR. For quanti-
ﬁcation purposes, calibration lines were constructed for three Sal-
monella strains pure cultures and with other bacteria background,
respectively.
Results: The PCR system is speciﬁc and sensitive with 100% in-
clusivity and 100% exclusivity. Calibration lines constructed for
three Salmonella strains were very similar to each other and facili-
tated quantiﬁcation in the range from 103–109 CFU/mL. Escheri-
chia coli (106) and Citrobacter freundii (106) background had no
effect on Salmonella quantiﬁcation by the system.
Conclusion: Presented highly speciﬁc real-time PCR system repre-
sents a good tool for quantiﬁcation of Salmonella sp. in clinical,
food and environmental materials.
P719 Experiences with Chlamydia testing using the BD
ProbeTecET and BD Viper focusing on inhibition in urine
samples
G. Lisby, H. Westh
Hvidovre, DK
Objectives: On June 1, 2003 our laboratory changed the Chlamydia
trachomatis (CT) testing platform from PCR/EIA to real-time
strand displacement ampliﬁcation (SDA) using the BD Viper sam-
ple preparation robot and two BD ProbeTecETs. The lab performs
70 000 CT analysis per year. The wet swab for cervix and urethra,
and urine testing for men was introduced. We evaluated the inhi-
bition rate in different specimen types and analysed the effect of
washing urine samples prior to testing.
Methods: We evaluated the ﬁrst 6 months of using SDA (33 000
samples). Information was obtained from our LIS. A patient was
only included once and a positive test result had priority over
negative results. We calculated changes in gender sampling,
sampling site, age-speciﬁc positive sample rate and age-speciﬁc
percentage of women tested in Copenhagen. After washing 91
negative urine samples and 90 positive urine samples were retest-
ed without the washing step.
Results: The average positive sample rate increased from 4.4
(EIA) to 6.4% (SDA). The age-speciﬁc positive rate for women
increased for all ages over 18 years. The positive rate from
female urine n ¼ 130 was 5.4% and from male urine, n ¼ 2220,
15%. CT samples from men were increased by 53% and posit-
ive rate from 12.5–13.7%. Inhibition was seen in 0.7% from cer-
vix, 0.16% from female urethra, 0% from female urine, 0.24%
from male urethra and 0.14% from male urine.Reportable
results were obtained from 80/91 (88%) unwashed urines that
were negative after washing. 11/91 had inhibition (12%) and
one of 80 was borderline positive. Reportable results were
obtained from 88/90 (97.8%) unwashed urines that were posit-
ive after washing. Two of 90 had inhibition (2.2%) and three of
88 were negative.
Conclusion: The positive sample rate was increased by 45% in
women and 9.6% in men with male sampling increasing by
53%. Inhibition was only seen in 0.46% of samples, primarily
from cervical samples. Washing of urine samples removes virtu-
ally all inhibition. Inhibition rate for unwashed urines was signi-
ﬁcantly higher in negative urines than positive urines P ¼ 0.02.
Omitting the washing step (with a CT prevalence of 15%) will
reduce the time spent on washing by about 66%. This will delay
laboratory answers on the inhibited samples by one day due to
washing and re-analysis of approximately 10% of the urine
samples.
P720 Development of a PCR test-system to detect the DNA
of Bacillus anthracis (pXO1 and pXO2) by using a hybridisation
method for considering ampliﬁcation results
O.V. Shevchenko, Y.N. Ilyina, Y.A. Plotnikova, A.N. Kulichenko,
V.M. Govorun, V.V. Kutyrev
Saratov, Moscow, RUS
Anthrax is the dangerous zooanthroponotic infection. Sporadic
and group cases and infection outbreaks are recorded every year.
Given such an unstable epidemiological situation, there is need for
constant control over this infection. The effectiveness of such con-
trol is largely dependent on the availability of highly speciﬁc and
sensitive diagnostic systems. PCR is currently a widely used
method of a rapid diagnosis. There is a possibility of nonspeciﬁc
DNA fragments, similar in size to the one sought far, forming dur-
ing ampliﬁcation. Separating such fragments electrophoretically is
very difﬁcult. Our aim was to develop novel PCR test-systems to
detect B. anthracis DNA in two plasmid replicons (pXO1 and
pXO2), on the basis of hybridisation principle of considering
ampliﬁcation results.A total of 29 B. anthracis strains and 20 strains
of nine closely related species, two Y. pestis strains and two F. tula-
rensis strains were used. Bacillus DNA was extracted by boiling
18-h agar cultures.The structural genes pagA (pXO1) and capB
(pXO2), ensuring the synthesis of the toxin and the capsule, were
chosen as DNA targets in developing the test system. Were selec-
ted following primers:PA1 – 5¢-CCCACCAATATCAAAGAACG-
3¢PA2 – 5¢-ATCACCAGAGGCAAGACACC-3¢CA1 – 5¢-AGA-
ACGCAGGCTTAGATTGG-3¢CA2 – 5¢-TGGGATTGATGAGG-
AAACAG-3¢A 214-bp fragment of the pagA gene is ampliﬁed with
the primers PA1–PA2. The primers CA1–CA2 ensure the synthesis
of a 104-bp region within the capB gene.For hybridisation, we
chose two speciﬁc probes. The P probe is complementary to the
pagA gene, and the C probe is speciﬁc towards the capB gene.P –
50-GCACTTCTGCATTTCCATGTACTTCA-3¢C – 5¢-ACGTGTAA-
TTCTCATTGCTCCTGGA-3¢The study included several stages:
ampliﬁcation of a speciﬁc DNA-target with biotinylated primers,
immobilisation of the PCR product on a streptavidin-coated micro-
plate, hybridisation of ﬂuorescently labelled probes with the com-
plementary inner regions of the amplicons formed, and signal
detection with the ﬂuorimeter.The test-systems developed for the
detection of plasmids pXO1 and pXO2 were tested using a variety
of strains of B. anthracis and heterologous species. The B. anthracis
strains used were natural isolates from various areas in Russia
and the former Soviet Union during anthrax outbreaks. Not a
single false-positive or false-negative result was obtained during
out study. The analytical sensitivity of the test system was
10 CFU/mL.
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P721 Early diagnosis of leptospirosis by polymerase chain
reaction (PCR)
S. Mitka, D. Karabaxoglou, H. Chaidouli, D. Arvanitis,
S. Sotiriadis, P. Mamasi, A. Kansouzidou
Thessaloniki, GR
Leptospirosis is a worldwide zoonosis that affects wild and
domestic animals and humans. The disease is characterised by
various clinical manifestations, ranging from asymptomatic dis-
ease to fatal icterohaemorrhagic forms, while the diagnosis is
mainly based on the detection of serum-speciﬁc antibodies (sero-
logical methods).The aim of the study was the contribution of
PCR ampliﬁcation in early diagnosis of leptospirosis and its eval-
uation in parallel to the results of the serological tests.
Material and methods: In this study, 58 patients (78 whole blood
and sera samples) with probable leptospirosis were examined
over a 4-year period, 2000–2003. Another group of ﬁve patients
(ﬁve whole blood and sera samples) with fever of other aetiology
(rickettsiosis, syphilis, borreliosis, brucellosis, tuberculosis) was
assessed in order to evaluate the speciﬁcity of PCR. 20 healthy
persons (20 whole blood and sera samples) were included in the
study, as a control group. PCR methods were performed in all
samples using two pairs of primers that amplify the rrs (16S) gene
and insertion sequence of IS1533 region in Leptospira interrogans
genome. An enzyme-linked immunosorbent assay (ELISA) was
used for the detection of speciﬁc antibodies against Leptospira spp.
(IgM, IgG). Only PCR techniques were performed in samples of
control group.
Results: The two PCR methods produced positive results in 25 of
58 patients (rate 43%) while serological tests gave positive results
in 22 patients of 58 (rate 38%). The remaining 33 patients were all
negative by PCR and only two patients demonstrated low serolog-
ical reactivity (cross-reaction). All patients of other infections and
the control subjects were found negative by PCR and ELISA. Both
PCR methods revealed identical results in all groups.
Conclusions: The diagnosis of leptospirosis is often based on sero-
logical tests, but the speciﬁc antibodies against Leptospira spp. are
detected 8–10 days after the onset of the disease, while cross-reac-
tions may be present. PCR is a highly sensitive and speciﬁc
method that contributes to the early diagnosis of the disease. The
combination of PCR and serological tests can substantiate the
deﬁnitive diagnosis of leptospirosis.
P722 Rapid detection and identiﬁcation of Aspergillus spp.
and Candida spp. by real-time PCR
M. Torres, J. Aznar, E. Martı´n, M. Ruiz, M. Ramirez,
J.C. Palomares
Seville, E
Objectives: To develop and evaluate a real-time PCR assay, based
in the Light Cycler technology, amplifying a highly conserved
sequence of the multicopy 18S rRNA gene and using speciﬁc
probes for genus-level identiﬁcation of Aspergillus spp and Candida
spp.
Methods: Aspergillus and Candida strains obtained from the Span-
ish Collection of Type Cultures (CECT) including: A. ﬂavus,
A. fumigatus, A. nidulans, A. niger, A. terreus and C. albicans, C. dub-
linensis, C. glabrata, C. guilliermondii, C. krusei, C. lusitaniae, C. para-
psilosis, C. tropicalis and C. sake, were used. Speciﬁcity of the assay
was assessed by using DNA extracted from a collection of patho-
genic and nonpathogenic bacteria and fungi. The analytical sensi-
tivity of the process was evaluated with of different inocula (101–
105 CFU/mL), and serially diluted DNA of A. fumigatus and
C. albicans.
Results: Reactions using genomic DNA from other species resul-
ted in negative results, indicating that speciﬁcity of that assay was
a 100%. Analytical sensitivity was 60 fg using DNA and 15 coni-
dia using conidial suspensions for Aspergillus fumigatus; while for
Candida albicans were 100 fg and three cells. The linear range of
the assay was from 6 to 6  107 fg for Aspergillus DNA and from
10 to 107 fg for Candida DNA. Species identiﬁcation was deter-
mined by analysing the melting curves obtained with the speciﬁc
probes, the Tm ranged from 67.34C to 70.7C for Aspergillus spp.
and from 51.3C to 64.5C for Candida spp.
Conclusions: We therefore developed a rapid, quantitative, sensi-
tive, and speciﬁc real-time PCR assay to detect Aspergillus and
Candida species. The PCR assay designed and tested as described
here provides a high sensitivity and speciﬁcity for the detection of
fungal DNA and rapidly identiﬁes most of clinically relevant
Candida and Aspergillus species.
P723 Molecular genetic identity of blood and oral isolates
of viridans streptococci
J. Dusˇkova´, Z. Broukal, T. Janatova´, G. Novotna´, J. Janata
Prague, CZ
Prevention of haematogenic dissemination of oral bacteria belongs
to the signiﬁcant issues of current emergency care of health-com-
promised individuals. The aim of study to ascertain the molecular
genetic relationships of oral and blood culture isolates of viridans
streptococci (S. salivarius, S. mitis, S. mutans and S. sanguis
groups).
Methods: An attempt was made to test the similarities of the rela-
tionships in a group of 30 patients with positive haemocultures
harbouring these organisms. Isolates were preliminarily identiﬁed
by means of colonial morphology and biochemical properties and
then genotyped by means of the PCR (spacer 16S and 23S rDNA)
and AP-PCR.
Results: Strain identity of blood and oral isolates has been proved
in S. salivarius in two of four cases, in S. mitis in eight of 10 cases,
in S. mutans in two of two cases and in S. sanguis in 15 of 16
cases. Clonal identity of blood and oral isolates has been proved
in 50% of isolates. Oral microbial ﬂora is thus the signiﬁcant
source of viridans streptococci in positive haemocultures.
Discussion: Based on these ﬁndings it should be recommended,
when managing oral health care of a patient at risk, to eradicate
not only the oral infectious foci but also to introduce the oral
home-care regime reducing substantially plaque and mucosal oral
ﬂora.
Supported by the grant Min. of Health, Czech Republic No.
0002377901.
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